<SEC-DOCUMENT>0001129928-14-000038.txt : 20140725
<SEC-HEADER>0001129928-14-000038.hdr.sgml : 20140725
<ACCEPTANCE-DATETIME>20140725115720
ACCESSION NUMBER:		0001129928-14-000038
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20131231
FILED AS OF DATE:		20140725
DATE AS OF CHANGE:		20140725

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ONCOLYTICS BIOTECH INC
		CENTRAL INDEX KEY:			0001129928
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-31062
		FILM NUMBER:		14993370

	BUSINESS ADDRESS:	
		STREET 1:		1167 KENSINGTON CRES NW SUITE 210
		STREET 2:		CALGARY ALBERTA CANADA T2N 1X7
		CITY:			ALBERTA CANADA
		STATE:			A0
		ZIP:			00000
		BUSINESS PHONE:		4036707380

	MAIL ADDRESS:	
		STREET 1:		210 - 1167 KENSINGTON CRES NW
		CITY:			CALGARY
		STATE:			A0
		ZIP:			T2N 1X7
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>a6kinfocircular2014.htm
<DESCRIPTION>6-K
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2014 Workiva -->
		<title>6K Info Circular 2014</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<a name="s62ac2c59d939434ca5fc04f97d93fe56"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Washington, D.C. 20549</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;  </font></div><div style="line-height:120%;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">Form 6-K</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Report of Foreign Private Issuer</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Pursuant to Rule&#160;13a-16 or 15d-16</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">of the Securities Exchange Act of 1934</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the month of&#160;July 2014</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Commission File Number 000-31062</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Oncolytics Biotech Inc.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(Translation of registrant&#8217;s name into English)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Suite&#160;210, 1167 Kensington Crescent NW</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Calgary, Alberta, Canada T2N 1X7</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(Address of principal executive offices)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Indicate by check mark whether the registrant files or will file annual reports under cover Form&#160;20-F or Form&#160;40-F.</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td width="40%"></td><td width="20%"></td><td width="40%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Form&#160;20-F&#160;&#160;&#160;</font><font style="font-family:Wingdings;font-size:10pt;">&#254;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Form&#160;40-F&#160;&#160;&#160;</font><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Indicate by check mark if the registrant is submitting the Form&#160;6-K in paper as permitted by Regulation&#160;S-T Rule&#160;101(b)(1):&#160;&#160;&#160;</font><font style="font-family:Wingdings;font-size:10pt;">o</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Note:</font><font style="font-family:inherit;font-size:10pt;">&#32;Regulation&#160;S-T Rule&#160;101(b)(1) only permits the submission in paper of a Form&#160;6-K if submitted solely to provide an attached annual report to security holders.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Indicate by check mark if the registrant is submitting the Form&#160;6-K in paper as permitted by Regulation&#160;S-T Rule&#160;101(b)(7):&#160;&#160;&#160;</font><font style="font-family:Wingdings;font-size:10pt;">o</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Note:</font><font style="font-family:inherit;font-size:10pt;">&#32;Regulation&#160;S-T Rule&#160;101(b)(7) only permits the submission in paper of a Form&#160;6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant&#8217;s &#8220;home country&#8221;), or under the rules of the home country exchange on which the registrant&#8217;s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant&#8217;s security holders, and, if discussing a material event, has already been the subject of a Form&#160;6-K submission or other Commission filing on EDGAR.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule&#160;12g3-2(b) under the Securities Exchange Act of 1934.</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td width="40%"></td><td width="20%"></td><td width="40%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Yes&#160;&#160;&#160;</font><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">No&#160;&#160;&#160;</font><font style="font-family:Wingdings;font-size:10pt;">&#254;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If &#8220;Yes&#8221; is marked, indicate below the file number assigned to the registrant in connection with Rule&#160;12g3-2(b):&#160;&#160;&#160;82&#160;-&#160;</font><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><a name="s3b93493a9e864c739eaf658698530dd6"></a><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td width="17%"></td><td width="1%"></td><td width="82%"></td></tr><tr><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">EXHIBIT</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NUMBER</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DESCRIPTION</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">99.1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Oncolytics Biotech</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">&#160;Inc. 2014 Information Circular dated May 9, 2014 </font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SIGNATURES</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td width="52%"></td><td width="3%"></td><td width="4%"></td><td width="3%"></td><td width="38%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Oncolytics Biotech Inc.</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Registrant)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date:&#160;&#160;July 25, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/&#160;&#160;Kirk Look</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Kirk Look</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Chief Financial Officer</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex9912014informationcircul.htm
<DESCRIPTION>INFORMATION CIRCULAR
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2014 Workiva -->
		<title>EX 99.1 2014 Information Circular</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<a name="s905b5c575ff94c1e834aae6b0068b1aa"></a><div></div><br><div style="line-height:120%;text-align:justify;"><img src="oncylogo.jpg" style="height:160px;width:682px;"></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;"><hr></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">NOTICE OF ANNUAL MEETING</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">OF SHAREHOLDERS TO BE HELD ON </font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">JUNE&#160;18, 2014</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">- AND -</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">INFORMATION CIRCULAR</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">May&#160;9, 2014</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div></div><hr style="page-break-after:always"><a name="sdbc27907b0ed40da9e6120816d2bf6e9"></a><div></div><br><div style="line-height:120%;padding-bottom:8px;text-align:left;padding-left:48px;text-indent:-48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:8px;text-align:left;padding-left:48px;text-indent:-48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:8px;text-align:center;padding-left:48px;text-indent:-48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Table of Contents</font></div><div style="line-height:120%;padding-bottom:8px;text-align:center;padding-left:48px;text-indent:-48px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:74.21875%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="85%"></td><td width="15%"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Page</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:8px;padding-left:48px;text-indent:-48px;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;" href="#s09e9701617a04536860ddbaf3e2c8ed2"><font style="font-family:Arial;font-size:10pt;">Notice of Meeting</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;" href="#s09e9701617a04536860ddbaf3e2c8ed2">i</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:8px;padding-left:48px;text-indent:-48px;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;" href="#s50e246a11cef479095e3611ba2037e83"><font style="font-family:Arial;font-size:10pt;">Solicitation of Proxies</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;" href="#s50e246a11cef479095e3611ba2037e83">1</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:8px;padding-left:48px;text-indent:-48px;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;" href="#s514218fad7cc4ec39b44700ab851d91d"><font style="font-family:Arial;font-size:10pt;">Voting Shares and Principal Holders of Common Shares</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;" href="#s514218fad7cc4ec39b44700ab851d91d">2</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:8px;padding-left:48px;text-indent:-48px;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;" href="#s1087dd8f3bf942a5ab0696e4e9f3f12d"><font style="font-family:Arial;font-size:10pt;">Compensation Discussion and Analysis</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;" href="#s1087dd8f3bf942a5ab0696e4e9f3f12d">3</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:8px;padding-left:48px;text-indent:-48px;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;" href="#sd8c10d1ee8874e15a4513f90efcbc9ca"><font style="font-family:Arial;font-size:10pt;">Summary Compensation Table</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;" href="#sd8c10d1ee8874e15a4513f90efcbc9ca">6</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:8px;padding-left:48px;text-indent:-48px;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;" href="#sdc678578f68346088a963e973a2f8f7f"><font style="font-family:Arial;font-size:10pt;">Incentive Plan Awards</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;" href="#sdc678578f68346088a963e973a2f8f7f">7</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:8px;padding-left:48px;text-indent:-48px;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;" href="#s97962ed529d241a5ba40d30b911de846"><font style="font-family:Arial;font-size:10pt;">Pension Plan Benefits</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;" href="#s97962ed529d241a5ba40d30b911de846">8</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:8px;padding-left:48px;text-indent:-48px;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;" href="#sd079d4d270de450da8765c87e593ac60"><font style="font-family:Arial;font-size:10pt;">Termination and Change of Control Benefits</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;" href="#sd079d4d270de450da8765c87e593ac60">9</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:8px;padding-left:48px;text-indent:-48px;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;" href="#s06698524608f4886863675db596b0846"><font style="font-family:Arial;font-size:10pt;">Director Compensation</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;" href="#s06698524608f4886863675db596b0846">9</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:8px;padding-left:48px;text-indent:-48px;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;" href="#s0dbe72f36fef49da9aacaf43d4c69bd1"><font style="font-family:Arial;font-size:10pt;">Indebtedness of Directors and Senior Officers</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;" href="#s0dbe72f36fef49da9aacaf43d4c69bd1">12</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:8px;padding-left:48px;text-indent:-48px;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;" href="#sef5cc086045741b4ac28fa24a7b48b0d"><font style="font-family:Arial;font-size:10pt;">Interest of Insiders in Material Transactions</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;" href="#sef5cc086045741b4ac28fa24a7b48b0d">12</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:8px;padding-left:48px;text-indent:-48px;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;" href="#s64e9d5a413aa4b6c94bfc069b38981f0"><font style="font-family:Arial;font-size:10pt;">Equity Compensation Plan Information</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;" href="#s64e9d5a413aa4b6c94bfc069b38981f0">12</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:8px;padding-left:48px;text-indent:-48px;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;" href="#se53b3ea52234485aabb3bcde07dff693"><font style="font-family:Arial;font-size:10pt;">Statement of Corporate Governance Practices</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;" href="#se53b3ea52234485aabb3bcde07dff693">14</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:8px;padding-left:48px;text-indent:-48px;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;" href="#se65456db1746427994dc7c8e89ee857c"><font style="font-family:Arial;font-size:10pt;">Matters to be Acted Upon at the Meeting</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;" href="#se65456db1746427994dc7c8e89ee857c">17</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:8px;padding-left:48px;text-indent:-48px;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;" href="#s632da167f8014c4dbd0507c704cc3de8"><font style="font-family:Arial;font-size:10pt;">Effective Date &amp; Additional Information</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;" href="#s632da167f8014c4dbd0507c704cc3de8">21</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;" href="#sc04205f4d09143869b1154c47a057419"><font style="font-family:Arial;font-size:10pt;">Schedule A - Board and Committee Meetings Attended</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#160;</font><a style="font-family:Arial;font-size:10pt;" href="#sc04205f4d09143869b1154c47a057419">A -  1</a></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:8px;text-align:justify;font-size:10pt;"><a style="font-family:Arial;font-size:10pt;" href="#s6f19729de1054b359f0500e5cc41bf16"><font style="font-family:Arial;font-size:10pt;">Schedule B - Mandate of the Board of Directors</font></a></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#160;</font><a style="font-family:Arial;font-size:10pt;" href="#s6f19729de1054b359f0500e5cc41bf16">B -  1</a></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div></div><hr style="page-break-after:always"><a name="s09e9701617a04536860ddbaf3e2c8ed2"></a><div></div><br><div style="line-height:120%;padding-bottom:16px;text-align:center;"><img src="oncylogo.jpg" style="height:60px;width:256px;"></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">NOTICE OF ANNUAL MEETING OF SHAREHOLDERS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">June&#160;18, 2014</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">TO THE SHAREHOLDERS OF ONCOLYTICS BIOTECH</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">&#32;INC.:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">NOTICE IS HEREBY GIVEN that the annual meeting (the "</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Meeting</font><font style="font-family:Arial;font-size:10pt;">") of shareholders of Oncolytics Biotech Inc. (the "</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Corporation</font><font style="font-family:Arial;font-size:10pt;">") will be held at the TMX Broadcast Centre, 130 King Street West, Toronto Ontario, M5X 1J2 on </font><font style="font-family:Arial;font-size:10pt;">June&#160;18, 2014</font><font style="font-family:Arial;font-size:10pt;">&#32;at </font><font style="font-family:Arial;font-size:10pt;">4:30 PM ET</font><font style="font-family:Arial;font-size:10pt;">. The purpose of the meeting is to consider, and to take action with respect to, the following matters:</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial;font-size:10pt;">1.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">the receipt of the audited financial statements of the Corporation for the year ended </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2013</font><font style="font-family:Arial;font-size:10pt;">, together with the auditors' report thereon;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial;font-size:10pt;">2.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">the fixing of the number of directors of the Corporation for the ensuing year at </font><font style="font-family:Arial;font-size:10pt;">ten</font><font style="font-family:Arial;font-size:10pt;">&#32;(</font><font style="font-family:Arial;font-size:10pt;">10</font><font style="font-family:Arial;font-size:10pt;">);</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">&#32;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial;font-size:10pt;">3.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">the election of directors of the Corporation for the ensuing year;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial;font-size:10pt;">4.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">the appointment of auditors for the Corporation for the ensuing year and the authorization of the directors to fix their remuneration; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial;font-size:10pt;">5.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">the transaction of such other business as may properly be brought before the Meeting or any adjournment or adjournments thereof.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Shareholders are referred to the accompanying Information Circular dated </font><font style="font-family:Arial;font-size:10pt;">May&#160;9, 2014</font><font style="font-family:Arial;font-size:10pt;">&#32;(the "</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Information Circular</font><font style="font-family:Arial;font-size:10pt;">") for more detailed information with respect to the matters to be considered at the Meeting.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">A shareholder may attend the Meeting in person or may be represented at the Meeting by proxy. Shareholders who are unable to attend the Meeting in person are requested to date, sign and return the accompanying Instrument of Proxy, or other appropriate form of proxy, in accordance with the instructions set forth in the Information Circular.  </font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">An Instrument of Proxy will not be valid unless it is deposited at the offices of Computershare Trust Company of Canada, Proxy Department, 100 University Avenue, 8th Floor, Toronto, Ontario M5J 2Y1</font><font style="font-family:Arial;font-size:10pt;">. Proxies may also be faxed. Faxes may be forwarded to 1-866-249-7775 for calls within Canada and the U.S. or to 416-263-9524 for calls outside Canada and the U.S. To be accepted, the proxy must be received </font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">by 4:30 PM ET on </font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">June&#160;16, 2014</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">&#32;which is two days (excluding Saturdays, Sundays and holidays) before the Meeting, or if the Meeting is adjourned, by 4:30 p.m. ET on the day which is two days (excluding Saturdays, Sundays and holidays) before the date of the Meeting. A person appointed as proxyholder need not be a shareholder of the Corporation.</font><font style="font-family:Arial;font-size:10pt;">&#32;Only persons registered as holders of common shares on the records of the Corporation as of the close of business on </font><font style="font-family:Arial;font-size:10pt;">May&#160;9, 2014</font><font style="font-family:Arial;font-size:10pt;">&#32;are entitled to receive notice of the Meeting.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">DATED as of the </font><font style="font-family:Arial;font-size:10pt;">9th</font><font style="font-family:Arial;font-size:10pt;">&#32;day of </font><font style="font-family:Arial;font-size:10pt;">May</font><font style="font-family:Arial;font-size:10pt;">, </font><font style="font-family:Arial;font-size:10pt;">2014</font><font style="font-family:Arial;font-size:10pt;">.  </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:288px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">BY ORDER OF THE BOARD OF DIRECTORS</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;padding-left:288px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(signed) </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Dr. Bradley G. Thompson</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;padding-left:288px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">President and Chief Executive Officer</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">i</font></div></div><hr style="page-break-after:always"><a name="seb5f9ccbc7604388be962581f7ead92a"></a><div></div><br><div style="line-height:120%;padding-bottom:16px;text-align:center;"><img src="oncylogo.jpg" style="height:160px;width:682px;"></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Annual Meeting of Shareholders</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">to be held on </font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">June&#160;18, 2014</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">INFORMATION CIRCULAR</font></div><a name="s50e246a11cef479095e3611ba2037e83"></a><div style="line-height:120%;text-align:center;padding-left:48px;text-indent:-24px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Solicitation of Proxies</font></div><div style="line-height:120%;text-align:center;padding-left:48px;text-indent:-24px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">This Information Circular (the "Information Circular") is furnished in connection with the solicitation of proxies by the management of Oncolytics Biotech Inc. ("Oncolytics" or the "Corporation") to be used at the annual meeting (the "Meeting") of the holders (the "Shareholders") of common shares ("Common Shares") of the Corporation, which is to be held at  the TMX Broadcast Centre, 130 King Street West, Toronto Ontario, M5X 1J2</font><font style="font-family:Arial;font-size:10pt;">&#32;</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">on </font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">June&#160;18, 2014</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">&#32;at </font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">4:30 PM ET</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">, and at any adjournment thereof, for the purposes set forth in the accompanying Notice of Meeting and in this Information Circular.</font><font style="font-family:Arial;font-size:10pt;">&#32;Solicitation of proxies will be primarily by mail, but may also be undertaken by way of telephone, facsimile or oral communication by the directors, officers and regular employees of the Corporation, at no additional compensation. Costs incurred in the preparation and mailing of this Information Circular and related materials and the costs associated with the solicitation of proxies will be borne by the Corporation.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Appointment of Proxyholders and Revocation of Proxies</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Bradley G. Thompson and Kirk Look (the management designees named in the accompanying Instrument of Proxy) are both officers of the Corporation. </font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Each Shareholder has the right to appoint a person (who does not need to be a Shareholder) other than Bradley G. Thompson or Kirk Look, to attend and to act for the Shareholder and on behalf of the Shareholder at the Meeting. To exercise this right, the names of the nominees of management should be crossed out on the accompanying Instrument of Proxy and the Shareholder should insert the name of the Shareholder's appointee in the blank space provided on the Instrument of Proxy or complete another appropriate form of proxy.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">A form of proxy will not be valid unless it is deposited at the offices of Computershare Trust Company of Canada, Proxy Department, 100 University Avenue, 8th Floor, Toronto, Ontario, M5J 2Y1. Proxies may also be faxed. Faxes may be forwarded to 1-866-249-7775 for calls within Canada and the U.S. or to 416-263-9524 for calls outside Canada and the U.S. To be accepted, the proxy must be received by 4:30 p.m. ET on </font><font style="font-family:Arial;font-size:10pt;">June&#160;16, 2014</font><font style="font-family:Arial;font-size:10pt;">&#32;which is two days (excluding Saturdays, Sundays and holidays) before the Meeting, or if the Meeting is adjourned, by 4:30 p.m. ET on the day which is two days (excluding Saturdays, Sundays and holidays) before the date of the Meeting.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">A Shareholder who has submitted a form of proxy may revoke it at any time prior to the exercise thereof. A form of proxy may be revoked by the Shareholder personally attending at the Meeting and voting his or her shares. In addition to revocation in any other manner permitted by law, a proxy may be revoked by an instrument in writing executed by the Shareholder or by his or her duly authorized attorney in writing or, if the Shareholder is a corporation, under its corporate seal or executed by a duly authorized officer or attorney of the corporation and deposited either at the registered office of the Corporation, being Norton Rose Fulbright Canada LLP, 3700, 400 - 3rd Avenue S.W., Calgary, Alberta, T2P&#160;4H2, Attn: Michael Bennett, at any time up to and including the last business day preceding the day of the Meeting, or any adjournment thereof, at which the form of proxy is to be used, or with the Chairman of the Meeting on the day of the Meeting or any adjournment thereof.</font></div><br><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></div><hr style="page-break-after:always"><div></div><br><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Signing of Proxy</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Instrument of Proxy must be signed by the Shareholder or the Shareholder's duly appointed attorney authorized in writing or, if the Shareholder is a corporation, by a duly authorized officer or attorney. An Instrument of Proxy signed by a person acting as attorney or in some other representative capacity (including a representative of a corporate Shareholder) should indicate that person's capacity (following his or her signature) and should be accompanied by the appropriate instrument evidencing qualification and authority to act (unless such instrument has previously been filed with the Corporation).</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Voting of Proxies and Exercise of Discretion by Proxyholders</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">All Common Shares represented at the Meeting by properly executed proxies will be voted on any ballot that may be called for and, where a choice with respect to any matter to be acted upon has been specified in the Instrument of Proxy, the Common Shares represented by the proxy will be voted in accordance with such instructions. The management designees named in the accompanying Instrument of Proxy will vote or withhold from voting the Common Shares in respect of which they are appointed in accordance with the direction of the Shareholder appointing them on any ballot that may be called for at the Meeting. </font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">In the absence of such direction, the Common Shares will be voted FOR: (i) the fixing of the number of directors at </font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">ten</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">&#32;(</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">10</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">) for the ensuing year; (ii) the election of directors set forth in this Information Circular; (iii) the reappointment of the Corporation's current auditors, at such remuneration as may be determined by the board of directors of the Corporation; and (iv) such other matters that may come before the Meeting, all as more particularly described in this Information Circular. The accompanying Instrument of Proxy also confers discretionary authority upon the persons named therein with respect to amendments of, or variations to, the matters identified in the Notice of Annual Meeting and with respect to other matters that may properly be brought before the Meeting. At the time of printing this Information Circular, the management of the Corporation knows of no such amendment, variation or other matter to come before the Meeting other than the matters referred to in the Notice of Annual Meeting.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><a name="s514218fad7cc4ec39b44700ab851d91d"></a><div style="line-height:120%;text-align:center;padding-left:48px;text-indent:-24px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Voting Shares and Principal Holders of Common Shares</font></div><div style="line-height:120%;text-align:center;padding-left:48px;text-indent:-24px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Voting of Common Shares - General</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The record date for the purpose of determining holders of Common Shares is </font><font style="font-family:Arial;font-size:10pt;">May&#160;9, 2014</font><font style="font-family:Arial;font-size:10pt;">. Shareholders of record on that date are entitled to receive notice of and attend the Meeting and vote at the Meeting on the basis of one vote for each Common Share held, except to the extent that: (i) a registered Shareholder has transferred the ownership of any Common Shares subsequent to </font><font style="font-family:Arial;font-size:10pt;">May&#160;9, 2014</font><font style="font-family:Arial;font-size:10pt;">; and (ii) the transferee of those Common Shares produces properly endorsed share certificates, or otherwise establishes that he or she owns the Common Shares and demands, not later than June 8, 2014, which is ten calendar days before the Meeting, that his or her name be included on the Shareholder list before the Meeting, in which case the transferee shall be entitled to vote his or her Common Shares at the Meeting. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Corporation is authorized to issue an unlimited number of Common Shares. As at </font><font style="font-family:Arial;font-size:10pt;">May&#160;9, 2014</font><font style="font-family:Arial;font-size:10pt;">, there are </font><font style="font-family:Arial;font-size:10pt;">86,523,190</font><font style="font-family:Arial;font-size:10pt;">&#32;Common Shares issued and outstanding. At the Meeting, upon a show of hands, every Shareholder present in person or represented by proxy and entitled to vote shall have one vote.  On a poll or ballot, every Shareholder present in person or by proxy has one vote for each Common Share of which such Shareholder is the registered holder.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">When any Common Share is held jointly by several persons, any one of them may vote at the Meeting in person or by proxy in respect of such Common Share, but if more than one of them are present at the Meeting in person or by proxy and such joint owners of the proxy so present disagree as to any vote to be cast, the joint owner present or represented whose name appears first in the register of Shareholders maintained by Computershare Trust Company of Canada is entitled to cast such vote.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Quorum for the Meeting</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">At the Meeting, a quorum shall consist of two persons present in person holding or representing by proxy not less than 5% of the votes attached to all outstanding Common Shares. If a quorum is not present at the Meeting within one half hour after the time fixed for the holding of the Meeting, it shall stand adjourned to such day being not less than 21 days later and to such place and time as may be determined by the Chairman of the Meeting. At such Meeting, the Shareholders present either in person or by proxy shall form a quorum.  </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Approval Requirements</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">All of the matters to be considered at the Meeting are ordinary resolutions requiring approval by more than 50% of the votes cast in respect of the resolution by or on behalf of Shareholders present in person or represented by proxy at the Meeting.</font></div><br><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></div><hr style="page-break-after:always"><div></div><br><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Advice to Beneficial Holders of Common Shares</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">The information set forth in this section is for Shareholders who do not hold their Common Shares in their own name.</font><font style="font-family:Arial;font-size:10pt;">&#32;Shareholders who do not hold their Common Shares in their own name (referred to in this Information Circular as "</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Beneficial Shareholders</font><font style="font-family:Arial;font-size:10pt;">") should note that only proxies deposited by Shareholders whose names appear on the records of the Corporation as the registered holders of Common Shares can be recognized and acted upon at the Meeting. If the Common Shares are listed in an account statement provided to a Shareholder by a broker, then in almost all cases those shares will not be registered in the Shareholder's name on the records of the Corporation. Such Common Shares will more likely be registered under the names of the Shareholder's broker or an agent of that broker. In Canada, the vast majority of such Common Shares are registered under the name of CDS &amp; Co. (the registration name for CDS Clearing and Depository Services Inc., which acts as nominee for many Canadian brokerage firms). Common Shares held by brokers or their agents or nominees can only be voted (for or against resolutions) upon the instructions of the Beneficial Shareholder. Without specific instructions, brokers and their agents and nominees are prohibited from voting shares for the broker's clients. The Corporation does not know for whose benefit the Common Shares registered in the name of CDS &amp; Co. are held. </font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Beneficial Shareholders cannot be recognized at the Meeting for the purposes of voting the Common Shares in person or by proxy except as set forth below. Therefore, Beneficial Shareholders should ensure that instructions respecting the voting of their Common Shares are communicated to the appropriate person.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Applicable regulatory policy requires intermediaries/brokers to seek voting instructions from Beneficial Shareholders in advance of Shareholders' meetings. Every intermediary/broker has its own mailing procedures and provides its own return instructions to clients, which should be carefully followed by Beneficial Shareholders in order to ensure that their Common Shares are voted at the Meeting. The purpose of the voting instruction form supplied to a Beneficial Shareholder by its broker (or the agent of the broker) is limited to instructing the registered Shareholder (the broker or agent of the broker) how to vote on behalf of the Beneficial Shareholder. The majority of brokers now delegate responsibility for obtaining instructions from clients to Broadridge Financial Solutions Inc. ("</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Broadridge</font><font style="font-family:Arial;font-size:10pt;">"). Broadridge typically mails a voting instruction form to the Beneficial Shareholders and asks Beneficial Shareholders to return the voting instruction forms to Broadridge, in the United States and Canada. Alternatively, Beneficial Shareholders can either call their toll-free telephone number to vote their Common Shares or access Broadridge's dedicated voting website at www.proxyvote.com to deliver their voting instructions. Broadridge then tabulates the results of all instructions received and provides appropriate instructions respecting the voting of Common Shares to be represented at the Meeting. </font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">A Beneficial Shareholder receiving a voting instruction form from Broadridge cannot use that voting instruction to vote shares directly at the Meeting, as the voting instruction form must be returned to Broadridge well in advance of the Meeting in order to have the Common Shares voted.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Although a Beneficial Shareholder may not be recognized directly at the Meeting for the purposes of voting Common Shares registered in the name of his or her broker (or agent of the broker), a Beneficial Shareholder may attend at the Meeting as proxyholder for the registered Shareholder and vote the Common Shares in that capacity. Beneficial Shareholders who wish to attend at the Meeting and indirectly vote their Common Shares as proxyholder for the registered Shareholder should enter their own names in the blank space on the Instrument of Proxy provided to them and return the same to their broker (or the broker's agent) in accordance with the instructions provided by such broker (or agent), well in advance of the Meeting.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Principal Holders of Common Shares</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">To the knowledge of the directors and executive officers of the Corporation, as at the date hereof, no persons or companies beneficially own, directly or indirectly, or exercise control or direction over, shares that carry more than 10% of the voting rights attached to the issued Common Shares.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><a name="s1087dd8f3bf942a5ab0696e4e9f3f12d"></a><div style="line-height:120%;text-align:center;padding-left:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Compensation Discussion and Analysis </font></div><div style="line-height:120%;text-align:center;padding-left:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Corporation has formed a compensation committee (the "</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Compensation Committee</font><font style="font-family:Arial;font-size:10pt;">") consisting of four outside directors: Mr. Dinning, Dr. Levy, Mr. Pisano and Mr. van Amersfoort, none of whom are nor have been employees or officers of the Corporation or any of its affiliates. Mr. Dinning is the Chair of the Compensation Committee. Mr. Schultz, lead director, serves as an ex officio member of the Compensation Committee.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The objectives of the Corporation's compensation arrangements are: (i) to attract and retain key personnel; (ii) to encourage commitment to the Corporation and its goals; (iii) to align executive interests with those of its shareholders; and (iv) to reward executives for performance in relation to overall corporate progress goals.</font></div><br><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></div><hr style="page-break-after:always"><div></div><br><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The key elements of the compensation program are the base salary, health benefits, payments allocated to employees to be directed by them to their personal retirement accounts, as well as bonuses and the granting of options, all based on corporate and personal performance. Performance goals are determined based on the strategic planning and budgeting process, which is conducted at least annually. The balance of performance during the year is assessed by the board of directors of Oncolytics (the "</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Board</font><font style="font-family:Arial;font-size:10pt;">" or "</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Board of Directors</font><font style="font-family:Arial;font-size:10pt;">") and is normally the key determinant for the allocation of bonuses and options. The elements of the compensation plan are intended to reward performance, and the various elements are intended to provide a blend of short-term and long-term incentives to align the interests of management and the Shareholders.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In arriving at its recommendations for compensation, the Compensation Committee considers the long-term interests of the Corporation as well as its current stage of development and the economic environment within which it operates, recognizing that the market for biotechnology companies in the development phase is extremely challenging. Based on these factors, the Compensation Committee recognized the need to strike a balance between compensation to retain employees and resources required to maintain operations.  In the past, the Compensation Committee has engaged Lane Caputo Compensation Inc., executive compensation specialists </font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">(the "Specialist&#8221;)</font><font style="font-family:Arial;font-size:10pt;">, to assist in benchmarking its compensation practices, and provide recommendations to the committee with respect to compensation for directors and officers.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">For </font><font style="font-family:Arial;font-size:10pt;">2013</font><font style="font-family:Arial;font-size:10pt;">, the following guidelines were employed by the Board in granting bonuses and stock option grants to the Corporation&#8217;s executive and senior officers. For </font><font style="font-family:Arial;font-size:10pt;">2014</font><font style="font-family:Arial;font-size:10pt;">, similar guidelines are expected to be applied.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Annual Bonus and Option Grants</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Chief Executive Officer ("CEO") was eligible for a cash bonus of up to 40% of his base salary, the Chief Operating Officer ("COO"), Chief Medical Officer ("CMO") and the Chief Financial Officer ("CFO") of the Corporation were each eligible for a cash bonus of up to 30% of their respective base salaries, and the other senior officers were eligible for a cash bonus of up to 20% of their respective base salaries. In addition, when available, the CEO of the Corporation is eligible for an option grant of up to 15% of base salary with such numbers of options calculated using the estimated grant date fair value, and the other officers are eligible for an option grant of up to 10% of salary based upon a similar calculation. The actual bonus provided and the number of options granted hereunder is based upon the overall performance of the Corporation as assessed by the Compensation Committee and approved by the Board. In the event that the Corporation is operating in a challenging environment, these guidelines could result in the Board reducing the bonus awards and grants of stock options and in some circumstances result in no bonuses or stock options being granted to executive and senior officers. However, the guidelines referenced above can also be exceeded at the discretion of the Board. Upon completion of their review, the Compensation Committee then provides their specific recommendations to the Board with respect to compensation paid to the Corporation's executive and senior officers.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Sale Transaction Bonus Pool</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In addition to the annual compensation paid to the CEO, COO and CFO, in an effort to maximize value for the Corporation's shareholders, the Board has approved the recommendation from the Compensation Committee that a Sales Transaction Bonus </font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">("STB")</font><font style="font-family:Arial;font-size:10pt;">&#32;be created in the event of a sale transaction. A STB pool would be created based on a scale between 1% - 2.5% of the Corporation's market capitalization for a sale transaction with a transaction price over $7.50 per share. The STB pool would be calculated as the sum of:</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:74px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:54px;"><font style="font-family:Arial;font-size:10pt;">a.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">for a Transaction Price of $7.51 to $10.00, the Transaction Price minus $7.50, multiplied by 0.010;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:74px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:54px;"><font style="font-family:Arial;font-size:10pt;">b.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">plus for a Transaction Price of $10.01 to $15.00, the Transaction Price minus $10.00, multiplied by 0.015;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:74px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:54px;"><font style="font-family:Arial;font-size:10pt;">c.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">plus for a Transaction Price of $15.01 to $20.00, the Transaction Price minus $15.00, multiplied by 0.020;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:74px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:54px;"><font style="font-family:Arial;font-size:10pt;">d.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">plus for a Transaction Price of $20.01 and higher, the Transaction Price minus $20.00, multiplied by 0.025</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">multiplied by the number of common shares outstanding at that time.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The STB pool would be split between the CEO (45%), COO (35%) and CFO (20%).</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">For the purposes of the STB, a sale transaction means:</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:74px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:62px;"><font style="font-family:Arial;font-size:10pt;">i.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">the sale by shareholders of less than fifty percent (50%) of the outstanding Common Shares of the Corporation for cash or securities of another entity, provided the Corporation has entered into an agreement with such entity or its affiliate to support the completion of such transaction;</font></div></td></tr></table><br><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></div><hr style="page-break-after:always"><div></div><br><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:74px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:62px;"><font style="font-family:Arial;font-size:10pt;">ii.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">a merger, amalgamation, arrangement or other similar transaction involving the Corporation where the shareholders receive cash or securities of another entity; or</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:62px;"><font style="font-family:Arial;font-size:10pt;">iii.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">the sale of all or substantially all of the Corporation's assets followed by a liquidating distribution to the shareholders of cash or securities of another entity, </font></div></td></tr></table><div style="line-height:120%;text-align:justify;padding-left:74px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">provided, however, that notwithstanding the foregoing, a sale transaction shall be deemed not to have occurred merely by reason of an acquisition of the Corporation's securities by, or any consolidation, merger or exchange of securities with, any entity that, immediately prior to such acquisition, consolidation, merger or exchange of securities was an affiliate of the Corporation.  </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Performance Graph</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following graph and table compare the change in the cumulative total shareholder return on the Common Shares over the period from December 31, 2008 to </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2013</font><font style="font-family:Arial;font-size:10pt;">&#32;(assuming a $100 investment was made on December 31, 2008) with the cumulative total return of the S&amp;P/TSX Capped Health Care Index over the same period, assuming reinvestment of dividends.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">As outlined in the compensation discussion and analysis, the Compensation Committee balances the various short-term and long-term objectives and provides bonuses and options based on performance against these objectives. The movement in share price based upon one index is not considered wholly representative of the actions to be taken regarding compensation.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><img src="ex9912014_chart-32924.jpg" style="height:480px;width:613px;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:607px;border-collapse:collapse;text-align:left;"><tr><td colspan="13"></td></tr><tr><td width="226px"></td><td width="55px"></td><td width="4px"></td><td width="59px"></td><td width="4px"></td><td width="59px"></td><td width="4px"></td><td width="59px"></td><td width="4px"></td><td width="59px"></td><td width="4px"></td><td width="59px"></td><td width="4px"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Dec&#160;31, <br>2008</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Dec. 31,<br>2009</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Dec. 31,<br>2010</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Dec. 31,<br>2011</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Dec. 31,<br>2012</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Dec. 31,<br>2013</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">S&amp;P/TSX Capped Health Care Index</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">100.00</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">128.13</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">179.17</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">203.16</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">225.47</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">315.63</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Oncolytics Biotech Inc.</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">100.00</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">184.56</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">451.68</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">268.46</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">267.79</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">111.41</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><br><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></div><hr style="page-break-after:always"><div></div><br><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Option-Based Awards</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Option based awards were granted to executives, officers, and directors of the Corporation in 2013. In assessing the grant of options, the Compensation Committee and the Board apply the principles outlined herein, and take into account factors such as existing grants, performance as discussed, and market conditions.  For the options granted in December 2013 to the Directors and Officers of the Corporation, the Compensation Committee recommended  and the Board approved option grants with the following vesting provisions:</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial;font-size:10pt;">1.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">One third vesting upon meeting one or more endpoints from any of the Corporation's randomized clinical trials.  </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial;font-size:10pt;">2.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">One third vesting upon meeting one or more endpoints from a second randomized clinical trial.   </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial;font-size:10pt;">3.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">One third vesting upon completion of financing activities that raise, in aggregate, gross proceeds of $25 million.</font></div></td></tr></table><a name="sd8c10d1ee8874e15a4513f90efcbc9ca"></a><div style="line-height:120%;text-align:center;padding-left:48px;text-indent:-24px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Summary Compensation Table</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following table sets forth all compensation paid, payable, awarded, granted, given, or otherwise provided, directly or indirectly, by the Corporation, or a subsidiary of the Corporation, in Canadian dollars, to the individuals who were, at </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2013</font><font style="font-family:Arial;font-size:10pt;">, the Chief Executive Officer, the Chief Financial Officer and the next three most highly compensated executive officers whose total compensation was, individually, more than $150,000, and such other individuals as required (collectively, the "</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Named Executive Officers</font><font style="font-family:Arial;font-size:10pt;">") of the Corporation.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:93.1640625%;border-collapse:collapse;text-align:left;"><tr><td colspan="10"></td></tr><tr><td width="18%"></td><td width="6%"></td><td width="9%"></td><td width="8%"></td><td width="10%"></td><td width="9%"></td><td width="9%"></td><td width="8%"></td><td width="11%"></td><td width="12%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:4px;padding-top:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">Non-equity incentive</font></div><div style="padding-bottom:4px;padding-top:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">plan compensation ($)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Name and principal position</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Year</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:4px;padding-top:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">Salary</font></div><div style="padding-bottom:4px;padding-top:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">($)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:4px;padding-top:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">Share-based</font></div><div style="padding-bottom:4px;padding-top:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">awards ($)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:4px;padding-top:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">Option-based</font></div><div style="padding-bottom:4px;padding-top:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">awards</font><font style="font-family:Arial;font-size:7pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(3)</sup></font></div><div style="padding-bottom:4px;padding-top:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">&#160;($)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Annual incentive plans</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Long-term incentive plans</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:4px;padding-top:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">Pension value</font></div><div style="padding-bottom:4px;padding-top:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">($)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:4px;padding-top:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">All other</font><font style="font-family:Arial;font-size:7pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div><div style="padding-bottom:4px;padding-top:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">compensation</font></div><div style="padding-bottom:4px;padding-top:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">($)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:4px;padding-top:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">Total compensation</font></div><div style="padding-bottom:4px;padding-top:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">($)</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:4px;padding-top:4px;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">Dr. Bradley G. Thompson</font></div><div style="padding-bottom:4px;padding-top:4px;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">Chief Executive Officer</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-top:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">2013</font></div><div style="padding-bottom:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">2012</font></div><div style="padding-bottom:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">2011</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-top:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">530,000</font></div><div style="padding-bottom:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">506,143</font></div><div style="padding-bottom:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">489,500</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-top:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">N/A</font></div><div style="padding-bottom:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">N/A</font></div><div style="padding-bottom:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">N/A</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-top:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">266,400</font></div><div style="padding-bottom:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">201,528</font></div><div style="padding-bottom:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">403,080</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-top:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">212,000</font></div><div style="padding-bottom:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">-</font></div><div style="padding-bottom:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">200,000</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-top:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">N/A </font></div><div style="padding-bottom:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">N/A</font></div><div style="padding-bottom:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">N/A</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-top:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">N/A </font></div><div style="padding-bottom:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">N/A</font></div><div style="padding-bottom:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">N/A</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-top:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">68,295</font></div><div style="padding-bottom:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">65,453</font></div><div style="padding-bottom:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">62,834</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-top:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">1,076,695</font></div><div style="padding-bottom:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">773,124</font></div><div style="padding-bottom:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">1,155,414</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:4px;padding-top:4px;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">Dr. Matt C. Coffey</font></div><div style="padding-bottom:4px;padding-top:4px;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">Chief Operating Officer</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-top:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">2013</font></div><div style="padding-bottom:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">2012</font></div><div style="padding-bottom:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">2011</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-top:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">365,000</font></div><div style="padding-bottom:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">341,363</font></div><div style="padding-bottom:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">330,139</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-top:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">N/A</font></div><div style="padding-bottom:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">N/A</font></div><div style="padding-bottom:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">N/A</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-top:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">177,600</font></div><div style="padding-bottom:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">104,963</font></div><div style="padding-bottom:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">225,980</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-top:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">109,500</font></div><div style="padding-bottom:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">-</font></div><div style="padding-bottom:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">100,000</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-top:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">N/A</font></div><div style="padding-bottom:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">N/A</font></div><div style="padding-bottom:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">N/A</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-top:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">N/A</font></div><div style="padding-bottom:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">N/A</font></div><div style="padding-bottom:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">N/A</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-top:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">54,682</font></div><div style="padding-bottom:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">51,882</font></div><div style="padding-bottom:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">49,686</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-top:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">706,782</font></div><div style="padding-bottom:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">498,208</font></div><div style="padding-bottom:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">705,805</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:4px;padding-top:4px;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">Kirk Look</font><font style="font-family:Arial;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(4)</sup></font></div><div style="padding-bottom:4px;padding-top:4px;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">Chief Financial Officer</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-top:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">2013</font></div><div style="padding-bottom:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">2012</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-top:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">280,000</font></div><div style="padding-bottom:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">38,654</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-top:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">N/A </font></div><div style="padding-bottom:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">N/A</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-top:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">118,400</font></div><div style="padding-bottom:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">175,248</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-top:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">84,000</font></div><div style="padding-bottom:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">-</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-top:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">N/A</font></div><div style="padding-bottom:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">N/A</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-top:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">N/A</font></div><div style="padding-bottom:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">N/A</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-top:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">47,638</font></div><div style="padding-bottom:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">5,893</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-top:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">530,038</font></div><div style="padding-bottom:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">219,795</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:4px;padding-top:4px;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">Dr. George Gill</font><font style="font-family:Arial;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2)</sup></font></div><div style="padding-bottom:4px;padding-top:4px;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">Senior Vice President, Clinical and Regulatory Affairs</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-top:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">2013</font></div><div style="padding-bottom:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">2012</font></div><div style="padding-bottom:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">2011</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-top:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">331,908</font></div><div style="padding-bottom:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">308,618</font></div><div style="padding-bottom:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">310,287</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-top:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">N/A</font></div><div style="padding-bottom:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">N/A</font></div><div style="padding-bottom:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">N/A</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-top:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">59,200</font></div><div style="padding-bottom:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">33,588</font></div><div style="padding-bottom:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">53,900</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-top:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">99,572</font></div><div style="padding-bottom:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">-</font></div><div style="padding-bottom:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">31,029</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-top:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">N/A</font></div><div style="padding-bottom:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">N/A</font></div><div style="padding-bottom:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">N/A</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-top:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">N/A</font></div><div style="padding-bottom:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">N/A</font></div><div style="padding-bottom:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">N/A</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-top:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">27,382</font></div><div style="padding-bottom:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">26,077</font></div><div style="padding-bottom:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">25,599</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-top:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">518,063</font></div><div style="padding-bottom:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">368,283</font></div><div style="padding-bottom:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">420,814</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:4px;padding-top:4px;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">Mary Ann Dillahunty</font><font style="font-family:Arial;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2)</sup></font></div><div style="padding-bottom:4px;padding-top:4px;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">VP Intellectual Property</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-top:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">2013</font></div><div style="padding-bottom:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">2012</font></div><div style="padding-bottom:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">2011</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-top:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">172,984</font></div><div style="padding-bottom:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">180,951</font></div><div style="padding-bottom:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">161,715</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-top:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">N/A</font></div><div style="padding-bottom:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">N/A</font></div><div style="padding-bottom:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">N/A</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-top:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">29,600</font></div><div style="padding-bottom:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">25,191</font></div><div style="padding-bottom:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">69,300</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-top:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">51,895</font></div><div style="padding-bottom:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">-</font></div><div style="padding-bottom:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">41,372</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-top:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">N/A</font></div><div style="padding-bottom:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">N/A</font></div><div style="padding-bottom:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">N/A</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-top:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">N/A</font></div><div style="padding-bottom:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">N/A</font></div><div style="padding-bottom:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">N/A</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-top:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">21,284</font></div><div style="padding-bottom:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">19,818</font></div><div style="padding-bottom:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">19,827</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-top:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">275,763</font></div><div style="padding-bottom:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">225,961</font></div><div style="padding-bottom:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">292,214</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:4px;padding-top:4px;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">Dr. Alan Tuchman</font><font style="font-family:Arial;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2), (5)</sup></font></div><div style="padding-bottom:4px;padding-top:4px;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">Senior Vice President, Medical and Clinical Affairs Chief Medical Officer</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">2013</font></div><div style="padding-top:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">2012</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">149,797</font></div><div style="padding-top:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">35,357</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">N/A</font></div><div style="padding-top:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">N/A</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">40,700</font></div><div style="padding-top:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">46,341</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">44,939</font></div><div style="padding-top:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">-</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">N/A</font></div><div style="padding-top:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">N/A</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">N/A</font></div><div style="padding-top:4px;text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">N/A</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">12,358</font></div><div style="padding-top:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">2,917</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">247,795</font></div><div style="padding-top:4px;text-align:right;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">84,615</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Notes:</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">The dollar amounts set forth under this column are related to contributions to the officer's respective retirement savings plan and amounts provided for health care benefits by the Corporation. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">U.S. Employees are paid salaries, bonuses and other compensation in U.S. Dollars. These amounts are presented in Canadian dollars using the Bank of Canada noon rate at </font><font style="font-family:Arial;font-size:8pt;">December&#160;31, 2013</font><font style="font-family:Arial;font-size:8pt;">&#32;of $1.0636 (2012 - $0.9949; 2011 - $1.0170).</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(3)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">The value of option based awards are based on the grant date assumptions as disclosed in note 8 "</font><font style="font-family:Arial;font-size:8pt;font-style:italic;">Share Based Payments</font><font style="font-family:Arial;font-size:8pt;">" in the Corporation's 2013 audited consolidated financial statements. </font></div></td></tr></table><div style="line-height:120%;text-align:justify;padding-left:24px;text-indent:-24px;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">(4)    Mr. Look was appointed Chief Financial Officer on November 12, 2012.</font></div><div style="line-height:120%;text-align:justify;padding-left:24px;text-indent:-24px;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">(5)    Dr. Tuchman was appointed Senior Vice President, Medical and Clinical Affairs, Chief Medical Officer on September 27, 2012.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:24px;text-indent:-24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Narrative Discussion</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Corporation has entered into employment agreements with each of the Named Executive Officers (each an "</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Employment Agreement</font><font style="font-family:Arial;font-size:10pt;">"). Pursuant to the terms of the Employment Agreements, Dr. Thompson is entitled to an annual salary of $537,950 for the calendar year 2014, Mr. Look is entitled to an annual salary of $284,200 for the </font></div><br><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></div><hr style="page-break-after:always"><div></div><br><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">calendar year 2014, Dr. Coffey is entitled to an annual salary of $370,475 for the calendar year 2014, Ms. Dillahunty is entitled to U.S.$165,080 based on a part-time basis for one-half of normal working hours for the calendar year 2014, Dr. Gill is entitled to an annual salary of U.S. $316,742 for the calendar year 2014, and Dr. Tuchman is entitled to an annual salary of U.S.$142,953. Further, each Named Executive Officer is entitled to additional benefits and performance-based bonuses. The Employment Agreements provide that each Named Executive Officer is subject to certain confidentiality and non-competition restrictions during and following the course of their respective employment with the Corporation. Each Employment Agreement shall continue until terminated by either party in accordance with the notice provisions thereof.</font></div><a name="sdc678578f68346088a963e973a2f8f7f"></a><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Incentive Plan Awards</font></div><div style="line-height:120%;text-align:center;padding-left:48px;text-indent:-24px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Outstanding Share-Based Awards and Option-Based Awards</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following table sets forth for each Named Executive Officer all option-based and share-based awards outstanding at </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2013</font><font style="font-family:Arial;font-size:10pt;">.   </font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">&#32;</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:91.2109375%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"></td></tr><tr><td width="12%"></td><td width="15%"></td><td width="15%"></td><td width="13%"></td><td width="15%"></td><td width="15%"></td><td width="15%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Option-based Awards</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Share-based Awards</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Name</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:4px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Number of securities underlying unexercised options</font></div><div style="padding-bottom:4px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">(#)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:4px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Option exercise price</font></div><div style="padding-bottom:4px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">($)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Option expiration date</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:4px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Value of unexercised in-the-money options</font><font style="font-family:Arial;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div><div style="padding-bottom:4px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">($)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:4px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Number of shares or units of shares that have not vested</font></div><div style="padding-bottom:4px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">(#)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:4px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Market or payout value of share-based awards that have not vested</font></div><div style="padding-bottom:4px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">($)</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:8px;padding-top:4px;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dr. Bradley G. Thompson</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">30,000</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">350,000</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">149,160</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">50,000</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">215,000</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">18,000</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">240,000</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">240,000</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">360,000</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">8.10</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">5.00</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">2.22</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">3.06</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">6.72</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">4.31</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">3.89</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">4.21</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">1.74</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">May 28, 2014</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 9, 2014</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 12, 2017</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 8, 2019</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 14, 2020</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">July 27, 2021</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 14, 2021</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 17, 2022</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 11, 2023</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:8px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">N/A</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:8px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">N/A</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:8px;padding-top:4px;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dr. Matt C. Coffey</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">20,000</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">180,000</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">33,333</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">30,000</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">115,000</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">18,000</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">125,000</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">125,000</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">240,000</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">8.10</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">5.00</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">2.22</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">3.06</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">6.72</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">4.31</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">3.89</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">4.21</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">1.74</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">May 28, 2014</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 9, 2014</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 12, 2017</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 8, 2019</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 14, 2020</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">July 27, 2021</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 14, 2021</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 17, 2022</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 11, 2023</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:8px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">N/A</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:8px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">N/A</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="padding-bottom:8px;padding-top:4px;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Kirk Look</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">15,000</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">15,000</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">4,700</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">9,000</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">10,000</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">25,000</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">35,000</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">200,000</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">40,000</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">160,000</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">8.10</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">5.00</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">2.25</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">2.22</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">3.06</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">6.72</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">3.89</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">2.00</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">4.21</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">1.74</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">May 28, 2014</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 9, 2014</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 15, 2016</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 12, 2017</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 8, 2019</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 14, 2020</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 14, 2021</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nov 13, 2022</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 17, 2022</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 11, 2023</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="padding-bottom:8px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">N/A</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="padding-bottom:8px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">N/A</font></div></td></tr></table></div></div><br><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></div><hr style="page-break-after:always"><div></div><br><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:91.2109375%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"></td></tr><tr><td width="12%"></td><td width="15%"></td><td width="15%"></td><td width="13%"></td><td width="15%"></td><td width="15%"></td><td width="15%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Option-based Awards</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Share-based Awards</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Name</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="padding-bottom:4px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Number of securities underlying unexercised options</font></div><div style="padding-bottom:4px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">(#)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="padding-bottom:4px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Option exercise price</font></div><div style="padding-bottom:4px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">($)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Option expiration date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="padding-bottom:4px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Value of unexercised in-the-money options</font><font style="font-family:Arial;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div><div style="padding-bottom:4px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">($)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="padding-bottom:4px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Number of shares or units of shares that have not vested</font></div><div style="padding-bottom:4px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">(#)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="padding-bottom:4px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Market or payout value of share-based awards that have not vested</font></div><div style="padding-bottom:4px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">($)</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:8px;padding-top:4px;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dr. George Gill</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">7,500</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">12,500</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">16,667</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">15,000</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">25,000</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">35,000</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">40,000</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">80,000</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">8.10</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">5.00</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">2.22</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">3.06</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">6.72</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">3.89</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">4.21</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">1.74</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">May 28, 2014</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 9, 2014</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 12, 2017</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 8, 2019</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 14, 2020</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 14, 2021</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 17, 2022</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 11, 2023</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:8px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">N/A</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:8px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">N/A</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:8px;padding-top:4px;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Mary Ann Dillahunty</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">100,000</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">16,667</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">15,000</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">25,000</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">45,000</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">30,000</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">40,000</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">3.28</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">2.22</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">3.06</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">6.72</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">3.89</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">4.21</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">1.74</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Feb 1, 2017</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 12, 2017</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 8, 2019</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 14, 2020</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 14, 2021</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 17, 2022</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 11, 2023</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:8px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">N/A</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:8px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">N/A</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:8px;padding-top:4px;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dr. Alan Tuchman</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">5,000</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">10,000</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">50,000</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">15,000</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">55,000</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">5.00</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">2.85</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">2.32</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">4.21</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">1.74</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 9, 2014</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">May 11, 2020</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Oct 1, 2022</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 17, 2022</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 11, 2023</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="padding-bottom:8px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:8px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">N/A</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:8px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">N/A</font></div></td></tr><tr><td colspan="7" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Note:</font></div><div style="text-align:justify;padding-left:18px;text-indent:-12px;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">(1)These amounts are calculated based on the difference between the closing price of the securities underlying the options on the  Toronto Stock Exchange (the "</font><font style="font-family:Arial;font-size:8pt;font-weight:bold;">TSX"</font><font style="font-family:Arial;font-size:8pt;">) at the end of the year ($1.66), and the exercise price of the options.</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Value Vested or Earned During the Year</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following table sets forth for each Named Executive Officer the value vested or earned on all option-based awards, share-based awards, and non-equity incentive plan compensation during the financial year ending </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2013</font><font style="font-family:Arial;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:91.015625%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td width="31%"></td><td width="23%"></td><td width="23%"></td><td width="23%"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Name</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Option-based awards - Value vested during the year</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">($)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Share-based awards - Value vested during the year</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">($)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Non-equity incentive plan compensation - Value earned during the year</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">($)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Dr. Bradley G. Thompson</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Nil</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">None</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">None</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Dr. Matt C. Coffey</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Nil</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">None</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">None</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Kirk Look</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Nil</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">None</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">None</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Dr. George Gill</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Nil</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">None</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">None</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Mary Ann Dillahunty</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Nil</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">None</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">None</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Dr. Alan Tuchman</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Nil</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">None</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">None</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Note:</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Option-based awards are granted at the market price at the dates of grant, and were either vested on the date of grant, or were out-of-the-money on the vesting date.</font></div></td></tr></table><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><a name="s97962ed529d241a5ba40d30b911de846"></a><div style="line-height:120%;text-align:center;padding-left:48px;text-indent:-24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Pension Plan Benefits</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Corporation does not provide Pension Plan Benefits for its Named Executive Officers and employees.</font></div><br><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8</font></div></div><hr style="page-break-after:always"><div></div><br><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><a name="sd079d4d270de450da8765c87e593ac60"></a><div style="line-height:120%;text-align:center;padding-left:48px;text-indent:-24px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Termination and Change of Control Benefits</font></div><div style="line-height:120%;text-align:center;padding-left:48px;text-indent:-24px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">If the Employment Agreements of the Named Executive Officer are terminated by the Corporation other than for cause, Mr. Look, Dr. Coffey, Ms. Dillahunty, and Dr. Gill shall be entitled to 12 months pay in lieu of notice, Dr. Thompson shall be entitled to 24 months pay in lieu of notice, and Dr. Tuchman shall be entitled to 3 months pay in lieu of notice. If the Employment Agreements other than Ms. Dillahunty are terminated by the Corporation other than for cause, then all unexercised and unvested stock options then held by each are governed by the terms of the Stock Option Plan. Should Ms. Dillahunty be terminated by the Corporation other than for cause, then all unvested options will vest immediately. Furthermore, if there is a change of control of the Corporation and Mr. Look, Dr. Coffey, Dr. Gill, or Ms. Dillahunty are terminated without cause within one year following such change of control, or two years following such change of control in the case of Dr. Thompson, then the terminated employee shall be entitled to 24 months pay in lieu of notice or 36 months pay in lieu of notice in the case of Dr. Thompson. In the event of a change of control of the Corporation, Dr. Tuchman shall be entitled to 3 months pay in lieu of notice. For termination in accordance with this provision, pay shall include payment in lieu of benefits that otherwise would have been earned during the applicable term.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following table reflects amounts payable to the Named Executive Officers with termination without cause or change of control benefits, assuming that their employment was terminated on </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2013</font><font style="font-family:Arial;font-size:10pt;">&#32;without cause or due to a change of control of the Corporation.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:73.4375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td width="42%"></td><td width="26%"></td><td width="1%"></td><td width="30%"></td><td width="1%"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Name</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Termination without Cause</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Severance</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">&#160;$</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Change of Control</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Severance</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">&#160;$</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Dr. Bradley G. Thompson</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,214,702</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,822,053</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Dr. Matt C. Coffey</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">426,059</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">852,118</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Kirk J. Look, C.A.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">332,667</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">665,334</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:8px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Dr. George Gill, MD</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">368,847</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">737,694</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:8px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Mary Ann Dillahunty</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">197,819</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">395,638</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Dr. Alan Tuchman</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">41,727</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">41,727</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Notes:</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">As at </font><font style="font-family:Arial;font-size:8pt;">December&#160;31, 2013</font><font style="font-family:Arial;font-size:8pt;">, all options granted to Officers had fully vested except for the options granted on December 11, 2013 and 100,000 options granted to Mr. Look on November 13, 2012.  As a result, all Officers shall be entitled to exercise all or any part of their vested Options, within the period ending on the earlier of the date of expiration of the Option and the ninetieth (90th) day after the date such Officer is terminated unless otherwise approved by the Board of Directors.</font><font style="font-family:Arial;font-size:8pt;font-weight:bold;">&#32;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">On a change of control of the Corporation, the Officers shall be entitled to exercise all or a part of their options, whether vested or not, within the period ending on the earlier of the date of expiration of the option and the 90th day after the date such officer is terminated.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(3)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">U.S. Employees are paid in U.S. Dollars and are presented in Canadian dollars using the Bank of Canada noon rate at </font><font style="font-family:Arial;font-size:8pt;">December&#160;31, 2013</font><font style="font-family:Arial;font-size:8pt;">&#32;of $1.0636.  </font></div></td></tr></table><a name="s06698524608f4886863675db596b0846"></a><div style="line-height:120%;text-align:center;padding-left:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Director Compensation</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Director Compensation Table</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following table details the compensation received by each Director in 2013 who is not a salaried employee of the Corporation.</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">&#32;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:91.796875%;border-collapse:collapse;text-align:left;"><tr><td colspan="11"></td></tr><tr><td width="18%"></td><td width="11%"></td><td width="1%"></td><td width="12%"></td><td width="10%"></td><td width="1%"></td><td width="14%"></td><td width="11%"></td><td width="14%"></td><td width="7%"></td><td width="1%"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">Name</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">Fees &amp; Retainers Earned</font></div><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">($)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">Share-Based Awards</font></div><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">($)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">Option-Based Awards</font><font style="font-family:Arial;font-size:7pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">($)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">Non-Equity Incentive Plan Compensation</font></div><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">($)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">Pension Value</font></div><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">($)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">All Other Compensation</font></div><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">($)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">Total</font></div><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">($)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Jim Dinning</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">53,750</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">N/A</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">25,879</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">None</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">N/A</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">None</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">79,629</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dr. Ed Levy</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">47,750</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">N/A</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">22,182</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">None</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">N/A</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">None</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">69,932</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Mark Lievonen</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">53,750</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">N/A</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">25,879</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">None</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">N/A</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">None</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">79,629</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Wayne Pisano</font><font style="font-family:Arial;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2), (3)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">25,417</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">N/A</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">76,182</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">None</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">N/A</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">None</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">101,599</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Robert Schultz</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">69,750</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">N/A</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">44,364</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">None</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">N/A</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">None</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">114,114</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Fred Stewart</font><font style="font-family:Arial;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(4)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">49,250</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">N/A</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">33,273</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">None</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">N/A</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">None</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">82,523</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Ger van Amersfoort</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">40,750</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">N/A</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">22,182</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">None</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">N/A</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">None</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">62,932</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><br><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9</font></div></div><hr style="page-break-after:always"><div></div><br><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Notes:</font></div><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:-15px;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">(1) Option based awards include grants from December 2013. The options granted on December 11, 2013 have an estimated grant date fair value of $0.74 per option using the following respective grant date assumptions: expected life of option - 3 years; volatility 63.15%; risk free interest rate 1.07%; dividend yield 0%. </font></div><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:-15px;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">(2) Effective May 9, 2013, Mr. Pisano was elected to the Corporation's Board of Directors at the 2013 Annual General Meeting.</font></div><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:-15px;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">(3) On May 9, 2013, Mr. Pisano was granted 50,000 options with an estimated fair value of $1.08 per option using the following respective grant date assumptions: expected life of option - 2 years; volatility 67.28%; risk free interest rate 1.02%; dividend yield 0%.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">&#32;&#32;&#32;(4) Mr. Stewart is not standing for re-election to the Board.  </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Narrative Discussion</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Each director who is not a salaried employee of the Corporation was entitled to a fee of $1,750 per Board and committee meeting attended. An annual retainer fee of $25,000 was paid for service during 2013 and the lead director, Mr. Schultz, was entitled to an additional annual retainer of $15,000. Mr. Stewart, the chair of the Audit Committee, received an additional retainer of $12,000. Mr. Dinning, as chair of the Compensation Committee, received an additional retainer of $6,000.  Mr. Lievonen, as chair of the Governance Committee, received an additional retainer of $6,000.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We also grant to directors, from time to time, stock options in accordance with the Stock Option Plan and the reimbursement of any reasonable expenses incurred by them while acting in the capacity of director. In the aggregate, a total of $340,417 in directors' fees was paid to the Board of Directors during the fiscal year ended </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2013</font><font style="font-family:Arial;font-size:10pt;">. During the fiscal year ended </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2013</font><font style="font-family:Arial;font-size:10pt;">, there were 315,000 options granted to these directors in accordance with a Compensation Committee recommendation.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Incentive Plan Awards</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Outstanding Share-Based Awards and Option Based Awards</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following table sets forth for each Director, other than Named Executive Officers who are directors, all option-based and share-based awards outstanding at </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2013</font><font style="font-family:Arial;font-size:10pt;">.</font></div><br><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></div><hr style="page-break-after:always"><div></div><br><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:90.8203125%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"></td></tr><tr><td width="20%"></td><td width="14%"></td><td width="11%"></td><td width="15%"></td><td width="12%"></td><td width="14%"></td><td width="14%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Option-based Awards</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Share-based Awards</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Name</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:4px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Number of securities underlying unexercised options</font></div><div style="padding-bottom:4px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">(#)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:4px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Option exercise price</font></div><div style="padding-bottom:4px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">($)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:4px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Option</font></div><div style="padding-bottom:4px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">expiration date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:4px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Value of unexercised in-the-money options</font><font style="font-family:Arial;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div><div style="padding-bottom:4px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">($)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:4px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Number of shares or units of shares that have not vested</font></div><div style="padding-bottom:4px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">(#)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:4px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Market or payout value of share-based awards that have not vested</font></div><div style="padding-bottom:4px;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">($)</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Jim Dinning</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">5,000</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">22,500</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">10,000</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">17,500</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">17,500</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">30,000</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">35,000</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">35,000</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">35,000</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">8.10</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">5.00</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">2.25</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">2.22</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">3.06</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">6.72</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">3.89</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">4.21</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">1.74</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">May 28, 2014</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 9, 2014</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 15, 2016</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 12, 2017</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 8, 2019</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 14, 2020</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 14, 2021</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 17, 2022</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 11, 2023</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">N/A</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">N/A</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dr. Ed Levy</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">50,000</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">10,000</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">17,500</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">17,500</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">30,000</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">30,000</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">30,000</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">30,000</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">4.10</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">2.25</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">2.22</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">3.06</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">6.72</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">3.89</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">4.21</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">1.74</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">May 16, 2016</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 15, 2016</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 12, 2017</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 8, 2019</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 14, 2020</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 14, 2021</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 17, 2022</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 11, 2023</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">N/A</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">N/A</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Mark Lievonen</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">5,000</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">22,500</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">10,000</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">17,500</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">17,500</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">30,000</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">35,000</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">35,000</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">35,000</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">8.10</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">5.00</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">2.25</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">2.22</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">3.06</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">6.72</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">3.89</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">4.21</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">1.74</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">May 28, 2014</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 9, 2014</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 15, 2016</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 12, 2017</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 8, 2019</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 14, 2020</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 14, 2021</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 17, 2022</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 11, 2023</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">N/A</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">N/A</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:16px;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Wayne Pisano</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">50,000</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">30,000</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">2.89</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">1.74</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">May 9, 2023</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 11, 2023</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">N/A</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">N/A</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Robert Schultz</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">5,000</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">22,500</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">10,000</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">17,500</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">17,500</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">50,000</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">60,000</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">9,000</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">70,000</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">60,000</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">60,000</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">8.10</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">5.00</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">2.25</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">2.22</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">3.06</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">3.13</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">6.72</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">4.31</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">3.89</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">4.21</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">1.74</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">May 28, 2014</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 9, 2014</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 15, 2016</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 12, 2017</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 8, 2019</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">July 28, 2020</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 14, 2020</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">July 27, 2021</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 14, 2021</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 17, 2022</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 11, 2023</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">N/A</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">N/A</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Fred Stewart</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">5,000</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">22,500</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">17,500</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">17,500</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">45,000</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">9,000</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">55,000</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">45,000</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">45,000</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">8.10</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">5.00</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">2.22</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">3.06</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">6.72</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">4.31</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">3.89</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">4.21</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">1.74</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">May 28, 2014</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 9, 2014</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 12, 2017</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 8, 2019</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 14, 2020</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">July 27, 2021</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 14, 2021</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 17, 2022</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 11, 2023</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">N/A</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">N/A</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Ger van Amersfoort</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">50,000</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">10,000</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">17,500</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">17,500</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">30,000</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">30,000</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">30,000</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">30,000</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">3.60</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">2.25</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">2.22</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">3.06</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">6.72</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">3.89</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">4.21</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">1.74</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">June 15, 2016</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 15, 2016</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 12, 2017</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 8, 2019</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 14, 2020</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 14, 2021</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 17, 2022</font></div><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dec 11, 2023</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Nil</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">N/A</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">N/A</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Note:</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">These amounts are calculated based on the difference between the closing price of the securities underlying the options on the TSX at the end of the year ($1.66), and the exercise price of the options.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Value Vested or Earned During the Year</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following table sets forth for each Director the value vested on all option-based awards, share-based awards, and value earned on non-equity incentive plan compensation during the financial year ending </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2013</font><font style="font-family:Arial;font-size:10pt;">.</font></div><br><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></div><hr style="page-break-after:always"><div></div><br><div style="line-height:120%;text-align:center;font-size:8pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:91.015625%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td width="25%"></td><td width="25%"></td><td width="25%"></td><td width="25%"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Name</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Option-based awards - Value vested during the year</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">($)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Share-based awards - Value vested during the year</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">($)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Non-equity incentive plan compensation - Value earned during the year</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">($)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Jim Dinning</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Nil</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">None</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">None</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dr. Ed Levy</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Nil</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">None</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">None</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Mark Lievonen</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Nil</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">None</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">None</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Wayne Pisano</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Nil</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">None</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">None</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Robert Schultz</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Nil</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">None</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">None</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Fred Stewart</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Nil</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">None</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">None</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Ger van Amersfoort</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Nil</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">None</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">None</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><a name="s0dbe72f36fef49da9aacaf43d4c69bd1"></a><div style="line-height:120%;text-align:center;padding-left:48px;text-indent:-24px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Indebtedness of Directors and Senior Officers</font></div><div style="line-height:120%;text-align:center;padding-left:48px;text-indent:-24px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">No director, officer or proposed nominee for election as a director of the Corporation or any associate of any such persons is, or has been, indebted to the Corporation.</font></div><a name="sef5cc086045741b4ac28fa24a7b48b0d"></a><div style="line-height:120%;text-align:center;padding-left:48px;text-indent:-24px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Interest of Insiders in Material Transactions</font></div><div style="line-height:120%;text-align:center;padding-left:48px;text-indent:-24px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">There are no material interests, direct or indirect, of directors, senior officers, any shareholder who beneficially owns, directly or indirectly, more than 10% of the outstanding Common Shares or any known associate or affiliates of such persons, in any transaction within the last financial year or in any proposed transaction which has materially affected or would materially affect the Corporation.</font></div><a name="s64e9d5a413aa4b6c94bfc069b38981f0"></a><div style="line-height:120%;text-align:center;padding-left:48px;text-indent:-24px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Equity Compensation Plan Information</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Stock Option Plan</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Corporation, with the approval of its shareholders, has established a Stock Option Plan (the "</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Plan</font><font style="font-family:Arial;font-size:10pt;">"), and, through amendments from time to time, has maintained a pool of options with a fixed maximum representing approximately up to 10% of the Corporation's issued and outstanding shares.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Under the Plan, the Board of Directors or the Compensation Committee may from time to time designate directors, officers, employees of, or consultants to, the Corporation or any subsidiary of the Corporation to whom options to purchase Common Shares of the Corporation may be granted and the number of options to be granted to each. The Plan as amended and approved at the Annual and Special meeting held on </font><font style="font-family:Arial;font-size:10pt;">June&#160;20, 2012</font><font style="font-family:Arial;font-size:10pt;">, presently provides for a fixed maximum of </font><font style="font-family:Arial;font-size:10pt;">7,653,275</font><font style="font-family:Arial;font-size:10pt;">&#32;Common Shares reserved for issuance pursuant to the Plan, which as of the record date represents approximately </font><font style="font-family:Arial;font-size:10pt;">8.85%</font><font style="font-family:Arial;font-size:10pt;">&#32;of the issued and outstanding Common Shares. Of this fixed maximum, </font><font style="font-family:Arial;font-size:10pt;">271,067</font><font style="font-family:Arial;font-size:10pt;">&#32;Options have been exercised since </font><font style="font-family:Arial;font-size:10pt;">June&#160;20, 2012</font><font style="font-family:Arial;font-size:10pt;">&#32;and are not available for future grants under the current fixed maximum amount, leaving </font><font style="font-family:Arial;font-size:10pt;">7,382,208</font><font style="font-family:Arial;font-size:10pt;">&#32;&#32;Common Shares currently reserved for issuance pursuant to the Plan, which represents approximately </font><font style="font-family:Arial;font-size:10pt;">8.53%</font><font style="font-family:Arial;font-size:10pt;">&#32;of the issued and outstanding Common Shares. There are Options outstanding to acquire </font><font style="font-family:Arial;font-size:10pt;">6,001,344</font><font style="font-family:Arial;font-size:10pt;">&#32;Common Shares, which represents approximately </font><font style="font-family:Arial;font-size:10pt;">6.94%</font><font style="font-family:Arial;font-size:10pt;">&#32;of the issued and outstanding Common Shares.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Corporation believes that the Plan is reasonable in the context of the market and with respect to other reporting issuers.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The number of Common Shares available that may be acquired under an option granted to a Participant (the "Option") shall be determined by the Board at the time the Option is granted, provided that: (i) the aggregate number of Common Shares reserved for issuance under the Plan at any time, together with all other security based compensation arrangements of the Corporation, to insiders shall not exceed 10% of the issued and outstanding Common Shares (calculated on a non-diluted basis); (ii) the aggregate number of Common Shares issued pursuant to this Plan to insiders, together with all other security based compensation arrangements of the Corporation, within a one year period shall not exceed 10% of the issued and outstanding Common Shares (calculated on a non-diluted basis); and (iii) the aggregate number of Common Shares reserved for issuance to any one Participant under this Plan, together with all other security based compensation arrangements of the Corporation, shall not exceed 5% of the total number of issued and outstanding Common Shares (calculated on a non-diluted basis).  </font></div><br><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12</font></div></div><hr style="page-break-after:always"><div></div><br><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">At the Annual and Special Meeting of Shareholders held on May 9, 2013, the Shareholders approved amendments to the Plan to limit the value of Option grants to each non-employee director to an amount not to exceed $100,000 annually for any individual non-employee director (other than initial Option grants to new directors).</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Options may be exercised at a price (the "</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Exercise Price</font><font style="font-family:Arial;font-size:10pt;">") which shall be fixed by the Board at the time the Option is granted. No Option can be granted with an Exercise Price at a discount to the market, which shall be the closing price of the Common Shares on the stock exchange upon which the Common Shares are listed on the first day preceding the date of grant on which at least one board lot of Common Shares traded on such exchange.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Options are generally granted for a term expiring on the tenth anniversary of the date of grant and typically either vest immediately or as to one-third on each of the first, second and third anniversary following the date of grant. Options are not transferable or assignable except to the person or persons to whom the Participant's rights pass by the Participant's will or applicable law following the death or permanent disability of a Participant.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Subject to any written agreement between the Corporation and a Participant providing otherwise, if any Participant who is a director, officer, employee or consultant of the Corporation ceases to be a director, officer, employee or consultant of the Corporation for any reason other than death or permanent disability, his Option will terminate immediately as to the then unvested portion thereof, and at 5:00 p.m. (Calgary time) on the earlier of the date of expiration of the Option Period (as defined in the Plan) and the ninetieth (90th) day after the date such Participant ceases to be a director, officer, employee or consultant of the Corporation as to the then vested portion of the Option. In the event of a sale by the Corporation of all or substantially all of its assets or in the event of a change of control of the Corporation, the Participants are entitled to exercise in full or in part any unexercised Options previously granted to such Participant pursuant to the Plan, whether vested or not, either during the term of the Option or within ninety (90) days after the date of termination of the employment of the Participant with the Corporation or the cessation or termination of the Participant as a director, officer, employee or consultant of the Corporation, whichever first occurs.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Notwithstanding the foregoing, the Board may, at its sole discretion, extend the period during which any Options may be exercised, in the case of Options held by non-employee directors, by not more than one (1) year, and in the case of Options held by other persons, by not more than three (3) years, but in no case longer than the normal expiry of the Options.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Under the Plan, Shareholder approval is required for any change to the Plan or Options granted under it which:</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">increases the number of Common Shares reserved for issuance under the Plan;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">extends eligibility to participate in the Plan to persons other than officers, directors, and employees of the Corporation or its subsidiaries and consultants to the Corporation or its subsidiaries;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">(c)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">permits Options to be transferred, other than for normal estate settlement purposes or to an RRSP or similar plan;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">(d)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">permits awards other than Options to be made under the Plan;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">(e)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">extends the term of an Option beyond the maximum expiry date set out in the Plan (except where an expiry date would have fallen within a blackout period established under the Corporation's Trading Policy); </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">(f)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">reduces the exercise price of an Option, except for the purpose of maintaining Option value in connection with a conversion, change, reclassification, redivision, redesignation, subdivision or consolidation of shares or a reorganization, amalgamation, consolidation, merger, takeover bid or similar transaction involving the Corporation (for this purpose, cancellation or termination of an Option prior to its expiry date for the purpose of reissuing Options to the same option-holder with a lower exercise price will be considered an amendment to reduce the exercise price of an Option);</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">(g)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">changes the insider participation limitation under the Plan; or</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">(h)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">amends the amending provision of the Plan.</font></div></td></tr></table><br><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13</font></div></div><hr style="page-break-after:always"><div></div><br><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Common Shares Authorized for Issuance Under Equity Compensation Plans</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">As at </font><font style="font-family:Arial;font-size:10pt;">May&#160;9, 2014</font><font style="font-family:Arial;font-size:10pt;">:</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">&#32;</font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:91.015625%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td width="25%"></td><td width="25%"></td><td width="25%"></td><td width="25%"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Plan category</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Number of Common Shares to be issued upon exercise of outstanding Options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Weighted-average exercise price of outstanding Options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Number of Common Shares remaining available for future issuance under equity compensation plans</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Equity compensation plans approved by security holders</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,001,344</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$3.61</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,380,864</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Equity compensation plans not approved by security holders</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">None</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">N/A</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">N/A</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,001,344</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$3.61</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,380,864</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><a name="se53b3ea52234485aabb3bcde07dff693"></a><div style="line-height:120%;text-align:center;padding-left:48px;text-indent:-24px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Statement of Corporate Governance Practices</font></div><div style="line-height:120%;text-align:center;padding-left:48px;text-indent:-24px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Board of Directors is responsible for overseeing the management of the business and affairs of the Corporation. The Board of Directors is responsible for establishing the Corporation's policy direction and fundamental objectives. The Board of Directors delegates to management the responsibility and authority to direct the Corporation's day-to-day operations, subject to compliance with Board-approved budgets and strategic plans. Certain matters, including the acquisition or development of new lines of business, divestments and long-term financing, among other things, must be approved in advance by the Board of Directors.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Board of Directors discharges its responsibilities through preparation for and attendance at regularly scheduled meetings, and through its committees. The Board of Directors reviews and provides advice with respect to key strategic initiatives and projects, and reviews and assesses processes relating to long range planning and budgeting. The Governance Committee assists the Board in matters pertaining to corporate values, beliefs and standards of ethical conduct, as well as other corporate governance issues and the Audit Committee assists the Board in matters pertaining to management information and internal control systems. The Board of Directors also monitors financial reports, the conduct and results of the annual independent audit, finance and accounting policies and other financial matters. In addition, the Audit Committee reviews and recommends to the Board for approval the Corporation's interim financial statements, and also reviews and recommends the year-end audited financial statements for approval by the Board. The Board of Directors also has a Compensation Committee, which is responsible for attracting, retaining and fairly compensating employees of the Corporation. The Compensation Committee is also responsible for succession planning. Subject to limited exceptions, these committees generally do not have decision-making authority. Rather, they convey their findings and make recommendations on matters falling within their respective mandates to the full Board of Directors.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Board of Directors supports the principle that its membership should represent a diversity of backgrounds, experience and skills. The Board, through the Governance Committee, reviews on an annual basis the appropriate characteristics of Board members in the context of the current composition of the Board and the objectives and needs of the Corporation.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following represents a tabular review of the corporate governance guidelines as outlined in National Instrument 58-101 - </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Disclosure of Corporate Governance Practices</font><font style="font-family:Arial;font-size:10pt;">, and the Corporation's alignment with each of them.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:91.2109375%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="49%"></td><td width="51%"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Corporate Governance Guidelines</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Commentary</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">1.Board of Directors</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(a)Disclose the identity of directors who are independent.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="padding-bottom:16px;text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">As at December 31, 2013, the Corporation had nine Board members. The seven independent directors of the Corporation are Jim Dinning, Dr. Ed Levy, Mark  Lievonen, Wayne Pisano, Robert Schultz, Fred Stewart</font><font style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font><font style="font-family:Arial;font-size:9pt;">, and Ger van Amersfoort.</font></div></td></tr></table></div></div><br><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></div><hr style="page-break-after:always"><div></div><br><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:91.2109375%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="49%"></td><td width="51%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Corporate Governance Guidelines</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Commentary</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(b) Disclose the identity of directors who are not   independent, and describe the basis for that determination.</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">The two directors of the Corporation who are not independent are Dr. Brad Thompson the Chairman and Chief Executive Officer of the Corporation and Dr. Matt Coffey the Chief Operating Officer of the Corporation.</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(c)Disclose whether or not a majority of directors are independent. </font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">A majority of the directors of the Corporation are independent.</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(d)If a director is presently a director of any other issuer that is a reporting issuer (or the equivalent) in a jurisdiction or a foreign jurisdiction, identify both the director and the other issuer.</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Directors who are presently directors of other reporting issuers and those issuers:</font></div><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Jim Dinning: Liquor Stores NA Ltd and Russel Metals Inc.; Wayne Pisano: Immunovaccine Inc.; Dr. Brad Thompson; Immunovaccine Inc. and Lorus Therapeutics Inc.</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(e)Disclose whether or not the independent directors hold regularly scheduled meetings at which non-independent directors and members of management are not in attendance. If the independent directors hold such meetings, disclose the number of meetings held since the beginning of the issuer&#8217;s most recently completed financial year. If the independent directors do not hold such meetings, describe what the board does to facilitate open and candid discussion among its independent directors.</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Independent directors hold an in camera session without the presence of any director who is not independent and without the presence of any management members, at each scheduled Board meeting. During the most recently completed financial year the independent Board members have held five such meetings.</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(f)Disclose whether or not the chair of the board is an independent director. If the board has a chair or lead director who is an independent director, disclose the identity of the independent chair or lead director, and describe his or her role and responsibilities. If the board has neither a chair that is independent nor a lead director that is independent, describe what the board does to provide leadership for its independent directors.</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">The Board has appointed a chair who is not independent, and has appointed Mr. Schultz, who is an independent and unrelated director, as Lead Director. As Lead Director, Mr. Schultz serves as an ex officio member of the Compensation Committee, the Governance Committee as well as a member of the Audit Committee.</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">The principal responsibility of the Lead Director is to ensure the independence of the Board in the discharge of its responsibilities. In this regard, the Lead Director, individually or with the support of the committees, consults with the Chairman/President and Chief Executive Officer on selection of committee members and committee chairs, Board meetings and planning meeting agendas, the format and adequacy of information provided to directors and the effectiveness of Board meetings. The Lead Director also consults directly with other directors on issues of Board independence or dissent, conflicts of interest of the Chairman/President and Chief Executive Officer, or personal liability matters.</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(g)Disclose the attendance record of each director for all board meetings held since the beginning of the issuer's most recently completed financial year.</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">There were five regularly scheduled board meetings and one special board meeting in 2013.  Schedule &#8220;A&#8221; outlines the attendance record for each director.</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">2.Board Mandate</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Disclose the text of the board's written mandate. If the board does not have a written mandate, describe how the board delineates its role and responsibilities.</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Attached as Schedule "B" hereto.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">3.Position Descriptions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(a)Disclose whether or not the board has developed written position descriptions for the chair and the chair of each board committee. If the board has not developed written position descriptions for the chair and/or the chair of each board committee, briefly describe how the board delineates the role and responsibilities of each such position.</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">The Board has developed position descriptions for the chair and the chair of each Board committee which delineate the role and responsibilities of these positions.</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(b)Disclose whether or not the board and CEO have developed a written position description for the CEO. If the board and CEO have not developed such a position description, briefly describe how the board delineates the role and responsibilities of the CEO.</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">The Board and the Chief Executive Officer have developed a written position description for the CEO which delineates the role and responsibilities of this position.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><br><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15</font></div></div><hr style="page-break-after:always"><div></div><br><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:91.2109375%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="49%"></td><td width="51%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Corporate Governance Guidelines</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Commentary</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">4.Orientation and Continuing Education</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;padding-left:22px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(a) Briefly describe what measures the board takes to orient new directors regarding:</font></div><div style="text-align:justify;padding-left:22px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"><br></font></div><div style="text-align:justify;padding-left:22px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(i) the role of the board, its committees and its directors, and</font></div><div style="text-align:justify;padding-left:22px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"><br></font></div><div style="text-align:justify;padding-left:22px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(ii)the nature and operation of the issuer's business.</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">The Board provides new directors with the Board and committee mandates and reviews these with the new Board members. The Board and management review the nature and operations of the Corporation, initially upon appointment and continually through scheduled Board meetings and other sessions as required.</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(b)Briefly describe what measures, if any, the board takes to provide continuing education for its directors. If the board does not provide continuing education, describe how the board ensures that its directors maintain the skill and knowledge necessary to meet their obligations as directors.</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">The Board provides continuing education for its Board members on issues relevant to the Corporation through Board interaction at Board meetings and ongoing communications between scheduled meetings as required or requested.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">5.Ethical Business Conduct</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(a)Disclose whether or not the board has adopted a written code for the directors, officers and employees. If the board has adopted a written code:</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">The Board has adopted a written code of conduct for the directors, officers and employees of the Corporation.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(i)disclose how a person or company may obtain a copy of the code;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">A copy of this code of conduct is available on the Corporation's website www.oncolyticsbiotech.com</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(ii)describe how the board monitors compliance with its code, or if the board does not monitor compliance, explain whether and how the board satisfies itself regarding compliance with its code; and</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">The Board satisfies itself regarding compliance with this code through its review of the activities of the Corporation, discussions by the audit committee with the external auditors of the Corporation without management present, and enquiries of management.</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(iii)provide a cross-reference to any material change report filed since the beginning of the issuer's most recently completed financial year that pertains to any conduct of a director or executive officer that constitutes a departure from the code.</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">N/A</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(b) Describe any steps the board takes to ensure directors exercise independent judgment in considering transactions and agreements in respect of which a director or executive officer has a material interest.</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">The Board encourages and supports the exercise of independent judgment by directors in considering transactions and agreements in respect of which a director or executive officer has a material interest. The Board requires that any director or officer with a material interest in a transaction or agreement under discussion disclose and declare their interest. The Board then conducts all discussions with respect to the transaction or agreement without the interested director or officer present for the determination and precludes any interested director from voting thereon.</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(c)Describe any other steps the board takes to encourage and promote a culture of ethical business conduct.</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">The Board encourages and promotes a culture of ethical business conduct through its actions and its support and interaction with management and employees of the Corporation.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">6.Nomination of Directors</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(a) Describe the process by which the board identifies new candidates for board nomination.</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">The Corporation identifies potential director candidates through a search process that includes the use of an executive search firm.  Qualifications of potential candidates are reviewed and interviews are held by members of the Governance Committee with the potential candidates.  The Governance Committee makes recommendations to the Board with respect to new director candidates.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(b)Disclose whether or not the board has a nominating committee composed entirely of independent directors. If the board does not have a nominating committee composed entirely of independent directors, describe what steps the board takes to encourage an objective nomination process.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">The Governance Committee is comprised entirely of independent directors.</font></div></td></tr></table></div></div><br><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16</font></div></div><hr style="page-break-after:always"><div></div><br><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:91.2109375%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="49%"></td><td width="51%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Corporate Governance Guidelines</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Commentary</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(c)If the board has a nominating committee, describe the responsibilities, powers and operation of the nominating committee.</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">The Governance Committee, in its capacity as the nominating committee, has the responsibility to present the annual slate of directors to the Board for the Board's approval.  Once approved by the Board, the proposed selection will be presented to the shareholders for their approval at the next scheduled annual meeting. During the year, this committee has the responsibility of locating and recommending additional directors to fill vacancies or supplement the Board as required.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">7.Compensation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(a)Describe the process by which the board determines the compensation for the issuer's directors and officers.</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">The Board has established a Compensation Committee comprised entirely of independent directors. The Compensation Committee reviews and reports to the Board on director and officer compensation issues. In determining the compensation for the directors, the committee assesses the directors' roles and responsibilities and an analysis of the competitive position of the Corporation's director compensation program including the ability to draw directors with the background and experience required to provide an effective Board. In determining the compensation for officers, similar principles are applied and an independent compensation consultant is engaged from time to time to provide additional relevant information to the Compensation Committee.</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(b)Disclose whether or not the board has a compensation committee composed entirely of independent directors. If the board does not have a compensation committee composed entirely of independent directors, describe what steps the board takes to ensure an objective process for determining such compensation.</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">The Board has a Compensation Committee comprised entirely of independent directors.</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(c)If the board has a compensation committee, describe the responsibilities, powers and operation of the compensation committee.</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">The responsibilities, powers and operation of the committee are as outlined above.</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(d)If a compensation consultant or advisor has, at any time since the beginning of the issuer's most recently completed financial year, been retained to assist in determining compensation for any of the issuer's directors and officers, disclose the identity of the consultant or advisor and briefly summarize the mandate for which they have been retained. If the consultant or advisor has been retained to perform any other work for the issuer, state that fact and briefly describe the nature of the work.</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">The Compensation Committee engaged Lane Caputo Compensation Inc. </font><font style="font-family:Arial;font-size:9pt;font-weight:bold;">("Lane Caputo")</font><font style="font-family:Arial;font-size:9pt;">&#160;in 2013.  Lane Caputo assisted the Compensation Committee with a compensation analysis on the CEO, COO and CFO positions, performed a change of control analysis, and assisted the Committee with the creation of the Sales Transaction Bonus structure.  Except as outlined above, Lane Caputo was not engaged to perform other work for the Corporation.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">8.Other Board Committees</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">If the board has standing committees other than the audit, compensation and nominating committees, identify the committees and describe their function.</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">The Board has established committees each of which are comprised entirely of independent directors. These committees are the Audit Committee, the Compensation Committee and the Governance Committee. Mandates for the Board and the Committees of the Board can be found on the Corporation's website under Investor Relations/Corporate Governance. http://www.oncolyticsbiotech.com/corporate-governance </font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">9.Assessments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Disclose whether or not the board, its committees and individual directors are regularly assessed with respect to effectiveness and contribution. If assessments are regularly conducted, describe the process used for the assessments. If assessments are not regularly conducted, describe how the board satisfies itself that the board, its committees, and its individual directors are performing effectively.</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">The Board, through its Governance Committee assesses, at least annually, the effectiveness and contribution of each member of the Board. The assessment is conducted through dialogue with Board members and is part of the information used in setting the slate of directors to be proposed to the shareholders at the next annual meeting.</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Note:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">1)  Mr. Stewart is not standing for re-election to the Board. </font></div><a name="se65456db1746427994dc7c8e89ee857c"></a><div style="line-height:120%;text-align:center;padding-left:48px;text-indent:-24px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Matters to be Acted Upon at the Meeting</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Receipt of Financial Statements</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The audited financial statements for the financial year ended December 31, 2013 of the Corporation have been delivered to Shareholders. No formal action will be taken at the Meeting to approve the financial statements. If any Shareholder </font></div><br><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17</font></div></div><hr style="page-break-after:always"><div></div><br><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">has questions respecting the December 31, 2013 financial statements, the questions may be brought forward at the Meeting.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Fixing Number of Directors of the Corporation</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">It is the intention of the persons named in the enclosed Instrument of Proxy, if not expressly directed to the contrary in such Instrument of Proxy, to vote such proxies FOR the ordinary resolution to fix the number of directors of the Corporation at </font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">ten</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;(</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">10</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">).</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Election of Directors</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The articles of the Corporation provide for a minimum of 3 directors and a maximum of 11 directors. There are currently nine (9) directors. At the Meeting, a board of </font><font style="font-family:Arial;font-size:10pt;font-weight:normal;">ten</font><font style="font-family:inherit;font-size:10pt;">&#32;(</font><font style="font-family:Arial;font-size:10pt;font-weight:normal;">10</font><font style="font-family:Arial;font-size:10pt;">) directors are to be elected. </font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">It is the intention of the persons named in the enclosed Instrument of Proxy, if not expressly directed to the contrary in such Instrument of Proxy, to vote such proxies FOR the ordinary resolution to elect each of the nominees specified below as directors of the Corporation.</font><font style="font-family:Arial;font-size:10pt;">&#32;If, prior to the Meeting, any vacancies occur in the slate of proposed nominees herein submitted, the persons named in the enclosed Instrument of Proxy intend to vote FOR the election of any substitute nominee or nominees recommended by management of the Corporation and FOR the remaining proposed nominees.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The term of office for each director of the Corporation is from the date of the Shareholders' meeting at which he or she is elected until the next annual meeting of the Shareholders or until his or her successor is elected or appointed.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following table states the names and municipalities of residence of all persons proposed to be nominated for election as directors of the Corporation, the position or office now held by them, their principal occupation or employment history, the date on which they became directors of the Corporation and the number of Common Shares owned by them or over which they exercise control or direction as at </font><font style="font-family:Arial;font-size:10pt;">May&#160;9, 2014</font><font style="font-family:Arial;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:90.8203125%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td width="31%"></td><td width="40%"></td><td width="15%"></td><td width="14%"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Name, municipality of residence and date appointed a director</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Five year history of principal occupations</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Number of Common Shares beneficially owned and controlled</font><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(5)</sup></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Number of Options held</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Matt Coffey, Ph.D.</font></div><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-style:italic;">Calgary, Alberta, Canada</font></div><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Director since May 11, 2011</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Chief Operating Officer of the Corporation since December 2008. Since April 1999 to December 2008, Dr. Coffey held other senior management positions with the Corporation and is a co-founder of Oncolytics.</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">288,550</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">886,333</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Jim Dinning</font><font style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)(3)</sup></font></div><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-style:italic;">Calgary, Alberta, Canada</font></div><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Director since March 24, 2004</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Chair of Western Financial Group since September 2004. Mr. Dinning was Executive Vice President of TransAlta Corporation (power generation and wholesale marketing company) from 1997 to 2004. Mr. Dinning is the Chair and Director of other public companies and not for profit entities. He is the former Chair of Export Development Canada. He will complete his four year term as Chancellor of the University of Calgary in June 2014. </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">45,000</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">207,500</font></div></td></tr></table></div></div><br><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18</font></div></div><hr style="page-break-after:always"><div></div><br><div style="line-height:120%;text-align:center;font-size:9pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:90.8203125%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td width="31%"></td><td width="40%"></td><td width="15%"></td><td width="14%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Name, municipality of residence and date appointed a director</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Five year history of principal occupations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="padding-bottom:16px;text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Number of Common Shares beneficially owned and controlled</font><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(5)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Number of Options held</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Linda Hohol, FICB</font></div><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-style:italic;">Calgary, Alberta, Canada</font></div><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"><br></font></div><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-style:italic;">Nominated for Director</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Ms. Hohol acquired significant experience and exposure to accounting and financial reporting issues as the former President of TSX Venture Exchange Inc. at the TMX Group Inc. in addition to her prior roles as the Executive Vice President, Wealth Management and Senior Vice President Alta and NWT for Canadian Imperial Bank of Commerce where she spent 26 years. Ms. Hohol currently serves on the Board of Directors of EllisDon Construction, Canadian Western Bank and NAV Canada and serves on the Audit and Finance Committees of all three companies. She has served on many Boards, including the Board of ATB Financial (Chair of the Risk Committee) as well as The Calgary Airport Authority, Canada Foundation for Innovation and United Way of Calgary (Chair of &#160;Audit and Finance Committees).</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">__</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">__</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Angela Holtham, F.C.P.A, F.C.M.A, ICD.D</font></div><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-style:italic;">Mississauga, Ontario, Canada</font></div><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"><br></font></div><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-style:italic;">Nominated for Director</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Ms. Holtham holds a number of governance positions in Canada including: board member &amp; chair of the Audit &amp; Risk Management Committee, Ontario Financing Authority (the Agency that manages the province&#8217;s debt and investments); Board director and Audit &amp; Finance Committee member, CMA Canada; and Resources &amp; Audit Committee member, Plexxus (supply chain &amp; IT service provider for 10 GTA hospitals). </font></div><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"><br></font></div><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Ms. Holtham also works part time providing finance executive services on contract after retiring from full time employment after 8 years as the Vice President Finance and CFO of The Hospital for Sick Children in Toronto.  Prior to that, she held a number of positions in both the for-profit and not-for-profit sectors, including 20 years with Nabisco Canada, the last 5 as Senior Vice President and CFO.</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">__</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">__</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Ed Levy, Ph.D.</font><font style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)(3)</sup></font></div><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-style:italic;">Lund, British Columbia, Canada</font></div><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Director since May 17, 2006</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Adjunct professor at the W. Maurice Young Centre for Applied Ethics at the University of British Columbia since retiring from QLT Inc. in late 2002.</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">27,200</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">215,000</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">J. Mark Lievonen,</font><font style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)(3)</sup></font><font style="font-family:Arial;font-size:9pt;">&#160;F.C.P.A., F.C.A.</font></div><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-style:italic;">Stouffville, Ontario, Canada</font></div><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Director since April 5, 2004</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">President of Sanofi Pasteur Limited, a vaccine development, manufacturing and marketing company, since October 1998.&#160; Mr. Lievonen serves on a number of industry and not-for-profit boards including Rx&amp;D, BIOTECanada, the Ontario Institute for Cancer Research and York University, and is a past Chair of BIOTECanada and the Ontario Genomics Institute.</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3,000</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">207,500</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Wayne Pisano</font><font style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></font></div><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-style:italic;">Asbury, New Jersey, USA</font></div><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Director since May 9, 2013</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Mr. Pisano has more than 30 years of experience as a pharmaceutical industry executive and was recognized in 2010 as Pharma Executive of the Year by the World Vaccine Congress. He is currently the president and CEO of VaxInnate a privately held biotech company. Mr. Pisano is the former president and CEO of Sanofi Pasteur, one of the largest vaccine companies in the world. Prior to joining Sanofi Pasteur, he spent 11 years with Novartis (formerly Sandoz). He has a bachelor&#8217;s degree in biology from St. John Fisher College, New York and an MBA from the University of Dayton, Ohio.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">__</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">80,000</font></div></td></tr></table></div></div><br><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19</font></div></div><hr style="page-break-after:always"><div></div><br><div style="line-height:120%;text-align:center;font-size:9pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:90.8203125%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td width="31%"></td><td width="40%"></td><td width="15%"></td><td width="14%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Name, municipality of residence and date appointed a director</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Five year history of principal occupations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="padding-bottom:16px;text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Number of Common Shares beneficially owned and controlled</font><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(5)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Number of Options held</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Robert B. Schultz,</font><font style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)(4)</sup></font><font style="font-family:Arial;font-size:9pt;">&#160;F.C.P.A,  F.C.A.</font></div><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-style:italic;">Toronto, Ontario, Canada</font></div><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Director since June 30, 2000</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Former Chairman and Director of Rockwater Capital Corporation (a financial services company) from 2001 to 2007. Chairman and Chief Executive Officer of Merrill Lynch Canada from August 1998 until his retirement on May 1, 2000. Prior to this, Mr. Schultz was Chief Executive Officer of Midland Walwyn. Since joining the investment industry in 1971, Mr. Schultz held a variety of senior positions, and has participated on various industry-related boards and committees including Director and Chairman of the Investment Dealers Association of Canada.</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">20,000</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">381,500</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Bradley G. Thompson, Ph.D.</font></div><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-style:italic;">Calgary, Alberta, Canada</font></div><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Director since April 21, 1999</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Executive Chairman of the Board, President and Chief Executive Officer of Oncolytics since April 1999.</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">662,900</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,652,160</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Ger van Amersfoort</font><font style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></font></div><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-style:italic;">Zaltbommel, The Netherlands </font></div><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Director since June 15, 2006</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">President and Chief Executive Officer of Novartis Canada, a pharmaceutical company, until his retirement in 2001.</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">16,000</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">215,000</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Notes:</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">These persons are members of the Audit Committee.  Mr. Stewart was the Chair of the Audit Committee.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">These persons are members of the Compensation Committee. Mr. Dinning is the Chair of the Compensation Committee.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(3)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">These persons are members of the Governance Committee. Mr. Lievonen is the Chair of the Governance Committee.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(4)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Mr. Schultz, as Lead Director, serves as an ex officio member of the Compensation Committee and the Governance Committee.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(5)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">The information as to the number of Common Shares beneficially owned, not being within the knowledge of the Corporation, has been furnished by the respective nominees.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Other than as described below, no proposed director: (a) is at the date of this Information Circular, or has been, within 10 years before the date of this Information Circular, a director or executive officer of any company that, while that person was acting in that capacity, (i) was the subject of a cease trade or similar order or an order that denied the relevant company access to any exemption under securities legislation, for a period of more than 30 consecutive days; (ii) was subject to an event that resulted, after the director or executive officer ceased to be a director or executive officer, in the company being the subject of a cease trade or similar order or an order that denied the relevant company access to any exemption under securities legislation, for a period of more than 30 consecutive days; or (iii) within a year of that person ceasing to act in that capacity, became bankrupt, made a proposal under any legislation relating to bankruptcy or insolvency or was subject to or instituted any proceedings, arrangement or compromise with creditors or had a receiver, receiver manager or trustee appointed to hold its assets; or (b) has, within the 10 years before the date of this Information Circular, become bankrupt, made a proposal under any legislation relating to bankruptcy or insolvency, or become subject to or instituted any proceedings, arrangement or compromise with creditors, or had a receiver, receiver manager or trustee appointed to hold the assets of the proposed director.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Majority Voting Policy</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Board has adopted a Majority Voting Policy which relates to the election of directors. This policy requires that any nominee for director who, on a ballot taken on the election of directors, has a greater number of votes withheld from voting than the number of votes received for his or her election shall tender his or her resignation to the lead director and to the President, subject to acceptance by the Board. The policy does not apply in circumstances involving contested director elections. The Board is required to consider the resignation, having regard to the best interests of the Corporation and all factors considered relevant and to: (i) accept the resignation; (ii) maintain the director but address what the Board believes to be the underlying cause of the withhold votes; or, (iii) reject the resignation . The Board is required to make its decision and announce it in a press release within 90 days of the annual meeting, including, if applicable, the reasons for rejecting a resignation offer. A director who is required to tender a resignation under the policy will not participate in the deliberations of the Board with respect to his or her resignation unless there are fewer than three directors who are not required to tender a resignation, in which event the entire Board will proceed in making the determination. To the extent that the Board accepts one or more director resignations, the Board will also determine whether to fill any vacancy prior to the next meeting of the shareholders.</font></div><br><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20</font></div></div><hr style="page-break-after:always"><div></div><br><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Appointment of Auditors</font></div><div style="line-height:120%;text-align:center;padding-left:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Corporation has requested that Ernst &amp; Young LLP, Chartered Accountants of Calgary, Alberta act as independent auditors for the Corporation subject to Shareholder approval. </font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Unless otherwise directed, it is management's intention to vote the proxies FOR the ordinary resolution to appoint the firm of Ernst &amp; Young LLP, Chartered Accountants, as auditors of the Corporation to hold office until the close of the next annual meeting of Shareholders or until the firm of Ernst &amp; Young LLP, Chartered Accountants is removed from office or resigns as provided by law or by the Corporation's by-laws, and to authorize the directors of the Corporation to fix the remuneration of Ernst &amp; Young LLP, Chartered Accountants, as auditors of the Corporation.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Interest of Certain Persons in Matters to be Acted Upon</font></div><div style="line-height:120%;text-align:center;padding-left:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Except as described elsewhere herein, none of the directors or senior officers of the Corporation, nor any of their known associates, has any substantial interest, direct or indirect, by way of beneficial ownership of securities or otherwise, in any matter to be acted upon at the Meeting.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Other Matters to be Acted Upon</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Management of the Corporation knows of no amendment, variation or other matter to come before the Meeting other than the matters referred to in the Notice of Meeting. However, if any other matters properly come before the Meeting, the accompanying proxy will be voted on such matters in accordance with the best judgment of the person or persons voting the proxy.</font></div><a name="s632da167f8014c4dbd0507c704cc3de8"></a><div style="line-height:120%;text-align:center;padding-left:48px;text-indent:-24px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Effective Date</font></div><div style="line-height:120%;text-align:center;padding-left:48px;text-indent:-24px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Except as otherwise specified herein, the information set forth in this Information Circular is provided as of </font><font style="font-family:Arial;font-size:10pt;">May&#160;9, 2014</font><font style="font-family:Arial;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:center;padding-left:48px;text-indent:-24px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Additional Information</font></div><div style="line-height:120%;text-align:center;padding-left:48px;text-indent:-24px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Additional information relating to the Corporation is available through the Internet on the Canadian System for Electronic Document Analysis and Retrieval (SEDAR) which can be accessed at www.sedar.com. Financial information of the Corporation is provided in the comparative financial statements and management's discussion and analysis of the Corporation for the most recently completed financial year. Copies of the financial statements and management discussion and analysis of the Corporation may be obtained from the Chief Financial Officer of the Corporation at Suite 210, 1167 Kensington Crescent N.W., Calgary, Alberta, T2N&#160;1X7 or by facsimile at (403) 283-0858.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21</font></div></div><hr style="page-break-after:always"><a name="sc04205f4d09143869b1154c47a057419"></a><div></div><br><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Schedule A</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Board and Committee Meetings Attended</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:98.046875%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"></td></tr><tr><td width="21%"></td><td width="16%"></td><td width="16%"></td><td width="15%"></td><td width="16%"></td><td width="16%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Regular Board Meeting</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Special Board Meeting</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Audit Committee</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Governance Committee</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Compensation Committee</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Dr. Matt Coffey</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5 of 5</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1 of 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">N/A</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">N/A</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">N/A</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Jim Dinning</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5 of 5</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0 of 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">N/A</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4 of 4</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">6 of 6</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Dr. Ed Levy</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5 of 5</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1 of 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">N/A</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4 of 4</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">N/A</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Mark Lievonen</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5 of 5</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1 of 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4 of 4</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4 of 4</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">N/A</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Wayne Pisano</font><font style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3 of 3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">N/A</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">N/A</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">N/A</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4 of 4</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Robert Schultz</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5 of 5</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1 of 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4 of 4</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4 of 4</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">6 of 6</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Fred Stewart</font><font style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4 of 5</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1 of 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3 of 4</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">N/A</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">N/A</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Dr. Brad Thompson</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5 of 5</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1 of 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">N/A</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">N/A</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">N/A</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Ger van Amersfoort</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5 of 5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1 of 1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">N/A</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">N/A</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">6 of 6</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;text-indent:37px;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Note:</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:56px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:8pt;">Mr. Pisano was elected to the Board on May 9, 2013 and was appointed to sit on the Compensation Committee.  The number of meetings reflects those meetings held after this date.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:56px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:36px;"><font style="font-family:Arial;font-size:8pt;">2)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Mr. Stewart is not standing for re-election to the Board.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A -  1</font></div></div><hr style="page-break-after:always"><a name="s6f19729de1054b359f0500e5cc41bf16"></a><div></div><br><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">SCHEDULE B</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">MANDATE OF THE BOARD OF DIRECTORS</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">ONCOLYTICS BIOTECH INC.</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">1.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Policy Statement</font></div></td></tr></table><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Board of Directors (the "Board") of Oncolytics Biotech Inc. (the "Corporation") has the responsibility to oversee the conduct of the business of the Corporation and to oversee the activities of management who are responsible for the day-to-day conduct of the business of the Corporation.</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">2.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Composition and Operation</font></div></td></tr></table><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Board is to be constituted of a majority of individuals who qualify as unrelated directors. An unrelated director is one who meets the requirements of NASDAQ Rule 5605 and National Instrument 58-101 who is independent of management and is free from any interest and any business or other relationship which could or could reasonably be perceived to materially interfere with the director's ability to act with a view to the best interests of the Corporation other than interests and relationships arising from shareholdings. In determining whether a director is independent of management, the Board shall make reference to the then current legislation, rules, policies and instruments of applicable regulatory authorities.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Chairman:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The members of the Board shall elect a Chair from among the members of the Board and the Chair shall preside at all meetings of the Board. The Chair of the Board shall be responsible for leadership of the Board, including preparing or approving the agenda, presiding over the meetings, and making board assignments.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Lead Director:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The independent members of the Board shall elect a Lead Director from among the independent members in the event the Chair of the Board is not independent. The Lead Director's role is to ensure the independence of the Board in the discharge of its responsibilities. In this regard, the Lead Director, individually or with the support of the committees and the Chairman/President and Chief Executive Officer, shall facilitate the selection of committee members and chairs, shall prepare or approve Board meeting and planning meeting agendas, shall assess the format and adequacy of information provided to directors and the effectiveness of Board meetings. The Lead Director shall also consult directly with other directors on issues of Board independence or dissent, conflicts of interest of the Chairman/President and Chief Executive Officer, or personal liability matters.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Board operates by delegating certain of its authorities to management and by reserving certain powers to itself. The Board retains the responsibility of managing its own affairs including selecting its Chairman, nominating candidates for election to the Board, constituting committees of the full Board and determining compensation for the directors. Subject to the Articles and By-Laws of the Corporation and the Business Corporations Act (Alberta), the Board may constitute, seek the advice of and delegate powers, duties and responsibilities to committees of the Board. The Board may establish ongoing committees of the Board with specific mandates and obligations to report to the entire Board, as well as establish ad hoc committees to deal with particular issues that might arise from time to time. The Board has presently established the following committees: the Audit Committee, the Governance Committee and the Compensation Committee.</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">3.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Responsibilities</font></div></td></tr></table><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Board's fundamental objectives are to enhance and preserve long-term shareholder value, to ensure the Corporation meets its obligations on an ongoing basis and that the Corporation operates in a reliable and safe manner. In performing its functions, the Board should also consider the legitimate interests its other stakeholders such as employees, customers and communities may have in the Corporation. In broad terms, the stewardship of the Corporation involves the Board in strategic planning, risk management and mitigation, senior management determination, communication planning and internal control integrity.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Board is essentially accountable to shareholders. In pursuing its objectives, the Board recognizes that the Corporation affects and is affected by many stakeholders. The Board will take these relationships into consideration in discharging its responsibilities, but these relationships do not change the nature of the Board's accountability.</font></div><br><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">B -  1</font></div></div><hr style="page-break-after:always"><a name="s6f19729de1054b359f0500e5cc41bf16"></a><div></div><br><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">4.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Specific Duties</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;"></font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Legal Requirements</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Board has the oversight responsibility for meeting the Corporation's legal requirements and for properly preparing, approving and maintaining the Corporation's documents and records.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Board has the statutory responsibility to:</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:144px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:96px;"><font style="font-family:Arial;font-size:10pt;">(i)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">manage the business and affairs of the Corporation;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:144px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:96px;"><font style="font-family:Arial;font-size:10pt;">(ii)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">act honestly and in good faith with a view to the best interests of the Corporation;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:144px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:96px;"><font style="font-family:Arial;font-size:10pt;">(iii)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">exercise the care, diligence and skill that responsible, prudent people would exercise in comparable circumstances; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:144px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:96px;"><font style="font-family:Arial;font-size:10pt;">(iv)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">act in accordance with its obligations contained in the </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Business Corporations Act</font><font style="font-family:Arial;font-size:10pt;">&#32;(Alberta) and the regulations thereto, the Articles and By-Laws of the Corporation, and other relevant legislation and regulations.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">(c)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Board has the statutory responsibility for considering the following matters as a full Board which in law may not be delegated to management or to a committee of the Board:</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:144px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:96px;"><font style="font-family:Arial;font-size:10pt;">(i)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">any submission to the shareholders of a question or matter requiring the approval of the shareholders;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:144px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:96px;"><font style="font-family:Arial;font-size:10pt;">(ii)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">the filling of a vacancy among the Directors;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:144px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:96px;"><font style="font-family:Arial;font-size:10pt;">(iii)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">the issuance of securities;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:144px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:96px;"><font style="font-family:Arial;font-size:10pt;">(iv)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">the declaration of dividends;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:144px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:96px;"><font style="font-family:Arial;font-size:10pt;">(v)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">the purchase, redemption or any other form of acquisition of shares issued by the Corporation;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:144px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:96px;"><font style="font-family:Arial;font-size:10pt;">(vi)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">the payment of a commission to any person in consideration of his/her purchasing or agreeing to purchase shares of the Corporation from the Corporation or from any other person, or procuring or agreeing to procure purchasers for any such shares;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:144px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:96px;"><font style="font-family:Arial;font-size:10pt;">(vii)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">the approval of management proxy circulars;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:144px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:96px;"><font style="font-family:Arial;font-size:10pt;">(viii)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">the approval of the audited annual financial statements;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:144px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:96px;"><font style="font-family:Arial;font-size:10pt;">(ix)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">the adoption, amendment or repeal of by-laws;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:144px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:96px;"><font style="font-family:Arial;font-size:10pt;">(x)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">review and approve all securities offering documents (including documents incorporated therein by reference) of the Corporation; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:144px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:96px;"><font style="font-family:Arial;font-size:10pt;">(xi)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">All material significant transactions, including, any take-over bid, proposed merger, amalgamation, arrangement, and acquisition of all or substantially all of the assets of the Corporation or of another entity by the Corporation, or any similar form of business combination and the establishment of any credit facilities and any other long-term debt commitments, including the approval of any agreements, circulars or other documents in connection therewith.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;"></font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Independence</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Board shall have the responsibility to:</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:144px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:96px;"><font style="font-family:Arial;font-size:10pt;">(i)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">implement appropriate structures and procedures to permit the Board to function independently of management;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:144px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:96px;"><font style="font-family:Arial;font-size:10pt;">(ii)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">schedule meetings of the independent Board members separately from management and management directors as part of each regularly scheduled Board meeting;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:144px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:96px;"><font style="font-family:Arial;font-size:10pt;">(iii)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">implement a system which enables an individual director to engage an outside advisor at the expense of the Corporation in appropriate circumstances; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:144px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:96px;"><font style="font-family:Arial;font-size:10pt;">(iv)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">provide an orientation and education program for newly appointed members of the Board.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:144px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:96px;"><font style="font-family:Arial;font-size:10pt;">(v)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In order to allow the Board to function independently of management during the period of time that the Chairman of the Board is also the Chief Executive Officer of the Corporation, the position of Lead Director shall be instituted. In this regard, the Lead Director, individually or with the support of the Governance Committee, will consult with the Chairman/CEO on selection of the committee members and chairs, Board meeting and planning meeting agendas, the format and adequacy of information provided to directors and the effectiveness of meetings of the Board. The Lead Director will also consult directly with other directors on issues of Board independence or dissent, conflicts of interest of the Chairman/CEO, or personal liability matters. The Lead Director will also participate with the members of the Compensation Committee evaluating the performance of the CEO.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;"></font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Strategy Determination</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Board shall:</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:144px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:96px;"><font style="font-family:Arial;font-size:10pt;">(i)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">adopt and annually review a strategic planning process and approve the corporate strategic plan, which takes into account, among other things, the opportunities and risks of the business; and</font></div></td></tr></table><br><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">B -  2</font></div></div><hr style="page-break-after:always"><a name="s6f19729de1054b359f0500e5cc41bf16"></a><div></div><br><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:144px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:96px;"><font style="font-family:Arial;font-size:10pt;">(ii)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">annually review operating and financial performance results relative to established strategy, budgets and objectives.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;"></font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Managing Risk</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Board has the responsibility to understand the principal risks of the business in which the Corporation is engaged, to achieve a proper balance between risks incurred and the potential return to shareholders, and to confirm that there are systems in place which effectively monitor and manage those risks with a view to the long-term viability of the Corporation.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Board shall review the amount and terms of any insurance to be obtained or maintained by the Corporation with respect to risks inherent in its operations and potential liabilities incurred by the directors or officers in the discharge of their duties and responsibilities.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;"></font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Appointment, Training and Monitoring of Senior Management</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Board shall:</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:144px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:96px;"><font style="font-family:Arial;font-size:10pt;">(i)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">appoint the Chief Executive Officer ("CEO"), the Chief Financial Officer and senior officers, approve (upon recommendations from the Compensation Committee) their compensation, and monitor the CEO's performance against a set of mutually agreed corporate objectives directed at maximizing shareholder value;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:144px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:96px;"><font style="font-family:Arial;font-size:10pt;">(ii)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">ensure that a process is established that adequately provides for succession planning including the appointment, training and monitoring of senior management;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:144px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:96px;"><font style="font-family:Arial;font-size:10pt;">(iii)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">establish limits of authority delegated to management through the annual business plan; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:144px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:96px;"><font style="font-family:Arial;font-size:10pt;">(iv)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">implement and monitor an appropriate Code of Ethics for all directors, officers and employees of the Corporation.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;"></font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Reporting and Communication</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Board has the responsibility to:</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:144px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:96px;"><font style="font-family:Arial;font-size:10pt;">(i)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">verify that the Corporation has in place policies and programs to enable the Corporation to communicate effectively with its shareholders, other stakeholders and the public generally;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:144px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:96px;"><font style="font-family:Arial;font-size:10pt;">(ii)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">verify that the financial performance of the Corporation is adequately reported to shareholders, other security holders and regulators on a timely and regular basis;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:144px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:96px;"><font style="font-family:Arial;font-size:10pt;">(iii)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">verify that the financial results are reported fairly and in accordance with generally accepted accounting standards;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:144px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:96px;"><font style="font-family:Arial;font-size:10pt;">(iv)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">verify the timely reporting of any other developments that have a significant and material impact on the value of the Corporation; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:144px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:96px;"><font style="font-family:Arial;font-size:10pt;">(v)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">report annually to shareholders on its stewardship of the affairs of the Corporation for the preceding year.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;"></font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Monitoring and Acting</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Board has the responsibility to:</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:144px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:96px;"><font style="font-family:Arial;font-size:10pt;">(i)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">review and approve the Corporation's financial statements and oversee the Corporation's compliance with applicable audit, accounting and reporting requirements;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:144px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:96px;"><font style="font-family:Arial;font-size:10pt;">(ii)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">verify that the Corporation operates at all time within applicable laws and regulations to the highest ethical and moral standards;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:144px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:96px;"><font style="font-family:Arial;font-size:10pt;">(iii)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">approve and monitor compliance with significant policies and procedures by which the Corporation is operated;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:144px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:96px;"><font style="font-family:Arial;font-size:10pt;">(iv)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">monitor the Corporation's progress towards its goals and objectives and to revise and alter its direction through management in response to changing circumstances;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:144px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:96px;"><font style="font-family:Arial;font-size:10pt;">(v)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">take such action as it determines appropriate when performance falls short of its goals and objectives or when other special circumstances warrant; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:144px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:96px;"><font style="font-family:Arial;font-size:10pt;">(vi)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">verify that the Corporation has implemented adequate internal control and information systems which ensure the effective discharge of its responsibilities.</font></div></td></tr></table><div style="line-height:120%;padding-left:0px;text-align:justify;"><font style="text-align:justify;font-family:inherit;font-size:10pt;padding-right:48px;">5.</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Other Activities</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Board shall prepare and distribute the schedule of Board meetings for each upcoming year.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Board may perform any other activities consistent with this Mandate, the By-Laws of the Corporation and any other governing laws as the Board determines necessary or appropriate.</font></div></td></tr></table><div style="line-height:120%;padding-left:0px;text-align:justify;"><font style="text-align:justify;font-family:inherit;font-size:10pt;padding-right:48px;">6.</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Date of Mandate</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">This Mandate was last reviewed and approved by the Board on March 12, 2014.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">B -  3</font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex9912014_chart-32924.jpg
<TEXT>
begin 644 ex9912014_chart-32924.jpg
M_]C_X``02D9)1@`!`0```0`!``#_VP!#``$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_
MVP!#`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_P``1"`'@`F4#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#^_BBBB@`H
MHHH`****`"BBB@`HHIN]<]2?<*Q7C(.6`*C&#G)X[T`.HI,CCKSTP"?Y`X'N
M>*"<8Z\\<`G\\#CZGB@!:*3(SCG/T./7KC'Z^W6C(SCG\CC\\8_6@!:*3.<C
MGCV(_(D8/X9HSUZ\>Q_3CG\,T`+1103@9Y_`$G\ADT`%%)D8SSCZ$G\@,_48
MX[TFX>C?]\/_`/$T`.HI-PYZ\?[+=_3CG\.G>ESQG\>AS^77\.M`!13=P]&Y
M_P!EOUXX_&E#`],_BK#^8%`"T4A('7/X`G^0-(&!XPWXJP_4C%`#J*:74>I[
M':K-@^AV@X/(X.*7(QGJ.G`)Y!P1@`G@\'T/6@!:*;N'HW_?#_\`Q-*2!US^
M`)/Y`$_C0`M%%%`!103CG^0)_0<TW</<`<DE6``]22`!0`ZBD)`QU.?0$_R!
MI-P/9O7[K#^8_3K0`ZBF[AZ-_P!\/_\`$TN1QUY]C^O''XXH`6BDSSCGGV./
MQ.,#\32;AZ-_WRQ_D*`'44F1R?3K@$D=\8ZYP0<8Z$&C/&>?7H<_EC/X8S0`
MM%'^?3^=(6`ZY/L`6/.<'"@G!P><=CZ4`+12`@]#]1T(R,\@\@XYP0#0#GGG
M\01^A`-`"T4@.>>?Q!'Z$`U4N]0L;`VPO;RUM#>74-C:"YN(8#=7MP',%I;B
M9T,]U.(Y##;1;YY1&YCC;8V`"Y10""`0001D$<@@]"#W!I`<],]<<@C^8''O
MT/:@!:*0,#T/7IZ'C/!Z-QSQF@L!U/U/.!@9Y/0<'/..*`%HHI,CGKQ[']..
M?PS0`M%)D8SSCZ'/Y8SGVQFC(SCGIGH0/S(QGVZT`+129Q@<\^Q/YD#`_'%)
MN'HW_?#_`/Q-`#J*3<,`\\]`003UX`QDG`)QCH,]*0,#TR#Z%2IXQD@,`2!D
M9(XY%`#J*;N'HW_?#_\`Q-+N&,_-_P!\MG\L9_2@!:*0G`SS^`)/Y`$_I1N`
MP>>?]EC^8`R/QQ0`M%(&!./F_%6`_,@"@'/KZ<@C^8'Y]*`%HI-PQGGKC[K9
M_+&<>_3WI-P]&_[X?_XF@!U%%%`!1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`?&_P#P4)_:ED_8H_8F_:=_:IMM%MO$>J?!#X/>+_''AW0+XS+I
MVM>++2R%CX/TK57MGCN8M(OO%.H:/;ZO-;.EQ%ICW;P.LJHP_F9_9K_X)/\`
M[<?[>O[#/@+_`(*!^,/^"MO[<'@W]OW]H7X<6O[0?PDM_"GQ>U#P)^RU\.Y/
M%EK<^*/AE\.]1^%GAC3#-9^$[O2KC2+?Q5=>&6T^ST1]1N#IOA'7[72);/Q%
M_4A^VE^S%X:_;/\`V4/V@?V6/%NIW&A:)\=OA7XM^'4OB&TMUO+KPSJ&N:<Z
MZ%XHMK%Y(8[^?PUK\.E:[%82S0Q7S:?]DDEC2=G7^7OX5^.?^#AS]D/]BG3_
M`/@F#\//^"<6C>/OBS\.O!=Y\`?@7^W[X*_:%^'NG_"'1/AHL5UH/@_XF7'A
M'Q&MGJ=MXL\`>';NV7P_'XBOO#\TMSI.F:GKW@N_N["]T?6@#U;_`(*8_$;]
MN+X%^+O^#<_X?_&G]H"<?''Q?^W3\/\`X<_M1>(?V>/%/C;P)\,OCBEKXH^%
MFFW0UW0(%\*CQ!H?B+2;DW>O^']8T"U\.R:SJNO#2M!T[1[JWL8O>O\`@NY\
M8OBY\,/VN/\`@A;H/PV^*7Q&^'NA_$W_`(*,>%?"/Q(T;P/XV\2>%-*^('A2
M?Q/\(X)O#/C;3M"U*QM/%7AZ:#4+^&71M=AOM.DBO;N-K<K<2A^'_P""DG_!
M-[_@I'\3/V+/^"9GQ%\&^/?"O[7O_!0[_@G'\:_`'[1'C.'Q3+X;\!Z-\?\`
MQ%IDUCKGB?P_X=OUM/!7A]6T#6-#\,Z)HLNL#PG?>,/"6E:EJU_>6_C6]@M+
MWQGQE\./^"I'_!7;]O?_`()M_$#X_P#_``3RO_\`@GY^S?\`L"?&8_M"^/?$
M/Q'^-W@[XD^)OB1X]TV[\+:SI_A;P7I'ABST;49;";4?`^FZ597CZ.=.BT[6
M-8UO5M?2:STS1=2`/SJ^/O[8_P"UE\`?^#DOXP_%"3]H3XV3?L?_``5_;4_8
MM_9_^*'P6N?B;XVN?@[H/A']L/\`9ZF\*1^(I?A[<:^?!=IIWA[7M'U7Q.0F
MBHR>*)K#6()$U`-*]CX]?M@?M7_%?_@XP^%7B+P1^T7\9?#7[(WAG_@IA\*_
MV"M.^$7AKXG^.-&^&_BGQ)\$?!_@V]^.,&O>#=*UVT\)ZVL_C+Q->QZY#?:3
M=-?6VJZ=;WS216L"5]B?M@_\$G_VP?V@/C)_P<9ZQI'P:UR#3?VG_"7[$OQ"
M_8P\7)KW@RWD^)/Q6_9@TG0?%$^F^%&D\2I=^']6DU/1-0\&)>>*H/#UFQUV
M4I=FU=[E?*/V;_\`@D=^W?\`#7P=_P`$+/%7CCX->+-<^,'@O_@H]^T1^V;^
MWWJ=YXE\!WFI_#S4OBGXU^'-GIWBGQC?IXJ\KQ'J.H^"/`6CZAJ+>%'\07*W
MD=_$]O'-Y4,@!^H/_!'+XP_%OX@_\%0_^"__`(*\>_%+XB^-_!OPK_:;^$NC
M?##PGXN\;>)/$GAGX<Z/?S?');[2O`>A:QJ5YI?A#3;Q=+TU;NQT"UT^UN!I
M]B)8G^RP;/A'X9?M'_M"R:]_P=XM+\=_C'*W[/NA>+[KX#&;XF>,IQ\$[FT^
M&O[35[:S_"5)M8D3X=2VUYHFBW<#^$ETDQW.D:9.N)+&V:/VW4/A1_P4X_X)
M4_\`!3K_`(*`?M,?LV_L(W'_``4%_9?_`."AFL>!OB5<6WP[^+W@_P"&GQ)^
M%GQ$\)6.M!]%UNR\36VIW,VG/K/B_P`5QRS67A_4=+U'0KCP[JL'B+3=8T[6
MM"GQ/V3O^"<G[>J_L2_\%Y_CI^T7\&](\"_M:_\`!5OPQ\9M<^'_`.R[X3\9
M^'O%.I^#HYOAO\5[/P!X/U/Q8FKKX477M>UWXFSZ+;0W&M@66G:/INH^(+W2
MK[5+S2=)`/V0_P""'?Q"\>_%?_@D_P#L.?$3XG^-?%?Q%\?>+/@G8ZKXH\;>
M./$&J>*O%GB+4W\2^)8'U#7/$&MW5[JNJWK0000M=7UU/.T4,2-(5C4#\^/^
M#@[XW_M$?$'Q)^Q!_P`$KOV*/BUXF^#_`.T]^W)\7KWQ#K?Q"\$>)/%'AC7O
MAW\"O@]I5]KGB+6M2UGP9>Z9XFT?1-9UY5U&[N=,OX'U/0_AWXJT=O-ANIHG
M^8/^"?W[3_\`P6P_89_8U_9]_9+'_!!GXA_$H_`OP#!X(_X3S_AL[X(^$O\`
MA)S!JFJZD-2/ALZ+XB_L@,VI>3]D&MZB1Y1D^T$2"..?4O\`@DG^V!_P4P_X
M*F_M:_ML?M/?$3]KS_@G;X*^&7AOX<?`W]BC5_V?_BIX#\*_%3Q%\/K+2?$-
MI\0KY?$VB7/C6^T+PEJVMOJ_B&>PFA\/ZGK<WQ'-O=0+;Z1=V1`/I/\`X)1_
M$3Q?_P`%=O\`@CI/^S7\=_CW^T?\$/VE_@%XW?\`9<_:-^)_P;^)ESX#_:3T
M+QM\!O&6CZ]X?UC_`(3J_L]:U>/5?''@NQT'0?B!J^I6UY<>)M4@\?6<UTUS
M)<SQ_DW^RS_P3P^)'QO_`."N/_!2']@;Q5_P52_X*V:?\)/V/O`_P3\2?#CQ
M+H7[9OB>#X@ZY??$WPGX1US7(O&>HWVE7_A_4+6QN_$%[#I*:/X=T.6.WCMC
M=2W,L<AF_23_`()L?\$U?VM/^"4W_!6SXXZ!X)G^.7[3?[!G[9WP7TWQO\0_
MVD_BOXS\"Z]XV\,_M.^&=3\3Z]%?_%.2&^T#Q!XAU?69IO&=A-XCTCP=>/J:
M_$_PHVLZC=7&B:S>P?3?[%W[(?[1_P`-/^"Z7_!6S]JCQS\+-8\/?`#]H/X=
M_LZZ-\'/B3=:IX8N-*\<ZEX,\$^`M,\2VNGZ;I^NWGB*Q;2[_2]1MI7UK1M+
MCE>TD:V>:-H7E`/QVT'2?VO?VF?C-_P<\_LN_#/]J#]IJ+Q?\!/#W[/6J_LK
MSZ?\;_B7:>(_"'B[X467CWQ-!HG@B[TKQ!9CPS=?%^#P2/"/C6/P_;Z;8^(I
M/$#W&H6;F"V^S^V?&+_@L9X\\:?\&R/PL^/OP]\;^(S^V/\`M!:5X&_80T75
M?#>NW]E\2)/VD/[9E\`?$#Q)IVI6=S'KNG^,]=^'WA+Q!\1M$U/3KJ*_LM7\
M6>'[V"YMYYH'K]"_^"87['?[2GP-_P""L_\`P6P_:#^*WPJUCP;\'OVG/B%\
M%=9^!'C>^U;PQ>:?\0].\+2_$1M;NM.LM'UW4M:TZ*Q_MC3&E37M,TF61;M!
M#'(5E6/\DOV=?^"'_P"V%X!_X+00>#?$O@2^@_X)'_`C]LKXJ?\`!0_X+7DN
MI^"YO"%_\6?&G@7P?<>"/">D:-%KLWBZ.\\%^+K'PGX9DM=8\-6NE+I'PTUR
M]M;EQKL<]Z`>-?\`!3N>\_9(_:\_X)"_L@?M>_\`!2_]MC]FS]GZP_8.UR+]
MJ?X\_!_]H'XP0>.?$OQATBX^(>HS^+]3OM(M_'>I>)+WQ+\6(+#PY%J&I^&/
M$5UIGA*ZMM+MYK#3M/@N+/\`6O\`X(L+_P`$Y_$_[3/C?6OV-_\`@L-_P4#_
M`&^_'/AGX.:U_P`)/\'_`-ISXP?%'QG\.=!\*:]XK\(V)\>6WA_QW\(?A_8O
MXGTO6+;3=&TS4++5;J\L;/7]21K%H+QIXN=_X*Y?`3]N72O^"N_[!W[=W[,?
M[!FJ_MS_``^_9Z_9U^*G@GQEX'3X@_##X?Z/?^)/B!+\3?#UK87NJ>/KC49(
M+G2+'Q?9>*89X/"6K6\LMK!:QW-I=.US:?>_[!G[5G[>7Q3^.B>"OCU_P1:E
M_82^&]]X1\0W^H?'&']H/X-?$&%=6TH6=QHGA.X\,>!O"&A:W<KX@N'F$=X;
MMK2PEM$EFADW!D`/<_\`@H__`,$]+?\`;=TOP7XCD_;#_;?_`&6;CX.^'?B)
M/:6G[(/QTD^#EAXYF\0VNBZ@DOQ$MX]"UAO$;^'Y/"Z1>'&$MFVFP:QKD:LY
MU#?#_.G_`,&[G[.GC;XV_LE?#;_@J1^T%_P4*_X*0^,_%?PH^(_QKU;7/@WK
M/[4/B+Q/\`?%?ASX3Q:G:1V'BKP'XKM=7U+7(+C3'N;V[M9O$T-O/JD%E-$M
MK';[)/[1O%]G=:CX5\2V%E"UQ>7OA_6[2U@4HK37-SI=W!!$K2,B*TDLB("[
MJ@+`LRC)'X/_`/!O'^Q?\<?V6_\`@E1HW[-'[7/PHU3X9>.[_P"(?QXD\2^`
MM<U7P]J=X_A+Q]K`2UDDO_"6N:]I8BU?2+BZ5!#J37$(),L<3;0P!^67_!.[
M]E?]IS_@O;\)/'O_``4=_:W_`."A'[;/P!\,?$[XE_$SPY^S#^SU^Q[\89/@
M_P##[X/^!?`VL_\`"-VFI:A"FFZI;^*-=@UJQO='%Q/I]GK&J)H$FO>(/$>K
M7FOQ6FA^O?L`7W[3/[7U_P#\%)?^"(_[97[9G[2DOQ`_86^+?PSUGX:?MJ_`
M;QX_PM_:0\=_!S6=4U#6-`T;Q;XV^RZ_/+?I;6WAN?7)]3;6=;U/3_%VI>&]
M0U_4H?#EEJ4V#^QYX)_X+#_\$,O#/Q2_8H^%G_!/MO\`@I1^RK'\1/'7C;]E
M3XQ_#CXY^#/A9XG\-:?XXNX=0/@[XK^'?$MEJM]9PI?@:MK,T&CZ?;:9X@O_
M`!&^C>)_$FB:AIHT;]#O^"+/_!/7]J#X$>._VT_V]_V\T\':-^V1_P`%`/B!
MI/BGQ3\+?`>IP:]X:^"'P]\*2:S+X5\`Q:_9WFH:?J.L;]7ALKZ/3M7\06-A
MH/A;PE"_B'5-9EUN2,`_#;]AO_@G=\2/VF_^"EG_``5/_8U\;_\`!5/_`(*W
M:1\-OV'M?^"NE?"S7?"_[9_B>T\:^(8/B5I?B2^UI_'FH:GI&JZ-J,ME+H]M
M'I;:%H7A]4BDF:Z2X?8%^QO^#@/XL_MB_M`?M&?L\?\`!+'_`()X_&?XG_#K
MXM^`_P!GCXU?ML?'3Q?\-_'7C+PMXNO/#GPU^'VOZ9\'_`.K>(/A_?Z1K;7O
MQ#\0:3JNE_V5?77]FW?BSQU\--:U"T:WA@:OOK_@G!^R'^T?\%O^"O'_``6G
M_:)^)WPMUCPE\&/VF?$W[/-]\#?'5WJGAJ[L?B#9^#='\66OB6?2[#2M;U#6
M]/\`[+EU"T5UUW3-)DF:=/LZ3`/L_.?]G?\`X(K_`+7G[;O[6G[=O_!0[]K[
MX^?MP_\`!.+XL?&3XWZGX(^"O@W]FOXS>!O!/C>Z_9@\)Z5X;M_`5MXZ\0>%
MG\<Q2Z4-/T;PEI=MX=MM6TU/^$@\&ZQKNHZ;,U_I5X@!Z9^T!_P4M^(7[47_
M``:P?$']MGX8?%#Q?\/?VA=(^$OPG\&_$'QO\/?%&K^#O'7A/XV>!OCY\*OA
MU\3[JPUSP_=:?K'AZ3Q@@NO$<$%K=Q2R^%/&]K!(\EO>2!_Z-?V']?UWQ7^Q
M=^R)XH\4:SJOB/Q+XD_9@^`&O>(?$&N7]SJNM:[KFL?";PCJ.K:SK&IWLDUY
MJ.J:IJ%S<7VH7]W++<WEW/-<3R/+(['^,;Q'_P`$A?\`@HG^RO\`LQ_\%J?^
M"8OP0^$?Q5_:2_9A_:'TKX#_`!K_`&/OB]KGBSX6P:MXG^*.D_%'X):C\6/"
MOB6VG\4>&'L_&6K>$XKYM5U:[\.Z)H6IR?!=KRTG2Y\1Z;:77ZT?LF?MS_\`
M!93X5_#C]FK]GCQ/_P`$'?B!9^&OASX)^#7P8\0?%"7]M#X+"*VT3P?H7AKP
M-JWCV7PK;^'+NX6.'3M.N/$3^'[?5KJ<*G]FQ:C,^+M@#[V_X+W>/_'?PN_X
M)#_MP>/OAGXU\6_#KQUX:^%^B7OAWQIX%\1ZOX2\6:!>2?$OP)9R76B^(M!O
M+#5]*N9;.ZN;1Y[&\@E:VN9X"YCFD5OXS_B-\6_V:?AI_P`$_P#P5^T+^S=_
MP<&_\%'/&?\`P4?NOA/\$_%>G?LRI^T]X^^+&@:Q\<_%5KX1N?'?PJ/P\MO!
M4-XFEZ/JNH^([!3K7B75+/3X=)C@U4>)!-]AU'^U[_@M?\"/BY^TY_P2V_;$
M^!/P*\$W_P`0_BU\1_AWI&B>"?!>F7NC:??:]J5O\1/!FK2V]O>^(-2T?1[=
MH],TR^O6:]U*U3R[=T1WG:**3\=?VK/^"+'Q4U#_`()X_L&?M"_L1_#O1OV<
M/^"M_P"PQ\"/@!K>DW'@.R\"^"_$/Q2\1^&_AGX6T?XN?!SXCZQI,UKX0\8Z
M_<:A;ZM/HVK>*M1UK1]9U2#7?".IZK)X;^(&L:A$`?$G_!9/]I7XUV'BK_@@
M+9_MM_M7_M*?L#^'?CG\`?&^N?MY>(?V</B%X]^$_B+PWXR_X0[X+:EK]Q?^
M&_`=EKBC6='\9ZC=Z:NDW'A'Q"?#!U?5],L[.*))G7ZY_P"":'@?_@F5^T%\
M<_''PX_9)_X+G_\`!4G]JOXH:Q^SO\:]*U#X>_$GX_?%JXTWPUX.\;^&8?AG
MK7Q2\/-XV^"/@_1[#Q_\.K[QOH^N_#_6(=5N;_0?%BZ9K<&FW\6GW"IE_P#!
M1OX=?\%,OVAOC;_P1/\`V_/"O_!,SQ;\3OB;^S/X9^.>N_M._LMZA\2/A#X;
MM/#7Q#\1?\(/X<D\.KXIUWQ-XFTBX\+>(;[2-<\5>"-7LK+Q/=?\(U%I2Z[:
M:3KCW%K;?IU^Q+^UQ_P4$^(O[17@KP)\:O\`@AO+^Q9\,/$5AXJM_%G[1%M^
MT9\$/&\?@Z/3/"VK:[HMC=>$_!?@S1/$&KV_BKQ)I.C^&%CL[Y8["ZU6UU2Y
MCDM;&4``_!+XJ?\`!.KXC^!/^"W/[,G_``38TK_@JG_P5NNO@G\9OV0_&G[0
M'B;Q5J'[9WB:3XFZ?XN\,ZC\5[*QTO1-6@TBW\-0^')HO`FD27=K>^%;W4'E
MN-06+4H4E@-O][?&33_BM^R#_P`%I/\`@@Q^QMX0_:B_:B^(GPG/PA_:EL/'
MLGQ9^,OB7Q-K?QHN=+\,?%;Q!I&M?&=+&;1_#_Q"UO1+R:U@T;4=:T*673K3
M2=(2U$4EE&]?9GQL_9(_:,\3_P#!Q9^Q]^V/H/PMUC4?V9_AS^PC\0_A3XU^
M+,6J>&(]%T'X@ZUJOQPN--\-7.DW&NP^*I[JYA\3:`ZW-CH%WIR_VK;A[U3%
M>?9N$_X+-?L??MK7O[7O_!/+_@IQ^PI\)?#W[27Q)_8BU7XFZ#XZ_9SU?Q?I
M'@/6_'W@'XGZ8-+NK_PCXCUZYL])2_T[2]2\7:==Q2376J6-[JGAW6]*T/Q#
M#I^K:6X!SW[>WQD^+WA;_@X:_P""+WPF\,_%3XC^'?A9\1?AK^TW>?$#X:Z%
MXW\2Z3X`\=7>C>`_B3=:1=>,?!UAJ5OX>\37.E75G9W.FSZUI][+8SVEM-:M
M%)#&R_@AX+^(W[.7QA_;R_X*R:-_P4`_X+;?MU?L1+\*/VZ?BQX0^`'@'X7_
M`+7WC;X?>&KOP''X[\?QZC!IOAJ^\.^-[*WTSPM<Z?HFDZ38:*-&T_3;)OLB
MV4B&%HOV9^`WP._X**_\%#_^"Q?[,7_!1/\`:K_8MNOV!_V?_P!B+X1?$CPI
M\/\`P)X[^+/A?XD_$OXH^._B+X?\7>'KRZ6'PI;:<VEZ99R>,_[1GFU'1-,T
MZ"P\-6UI9WFM:AKDXTB']BS_`((S6/Q9^)O_``7*\-?M_P#[*VD1_#?]KO\`
M;'\<^,/V?_B!XCL?AYK'C:7P!X@UOXH7FG_$CX3^*]-N_$/B;X?ZWI=UJGAO
MQ#H\US_85ZM^UDNHZ7=0?VE8T`?G]^RG^UA^V9XB_P"",O\`P72\0R?M/_M#
M_''X#_`74O&FB?\`!/S]M;XA:AXR\)_&GQ_X*L+C5X-:UC1O'-Z^D^-;NUT?
M3K'P'JUCJ,ER+S0M4\7:WHEM=6<-N-"T7#_8^_X*I?M+^*/^",'_``4-_8^_
M:;^('Q0\(_MX?LQ?L0ZC^T+\%/BM?^-=?7XH?%C]F#XK>#O#GCWX8?%71?B+
M9ZD-?U?Q%X#L?&OA[3;SQ;::FNH2^%_$7@F2YN9M>TWQ7-;_`&#\+_V6?^"M
M7AO_`()4?\%-?^"3?[0'P>\9_&^\^'/PN\7^`OV!?VB[+Q1X`N-+^/7PKO=1
MTZP\.?#JZ_M3QLFO^'M:\.6*6.K^%(/&,5HNG^';_5_!%SJ<2>`M%.L<;_P5
M'_X(C?M(_M$_\$O/V"/B%^SEX*USPU_P4/\`V8/V,_@[^S'\5?AQI'B/PYHG
MB+XK_!CQ%\*=%\!?%7X+ZSKL^NVWA/4KWX?:SJ6NZKID%UXC.@W_`(>U#X@:
M78W6H:AJ'AOR@#^D+_@E%XL\4>.?^"9/[`7C/QMXDU[QAXQ\5?L??L]:_P")
MO%?BK6-0\0>)/$>OZQ\,_#MYJ>MZ_KFJW%UJ>KZMJ=[-+=ZAJ-_=3WEY<RR3
MW$TDKLQ_GJ^%'A3]HS_@OA^WG_P4#F\?_MH?M0_LM?L+?L-?'74?V8?A'\&O
MV2OB++\(_$/Q*\<>%+OQ)I?B/X@?$#Q;;6FH_P!IF1]"_MZ.VU/2=6DC@\5:
M1HFA3:':>'M1N-?_`*,O^"97PL\?_!'_`()V_L0?!SXK>'+KP?\`$SX7?LJ_
M`KP%X]\+7USI][>>'/&'A/X>:%H^O:-=7>DWNH:7=3Z;J=G/;2S:??WEG*\1
M>"YFB99&_!G3?V>?^"F'_!&_]N[]L_XR_L;_`+($'_!0;]B/]N_XES_'G7?A
MKX-^*OACX8?&+X%_&+5[OQ#JNNQVD/BN&^AUCP]>ZIXCUJUB;2]%URVU#PW%
MX56]U'PUK.@7D.O`%7]CKXQ_M2_\$\O^"HGQP_X(\_&;]IOXJ_M;?`KQ]^R!
MXC_:B_9)^*_QLUF3Q!\=OAP^CZ5KL6H^!/%'C=,7>N:>8O"WC5(Y9[C[)9W7
MA?POJ_AO3O#2^(];T=/S[_X-GO\`@JI^TY:"Q_9"_;F\>?%+QQHO[87@CXH_
M&3]@OXZ_%?QIKOC?6/%7BKX;7WB?P-\6_@Y:^-_$FIZGJ\\IU3P3?Z]X3T"[
MOX+C0==T?5;6VAE/Q%\*13?JG^Q#^PS^W?\`M&_M\_M!?\%=?^"AGPD\-?LZ
M>/=5_9NUS]F?]DW]DKP[XTT;X@^(OA]X)U'3;Q+KQ#X[\8Z1/)H[ZQ>+>Z[;
M64'VN&]U/5?'OBF^U'1/"&EZ/X>TRZ^-/@Y_P0Z_:.^)O_!OG\"/V?O&W@;6
M/@!_P4A_9!^)?QL_:$_9@OY?$?AVW\5>%/B,_P`7/$WC'2?"2>+O#6N:II&F
MZ3\6O#2:1;1W*Z[%9:-XLMO`_BC6=J^%Y;9@#]/?^#8+XL_%+XU?\$D?A-X^
M^,/Q*\??%GQQJ'Q2^/EE>^,_B7XQ\0^._%5]9:7\2M2L]+M+KQ%XGU#5-6N+
M73[1$M;""6[>&TME6"W2.)0H_!'_`(+L_%#Q5XE_X*U:?\$/VUOVIOVG?V1O
MV>='^)W['&M_L3>,?AKX@UCP'\$M!\"ZEX5\5_\`#27[1VJ^)M.LFM[KXW?"
MGXFW6CZ?X3UB<_VAH>B-XCT8WVD6(TBZO?Z,?^#=+]EG]H/]CK_@F#\-/@?^
MTW\-]5^%'Q;T;XD_&W7=7\'ZUJ'AK5+ZST[Q5\0+_6M#O9+GPGK&N:*R:A83
MI=)%;Z@SQ*WERQ0L`E?F'_P7!O?^"C^E?M+_``H\`?$/]DKX;?M\?L#?$O\`
M;"_9<\2?LV>"["^^%W@G7]-^)>D^%OB)H_BS]F7XKV_C&"].MZ;\9+_5[Z\M
M/'^NVK>%="T#PWI9^W6^L2:KIR`'Z\>*/$W_``42^'__``3[_9?\#?L3^/?A
M1_P41_:/^(MKH?P^O?VW_'VM>'O`OP>T#P'?^'O$VIV'[4OBG0O#VN^,A\21
MHUI9^&/#\>A^&-=UO4_'7B2[7Q3?6FI++JNA7'XX_P#!*C]N[]H?X*?\&\/[
M<?[8GQ%^*7BSXV?'GX,?$K]KN]\,>./BCXAUGQK-<>---MO!>C>"FN?^$FNK
MV?\`X1;3_&FN6^KKX7A-KIJ6DEUI]M:VJ7+K7[C?\$3_`-BKXJ?L`_\`!./X
M$?LV?&K4](N?B5X=G^(/B_Q+H/AO5I]>\+^`;GXE_$'Q#X\@^'GAW69YI_[3
MLO!]IKD.F7NHVTT]A?Z]_;-YIMS=Z?/;7=Q^6/\`P3@_X)8_M&7O_!#?]M']
M@/\`:(\$W?P'^+7[07Q#_:O?P=;>+-1T#6+;35\?6OAB^^&'B[5)_!VK^);8
MZ#)XFT6SGU&W@N#JT>GVE[MM$F-MYH!\!?`/QY^U_P#L&^/?^"#7[6_BS]O#
M]JC]H[3?^"N/B7PGX(_:W^$7Q\^(MQXV^$VGZM\>]*\$ZOX`UCX4^&+JWCC^
M'MSX$;XB6B(=)/G7DWA:&VM)M.\.:UJGAQX/CSX__;#_`&[?&7_!>/\`;"\(
M?MW_`+5?[.T'_!)3QEXM\#_LC_!SX#?$6;P5\([RZ^`NG^,-3\>ZM\5O"5O;
MR6OQ$NOB#%X`NMSZO,TME=>)+F"_?4O#6DZ3X:C]?_9T_8N_X*>?M1_$W_@C
M!^SS^U5^Q:_[,'P8_P"".FN:?XJ^)'QRUGXL>`_&^A_'SQ#\(M/\)Z-\&['X
M6>'?"U]>W\L>LQ^`=`N-?OKE[K3K:'5]?OGU#2IM-TO1-9J_M"_L4_\`!4']
ME[Q__P`%G_V:_P!ES]B]OVG/@S_P6%\6ZKXP^&/Q[T+XM^!?`^C?`;5?C!;^
M*-,^+^F?%?0/%-]9:I$F@VOCG6CH%Y:R6VFW$6D:1J,5_J[ZMJ6AZ,`?T[_\
M$U/VFM?_`&Q_V!OV2?VF_%L-E!XR^,7P.\!>+/&Z:9"EKIA\<OIZZ5XVDTRT
M0*MEIUQXITS5[BQL5W"RM9HK0.ZPAC_'WIW[4G[3<G_!/O\`X.E/%3?M%?'5
M_%'P3_;<U;PW\&O$;?%OQZ=>^$GAR/\`:"NM*70/AEK!UXZAX#T5-)4:8NE>
M%KC2[)=/46:P"`;*_LJ_8%_9B;]C+]BS]F']EJ;5;77]2^!OP8\!_#_7]=T]
M)(].USQ3H^E02>+=9TV.:*&XCTW5/$]SK%[IT=S&MRMC-;BY`G\ROY4=._X)
MB_MWP_L.?\'(/PME_9T\4)X^_;1_;`U3XB_LQ>&SXB^'QNOBUX+N?CG=^)HM
M?T:Y7Q@=/TFV;P^Z:KY'BF\T&_%NXB^R?:PUL`#QKX6_\%4OVE?%_P#P0J_X
M*%_LJ_M#?$+XD_#;_@HQ^Q#^S_\`#OQ3I/CZ+QQK>G_%;XD?L]_$KQ+\+M>^
M$_QITKQ_H^IPZYJNLV/AGQIHGACQ/XJL-1DN=5T+7O`7B/5=3NM5\9ZH%^G_
M`(B?M`?'W]B_]J[_`(-[/VT?%7QU^,.M?LN?MF?LK_`7]D[]J#PCXI^)OC;6
M?AO'\8/&?P=\*R>%/B]XCT+5]9NM`B\8Z[?^-],\4:QXL:S;6+ZV^%WB&\OK
MN2;4=0FGS/\`@L__`,$1_P!I/]HW]B7]D'XV_LB>"=:T_P#;?^$W[*?P?_94
M_:&^%'AWQ#X9\-:O\:/@E>^`_#&E>(/!VN:I?ZW8^%-<UCX4^-[26Y6VN]9%
MGK'A>[U@VNI7MYX4\'6I_2']OG_@FS\4?VNO^"`OPU_9,MO!=Y;_`+5?P4_9
M<_9B\7?#7PF^J:);:YH_[0WP$^&OA.UU+P;9:T=4'AZWUW7["'QO\-H-5&NQ
M:/#>^($O?[7%E&+N@#SSQ7\6OC#^V-_P<A>"?V?_`(>?%CXE>%OV8O\`@FG^
MS<OQ,_:&\)>"/'_B7P[X(^(_QY^+4<-QX,\'^/=*\/:E9Z3XLATNS\4>`M:T
M_1O$5OJ,,)\$>,K%HHH[N_AD_F%_83_:"_8F^*WP_P#BOKO_``4>_P""\7_!
M47]F/X\:7^T1\4O#?A[X:_"[]HWX^R>%V^%.F2Z+)X4U[_0/A9\4;6&]O-6N
M_$^G2P+XCMO)M-)LU&CV<>R>\_K3_P"#?/\`8F_:?_9R^"W[2'[1G[>'A^]T
M3]M_]MK]H37?BE\98=7N/#%UK5CX7\*++X?^'^CZ@WA'4];T"W6>]O?&OB^R
MLM+U2:VL=*\4Z58-#;S6301?CC_P3*T/_@K1_P`$U?@Q\4_@3J7_``07U/\`
M:@'BW]I'XJ_&;3?B7K?[17[._@N\CTGQO#X:TVP\/)I&I:5X\NFM[&/PP=1C
MO&UJ$2MJ[PC3;9K=I;D`]6_X*5?$[XB_`;_@DQ_P3_U/]BC]L+]O7XV?\$_/
M&OQSU6^_:U_;A\&>(]9\:?MN2_LZ>*/%&NZI]HM/&_B+0?!OB#0M)BU.[\7^
M&K#5-7TKPM:64GA7P!X,UO4UT?6)K37-_P#X(\^*/A'XO_;J\):O_P`$WO\`
M@LU\2_VD?V5/$/PJ\3-^T1^Q/^W1\0/B9XI_:6MO$4.F:E!8>.?@I8^-/!?A
MG3X8]"UMO"FJ>(=<\/BZCL-/CU[2]3U#6--US27T7[H_:0\:_P#!;GXB?LX?
MLE?M2_LF?LP6'[-GQ,^#WQ8\;C]I/_@EYXC^)'P:\1Z?\>/@N-3L+?0DTOXM
M#POI>BZ3J+Z;I6K7,.A:'J?AVX-IXTEOE36]8\,V6CZM\._"+]C3]LC]N/\`
MX*W_`+&/[<NN?\$N/!O_``2<^%?[),GC/Q1\4?&1\;?#74_B]^TGXCU_2KNP
ML?"5_I/PQTOPP=5L;>6:YT8:WKWAJV"^$/$/C&34O%.K377AWPO"`?,7_!1+
M_@G?\2/V4OV]?^"5'[,OP_\`^"J'_!6K5O`W[>/QD^)W@3XKZEXI_;,\377B
M3PQH_A%OAU+ILWP[NM)TC1]+TJ]G/C+4XKMM=TCQ#;^7;6)@MXS',)O0/^"X
M/[-_[2_[''[/W_!-_P#8_P#V3/V\/VZ-;\=?&[]K#XRZ+#\6/B9^T9XUU3XO
M>*=3\7?#_P`.7'ASP5KOC#P;<^#;O6?"^FZQ;QV_AC1;N*6+2+O5KN>$O)*6
M/Z]_\%4?V1OVC?CO_P`%+/\`@B)\:OA'\+M8\;_"W]E_XZ_%SQ5\>?&6GZIX
M9LK'X=>'_$(^$::-J>J6>M:[IFKZC'?_`-@:R\<7A_3M8N(UTZ;SXHFDMEGZ
M;_@KE^RG^T%^T+^U)_P1H\=_!KX::OXZ\)?LV?M\>%_BU\;]:TW4_#=A!X`^
M'=A+X+^U^)=2@US6]*O-0LXETZ_,EKH5MJVHLEM*$LG9X5E`/YTO^"CO_!3O
M]HW]I;_@D+_P21T/]GCXZ_%'X<?'+XO?!#X[?M#_`+0WQ+^&GCGQ7X4\;/HO
M_!/CX,>+_#'Q:/B7Q'X;U?3=>CT[QY\0=%\0:Q/:W5_Y&HZUH]C<7*3^5%OY
M;]N+]IWQG:_LK?\`!LU-\=/VZ_VL/V;OA!\=?@?XRN?VL?CC\(_C5\4-`^)&
MKZ%#H7P/EG\8^)-8\/CQ+K/C'Q#IL^HW7V._US0?%E[`VK:C)%:2-=3EO3O@
M[_P0Z_;G^&/Q6_X+517WPH\2ZY\(K3]D;]N3X!?\$T="N/$W@:73?%2?M7^-
MM:\3V=IX$L?^$F$OAFZC\.I<Z-K3>*E\/6QU+Q;.?-V"1H/9_P!HC]A/_@HG
M\/\`X/\`_!N+XV^&/["7B+]I/QW_`,$\_A?XHF_:%^!S>/\`X5>%8]*\1'1?
M@_8Z?X,USQ%XCUS4]&\S59M$UQHM0T/3?%EE;G2)6G5&EM3*`?5W_!(J3_@F
M-XN_;.\)S_LD_P#!;#_@I!^V[\6O"7@KQ]XF/P`_:&^-'Q;\4_"G7/#%QHB^
M$]<UWQ%X>\;?!?P/HNI7/A=_%%CJVA1CQ`EY::Y%8ZA;VUVEG,J_G/\`\$.?
M^"JO[3/P:_;V^)?P2_;,^(WQ.\??LG_ML?M8_'CX*_LT?%CXH^.M=\=:=\./
MVGOA'XUL8E^$^DZIX@U34;OPOX?\=^&/'/@CPW'X7+Q6,/B34?A[?Z'9VUC?
M>*;I/Z`OV-_VOO\`@H=\0/VB?AYX%^,'_!"F3]COX8^)GU^R\9?M$6W[2/P.
M\9)X!L;#PSJ^N:<;GPGX.\%Z+X@UNW\1>(=)T?PQ]FL+^,6D^L0:E<)+;6,J
M'\Y?V9_^")GQ8^.__!*3]NK]DO\`:7\`7_P'^.OBO_@H9^T3^U1^R5XTU?5M
M"N]4\%>,)--\$W/P=^*6G:KX.UG7GTO0O$ESI^M^#_$L0FM_$$?A?4];FAL+
M74H-&NXP!W_!*KX'_$W_`(*@?L>?MS_#;XR_ML?MS?"^^^&G_!8C]HNX\+_$
MKX'_`+0WB7PE\5M/\(^$_!/AO1-'^$L?BSQ'!XKN;'X4VLGBV]UA?`UC;V>F
M6VNV.FWUM'`UO(DWRO\`\$@OV"_B3^UO^TC_`,%$O#_Q0_X*??\`!55=(_8+
M_;KU/X)_##3]'_;!\3?8O''@[P/XJ\4R69^*EGKFF:Y;:[?:O%X3LK77%T6+
MP_IMW:W6H016$*W*&W_6?_@V4_9%_;%_8]_8Y_:)\(_MO_#CQ)\.?C1\1_VS
M_B-\7IXO%7B+PEXHU7Q;IOBOX<_":SO/&DFK>#_$'B+3I_[9\5:/XE69[FZM
MKV>ZM;BZ:S2WGMIINZ_X(J?LC?M&_LS?M"_\%A_&'QU^%FL?#KPW^T;_`,%`
MO'/Q=^"FJZIJGAC48?'OPYU37OB'<:?XHTZ+P_KNL7-A:75MJVF3I:ZY!I6I
MHE[$LMC'*D\<(!_0*!@8R3RQY.3\S%L?09P!V``I:**`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`*:40D,54L.C%1D?0XS3J*`#KUIJHBYVJJ
MYZ[5`S]<#FG44`)M7GY1\W#<#D>A]?QHVKQ\J_+]W@<?3T_"EHH`:RJW#*K#
MT8`_S!I<#&W`QC&,#&/3'3'M2T4`,\N/_GFG_?*_X4X*HS@`9Y.`!D^IQUI:
M*`$P"02!D=#@9'T/448`)(`!/4X&3CID]3BEHH`0*H)(`!/4@`$_4]Z-JYW8
M&[IG`SCTSUI:*`&E5;[RJWU`/\Q0$13E54'U"@'\P*=10`4@`48``'H``/R%
M+10`UD1L;E5L=-R@X^F1Q3J**`$``)(`!/4@#)^I[T`!1A0`/0``?D*6B@!I
M5222JDD8)(!)'H3CI2>7&.B)_P!\K_A3Z*`$(!&"`0>H(R#^!HP,8P,8QC'&
M.F,=,8XQ2T4`-V(0`44@=!M&!GDXXXR:`B`Y"*".A"@'\P*=10`F!G=@;@,`
MX&<>F>N*"`1@@$'J",@_@:6B@!%55&%55'HH`'Y#%``&<`#)R<`#)]3CJ?K2
MT4`-VKDG:N2,$X&2/0G'(X'6EP,;<#;C&,#&!T&.F*6B@```&`,`<`#H!Z4C
M*K##*K#T8`C\CFEHH`0``8``'H!@?E0``,``#T``'Y"EHH`0`*,``#T``'Y"
MHIK:WN#$9X(9C#*L\)EBCD,4R9V2Q[U;RY%R=LB;77)PPR:FHH`*0`#@``=<
M``<^O%+10`T*H)8*H)ZD``GZD#)_&@JI(8JI(Z$@$CZ$C(_"G44`%-VKS\J_
M-RW`Y/J>.?QIU%`"$`C!`(]"`1QTXZ<48&,8&,8QCC'3&.F,=J6B@!``!@``
M#H`,#\A3?+C_`+B?]\K_`(4^B@!-J@;0H"^F!C\NE(JJO"JJCT4`?R`IU%`"
M$`D$@$CH2`2/H>WX4$`X)`)'()`.#ZCTI:*`$VKS\J_-][@<_7U_&D*(0`54
M@=`5!`^@QQ^%.HH`:$0'(101T(4`_F!2@!>@`R<G``Y]>.]+10`@`7H`,G)P
M`.?7CO0`!G``R<G``R?4XZGZTM%`!1110`4444`%%%%`!1110`4444`%%%%`
M!2;AG&1GTSSQC/Y9&?3(SU%#9P<=>.G7&><>^,X[9QFOYQ/@/\8_V@]"_P""
MFFJ>!?VK_P!IG]HSX&_$GQ!XWUO3?"7P9\;^#M"\0_L2?M#?#/6OB-^U;_PJ
M;P)\`_$6AZ'%X:\">,I_@KX5^#GC71/$_B/QMH?QX\4>/O`GQB\(^)/"WC?2
M@^G>&P#^CO(Z9&?3-`()(!!(Z@'D?7TK^>7X!_M9_M$>"OB+I_Q(_;(UW_@H
M'\.+GXH^+/VQKSX-_!CXE?"+]E?PA^REXO/PZ'QP^(7PV^".BZKX4\$:E^U'
MX5\<:=^SU\/8_'/A74?BUKOA*V^)NJ>%/$=[HFH>([9(]!O_`"[Q!^V]^UM^
MRE\`/@'^U=XS^.&K?M`7W[6__!//]I[]J#7/A7XU\%^`](^&_P`)_CC\,OV6
M]!_:I^&EC\(D\`^%_#'C;2OA/96,^O?"SQ7H'C?Q1XXUC7[!/#7B]_$FF^*8
MM<FU\`_IK!!Z$'G'!SR.HX[TM?E;^SYX@_:"^"G[9WAC]EWXL_M$>,OVF=`^
M,7[&_B+]I*3Q1\1?"OPV\.Z[X(^+/PH^*?PP^'OQ&LO!J_"[P9X(TVQ^%OQ$
MM/C3X?U7P[X)\066O:AX$O\`P9>0:5XKU.QUVYM;+]4J`"BOGGX@_M2_!GX6
M77B6V\=:UXIT.+P?:76H>)-5/PK^+FI^'=*T^QTX:M?:C<>*-%\!ZEX;;3K'
M3MUW>W]OJTUI9Q13_:9HGMYUC[?X>?&;X:?%GP+X1^)OPU\5V/CCX?\`CWP[
MI/BWP9XO\-6VIZIH'B7PUKEI'?Z1K6D:A;V#0WFGZA9RQW%M<(=LD;`X!R``
M>GT5@_\`"2:7ZWW_`()]:_\`E=1_PDFE^M]_X)]:_P#E=0!O45@_\))I?K??
M^"?6O_E=1_PDFE^M]_X)]:_^5U`&]16#_P`))I?K??\`@GUK_P"5U'_"2:7Z
MWW_@GUK_`.5U`&]16#_PDFE^M]_X)]:_^5U'_"2:7ZWW_@GUK_Y74`;U%8/_
M``DFE^M]_P""?6O_`)74?\))I?K??^"?6O\`Y74`;U%8/_"2:7ZWW_@GUK_Y
M74?\))I?K??^"?6O_E=0!O45@_\`"2:7ZWW_`()]:_\`E=1_PDFE^M]_X)]:
M_P#E=0!O45@_\))I?K??^"?6O_E=1_PDFE^M]_X)]:_^5U`&]16#_P`))I?K
M??\`@GUK_P"5U'_"2:7ZWW_@GUK_`.5U`&]16#_PDFE^M]_X)]:_^5U'_"2:
M7ZWW_@GUK_Y74`;U%8/_``DFE^M]_P""?6O_`)74?\))I?K??^"?6O\`Y74`
M;U%8/_"2:7ZWW_@GUK_Y74?\))I?K??^"?6O_E=0!O45@_\`"2:7ZWW_`()]
M:_\`E=1_PDFE^M]_X)]:_P#E=0!O45@_\))I?K??^"?6O_E=1_PDFE^M]_X)
M]:_^5U`&]16#_P`))I?K??\`@GUK_P"5U'_"2:7ZWW_@GUK_`.5U`&]16#_P
MDFE^M]_X)]:_^5U'_"2:7ZWW_@GUK_Y74`;U%8/_``DFE^M]_P""?6O_`)74
M?\))I?K??^"?6O\`Y74`;U%8/_"2:7ZWW_@GUK_Y74?\))I?K??^"?6O_E=0
M!O45@_\`"2:7ZWW_`()]:_\`E=1_PDFE^M]_X)]:_P#E=0!O45@_\))I?K??
M^"?6O_E=1_PDFE^M]_X)]:_^5U`&]16#_P`))I?K??\`@GUK_P"5U'_"2:7Z
MWW_@GUK_`.5U`&]16#_PDFE^M]_X)]:_^5U'_"2:7ZWW_@GUK_Y74`;U%8/_
M``DFE^M]_P""?6O_`)74?\))I?K??^"?6O\`Y74`;U%8/_"2:7ZWW_@GUK_Y
M74?\))I?K??^"?6O_E=0!O45@_\`"2:7ZWW_`()]:_\`E=1_PDFE^M]_X)]:
M_P#E=0!O45@_\))I?K??^"?6O_E=1_PDFE^M]_X)]:_^5U`&]16#_P`))I?K
M??\`@GUK_P"5U'_"2:7ZWW_@GUK_`.5U`&]16#_PDFE^M]_X)]:_^5U'_"2:
M7ZWW_@GUK_Y74`;U%8/_``DFE^M]_P""?6O_`)74?\))I?K??^"?6O\`Y74`
M;U%8/_"2:7ZWW_@GUK_Y74?\))I?K??^"?6O_E=0!O45@_\`"2:7ZWW_`()]
M:_\`E=1_PDFE^M]_X)]:_P#E=0!O45C0Z]IUQ+'#&;SS)76--^EZM$NYC@;I
M);&.)%SU>1U1>K,*V:`"BBB@`HHHH`****`$(R,?0_B#D'\"!QT/0\5^2?A/
M_@E;8Z'^TA:_$C7_`-HWXO>-OV?_``=XZ\(_&7X8?L[^*&\+ZH/#_P`6?"OQ
M)^/?Q2\.0^(OBO/X>/Q.\7?"?X7>,_CQXF\4_"'P!JWB66ZT#5IM/TC7_$&O
M^#/!7@OPY8?K;10!^;G@#_@G/I?AKQU\+=3\?_M%_'CXZ?"G]GWQ'X\\7_L_
M?!;XNZCX1\1Z/X$\2?$#PKXU\!7&I>+?B`/#4/Q2^,K^!OA_\1_'7@+X7_\`
M"S/%>LR^&/#'B6Z;69_%?B.PT3Q#I?'^!_\`@E%\*=)TFP\!_%/XL_%_X]?!
MKP#^SO\`%?\`92^!/PE^(=QX+T_1_@[\"_C5X=TGP1X[\.VOBCP1X4\,^-O'
MGB3_`(5MX?T'X6>&/'?CW7M8\2>&OA_IT]C;3W'B'7O$WB;6?U3HH`^'_P!G
M3]BX_!7XD7?QA^(/QZ^+?[2/Q/L?A1HOP!\">+OBO;^`-+N?`WP8T374\3S:
M!:6/PY\(^#]/U[Q?XU\1VNBZS\3?B)XAM[W7O&-UX5\)Q1PZ+8Z,+2Y^X***
M`/G?]KLE?V5/VERK,I_X9^^-/*LRGCX9^*2.A'0@$>A`/45\H?\`!%XEO^"3
M/_!.4DDG_AC/]GXY)).3\/='R>>_`_*OJ[]KS_DU/]I?_LW[XU?^JR\55\H?
M\$7?^43'_!.3_LS/]G[_`-5[H]`'Z<4444`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!12,<#/T_#)`R?89R3V`)K\2
M_P!EG_@H'^U)^TQ^V+\2O`'A[PC^S;+\$?AQXY\6^`?B3\)?^$T\0Z+^UM\"
M=,\)?%']H;X5Z;\3OB#8ZM=R>'M:G\6ZI\'?"'B>Z^%5KX2\-S:3\.?C-\/_
M`!AX5\?>-88;Y=;`/VUHK\X_!7[?,7Q&_P""@FN_LA^$?`L%S\*O"'P'^,7C
M;7/C]=ZZ(M-UOXT_!?XI?!CP'\1?A/X+TB.%K?5M*^%MK\6;*S^)'C.6^6SL
M/B-]M^'6G0RZSX*\<C3?B7]F;_@L?J?QB^$_QH_:;\6:C^Q?-\&/A)^SA\3?
MVG-2^$WP5_:,\4?$?]K;2_`/A>SO-;\&CQ3\/-3^'GA[P1IUSXAT>VM=/U^Y
MT[QCJ.F^%_&&M:3X;N[MKIY]@!^^U%?G7^SA^U'^T-K'Q\C_`&;?VK_A-\,/
MAU\0_&WP`'[3GPQN_@]X^\2^.O#J>#=*\8^'/`GQ)^&GC.?Q=X7\*WR^//A=
MK_CCX?EO%6@VTOA/Q_IGBN:\TO3?#-QH%U8WGZ*4`?.W[7G_`":G^TO_`-F_
M?&K_`-5EXJKY0_X(N_\`*)C_`()R?]F9_L_?^J]T>OI;]L+Q'X>M_P!E_P#:
M9L+C7=%M[Y/@%\9HFL[C5M/@NEEE^&7B;RXVMYKE)A(_F(50H&(96`VG-?,G
M_!%^XMU_X),_\$Y0T\*D?L:?L_@@RQ@@CX>Z/D$%L@@\'(Z@CJ#0!^GM%0?:
MK;_GX@_[_1__`!5'VJV_Y^(/^_T?_P`50!/14'VJV_Y^(/\`O]'_`/%4?:K;
M_GX@_P"_T?\`\50!/14'VJV_Y^(/^_T?_P`51]JMO^?B#_O]'_\`%4`3T5!]
MJMO^?B#_`+_1_P#Q5'VJV_Y^(/\`O]'_`/%4`3T5!]JMO^?B#_O]'_\`%4?:
MK;_GX@_[_1__`!5`$]%0?:K;_GX@_P"_T?\`\51]JMO^?B#_`+_1_P#Q5`$]
M%0?:K;_GX@_[_1__`!5'VJV_Y^(/^_T?_P`50!/14'VJV_Y^(/\`O]'_`/%4
M?:K;_GX@_P"_T?\`\50!/14'VJV_Y^(/^_T?_P`51]JMO^?B#_O]'_\`%4`3
MT5!]JMO^?B#_`+_1_P#Q5'VJV_Y^(/\`O]'_`/%4`3T5!]JMO^?B#_O]'_\`
M%4?:K;_GX@_[_1__`!5`$]%0?:K;_GX@_P"_T?\`\51]JMO^?B#_`+_1_P#Q
M5`$]%?-O[7GB34O#G[+/[1.O^&]=N]#\0:+\%OB1J>BZSHVI2Z?JVEZI9>%-
M3N+'4-,OK2:*ZL[ZTN(TFM;FVD2>&9$>)U<*:_B_/[8/[6`_YN8^/?0'_DK7
MCCN,_P#0:K^GO`?Z,6>^.^2Y[G64\491D-+(\THY76H9C@\9B:E>I6PL,6JM
M.6&:C&$8SY'&7O.2NM'I_+?CY]*/(/`/.\BR3-^%LWS^KGN5ULTI5LNQF#PU
M.A3HXN6$=*I'$Q<I3<HN:<=+:;G]Z5%?CQ_P1C^*7Q`^)W[//Q)UGXG?$'Q9
MX]UFQ^,^I:98ZIXW\3ZIXDU*TTM/`W@F[2PM;O6;RZN8;%;NZNKA+:)UA%Q<
M7$H3?)(3^P'VJV_Y^(/^_P!'_P#%5^,>)'!&*\....(^!\=CL/F6+X<QRP-?
M'86G4I8?$S>'HXCVE*G6O4A&U91M/6\6]FC]K\-..<+XE<"\-\=8+`8C+,+Q
M)@/K]#`8JI3K8C#0]O6H>SJU:*5.<KT7*\%:S2W3)Z*@^U6W_/Q!_P!_H_\`
MXJC[5;?\_$'_`'^C_P#BJ^(/N2>BH/M5M_S\0?\`?Z/_`.*H^U6W_/Q!_P!_
MH_\`XJ@">BH/M5M_S\0?]_H__BJ/M5M_S\0?]_H__BJ`)Z*@^U6W_/Q!_P!_
MH_\`XJC[5;?\_$'_`'^C_P#BJ`)Z*@^U6W_/Q!_W^C_^*H^U6W_/Q!_W^C_^
M*H`GHJ#[5;?\_$'_`'^C_P#BJ/M5M_S\0?\`?Z/_`.*H`GHJ#[5;?\_$'_?Z
M/_XJC[5;?\_$'_?Z/_XJ@">BH/M5M_S\0?\`?Z/_`.*H^U6W_/Q!_P!_H_\`
MXJ@">BH/M5M_S\0?]_H__BJ/M5M_S\0?]_H__BJ`)Z*@^U6W_/Q!_P!_H_\`
MXJC[5;?\_$'_`'^C_P#BJ`)Z*@^U6W_/Q!_W^C_^*H^U6W_/Q!_W^C_^*H`G
MHJ#[5;?\_$'_`'^C_P#BJ/M5M_S\0?\`?Z/_`.*H`GHJ#[5;?\_$'_?Z/_XJ
MC[5;?\_$'_?Z/_XJ@">BH/M5M_S\0?\`?Z/_`.*H^U6W_/Q!_P!_H_\`XJ@"
M>BH/M5M_S\0?]_H__BJ/M5M_S\0?]_H__BJ`)Z*@^U6W_/Q!_P!_H_\`XJC[
M5;?\_$'_`'^C_P#BJ`)Z*@^U6W_/Q!_W^C_^*H^U6W_/Q!_W^C_^*H`GHJ%;
MBW8A5GA9B<!5E0DD]``&R3["IJ`"BBB@`HHHH`****`$.<<'!R#^1!(]LC(S
MVSD<BOP!O?V#?VS/BI^WIX)^*/QFL_@+!8?!CQ=X*\9>'/VX?`+S>&/C_P"+
MOA3X<\8?M63:/\`]+\!Z/X%TBW\*^(?$'@KXJ^`?AU\==2U+Q[XC^'6M^#O`
M7AOQ?H&A:KXR\11Z5\._W_H_S_G\S0!^*'P1_P""2GB+]G/]J3X%_$CX:_M6
M_M`ZW\$O@Q^RU\<_@GIO@SXH>,_A]XMU0^(?B5XT^%&O:+87VEZ=\#_#<?BS
MP+?-X4\0^.OB%J'B#Q:/'7B?XG:1X(U6_P!:U&SNO%ZZMPWQ`_X)O_M._M;:
M%\/OAO\`M/3_`+,_PD\-_!C]D[]JW]G'2?'_`.S;'XBOM1^*_B+]IOX0V_P3
M?Q:GPKU?P'X!\/\`P.^%_AW18D^)NH_!33/%_P`2+?4_BEI_A.SLO$MKH'@:
MTU?Q!^]%%`'YN_L_?`7]J'6?VF](_:A_:M@^"?A?Q+\-OV79?V8?!'A7X(^*
M_&7CO2?%-[XS\=^#OB!\8_BSK6J^-?`W@&Z\)6/B75/A?\.].\!_#>TLO$][
MX9TV#Q'/XB\<Z]=7^G0V/Z1444`?$W[:'P1^#.M_L[?M.>+]:^$GPPUCQ7/\
M"OC!J$_B75OA]X/U/7YK^R^&/B(6=[+K-]HMQJ4MU:BUMEM[B2Y::%8(4C=5
MC0#P[_@C%HVD3_\`!)S_`()S23Z7ILLC_L:_`!WDDT^S>1V?X?:.SL[M`69F
M8EF9B2S%F)+,Q/V#^UY_R:G^TO\`]F_?&K_U67BJOE#_`((N_P#*)C_@G)_V
M9G^S]_ZKW1Z`/TA_L#0_^@-I7_@MLO\`XQ1_8&A_]`;2O_!;9?\`QBM>B@#(
M_L#0_P#H#:5_X+;+_P",4?V!H?\`T!M*_P#!;9?_`!BM>B@#(_L#0_\`H#:5
M_P""VR_^,4?V!H?_`$!M*_\`!;9?_&*UZ*`,C^P-#_Z`VE?^"VR_^,4?V!H?
M_0&TK_P6V7_QBM>B@#(_L#0_^@-I7_@MLO\`XQ1_8&A_]`;2O_!;9?\`QBM>
MB@#(_L#0_P#H#:5_X+;+_P",4?V!H?\`T!M*_P#!;9?_`!BM>B@#(_L#0_\`
MH#:5_P""VR_^,4?V!H?_`$!M*_\`!;9?_&*UZ*`,C^P-#_Z`VE?^"VR_^,4?
MV!H?_0&TK_P6V7_QBM>B@#(_L#0_^@-I7_@MLO\`XQ1_8&A_]`;2O_!;9?\`
MQBM>B@#(_L#0_P#H#:5_X+;+_P",4?V!H?\`T!M*_P#!;9?_`!BM>B@#(_L#
M0_\`H#:5_P""VR_^,4?V!H?_`$!M*_\`!;9?_&*UZ*`,C^P-#_Z`VE?^"VR_
M^,4?V!H?_0&TK_P6V7_QBM>B@#P+]HKX33?$[X"_&7X=>$=,\.V_BCQU\,O&
MOA+P]/J,%O86$6LZ_H%]ING27E[;V%U/:6R75Q$TUS#;3RP(#+'$[J%K^5+X
M6?\`!)W]J/XQ^%IO&O@R^^$TWAC_`(23Q7X;TO5[[QOJ<%KXB'@[Q%J/A:_\
M0:`]MX3O1>^&=0U72+_^P]4E-L^J64*W\=K';7%N\O\`3S^U[XT\1Z?X`TCX
M2?#J_EL/BU^T1X@3X0^`[ZU)-UX9M-7L;J^^(7Q&81NMQ#:_#CX>6?B'Q*MU
M$"1K46AV2LL]_!GZ&\"^"_#GPY\&>%?`/A#3H])\+>#/#^D>&/#VFQ<K9:/H
MEC!IVGP,Y`>65;:W0SSR;I9YVEGE9I)'8_U!X5^.?''@1X?8O_5EY.L5QMQ'
M''X&AFF7RQDJ>5Y)A*F`S',I16*PTG0S#,:N'R[*ZD.>E[?).(:=5.I"CR?R
MUXK^!'`?CWXAX7_6F.<2PO`_#CP&.KY5F,<'&KFF=XNEF&799"7U;$1C7R_+
MJ>(S'-*<N6JZ.></5*35.=93_*K_`()'_!K5/@W\,/CM\)OB5;>'!\1?!WQZ
MU6'Q'X=C9-0U+1K.X\&>$H=!U*87EA;R2:%XLLK&37_"FK6HFT_6-(G\V.6'
M4+?5-/L?UI_L#0_^@-I7_@MLO_C%?)O[1OA;Q%\.O$VB_M8_##2+[6/$_@'1
MSX>^,7@C1X3<WWQ8^!0O6U+5[+3]/7'V[Q_\,+F6\\<?#IXV2ZOD_P"$I\&J
M98_%<20_5'A+Q7X=\=>&/#_C/PEJ]GK_`(7\4Z/IVO\`A_6M/D,MEJNCZM:Q
M7NGW]LY`8Q7-K-'*JNJR1EC'*B2HZ+^:>*F;8OCK.:WBI/V4X\98A2SFCAX.
M$,EXGP>#PU',<JJ0;E*&&Q-.%+-,FK3<XXG+<5]6>(Q&8Y9FT:'Z=X49/@^`
M\DH^%5/VL'P9AW')JV(J>TGG/#&,Q>(K9=FD)\L8SQ.&J5*F5YU2A&$L/F6&
M^LK#X?+\SRIU[7]@:'_T!M*_\%ME_P#&*/[`T/\`Z`VE?^"VR_\`C%:]%?E1
M^KF1_8&A_P#0&TK_`,%ME_\`&*/[`T/_`*`VE?\`@MLO_C%:]%`&1_8&A_\`
M0&TK_P`%ME_\8H_L#0_^@-I7_@MLO_C%:]%`&1_8&A_]`;2O_!;9?_&*/[`T
M/_H#:5_X+;+_`.,5KT4`9']@:'_T!M*_\%ME_P#&*/[`T/\`Z`VE?^"VR_\`
MC%:]%`&1_8&A_P#0&TK_`,%ME_\`&*/[`T/_`*`VE?\`@MLO_C%:]%`&1_8&
MA_\`0&TK_P`%ME_\8H_L#0_^@-I7_@MLO_C%:]%`&1_8&A_]`;2O_!;9?_&*
M/[`T/_H#:5_X+;+_`.,5KT4`9']@:'_T!M*_\%ME_P#&*/[`T/\`Z`VE?^"V
MR_\`C%:]%`&1_8&A_P#0&TK_`,%ME_\`&*/[`T/_`*`VE?\`@MLO_C%:]%`&
M1_8&A_\`0&TK_P`%ME_\8H_L#0_^@-I7_@MLO_C%:]%`&1_8&A_]`;2O_!;9
M?_&*/[`T/_H#:5_X+;+_`.,5KT4`9']@:'_T!M*_\%ME_P#&*/[`T/\`Z`VE
M?^"VR_\`C%:]%`&1_8&A_P#0&TK_`,%ME_\`&*/[`T/_`*`VE?\`@MLO_C%:
M]%`&1_8&A_\`0&TK_P`%ME_\8H_L#0_^@-I7_@MLO_C%:]%`&1_8&A_]`;2O
M_!;9?_&*/[`T/_H#:5_X+;+_`.,5KT4`9']@:'_T!M*_\%ME_P#&*/[`T/\`
MZ`VE?^"VR_\`C%:]%`&9%HNCP2)-#I6FQ2QL'CDCL+2.2-UY5T=(59&4\JRD
M$'H:TZ**`"BBB@`HHHH`****`"BD)`&3[#ZDG`'XD@>E?F)\)/\`@IIH/QE_
M:/D^#OA#]G'X^7OPEO\`Q%XB\#^&/VG;#3O"&O?#K5/&7A'QO\<OASKL^O>$
M?#WB;4_B9X#^&5WXX_9Z^(_@SPI\6/%WAC3_``SKGBK3+2QU&'P[I?B;P/K?
MBL`_3RBODN+]M3X'W/[7^L?L366IZO>_&#PM\`]6_:(\:7\&GP#P%X)\'Z9X
MF\%>'8=`\3^+)KZ**Q\>ZG;>/-#\7V_A2*TN+K3O`T]GXG\03:/8^(/"G]O>
M$?#[_@J=^SUXPCCU[Q;X6^,?P2^&/B3X&?$S]IOX0_&3XQ^#='\/_#OXZ?L_
M_!^PTO7/B!\3OAV^@^*_%'B[3['1_"6MZ+\0+/PQ\2?"?@'QSXB^'6LV'C3P
MYX9U328M5;2P#]*Z*^+/V<_VV_"'[07CG4/ACJ'PF^./P%^(P^&'AGXW^%?!
M?QZ\+>&/#6M^/_@UXLU2;0]/^(7A9/"/C7QS:00Z7K2V6C^-/!GBF[\-_$GX
M?ZGK?AVV\:>#M&'B#2)+O[3H`^=OVO/^34_VE_\`LW[XU?\`JLO%5?*'_!%W
M_E$Q_P`$Y/\`LS/]G[_U7NCU]6_M>.@_94_:7!=0?^&?OC3P6`/_`"3+Q3VS
M7RC_`,$72/\`ATS_`,$Y>1_R9G^S]W'_`$3W1Z`/TYHI,CU'YBC(]1^8H`6B
MDR/4?F*,CU'YB@!:*3(]1^8HR/4?F*`%HI,CU'YBC(]1^8H`6BDR/4?F*,CU
M'YB@!:*3(]1^8HR/4?F*`%HI,CU'YBC(]1^8H`6BDR/4?F*,CU'YB@!:*3(]
M1^8HR/4?F*`%HI,CU'YBC(]1^8H`6BDR/4?F*,CU'YB@!:0G`S_D^@'N3P/>
MC(]1^8KYH_:M^)GB'X?_``N_L?X?O$?BU\6O$.D?![X1)*6\JV\=>.?M-I#X
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MV<*1W7ANU;[IR/4?F*\U^+WPL\*?&KX=^)OAOXPBN&TCQ%9+''?:?/\`9-:T
M#5[.:._T'Q1X=OU!DTSQ+X7UJVL==\/ZE%^\LM5L+68!D#H]<*YU@\!6Q>4Y
MVJM7AGB"G2P>=4Z,%5KX.=*<I9?G^`HRG3C+-,BQ%2>)P\55P\L;@JN8Y+4Q
M5#!9OC).>*LEQF/I8/-LD=&EQ-P_5J8S)JE:;I4,9"JH1S'(,?6C&<H97GN'
MI0P^(DZ=>."QM++LZIX:OC,HP<5Z6#D9'0\BBOE[]FSXJ>*/$5KXJ^$/Q<FM
M$^._P4N[#0/'4UM`+&R\>^'K^!Y?`_QD\.V@9DCT#XC:5;RW-[:0,R>'?&=A
MXI\+RA#I5NTWU!D>H_,5Y>>Y+C.'\TQ658UTIU<.Z4Z6)PTY5,'CL'BJ-/%Y
M?F6!K2C!U\OS+`U\/CL#B.2/M\)B*-7ECS67JY%G6$XARK"YM@E5ITL0JD*N
M&Q$%3Q>!QN&K5,+C\MQU&,YJAC\MQM'$8''4.>?L<5AZU+FER\S6BDR/4?F*
M,CU'YBO(/7%HI,CU'YBC(]1^8H`6BDR/4?F*,CU'YB@!:*3(]1^8HR/4?F*`
M%HI,CU'YBC(]1^8H`6BDR/4?F*,CU'YB@!:*3(]1^8HR/4?F*`%HI,CU'YBC
M(]1^8H`6BDR/4?F*,CU'YB@!:*3(]1^8HR/4?F*`%HI,CU'YBC(]1^8H`6BD
MR/4?F*,CU'YB@!:*3(]1^8HR/4?F*`%HI,CU'YBC(]1^8H`6BDR/4?F*,CU'
MYB@!:*3(]1^8HR/4?F*`%HI,CU'YTM`!1110`4444`%%%%`"-T.!GID9QQD9
MQCN!DCWP,CK7\PWP]\`?M#Z7_P`%+M2U/X"_LT?&_P#9*^*.I_$?PUK7[4>G
MZ)XCN?$O[`WQ,^#.I_$O]KZ?Q?\`&S5%U35X/"WB/QE\:=%G^$_C;P%I?PS\
M*^!_BUH?QNU3XD1_$"SMM,A\?^)/$7]/5)M7.<#/7.!G)`!.?4@`$]P`#T%`
M'\X7P:_X)_\`[>?P]_:Q^'^A?$?QY\"O'WPY\2_L7_MQ^#OC3^T'X0^#WQ0\
M,>*?&'Q1_:+^(_P(UWQ#KOB?4]?^-?BBQB^+OC?Q/X?T[Q-X9>QT!O`GA'X4
M?#G6_AGH7AK2]-T[X>MX;\M\6?LG?M2_M<?LW_L\?LJM\`/B1\$?&O[(_P#P
M3=_:I_9Q^(/C3XHR^'=!^&OB[X_?$']D[1?V3_AQX5^$WB_1-=U^;XD>`/%.
MJ67B7XE:GX[T_2K30_#_`(&MO#-IKR6?C36Y?#.C_P!1^!G.!G!&<<X."1GK
M@D#(]A0%4$D*H+=2``3]2.3^-`'Y.?L]-\7/V@_VW_"7[3OB7]GKXM_L[^"?
M@]^Q3XH_9]U72OC1INA^'O$/B3XP_&'XL?"3XA>*]"\)Z=H>N^((_$OA/X4Z
M5\%K2PN_B+;W">$/%FJ^-K1/`E]KMKIFMW=I^LE-557.U57/)V@#)]3@<TZ@
M#X/_`&U?@AH>M_`#]I[QA/XZ^->GWD_P-^+NH'2-!^-7Q'T'PK'+8_#+7_+M
MX/"NF:]!H4%C-]D5KJQBLEMKJ26>2XCD,\P?R#_@C)HT-Q_P2<_X)SR-?:RA
M?]C;X`N4AUG4(8E+_#[1R5CBCG5$5?NHJ@*B!$4!4`K[&_:\_P"34_VE_P#L
MW[XU?^JR\55\H?\`!%W_`)1,?\$Y/^S,_P!G[_U7NCT`?HW_`&!;_P#00UW_
M`,'NJ?\`R31_8%O_`-!#7?\`P>ZI_P#)-;M%`&%_8%O_`-!#7?\`P>ZI_P#)
M-']@6_\`T$-=_P#![JG_`,DUNT4`87]@6_\`T$-=_P#![JG_`,DT?V!;_P#0
M0UW_`,'NJ?\`R36[10!A?V!;_P#00UW_`,'NJ?\`R31_8%O_`-!#7?\`P>ZI
M_P#)-;M%`&%_8%O_`-!#7?\`P>ZI_P#)-']@6_\`T$-=_P#![JG_`,DUNT4`
M87]@6_\`T$-=_P#![JG_`,DT?V!;_P#00UW_`,'NJ?\`R36[10!A?V!;_P#0
M0UW_`,'NJ?\`R31_8%O_`-!#7?\`P>ZI_P#)-;M%`&%_8%O_`-!#7?\`P>ZI
M_P#)-']@6_\`T$-=_P#![JG_`,DUNT4`87]@6_\`T$-=_P#![JG_`,DT?V!;
M_P#00UW_`,'NJ?\`R36[10!A?V!;_P#00UW_`,'NJ?\`R31_8%O_`-!#7?\`
MP>ZI_P#)-;M%`&%_8%O_`-!#7?\`P>ZI_P#)-']@6_\`T$-=_P#![JG_`,DU
MNT4`81T"W`)_M#7>/37-4S_Z4U\5^!=(@^.?[4_C;XCO=:Q=_#G]F>WU3X,?
M#B>76+^2'4?C+KD4-S\;_%NG2F2.=1X5T:3P_P#"FUN-TL*ZD/']K"RGS37N
M'[3GQ9U/X/?"'7M?\+6L&J?$?Q!=Z5X`^$?A^8(__"1?%;QU>Q^'_`^F>0Y4
M7%K;ZK=+K>M*&46_A_1]6O)7C@MI9$Z?X%_"C3/@C\*/!?PRTR]N-6;PWI;#
M6-?O"[:AXI\5:K=W&M>,/%VI-(\CMJ7BOQ3J.K^(+XM(X%QJ#QH?+1`/O<H7
M^KW".;<0R]S,N))8OA'(&TU.C@/84*O&&9TY+6G*>7XS`<-TN=.CC,)G^>P@
M_;9?+D^`SB_$7%^4\.Q?-EG#<,)Q=Q`K7A7S!8BK3X.RR:?NU(PQ^$QW$M7D
M:K8+&9!D,YIT<PCS=[_8%O\`]!#7?_![JG_R31_8%O\`]!#7?_![JG_R36[1
M7P1]^87]@6__`$$-=_\`![JG_P`DT?V!;_\`00UW_P`'NJ?_`"36[10!\=?M
M'?"/Q-;3>'?V@?@Y!K.J?&;X16U\@\.1:U?13?%WX6:E<6EWXZ^#UU>//F*]
MU6"QBU_X?7LI>/1OB#I6D.PCT_5-8$WN'PU\3>"OBWX$\+_$CP-XBUS5O"GB
M_2;?6-'O#K.K03B&4O%/9W]G+<+/I^K:9>PW.EZSI=TD=YI>K6=[IUW%'<VL
MJ+ZJ1GC_`#_GWKX5N0W[*'QS_M!%:V_9R_:4\80PZJ`?^);\'OVB_$,S1VVK
M;<@:9X'^/-T8;+4F"FQT?XM16=Y(]NGCVY:/]"RM+C'(8\.S][B7AW#XK$\*
MU';VF;9.IU<=FG"K;TJ8O"U*F*SOAR"<*E:K4SG*(+&XS,<DPN'_`#W-+\'9
M]+B*FN7AKB+$87"\54TG[/*<XE&C@,KXJLOX>$Q5.&%R3B*;4Z=&E3R7-JCP
M6#RW.L5B/LW^P+?_`*"&N_\`@]U3_P"2:/[`M_\`H(:[_P"#W5/_`))K<!R,
MC_/L?<=".QI:_/3]",+^P+?_`*"&N_\`@]U3_P"2:/[`M_\`H(:[_P"#W5/_
M`))K=HH`PO[`M_\`H(:[_P"#W5/_`))H_L"W_P"@AKO_`(/=4_\`DFMVB@#"
M_L"W_P"@AKO_`(/=4_\`DFC^P+?_`*"&N_\`@]U3_P"2:W:*`,+^P+?_`*"&
MN_\`@]U3_P"2:/[`M_\`H(:[_P"#W5/_`))K=HH`PO[`M_\`H(:[_P"#W5/_
M`))H_L"W_P"@AKO_`(/=4_\`DFMVB@#"_L"W_P"@AKO_`(/=4_\`DFC^P+?_
M`*"&N_\`@]U3_P"2:W:*`,+^P+?_`*"&N_\`@]U3_P"2:/[`M_\`H(:[_P"#
MW5/_`))K=HH`PO[`M_\`H(:[_P"#W5/_`))H_L"W_P"@AKO_`(/=4_\`DFMV
MB@#"_L"W_P"@AKO_`(/=4_\`DFC^P+?_`*"&N_\`@]U3_P"2:W:*`,+^P+?_
M`*"&N_\`@]U3_P"2:/[`M_\`H(:[_P"#W5/_`))K=HH`PO[`M_\`H(:[_P"#
MW5/_`))H_L"W_P"@AKO_`(/=4_\`DFMVB@#"_L"W_P"@AKO_`(/=4_\`DFC^
MP+?_`*"&N_\`@]U3_P"2:W:*`,+^P+?_`*"&N_\`@]U3_P"2:/[`M_\`H(:[
M_P"#W5/_`))K=HH`PO[`M_\`H(:[_P"#W5/_`))H_L"W_P"@AKO_`(/=4_\`
MDFMVB@#"_L"W_P"@AKO_`(/=4_\`DFC^P+?_`*"&N_\`@]U3_P"2:W:*`,>'
M1(()8YEO=9<QNKA)M8U&:)BIR%DBDN&21#_$CJ58<$&MBBB@`HHHH`****`"
MBBB@`HH)QR:^+/#?_!0[]CGQ9^T=J'[*&@_'#PY??&^QU'4]`A\._P!G>)+;
M0=<\7Z!_PDS>*/A_X6^(5WHMO\//%GQ(\(Q^#O$\WBOX>^'/%.I^+M`B\/:^
M=0TF.3P]X@BTH`^TZ*^:/AU^V/\`LN_%OXJ^)_@C\-?CI\./&GQ3\(_V^-9\
M&Z!XA@O=3)\(ZK!H'C-=(E"KIWB5_`_B"ZM?#_CI/#%]K+^"=>NK;1?%2Z1J
M<\5J_+_"W]OS]C'XV_$'Q#\*_A-^TI\)?B!X^\)VGBJ_\1^'/#'BJVU&ZT>Q
M\#ZA_9?BZ\O;E$738K7P[J&ZTU:X^VM%:3)(LC@1R%0#Z_HKYT^`7[6_[-?[
M48\5']GWXT^`?BRW@J;2T\21^#]:34)].LM?CO)?#6O"WEBMY[[PGXKBT[4I
M?"/C'38[SPGXLBTS4I/#FM:FFGWAA^BZ`/G;]KS_`)-3_:7_`.S?OC5_ZK+Q
M57RA_P`$7?\`E$Q_P3D_[,S_`&?O_5>Z/7U?^UY_R:G^TO\`]F_?&K_U67BJ
MOE#_`((N_P#*)C_@G)_V9G^S]_ZKW1Z`/TXHHHH`****`"BBB@`HHHH`****
M`"BBB@`HHHH`****`"BBB@`HHHH`*"<`D]!R:*\7_:#^+4'P2^$GB[X@+8OK
M6N6-K;:3X*\,6X+WOB_XA>);VW\/>`?"-C"C"66Y\1>+-2TK3B8E<V]K+<WL
MB^1:S,O?E>6XS.<RR_*,NHO$8_-,;A<OP5!2C!UL5C*T,/0I\\VH04ZM2*<Y
MM0@FY3:BFUP9IF>"R;+,PS?,:RP^7Y7@L3F&-KM2DJ6%P=&>(KU.6*<IN-.G
M)J$$YS=HQ3DTGX99!_CQ^UW>:GCSOAM^Q_;7&AV#`A[37_VC/B/X;MIM<NE(
M::WG7X4_"S5K/28F9(IK?Q'\2-5C5UFTAU'VWTZ5X7^S?\))?@M\(?"W@S5;
MY=:\93)?>*?B7XGR))O%WQ2\8WT_B3XA^)IIS%%+.FJ>*-1U`Z>)E+VNCPZ;
M8(1!:1(ONE?0<:YE@\9FU++LIK*OD'#6!H\.Y'6BI1AB\)@JM>MC,VC"?[RF
M\_SC%9GG\J%24Y81YG]3C)T<-2C'YW@C+,9@\IJYEF]%T,_XGQM7B//*,I*<
M\)BL;1H4<'E,IP?LZG]@9/A<LR!5J<81Q2RSZW*/ML15<BBBBOD#[$****`"
MN.^(/@+PI\4?!/B?X>^.-(M]>\)^+]&O="UW2[D$+<V-[$49H9D(FL[VVD\N
M\T[4+9XKS3=0M[74+*:&[MH94[&BM\+BL1@L3A\9@Z];"XO"5Z.*PN)P]2=&
MOA\1AZD:M"O1JTW&I2K4:L(U*=2$HSA.,91:DDS#%87#8W#8C!8RA1Q6$Q="
MKAL5AL13A6H8C#UZ<J5:A6I5%*G5I5:<Y4ZE.<90G"3C)--H^1OV;/'GBO1M
M5\2_LS_%[5YM7^*WPCT^RO=`\7WX\JX^,_P9O)SIW@[XHQ*^#-XAL98CX.^*
M-O;M.NG^-]/_`+39X[#Q5HZO]<U\S?M)_"?Q+XSTGPW\2?A4]I8_'GX,7U]X
MI^%UW>2+;Z;XCCO+>.W\7_"KQ/,<?\4?\3]%MUT/4)"Z'1==A\.>++=A=^'H
M0_I'P;^+'AOXV?#S0/B%X86]M+;5H[FUU70M7A:S\0>$?$^D74VE^*?!GB?3
MW`ET[Q+X3UZUOM#UJS<82\LWE@>:TFMYY?M.)\-A\ZP-'CC*Z%*A2QV)C@>*
M,NPU.%*ADW$U2E4K^VP]"E&-'#Y1Q+2HXG,\JHTH4:6#Q=#.LFP^'A@\HPF(
MQ?Q7"^)Q.2XZMP/FM>MB*F`PLL;POF.)J2JULXX9IU*5#V%>O5E*MB,WX:JU
ML/EF:U:DZU7%X2ODV<8C$3QF:XNAA/4:***^$/O`HHHH`****`"BBB@`HHHH
M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`
MHHHH`****`"BBB@!KXQSG&5Z=CN&&^BG#'/&`<@CBOY3/@-\9O!7PE_X*$Z)
M\./V:O&D?Q4\#_$']H&P\%>,/V'OV@/AMH4_[2'[,_BKQ#\??V[/&_QG^*?P
MN\0:!=IXH\"^!/@MXMUCQ)\9(=2^+FB>,K#Q%\%OV@-#TSP3\3](M]:^'^DZ
MA_5K7,V_@SPG:^+=3\>V_AS18?&NM:!HWA75O%<>G6R>(-1\->'M0UO5M#T&
M\U81B\N-(TK4_$>NWUAI\DK6UM=:K>S1QAYB0`?SV:7\5?@S\0OVV?\`@GYX
MF_9?\1:5XD\+^`3^U3X`_P"&$/#_`,)--^%WQ)_82NH_@Y\1+?XI_'_QQX*\
M-+IVN>%_$#^/O"^E_!!/AW\:;6R\)>+]3^/-EKWPVEU+7/L.NW'Q&-5\4VW[
M(:?L<_L&?M:_&']MGPQ\5_\`@F/^VEX=^+?P1\8>`_AGIGQ"_9WUWPA\"I[?
MX6ZAJ'A;X:^`O"'CCX%?%KQO\7+_`%3X$^(_@=\6=<\3^)O''B;Q/K6N:>$U
M?X?>(=:N/["XK&SAN+J[AM;>*ZO?(^V7,<,27%W]F1H[874ZJ);@6\;LD`F=
MQ"A*Q[5XHAL;.VEN9X+:"&>\D26[FBACCENI8XDACEN9$57N)4AC2))9FDD2
M-516"@"@#\9_V=/BG\&/VC/^"C/PT^*/[+'B#PWXY^$7PY_X)H:IX`^)'B3P
M%#'-X;\*^(?B)\;O@_XI^`GPI\3S6L4,.@>._"WA;P+\9M5E^&>IK;^*?AUI
M^IW(U[0/#O\`PDUHNI?M%5>WL[6T\[[+;06PN;B6ZN!!#'")[J=MTUS,(U42
MW$S?--.^Z64@&1V(&+%`'P9^VMX6^.MU\`?VGM1T+XO^"]&\&O\``WXNS0>&
M;WX+R:]JT.G1?#+7_MMD_B@_%32(Y[BZ,=TT-[_PCT(MA<1QM:7"PLTWD7_!
M&2VUM_\`@D[_`,$YVM]6M(HC^QM\`2D<FC^:R(?A]HY13*-4B\PJN%+&--Q7
M?M4N47['_:\_Y-3_`&E_^S?OC5_ZK+Q57RA_P1=_Y1,?\$Y/^S,_V?O_`%7N
MCT`?HU]D\0_]!JQ_\$;?_+BC[)XA_P"@U8_^"-O_`)<5O44`8/V3Q#_T&K'_
M`,$;?_+BC[)XA_Z#5C_X(V_^7%;U%`&#]D\0_P#0:L?_``1M_P#+BC[)XA_Z
M#5C_`."-O_EQ6]10!@_9/$/_`$&K'_P1M_\`+BC[)XA_Z#5C_P""-O\`Y<5O
M44`8/V3Q#_T&K'_P1M_\N*/LGB'_`*#5C_X(V_\`EQ6]10!@_9/$/_0:L?\`
MP1M_\N*/LGB'_H-6/_@C;_Y<5O44`8/V3Q#_`-!JQ_\`!&W_`,N*/LGB'_H-
M6/\`X(V_^7%;U%`&#]D\0_\`0:L?_!&W_P`N*/LGB'_H-6/_`((V_P#EQ6]1
M0!@_9/$/_0:L?_!&W_RXH^R>(?\`H-6/_@C;_P"7%;U%`&#]D\0_]!JQ_P#!
M&W_RXH^R>(?^@U8_^"-O_EQ6]10!@_9/$/\`T&K'_P`$A_\`EQ7Q9K\&L_';
M]K#1?!C:K:7OP^_9.M=)^(OB9ET=OL&J?'_QMI.HVWP\T"\BDU`I=2_#CP%=
MZCX\GC@N@;/6?%W@VYGC,MO$J?4'QK^*FB?!+X5>.?BGX@@GO-.\&:#<ZHFE
MVG-]KVJN\5CH'AK31L</JGB;7[O3-`TR,J0]_J5NIX)-<-^RY\+-<^%7PGL+
M;QK+;7GQ2\=:UKOQ3^,&IVH!AOOB?\0+XZYXEM[:17D$VE^&A)8^#/#[[L)X
M=\-:3"H5(U4?>\.)9#P[GG%T_=QN*6)X1X8NTI?7\QP:_P!9,SI7NIK)N'L6
ML#*W)6PN8<49-F&&FIX.3C\!Q(_[?XBR/A"G[^"PDL-Q?Q197C]0RW&WX:RN
MK:S@\ZXAPKQ\;\]'%9=PMG678F')C(\WM@M/$(&!K-C@<#_B1M_\N*/LGB'_
M`*#5C_X(V_\`EQ6]17P1]^8/V3Q#_P!!JQ_\$;?_`"XH^R>(?^@U8_\`@C;_
M`.7%;U%`&#]D\0_]!JQ_\$;?_+BC[)XA_P"@U8_^"-O_`)<5O44`8/V3Q#_T
M&K'_`,$;?_+BC[)XA_Z#5C_X(V_^7%;U%`&#]D\0GKK-C_X(S_\`+>OB#XAV
M^L_LK?%F;XVV6IVMK\#OC3KVBZ-^T%;1:4(]*^'?Q$NQ9>'?!?QYCL3J2V]G
MHWB'&E^!?B]>1W$"1*GA+QI=PR_V=X@O#]^UC>(O#VB>+-!UGPOXETNRUOP]
MXATN_P!$US1M2@2ZT_5=(U2UELM1TZ^MI`8Y[2]M)YK>>)P0\<C#K@CZ3AC/
M*62XZK''T*F.R+-L-+*^(<MISC3J8W*JU2E5D\-4FI4Z.8Y?BJ&&S3*,34A4
MI8?-,%A*M>CB,-&OAJWS7%&15,[P-*6!Q$,#GN4XF&:</9E.#J0P6:4*=2E&
M.(A&TZN79AAJV(RO-\/3E3JXC*\;BZ5"MA\1*CB*,0M?$)&1K5B0?^H(?_EQ
M_P#6],BC[)XA_P"@U8_^"-O_`)<5\E?LZ^(=;^$?C#4OV1?B+JEUJ5UX3T63
MQ)^S[XSU>=Y;WXD?`^VNUL(=#U&^E9EU#X@?!J>:R\)>+/F2\UCPU-X0\8O`
MS:KJ<D/VG6/$F15.'LSG@OK$,?@JU&CC\HS6C"4,-G&48R/M<#F6'C)RE35:
ME[F)PM1_6,OQU+%9;C84L=@\31I[\-Y[2XARN&-6'G@<91JUL#F^55IQGB<H
MS?"25/'Y;B)02C4="I:>'Q5-?5\PP-7"YE@Y5<%C,-6J8/V3Q#_T&K'_`,$;
M?_+BC[)XA_Z#5C_X(V_^7%;U%>">\8/V3Q#_`-!JQ_\`!&W_`,N*/LGB'_H-
M6/\`X(V_^7%;U%`&#]D\0_\`0:L?_!&W_P`N*/LGB'_H-6/_`((V_P#EQ6]1
M0!@_9/$/_0:L?_!&W_RXH^R>(?\`H-6/_@C;_P"7%;U%`&#]D\0_]!JQ_P#!
M&W_RXH^R>(?^@U8_^"-O_EQ6]10!@_9/$/\`T&K'_P`$;?\`RXH^R>(?^@U8
M_P#@C;_Y<5O44`8/V3Q#_P!!JQ_\$;?_`"XH^R>(?^@U8_\`@C;_`.7%;U%`
M&#]D\0_]!JQ_\$;?_+BC[)XA_P"@U8_^"-O_`)<5O44`8/V3Q#_T&K'_`,$;
M?_+BC[)XA_Z#5C_X(V_^7%;U%`&#]D\0_P#0:L?_``1M_P#+BC[)XA_Z#5C_
M`."-O_EQ6]10!@_9/$/_`$&K'_P1M_\`+BC[)XA_Z#5C_P""-O\`Y<5O44`8
M/V3Q#_T&K'_P1M_\N*/LGB'_`*#5C_X(V_\`EQ6]10!@_9/$/_0:L?\`P1M_
M\N*/LGB'_H-6/_@C;_Y<5O44`8/V3Q#_`-!JQ_\`!&W_`,N*/LGB'_H-6/\`
MX(V_^7%;U%`&-#;:XLL;3ZM9RPJZF6)-(,+21@_,BR_VI+Y;,.`_EN%Z[&K9
MHHH`****`"BBB@`HHHH`***YZ#Q;X6NO$U_X*MO$F@7'C'2M)L=?U/PI#K.F
MR^)=.T+4[FZL]-UJ_P!!CN6U6STC4;NQO;6PU*YM(K*\N+.ZAMYY)()%4`Z&
MBHUFB:1XE=3)%M,B`@M&&!*F10<H'`)0N%W@%DW`$T++&Y=4=6:-MDB@@M&^
MQ)0CJ.4<QR1R!&`8QNK@%64D`DHJ..6.7=Y;J^QF1MI#;70E71L$[71AAT;#
MH>'4$BI*`/G;]KS_`)-3_:7_`.S?OC5_ZK+Q57RA_P`$7?\`E$Q_P3D_[,S_
M`&?O_5>Z/7U?^UY_R:G^TO\`]F_?&K_U67BJOE#_`((N_P#*)C_@G)_V9G^S
M]_ZKW1Z`/TXHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H
MHKA_B9\0?#?PI^'WC/XD^+[P6/AGP/X;U?Q/K5QE?,^PZ/9RW<EO:H2#/?7K
M1I9:?:QYFN[ZXM[:!'EE1#T83"8G'XO#8'!T*N)Q>,Q%'"87#48.I6Q&)Q%2
M-&A0I4XWE.K5JSC3IPBFY3DHK5G/B\7AL!A,3CL;7I87!X+#UL5B\36FJ='#
MX;#TY5:]>K4DU&%*E2A*I4G)J,8Q<FTDSY;^)9'QU_:?^'WP:MR;SP!^S_%I
M'QZ^,*+\UC?_`!`NY+FU_9_\"W[1N&DDL;JV\0?%C4M-GC:)#X?\$W4XV7EN
MLGVX!@8_S^/OZU\N_LE^`/$OA7X9W'C;XBV[0?%[XX^(+SXR_%."42^9HGB#
MQ;9V*:+X&B%POG16/PU\%V/AKP#:0%V3S-`N[M?GO92?J*OK>-\5AJ>.P?#6
M6UZ6(RKA#"?V+0Q.'DIX?,LS56>)XASFG4C:.(I9CG57%K+L5*$:\L@PV2X6
MM?ZG"WR'`V$Q-3`8SB;,Z%7#YMQ?BUG=?#8B')B,MRMT*6&X>R:I3E>6'JY=
MDU'"/,<+&<J"S[$YSBJ-OKDVRBBBOBC[<****`"BBB@`HHHH`****`/G_P#:
M)^#M]\6/".FWGA#5;?PK\7OAQK</C[X-^-IHFDC\.^.=,M;FWBLM72,&6]\&
M>,-,NKWPAX[T<!TU/PQJ]YLC^WVFGS0:WP$^,=C\;/A_;>)3I5SX6\6:-J-_
MX/\`B7X#U&2.35_A[\2?#C16OBSP?J3QDK/_`&?>.EUI&IH!;Z_X<OM&\066
MZRU2!J]JKX>^.%G=?LZ?$L?M8>&K:YD^'NM6>F>&/VK/#NGPO-N\*6`BL?"7
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M8SBU*,DI1E%IQE&2NFFM&FFFFM&M0HHHI#"BBB@`HHHH`****`"BBB@`HHHH
M`****`"BBB@`HHHH`****`,K7=<TCPSHVJ>(=?U"VTG1-%L+K5-5U.]D$5I8
M:?8PO<7=W<2'A8H(8W=L`L<!45G95/YQ3?\`!4/X-IXE.G0^#/B#<>&ENOL_
M_"4);Z*C/")/+-_%X>EU%-5:T(_?I%(\6I-"<&P6XQ;U[K^VU=V6I_`;Q?\`
M#NRU%F\<^/K:RT[P3X4TVWNM4\2^+=0T[6-,UBZTK2=$TV&ZU&YMYK.PFAU'
M4/LZZ7ID,HEU2ZMH#N/\W\UC>PZE)H\UI=Q:O'>-82:3+;3IJR7RS&!K)],:
M/[>+SS_W7V3[.;@R_NQ&7(6O\YOIC?2=\3?"'C/ACA?PZED]#!U,JI9GG.98
MC`8?.:N(S6MC*].'#E:E5G.&7NCE]+!YA5IQA1S#$4,WPM6C6I48Q=7\IX]X
MPS?(LPP>#RJ6'A3=&-;$59TH8ASKRJ32PDE)M4^6E&%644H5I1KTY1G&-G+^
MN#PSXFT'QEX?T?Q5X7U2UUKP_K^GVVJ:1JEFY>WO+&[C$D,R;@LD;8)26&9(
MY[>9)+>XCBGBDC7=KY>_8U\`>*OAI^SK\/O"_C.WN-/U](-9UBZT>Z_U^BP^
M(==U#6[+2;A-Q\F[M+2]A-[;$*;2]EN+5AOA?/U#7]X<#9SFO$7!?"6?Y[E4
MLBSO.^&\DS;-\FG&I"659EF&6X;%XW+W"M^_IO"8FM4H>SKVKT^3DK)58R1^
MDY;B*^+R_`XK$T'AL3B<'AJ]?#M23H5JM&%2I2<9>]'V<Y./+/WHVM+WDPHH
MHKZD[0HHHH`****`"BBB@`HHHH`:_P!WJ!R!ST)+`!3[,<*?4&OY1O@/X0^%
M?P"_X*%^'?B=XX\&?"S]I7P9\5?VA8;?X,?M^?`SQ[<:7\8]$^*O[1GQ^_;P
M\/:)X!_:(T>&&QU/XH:39:II_C#]F3QG8^&/'?B[P%X;TKX.?"K5/$'PI\-0
M^&8Q\//ZNR,\&OBGPO\`\$[_`-CWP9^TMKG[6GASX*>%]-^-.N32:K_:\271
M\/Z)XRU&;Q?)XI^)?ACP:UP?"OAWXH>.H?&VNV7C;X@:7I-OXD\06EU=">^B
MN=:\3W.O`'Y`^(_`/AC]FO\`:G_9&^./[+$'A77OAC\=O!_[8?AKP9^T?\./
MBY>?&KXS?ME_M%^,_@-\2_V@]!T+]J*]U*RL++QG\']"N?A+XZ\1^`?%^CZ_
M\4=0\*^/_#?@/P79Z;\*_`=[J5EJ?R#X_,G[+W['_P"QW^T;^RO=ZAX3^//[
M27_!'_\`;;^+'Q_^)_AKQ!J,_C7XS^+-$_8F\%_M`V_[07Q'UNXN[V7QI\2?
M`OQ^UNRUCPUX]U5+G5O"]QXZU'P=HU[IVA:W'H+_`--'PX_8@_90^$7Q5U#X
MU_#CX&>!?"?Q*OYO%US!XBTRRO=GAZZ^(.H)JWQ!O/!.A75_<^&OA_>>/]53
M^T_'5WX%T7PY<^,;]YKOQ'+J<\\[R.^%?[$7[)WP3\5^-_&OPM^`OPZ\'>(O
MB%I.M>'?$MWINBF:V;POXFUVY\4>)_"&AZ1J-Q?:)X1\&^)_$UW-XB\3>#_!
M^FZ!X8\0ZYY6K:SI-]?6]O/$`?`G[-_PB^$7[,/_``46^'GPC_9@T?3/!GPC
M^)__``3@U[XD_$_PUX6U*XN-"\6^-OAM\;O@WX2^#?Q?\2I+=7J:U\1/&7AC
MX@_%G3-;^)E])+XG^)EKI,<OB76_$4OA:PET[]HZ^;?@!^R#^S9^RVWB63X!
M?"#PE\-)_%MOH6GZY=:%#J$UY/H7A1+^+PCX2L[W6-0U2[TCP/X.CU754\'>
M!-%FT[P;X375=3'A[0M-_M"\\[Z2H`^!_P!M;QW\8['X"_M.Z+HWP,_M_P`*
MI\#_`(N6T/B__A:O@[1?M%A/\,M>^UZA_8%_82ZC#]C,URGV624S3?9O,1@D
MB@>3?\$9;W5H_P#@D[_P3G6'1?.C'[&OP`"2_P!J6<?F*/A]HX5_+:,NF]</
MM8DKN\L_,C$_9'[7G_)J?[2__9OWQJ_]5EXJKY0_X(N_\HF/^"<G_9F?[/W_
M`*KW1Z`/T8_M'6_^@#_Y5K+_`.-T?VCK?_0!_P#*M9?_`!NN@HH`Y_\`M'6_
M^@#_`.5:R_\`C=']HZW_`-`'_P`JUE_\;KH**`.?_M'6_P#H`_\`E6LO_C='
M]HZW_P!`'_RK67_QNN@HH`Y_^T=;_P"@#_Y5K+_XW1_:.M_]`'_RK67_`,;K
MH**`.?\`[1UO_H`_^5:R_P#C=']HZW_T`?\`RK67_P`;KH**`.?_`+1UO_H`
M_P#E6LO_`(W1_:.M_P#0!_\`*M9?_&ZZ"B@#G_[1UO\`Z`/_`)5K+_XW1_:.
MM_\`0!_\JUE_\;KH**`.?_M'6_\`H`_^5:R_^-T?VCK?_0!_\JUE_P#&ZZ"B
M@#G_`.T=;_Z`/_E6LO\`XW1_:.M_]`'_`,JUE_\`&ZZ"B@#G_P"T=;_Z`/\`
MY5K+_P"-U\7?'.[U;XW?&WX6_LX0:(9O"O@^?0OVB?CG$=1M9;*]\/>%]<NH
MO@_X`OF\J2QE'C3XE:0WB?4--O$#3^'?AW?+M*7\8;[.\7^*]`\"^%?$GC3Q
M5J4&C^&?">AZKXD\0:K<DB#3=%T2QGU+4[V4J"Q6WL[::3:@9W951%9V53\T
M_L@>%==D\&>(_CGX]TVXTWXF_M)^(O\`A:/B'3[]4&H>%O!TMJFF_"'X>2A0
MKVZ>"OAQ#HT=_8R+O@\5ZMXIGD)GNIF;[WA'_A#R_.>-JGN5\KA')N&;Z2EQ
M1G%&O&GCZ7PR_P",=RFGF&;T\51DY8'/%PVJT?9XV-_@.+_^%W,<EX'IKGH9
MK.6<\36?NPX6R:OAYU,!5MS1_P",BS:KE^45,+6C&./R-\2.C/VF"E;Z8&H:
MV!C^P?\`RK67)[D_N^I/)]Z7^T=;_P"@#_Y5K+_XW7045\$??G/_`-HZW_T`
M?_*M9?\`QNC^T=;_`.@#_P"5:R_^-UT%%`'/_P!HZW_T`?\`RK67_P`;H_M'
M6_\`H`_^5:R_^-UT%%`'/_VCK?\`T`?_`"K67_QNC^T=;_Z`/_E6LO\`XW70
M44`<_P#VCK?_`$`?_*M9?_&Z/[1UO_H`_P#E6LO_`(W7044`<_\`VCK?_0!_
M\JUE_P#&Z/[1UO\`Z`/_`)5K+_XW7044`<__`&CK?_0!_P#*M9?_`!NJUY+J
M&H6ES87_`(7M[VQO8)K6\L[O4--N;6[M;B-H;BVN;>:%X9[>XA=X9X94>.6)
MWCD5D9@>IHIQE*,E*+<91:E&46U*,D[IIK5-/5-:IZH4HQG&49Q4HR3C*,DI
M1E%JS4D[IIK1IJS6Y\#_``3U?7_V<?B(G[*WB'3YI/`'B&#6O$W[*^MW^LP/
MY/AFQ=M1\5?`6[U&Y#FZUOX7I<R:IX%CEFFN]4^%;1VX9YO!.HD_;']HZW_T
M`?\`RK67_P`;KS?X]_!VQ^-OP^NO"QU>Z\+>*-)U+3?&'PX\=Z;%%-K'P]^(
M_AJ5[WPGXQTI)@4F?3;TM;:II[E8-<\/7VLZ!>$V>J7`.+^SK\8M0^*WA'4;
M#QGI5MX5^,?PVUAO`GQG\$0R.R>'O&^GVEO<G4=(\[]]>>"_&FEW%EXQ\!ZN
M#+#J/AK5[2-IVU"QU&&#]`XABN*\JEQMAK2S>A5HX3CC#02YY8^NU3P7%L8)
M<WU;B"I>CG-1<]/"\31G6K5,-3XCRC`P_/N'I/A3-8\$8EN.45Z5?%\#8F;]
MR.`H>_C.$93;:>)X?IM5LFIOV=3$\-.%&C3Q-3AW-\;+V+^T=;_Z`/\`Y5K+
M_P"-T?VCK?\`T`?_`"K67_QNN@HK\^/T(Y_^T=;_`.@#_P"5:R_^-T?VCK?_
M`$`?_*M9?_&ZZ"B@#G_[1UO_`*`/_E6LO_C=']HZW_T`?_*M9?\`QNN@HH`Y
M_P#M'6_^@#_Y5K+_`.-T?VCK?_0!_P#*M9?_`!NN@HH`Y_\`M'6_^@#_`.5:
MR_\`C=']HZW_`-`'_P`JUE_\;KH**`.?_M'6_P#H`_\`E6LO_C=']HZW_P!`
M'_RK67_QNN@HH`Y_^T=;_P"@#_Y5K+_XW1_:.M_]`'_RK67_`,;KH**`.?\`
M[1UO_H`_^5:R_P#C=']HZW_T`?\`RK67_P`;KH**`.?_`+1UO_H`_P#E6LO_
M`(W1_:.M_P#0!_\`*M9?_&ZZ"N5\9^-_"OP]T"Z\3^,M;L]"T6S>*&2[NV=G
MGNKAMEKI]A:0)->ZGJE])B'3]*TZWNM1OYV2"TMII&"US8S&83+\)B<?C\5A
ML#@<'1J8G%XS&5Z6&PN%P]&+G5KXC$5I0I4:-*$7.I5J3C"$4Y2DDFR*E2G2
MA.K5G"G3IQ<ZE2I*,(0A%7E*<Y-1C&*3;E)I)*[9:_M'6_\`H`_^5:R_^-UX
M'K/QF\7^,M2U;P3\#O#>F^(->TV8V'B+XAZKJ,5S\,O`MX'"75C<7MB8IO&7
MC"R3+-X1T";R+.=HH_$FMZ*"T,C!H_Q'^/7[WQ9%KOPF^#\Q(C\%6]S)I7Q0
M^(5B_)_X3;5;"83_``_\,WL6Q'\(Z%=_\)9J%M))'K^M:-')/HK?1&@^']$\
M+:/IWA_PYI.GZ'H>D6R6>F:3I5I!8:?86L>2L%I:6R1PPQ@DLP1`7=FDD+2,
MS'X58S/^-?=RIX[A?A.>E3.ZU&>$XFSZEHY0R+!8JFJG#V6UE^[>>9E0_MC$
MTOK#R?+<NC4RSB1^9[3%9CI0]I@L"]\3*+AC,5'JL+3FKX2C)>[]9K0^L37/
M]7HT4Z.,?D'P^^&<?@2[U#Q%<Z=J7C+XA:]$D?B;XC>*=8TJY\2ZO&C^:FFV
M:V]O%I_AGPU:RD_V=X4\.V]CHMD@1GANKSSKV;O6TV-]376V\"Z0VLJ`%U9I
M-$;4U"C:`NH&T-V,+P,3#`X&!7<T5]7EW#^2Y3@</EN7Y;A</@L-6EB:5)T_
M;2>,G.56MCZ]?$.KB,5F.(K3GB,7F.)JUL=B\34JXG$XBK7JU*DNZCA</0I0
MHTJ,(TX2<XQMS/VCDY2JRE*\YU9S;G4JSE*I4FY3G*4I-OG_`.T=;_Z`/_E6
MLO\`XW1_:.M_]`'_`,JUE_\`&ZZ"BO8.@Y_^T=;_`.@#_P"5:R_^-T?VCK?_
M`$`?_*M9?_&ZZ"B@#$@OM7DFB2;1?)B=PLDW]IVDOE(>K^6B!WV]=JD$]JVZ
M**`"BBB@`HHHH`****`"BBD#*20""0<'GOC./J!R1U`P2,$4`+12!E)*AE+#
MJ`02/J.H_&D#*3@,I/H"">.O`.:`'44@96SM8-@X."#@^AQT/M2T`?.W[7G_
M`":G^TO_`-F_?&K_`-5EXJKY0_X(N_\`*)C_`()R?]F9_L_?^J]T>OJ_]KS_
M`)-3_:7_`.S?OC5_ZK+Q57RA_P`$7?\`E$Q_P3D_[,S_`&?O_5>Z/0!^G%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`445G:OJVFZ#I6I:WK%[;
MZ9I.CV%YJFJ:C=R+#::?IVGVTMY?7US*WRQ6]I:0S7$TC?*D<;,3@5=.$ZLX
M4Z<)3J5)QA3A"+E.<YM1C",8IRE*4FE&*3;;22;9%2I"E"=6K.-.G3C*=2I.
M2A"$()RE.<I-1C&,4W*3:22;;L?&W[3C'XP?$/X3_LF63B;1O&=P?BY\=1$=
MSVWP4^&VM:;/8^&;M?D>!/BQ\1O["\*;EF5KGPSI'C>.-)/);;]LJ,`#CCTZ
M#V`[#T'8<5\;?LA:7J7C#3_'O[4'BFPGL/$7[2>MZ?XD\+:=?1R1W_AGX%^&
M[)](^"OAN:)Y)5MI]1T"6^^(VL6T)B6/7_'VHQ2Q^=;[J^RJ^XXXG#+*F6<%
M8:470X0HU\/F4Z<E*GBN+<P=&KQ1BN:+E3J/"8BAA.&J&)HSE0QF7<.9?C*=
MGB)W^%X&ISS*GFG&V*A*.(XPK8?$9;"I%QJ83A'+XU:7"V$<9*-2FL7A\1B^
M):^&K0C7P>9<29C@YMQH02****^$/O0HHHH`****`"BBB@`HHHH`****`"BB
MB@`K\9_^"BG[3W_#$7Q_^`_QE\'^"SKVN?$3PKXX\)_%#2U\0_V%I/C[P1X2
MFT:X\+Z?JL2Z1J@B\3>$?$'B>?4_"OBM(WN-/TF\\1>&;JTO=/UN&32_V8K^
M;;_@OH5&O?LO@LBG^R?B\?F=5_Y?OAWTW$9_"OZ-^BCD&4\6>-W#7"W$&$_M
M'A_B'*^+LNSG+)5\3AZ.88+_`%3SG%QH5YX6M0K<M+%X7"XRA*%2%3#XS"X;
M%T)T\3AZ-6'\W?2SXASCA#P.XFXKX=Q?]G<0\/9GPCF.2YG'#X;$5LOQKXNR
M/"3KT(8JC7HWJX/%8K!UX3I3IXC!XK$X2O"IA\16I3VA_P`%]2<#_AEHY)`.
M/C$G<@?]$V]__P!5?T1V5XEY:6MU\L?VFW@N/+WAMGGPI+LW87=MW[<[1G&<
M#.*_SK%9-PS+&.1TEC_O#_:_'\*_NOTS]FAY]/L9O^&@OVGE\ZSM9=O_``MT
MMM\RWB?&[_A'%SC=C.!GK@9P/WOZ8/@;X1>%]/P^EPCA/]2GG<^*5F$O;\1\
M0_VBLN7#GU56S'-,<L)]4^O8EWHJE[?ZS^\Y_94^3^?_`*&_CMXP^*53Q#CQ
M?BO]=ED<.%'E\?8<-\.?V;_:4N(UBW?+LJP/UOZW]0PR_?>U5#ZLO9\GM9\_
MU=O3^\O_`'T/\:7(]1^8KY>/[,<PYB_:(_:?AD',<H^*T$YB<'*2>1>>%[FT
MGV,`WDW5O/;2XV3PRQ,\;3_\,Z^)?^CI/VF?_"@^%/\`3X/U_$G]B<-2M[/C
M/"Q758C)<ZIO[/PJAAL6FM6FY2@TTM&KM?W%'/.)U_%X*Q;VM]6SS)*JMI?F
M>(Q.$<7K=*,9JV[333^FLCU'YBC(]1^8KYE_X9U\2_\`1TG[3/\`X4'PI_\`
MG/T?\,Z^)?\`HZ3]IG_PH/A3_P#.?H_L/AW_`*+7+.G_`#*>(?+_`*EGF_Z3
M'_;O$7_1$9IT_P"9MPY_=_ZFOF_N\F?361ZC\Q1D>H_,5\R_\,Z^)?\`HZ3]
MIG_PH/A3_P#.?H_X9U\2_P#1TG[3/_A0?"G_`.<_2_L/A[_HM<L_\-/$/E_U
M*_-_TF']O<1_]$1FG3_F;\.?W?\`J:^;^[R9]-T'C]/U.*^:T^!'Q#MU$-I^
MUG^T%';IGRDN]._9_P!2G4-\Q5[V]^!LEU/ARVQIY'=4*Q[BJ*:4_`[XE_\`
M1VWQZZC_`)@'[.WJ/^J%#_/KTJ?[`R5O3C?AZS>BEE_%RG;2RDH\,SBI6W49
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M-=&5.<JLIQHUL.HI22E3B]%_F#X6?2O\;>*/'?AK@;.L]P4^',RXUQ&2XS`+
MA_(Z.(^H0Q&*IQP[QF&PCJQJ0C2A&5:C7<I-.2JR4G*7]8]%%%?Y/G^M04=.
MM4=3U/3=%T^\U;6+^RTK2].MIKS4-2U&Z@LK"PL[=&EGN[V\N9(K>UMH(U:2
M6>>1(HT4LS`"OF[_`(2[X@?'8FU^&%QJ'P[^%4Q:*\^+=[I_E>+?&-JV/,C^
M$V@ZI#C3-+GB+)'\1O$MD\<HD\_PKH.H+Y.LQ?-9]Q1@<CJ8;!1HXK-L]S",
MY99P]E<:5;-<="G*,*N)<:U6AAL!EN'G.G#%9OFF)P65X:I4HT*N+6)Q.%H5
M^/%8VEAG"DHSKXJJI.AA*"C*O54;*4[2E&%*C!M*>(K3IT(2E&,JBG.$9=GX
M[^,<&BZXWP_\!:)/\1?BG-;0W)\+:9=)9Z7X7L[K'D:Y\1?$K17%IX-T1D)F
MMXYH;OQ#K*J8]`T/47W/'4\&?!N5-?MOB+\5M:A^(?Q,A5GTNZ-F]GX.^'R7
M*_Z1IOPV\-7$MRND?*1;WGBC4);SQ=K2(6O-2M;61=-@]#\"?#WPE\-M#30/
M"&DQ:;9M/+?7]P\L][JNMZK<D->:WX@UF]DGU/7=;OG`>\U75+FYO)R%4R+$
MD<:=I7DX/A?'9OB\-G/&];"YABL+6IXO*^&\%*K4X9R#$4Y*I1Q"5>G0J\19
MUAZBBZ>>9IAJ-/"U*5.MD>49'5GBZF,PIX.K7G#$9E*%6I"2J4,)3;E@\+)-
M.,ES1C+%XF#2:Q5:$5!Q4L-A\+)U'4****^[/3"BBB@`HHHH`****`"BBB@`
MHHHH`****`"BBB@!&SCCKQ^61G'OC..V<9XK^;/X(>.?CCX"_P""G&I>&?VO
M?C_^U?\`!OXE^*O']Y8>!]%U1H/''[!W[1WP^\8?$K]K8_!?X2?#Z'1H]4\#
M_!GQ%=_!O0/A=JW@NZ\7I\-?COK?Q4^%GQ6T"YOOB19:W<QZK_280",'U!^A
M!!!_`@'GCU!%?D_X-_X)1>`O"G[1-O\`%.?XW_&?Q%\%_"_C+P_\7?AM^S1K
MVJ>&;[P/X-^,6B?$+X[?$O2M;G\6?\(M'\2/$_@+P%XT^.WBGQI\)OAIXC\8
M:EHG@GQ??W%Q--K/AS0O`/AOPB`>2>!-9_:(^'?[<?P6^$UG^UE\4/VJ?BA)
M:_$OXC?\%!/`]AX;\&V/[.'P2^#.O^!/&VJ_`JS\(>%;/2#KOP6^)>K?$L_#
MCPM\&O!4GC_Q)XU^*?PPT[XI>/?B+;:Y:V-CXML_A;P7^U]^UA^RO\#/B#\:
M/VN-1_;P\)?M2>*OV*?VI_CU\'OAE^T5??LP:M^RKXH^*GPM^'US\5O$?P_T
M3P3\%-.O?BI\/]>^%>D366H^'/"GQ2\3:/J/B_X<^'?&6I0W%WK>FZC8:?\`
MK7^R_P#\$U)?V6KRYL_#_P"VA^UE\1/A_P"(/%WQ(\>_$CX:_$VW_9BU'2_B
M_P",OBJNKOXP\4?%+Q[X7_9P\*?&CQ3XBO+[5(+NVUV3XFVVJV5KH/AKPW;7
M<?A#0[#P_$_PU_P2S^#BQZ+H?QA^*GQZ_:7^'G@3X*_%/]GKX1_#;XY^+?"^
ML:#\,/A5\:/"T7@'XAZ;9Z]X0\%>#?'OC[Q5JWPVC/PQLOB/\6/%OCGQ[I'@
M.;4--LM>75M?\3ZYK8!RG[.\WQL^`'[;/A?]E_QQ^T7\4?VD_"'QD_8R\4_M
M&:AKGQAC\'W?B'PC\8/A+\5OA/\`#WQK>^#KOP;X6\)6V@>`OBEIOQHTW48?
MAU-:7VA>"=3\$H/!DNGV6LZM9/\`K%7Q;^SQ^Q7X?^!/C^\^*OB'XR_&S]H/
MXDP_"KPU\"/!_C3XXZSX*U'5_`?P8\+:M)K]OX*T)/`7@7P#8:C?^(M=73-:
M^('C[Q59Z_\`$#Q_J7AWPS+XC\1W,&@Z?;Q_:5`'PU^VG\;/!VA_L\_M.^$[
MW1OBS-JD'P+^,%@]UI'P%^./B#PTT]W\,/$31/#XRT'X=ZEX0N+)!<Q_:M1M
M]<ET^R99UO+FW:UN1#XQ_P`$8M8M(?\`@DY_P3GB>'5"R?L:_`!28M#UJ>,E
M?A_I"DI+!I\D4BDJ2KH[(ZX=&9&5C]A_M>?\FI_M+_\`9OWQJ_\`59>*:^4/
M^"+O_*)C_@G)_P!F9_L_?^J]T>@#](/[<LO^>&L?^$]K_P#\K*/[<LO^>&L?
M^$]K_P#\K*V**`,?^W++_GAK'_A/:_\`_*RC^W++_GAK'_A/:_\`_*RMBB@#
M'_MRR_YX:Q_X3VO_`/RLH_MRR_YX:Q_X3VO_`/RLK8HH`Q_[<LO^>&L?^$]K
M_P#\K*/[<LO^>&L?^$]K_P#\K*V**`,?^W++_GAK'_A/:_\`_*RC^W++_GAK
M'_A/:_\`_*RMBB@#'_MRR_YX:Q_X3VO_`/RLH_MRR_YX:Q_X3VO_`/RLK8HH
M`Q_[<LO^>&L?^$]K_P#\K*/[<LO^>&L?^$]K_P#\K*V**`,?^W++_GAK'_A/
M:_\`_*RC^W++_GAK'_A/:_\`_*RMBB@#'_MRR_YX:Q_X3VO_`/RLKXQ_:Q\1
M+\3+SX<_LIZ#)K<<_P`;]5N=0^+$EEI.N6]_HO[.G@F2UO\`XES%X[5+NT_X
M3R^N/#WPHLIQ;RK*/&.J/$0]D[)]PS316\4D\TD<,,,;RRS3.L<44<:EY)99
M'952.-%9Y'9@JHK,2`":^+OV4HIOBIK_`,3OVMM61F3XQ7]MX1^#\,\;+)I/
M[/?PWU+6+#P7>0K/"D\$GQ+\17GB;XH7;*[Q7.F:_P"&(@SIIT)'WO!$5E/]
MJ\;UDN3A2GA_['YE=5N,,S=>GPW".DESY8\-F'%#C5A+#XB'#L\!6<7C::E\
M#QQ)YL\JX'HM\_%E7$?VSR_%1X.RMX>IQ).7PODS-8K+^%U*G..(P]3B&&.H
MJ2P=3E^M;/4=)L+2VLK*PU&SL[2"&UM;2U\,ZY!;6MM;QK#!;6\,6E)'#!!$
MB0PQ1JJ1Q(B*`J@59_MRR_YX:Q_X3VO_`/RLK8HKX-MR;E)N4I-N4FVVVW=M
MMZMMZMO5L^]C&,(QC%*,8I1C%))**5DDE9))*R25DMC'_MRR_P">&L?^$]K_
M`/\`*RC^W++_`)X:Q_X3VO\`_P`K*V**0S'_`+<LO^>&L?\`A/:__P#*RC^W
M++_GAK'_`(3VO_\`RLK8HH`Q_P"W++_GAK'_`(3VO_\`RLH_MRR_YX:Q_P"$
M]K__`,K*V**`,?\`MRR_YX:Q_P"$]K__`,K*/[<LO^>&L?\`A/:__P#*RMBB
M@#'_`+<LO^>&L?\`A/:__P#*RC^W++_GAK'_`(3VO_\`RLK8HH`Q_P"W++_G
MAK'_`(3VO_\`RLH_MRR_YX:Q_P"$]K__`,K*V**`,?\`MRR_YX:Q_P"$]K__
M`,K*/[<LO^>&L?\`A/:__P#*RMBB@#'_`+<LO^>&L?\`A/:__P#*RLS46\-:
MN8CJNAS:D8`X@.H>#]5O3")-ID$1N=&E,8<HA<)MW;%W9VC'5T5=.I4I24Z<
MYTYQO:<).,E=-.THM-73:>NJ;3T(J4Z=6+A5A"I!V;A.*G%V:DKQDFG9I-76
MZ3."_LGP)_T*%I_X0-W_`/*&ND&MV(``@U<````>'=?``'```TS``'05LT55
M6O7K\OMJU6KRWY?:5)SY;VO;F;M>RO;>VI%+#T*'-[&C2H\UN;V5.$.;ETCS
M<J5[7=K[7?=F/_;EE_SPUC_PGM?_`/E91_;EE_SPUC_PGM?_`/E96Q161L8_
M]N67_/#6/_">U_\`^5E']N67_/#6/_">U_\`^5E;%%`&/_;EE_SPUC_PGM?_
M`/E91_;EE_SPUC_PGM?_`/E96Q10!C_VY9?\\-8_\)[7_P#Y64?VY9?\\-8_
M\)[7_P#Y65L44`>$7WP8_9XU2^O-3U+X%_#K4-1U&[N;_4-0OO@II5W>WU]>
M3/<W=Y>7=QX1DGNKJZN)9)[FXGDDFGFD>65W=V8_-7QP^`-KX(U'P[^T)^R5
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M`/QR^'N@_$7P3-K4^EZQ%-#>Z=<^']976/#6OZ=,UGK_`(3\26<-C,--\1^&
M]4CGTS6+!W)AN8?,B:6UFMYI;7CWXV>$/`0L[">W\1:_XPUN*X;PKX!\/^'M
M5N_%_BF6V`,W]EZ;/:VL<-A;[E-_KNIW%CH6FH=][J$1PC?G-\6_%VH_!3XH
M?%']H3]F/^V=2^%6MV8A_:MGT;PD_B[X<^'O%UO?6.E?\+N\#Z=!KNAOXK\>
M>"]#6]G^+6F>$AJ.DZMI%C977B&X_MVSNZ_1+X.^!/`>C:-#XY\,:W)\0=7\
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M;281\3/%UIMC*WNHV\7A+1[D.V@:$]PBZQ-](#6[%1A;?5P!T`\.Z^`,#`&/
M[,Z```#L``.!6S17!D/#>6</4\0\(J^)Q^/G"MFV=9C56+SG.,134HPKYCC7
M"#FJ2G.&$P="GA\MRVA)8/*\%@<%3I8:G]WA<'1PJFZ?-.K5:E7Q%67/B,1-
M)I3K5+*_+=JG3@H4:,'[.A3I4E&"Q_[<LO\`GAK'_A/:_P#_`"LH_MRR_P">
M&L?^$]K_`/\`*RMBBO?.HQ_[<LO^>&L?^$]K_P#\K*/[<LO^>&L?^$]K_P#\
MK*V**`,?^W++_GAK'_A/:_\`_*RC^W++_GAK'_A/:_\`_*RMBB@#'_MRR_YX
M:Q_X3VO_`/RLH_MRR_YX:Q_X3VO_`/RLK8HH`Q_[<LO^>&L?^$]K_P#\K*/[
M<LO^>&L?^$]K_P#\K*V**`,J+6+2:2.)(=5#2.$4RZ%K<$8+'`,DTVGQPQ)Z
MR2R(BCEF`K5HHH`****`"BBB@`HHHH`****`"BBB@`HHHH`^=OVO/^34_P!I
M?_LW[XU?^JR\55\H?\$7?^43'_!.3_LS/]G[_P!5[H]?5_[7G_)J?[2__9OW
MQJ_]5EXJKY0_X(N_\HF/^"<G_9F?[/W_`*KW1Z`/TXHHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`***0G`)_+Z]L^V>I[=:-P/CG]L+6=6\2Z!X,_9J\(
M7UU8>,?VF=<O?!-]JEC(T5SX5^#^BVL.K_&[QBLH`6.6U\&R#PCH[>;#(WBG
MQKH*12`ABOUGH>BZ5X;T72/#VA:?:Z3H>A:98:-HVE642PV6F:5I=I#8Z=IU
MI"ORPVME9V\%M!&ORI%$JC@5\;_LWA?C/\5/BQ^U7>,;OP]?W5Y\$/@!*0K6
MJ_"3P'K$B^+O&>FLKX<?%7XH6VK7JWCP))?>%/!W@R6)WMF0O]N5]]QE_P`(
MF$R;@>G[E7(:=;,.(TKISXNSFGAIYEA:J?OQGP_@,-E?#M;#5+PP^;Y=G6(P
M[4,PJ<WY_P`%_P#"WB\ZXZJ>]2S^='+N'+ZQAPADU3$0RW%TVO<G'B#'XC,^
M(J.*I\L\1E&8Y)A\0G4R^'*4445\"?H`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%!./\_P`AU/T%`!130ZMG:P;:2K8(.UAC*DC@,,CY3@^U.H33
MU3NNZ`**"0.2<#U-)D<'J#T(!/\`('\Z`%HKA?$?Q/\`AQX/9T\5>//!_AR5
M/^6&M>)=&TZY8Y("1VMS>QW4KL00L<<+.Q!`4D8KAO\`AH3P%?1NWA2S\=>/
M9$D6/_BB?AUXUUNQ<L0%9->?1;+PV8FW`B8ZRL6W+;]HS7S..XSX1RS$2PF/
MXFR+"XV"=\!5S3!+,)..\:>`59XRK4[4Z="<VTTHMIG)4S#`T9>SJ8S#0J?\
M^G6I^U?E&DI.I)Z[1BWY'N=%>&M\1?BKJC+_`,(W\"M9LX9!B.[^(GCCP=X3
M@R0/G>S\-W'Q`UE$4GE)=/AE/`"#)*G]G_M%:SY\=UXC^$O@6"1?W?\`8_AS
MQ7\0-1B;G.S4-9UKP1II)X(,F@SJIR#&PY/'_KKA<0^3*LAXNS>MK:E3X:S+
M)Z<URJ494\?Q53X?RJI"2:49PS"46VG?E=S/^T(2THX;'5Y=EA*V'36]U5QJ
MPM%I]&JKONM'<]Q)`(!(!/0$C)^E13W$-O%+//+'!#"A>2:=UAAC4=6DED*Q
MJ@[L6``KQ/\`X5%XGU14/BOXW_%352"-]GX>N?"_P^TXCDLL;^$?#EGKZ*<E
M5+^(I957'[TR*)*GM_V=O@\MS'>ZIX.A\6WL:X%WX^U;7_B%<%C@L^[QMJNO
M1JS,-YV1(N\EE4$FA9OQGB_>P/!^#P-)V37$O$]#!8R-TKRCA^'<LXLPE10=
MWR3S*@YJR3BVW$]OCYZT\!3IQZ_6\9&G4]5#"T<;!V[.M&_D?BU^U/\`MB_%
MWQ5\5O%VA>"/'FN^#/`WA'7]3\.:):^#=7FTI]8&CW;V%UKNI:OICQ7>HMJ5
MY:RW%E`MU_9]I8&V2"*29I[J?VC]CCXH_$']I;7-0^"WQ@^(?BK7/".A^';O
MQ7)9VLR:=J_C2UAU+3M-N?#7C+Q?8M!X@O/#<!U2*Y&F6D]I<ZR))['6=4NM
M,A2PG]"_:&_X)O7WC3QOJ/C+X-:_X5\,V>OS?;=5\'Z_;W^G:5INH,L:7$_A
MVZT33]02WL;U@UR^D2Z?##97#3?8K@6TL=K;_1/[(/[']M^S=#KGB#7M=M?$
M_C_Q):0Z7>7NF07%MHNC:+;W(NO[+TH7>R\NVO;N.WN]1U"[AMFF-M:6\%I!
M#`[W'^</`OA#]*3&?25Q^8>(-?/L7P#BL]S;$\48S$<35ZO!7$'"\YXFM@,F
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M=GXD\'^,-'N]#U_1KY28+RQNU`;9(A6:UN[:58KS3]0MGBO--U"WM;^RFAN[
M:&5/]?>#<^P.1+$Y%FN$GBN#,ZHX7`YUE.$C2IU,+3PG-'+<ZR2G)T\/AL\X
M?=6I5RN=Z-*MAZN-R7%3659KF%&K]KQ7PU7S6G@,TR*M0R[BKAZ56OP_CJL9
M1PM2%54UC<@S54HRJ5>'\[IT*.'S"C"$YX:K2P6;X.FLSRK+ZM+L@<C(_P`^
MQ]QT([&EKX*_9X^(/C'X-^/X_P!CSXZZW?:]KEIINH:M^SI\6M9D#2_&GX8:
M.L;3>'];O3B.7XN_#2T>&Q\56N5N/$>@Q6GBZVBD0ZA/)]ZUR<4<.8GAC,U@
MZF(HYA@<5AZ68Y+G.#4_J&>9-BG-8/-,"YI35.JZ=6AB<-6C#%Y;F&'QF5YA
M1P^88+%8>EW\+\1X;B;+'C*="M@,=A<14R[.LGQ;A]?R/.<-"G+&97C53<H.
MI256E6P^)I2GA<QP%?!YG@*M?`8W"UZI1117SI]$%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`C'`)'M]!DXR?8=3[`U^&/[*_[?O[57[1W[;WQ
M(^&-K=?LN:?\./AOXS\6^#/B3^S)K,_BCP?^UA\'O"7ACXH_M$_#K0OBKJ&J
MZIXDU&U\>:SXIB^&?PS\?:IX*M_AIX9\%'X7_&;P7K?@KXC:M<:5+J/C[]SC
MDC@X.0?K@@D<@X!'!.,@'(YQ7X.W'[`W[9WQ)_;E^'WQ0^.?B?X#^*?!7P%^
M(7@/XG?#O]JK1]#GT#]I3Q+X)\'>/OVI_$'AS]G:/PUH?AG2?#O@-+GPU\9?
M#7PV^/'B^P\1:EX6^)_PT\)^'Y].\&_\)?XGU[_A!0#W"#]M;]JCX3_&/X!Z
M7^UA\,?@?\.O`7[35]^T.-`^%G@_Q?XC\2?M!?`CPI\"OA;XW^,K?$+XEZS:
MWFL?#'XF>&;CPEX-TKPW\0YO`<'A?3OAG\2/BA\./"VFZ]\0X=6.HR^+:?\`
M\%5/C7\*?AYX`_:$_:@^%'PMLO@I^T=^QS\>/VQO@7X<^$?B+Q5<_$WP+9?!
M7X0Z3^T-:?!7XLZEXP5/"7B_QCX[^#6M/?V_C7P3:>&?#_AGQWX:UOPC+H&O
M:/>:/XOGZ?\`9A_8^_;LT;XN?$OQY^V'HO[''Q8UO]H72/&W@'XT_'+P?\4_
MCW=?$[PU\$M5C\3S>"?@5\`/AOXK^#VG^!OAC\*/"KZEHMIJ/A:R\80S^,]>
MM]6^*OCS6?%_CV[M3;\C;_\`!*_X[?%_X9?#3]G;]ISXE?""'X/_`+./[%WQ
M]_8Z^#OB[X0:9XPNOB)\0I?C/\(M-_9STGXV_$OPSXSLK'PMX!\0^!O@SHNY
MO`'A+7O'&D>)_B%XFUC75\4^'?#^E:5X=N`#[%_9R_:3_:9D_:)M/V9OVM_!
MGP9T;QQX]_9R;]IWX;:S\"]3\:7/A_3-$\.^-?"G@'XJ_"KQ?%X\DFU#5_$?
MP\USXA_#VXT;XBZ'_9&B_$/2]?U29O`W@>YT!;;5OT>K\X_V>OV=/VFY?VD-
M-_:<_:R\1?!.3QCX`_9G'[,OP_\`#_P)?QQ?Z#K-KXI\;>$_'_Q<^*OBF[\?
M:+H5_P"']2\;ZU\-_AY9^&OAKH\7B&Q\!Z9I&M?;?B#XVNM<MI-)_1R@#X^_
M;)^)GPYTW]FS]IKP[J/C[P1IVO1_`?XQV<FC:AXN\.6.JQW5S\,O$GV>VDTZ
M[U.&\2>83PF*%X!(ZRHRJ592?GS_`((PZCI\7_!)O_@G,DE]9(Z_L:?L_JR-
M=VRNK+\/M'#*RM*&4J<J00"&#*?F5@/H/]LGX9_#G4OV;/VFO$6H^`?!&HZ]
M)\!_C'>2:SJ'A'PY?:K)=6WPR\2?9[F34;O3)KQYX1!"(IGG,B+$BJP55`^?
M/^",.G:?+_P2;_X)S/)8V3NW[&G[/[,[6ELSLS?#[1RS,S1%F+'+$DDEBS'Y
MF8D`_33^UM,_Z"%C_P"!EM_\=H_M;3/^@A8_^!EM_P#':/[)TS_H'V/_`(!V
MW_QJC^R=,_Z!]C_X!VW_`,:H`/[6TS_H(6/_`(&6W_QVC^UM,_Z"%C_X&6W_
M`,=H_LG3/^@?8_\`@';?_&J/[)TS_H'V/_@';?\`QJ@`_M;3/^@A8_\`@9;?
M_':/[6TS_H(6/_@9;?\`QVC^R=,_Z!]C_P"`=M_\:H_LG3/^@?8_^`=M_P#&
MJ`#^UM,_Z"%C_P"!EM_\=H_M;3/^@A8_^!EM_P#':/[)TS_H'V/_`(!VW_QJ
MC^R=,_Z!]C_X!VW_`,:H`/[6TS_H(6/_`(&6W_QVC^UM,_Z"%C_X&6W_`,=H
M_LG3/^@?8_\`@';?_&J/[)TS_H'V/_@';?\`QJ@`_M;3/^@A8_\`@9;?_':/
M[6TS_H(6/_@9;?\`QVC^R=,_Z!]C_P"`=M_\:H_LG3/^@?8_^`=M_P#&J`#^
MUM,_Z"%C_P"!EM_\=H_M;3/^@A8_^!EM_P#':/[)TS_H'V/_`(!VW_QJ@Z5I
M@!/]GV/`S_QYVW_QJ@`_M;3/^@A8_P#@9;?_`!VOE']KOX@ZE;^`-%^$GP]U
MRTL?B;^T3XEA^#WA'4[>ZMY;CPGI6LZ=?ZA\1OB(8H[A)A'X`^'=AXAURUGC
M;:/$#>'[1R&O8PWPY^U!_P`%9O!?[-'QU\>?!&]_9ZU#Q==>!I]"@E\16GC'
M0-'MM2.M^&=&\2*T6G7'A:_FMOLZ:PMHPDNI3*]NTPV+(J+X9^R[_P`%$/"O
M[37[>7A$ZK\&+S1V\3^!;KX6_"^WF\3Z/J6G_#R$6>O>/OB3XEOK1?#MNNL:
M[X[F\->%-`CFL3IS:5H?AV&`R71U"^1OZ;X.^COXL9;E</%3-."75X2R3A2O
MXA9=7JYKPY7HYM1PV5PS?))5L!_:TL1+`IU<+FV:X/%4*-:MD^#S#!PIO,*V
M&PM;^7^,OI&>$F99M+PIROCF%/B_/.+:'AYF-"CE?$="ME-;$9G+*<[A2QZR
MF.&ACW&EBLHRK%X;$5:-'.<9E^+G4C@*5?$T_P!W/!&A^#/AYX.\+>`_"C:?
MIGAGP9X>T;POX?T]+VU86>C:#I]OI>FVY?S`9'CM+6(2RL-\TIDE<EW8GJ/[
M6TS_`*"%C_X&6W_QV@:5IA`/]GV/(S_QYVW_`,:H_LG3/^@?8_\`@';?_&J_
MFK$8BOBZ]?%8JM4Q&)Q-:IB,17K3E4K5Z]:<JE6K5J2;E.I4J2E.<Y-RE)MM
MML_IK#8>AA,/0PN%I4Z&&PU&EA\/0HPC3I4:%&$:=*E2IQ2C"G3IQC"$(I1C
M%))60?VMIG_00L?_``,MO_CM']K:9_T$+'_P,MO_`([1_9.F?]`^Q_\``.V_
M^-4?V3IG_0/L?_`.V_\`C58FP?VMIG_00L?_``,MO_CM']K:9_T$+'_P,MO_
M`([1_9.F?]`^Q_\``.V_^-4?V3IG_0/L?_`.V_\`C5`!_:VF?]!"Q_\``RV_
M^.T?VMIG_00L?_`RV_\`CM']DZ9_T#['_P``[;_XU1_9.F?]`^Q_\`[;_P"-
M4`']K:9_T$+'_P`#+;_X[1_:VF?]!"Q_\#+;_P".T?V3IG_0/L?_``#MO_C5
M-.F:2"%-A8!FSM4V=KEMHW':/*RV`<G:#BAM+=VV6O=NR7S>B\P'?VMIG_00
ML?\`P,MO_CM']K:9_P!!"Q_\#+;_`..T?V5IG_0/L?\`P#M?_C5']DZ9_P!`
M^Q_\`[;_`.-4`']K:9_T$+'_`,#+;_X[1_:VF?\`00L?_`RV_P#CM)_9>E\D
M:?8G'!Q9VS?H(2:Y3Q'XF^&O@\*WBSQ!X)\,*XW(WB#4_#^C;QSQ&NHS6SR$
MXP%16))``)XKEQF.P67X>>+Q^+PN!PM-)U,3BZ]+#8>FF[)SK5IPIQ3?64DB
M*E2G2BYU9PIPC\4ZDHPBO64FDOFSK/[6TS_H(6/_`(&6W_QVC^UM,_Z"%C_X
M&6W_`,=KP[_A=_PJOE?_`(133/$/C^57**/`?PW\3>);*3!`+#7;?0H?#:ID
M@>;)K21<YWXYIP\7?$#5GA_X1O\`9\N;.WF^[>_$;Q5X+\)1*"`!(]AX:_X6
M!K2@$D^5-IUO*0N&5"<#YC_7_A.K9Y?FD\^7N\TN%\MS7BN%/FDHKV]3AO!9
MI3P^K5_;SIVWE9:G'_:>"?\`"K/$VW>"HU\:E?3WGA*=91_[>:MU/;_[6TS_
M`*"%C_X&6W_QVC^UM+)"C4;`L>B_;;7)^@\[)KPX^%/CEKB2+?Z_\(?`L1?B
M'PUX%U;QMJ*QD](]:\2ZOX;TWS`.DDGA*9-WS&,@[:L#X&OJ2H/%WQ2^)WB.
M,@">QL=6T7P#I4J8(,7V7X<Z!X6O3&P^]YVJSRMSF7!((N),ZQ34<MX)SZ49
MV='&9QBLCR;`27-9NO3_`+3QV?X56UY:G#[JI;TKZ#^MXB?\++\3K\-2O/#4
M*3_Q+VU3$P[ZX5R_NWT/8=0\0:%I-N]WJFLZ5IMK&I>2YO\`4K&SMT0<EWFN
M;B*)5`Y+,P`'4U^57_!03]J*!?#/ACX?_![XC:/?1^)+G69/'6I^"/$5K?7U
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M/_@':\D\D_ZGJ3R?>OPWZ'O@/XN>&_#'%.`\3,[SGAS`9GF>`KY-P?E.?93C
M?J[P]/%+,\QQ&89?',W@/[2=3`TZ5+)<WP=::P=6KCXN;PKI_.\"<-YYE.#Q
MM+-\1B,)2K5:4J&!H8FA4Y>2,E6JRJ4E6]E[6].*6'KTYR]G*557]G;PY?!W
MQ!U1F_X23]H>]M89!F2S^'GA7P+X2@)Q]Q+SQ%%X^UE$4\AH]2BE/S9<`A5;
M_P`*0^%U]&B^*];\5^/9$D:3_BN/BCXKUVQ<MG<KZ$-?L_#9B;<<PKHRQ8.W
M9M``]S_LG3/^@?8_^`=M_P#&J/[)TS_H'V/_`(!VW_QJO[#_`-0.$ZFF8994
MSZ.O+#BG,LUXLIT[M2_=4N)<=FM.C9Q37L84^5K2Q]W_`&9@7_%HO$^6-K5\
M:EM\*Q=2LH[?92.'\.>"/A/X/9'\*>%/`/AR1/\`EMHFC>'=-N&;@EY+FU@C
MN9)&(!:225G8@%F)YKM_[4TOD?VA8D'J#>VQ_G,?RI?[)TS_`*!]C_X!VW_Q
MJC^R=,_Z!]C_`.`=M_\`&J^EP.79?E=".%RS`8/+L+#X<-@<+0PE".B7NT</
M"G3CHEM%;'73I4J,%"C3ITH+:%.$:<%Z1BDE]P#5=+'`U"Q`]!>6O_QVC^UM
M,_Z"%C_X&6W_`,=H_LG3/^@?8_\`@';?_&J/[)TS_H'V/_@';?\`QJNTT#^U
MM,_Z"%C_`.!EM_\`':/[6TS_`*"%C_X&6W_QVC^R=,_Z!]C_`.`=M_\`&J/[
M)TS_`*!]C_X!VW_QJ@`_M;3/^@A8_P#@9;?_`!VC^UM,_P"@A8_^!EM_\=H_
MLG3/^@?8_P#@';?_`!JC^R=,_P"@?8_^`=M_\:H`/[6TS_H(6/\`X&6W_P`=
MH_M;3/\`H(6/_@9;?_':/[)TS_H'V/\`X!VW_P`:H_LG3/\`H'V/_@';?_&J
M`/"/VA?@YX-_:`\!_P#",WWB/_A%?%>@ZK8^+_AG\1=$N[1/$WPU^(>ALT_A
MWQAH$QG0^=9SDV^IV#2);ZUHUQ?:5=D1W*R1<;^S%^T-J/Q#L/$OPS^+\6C>
M%/VB?@]<6FB?%+P[:74,>C:_;7*'_A'/BGX$DE=/M_@'Q_9H-2TXK_I&@ZDU
M]X<U*.*XLH)+KZI_LG3/^@?8_P#@';?_`!JODG]IW]G_`%[Q:_A;XT_`Y-%T
M+]HOX/)?W/@J:^@M[?0?B+X7O0)?$OP:\>;41+GPMXP2/.F7TY\[PGXH%CK^
MG3V8.HO-^A\,9I@,ZRW_`%$XEQ='!X&MB*N*X5S_`!<FJ?"N?8F,(SIXNK:4
MX\+Y]*E0PV>4XIO+,1#"<086,W@\QR_./SSB;*\?DV9_Z]<-82MC,=1P]+"\
M4Y!A$G4XIR+#S<H5,)3;47Q/D,9U\1DDVXK,\/4Q>08J4%C,OQ^4_6W]K:9_
MT$+'_P`#+;_X[1_:VF?]!"Q_\#+;_P".UXG\`/B_X"_:$^'=EXZ\-Z/_`&-?
M07M[X=\:>"];L+:V\4?#WQWHC);^)O`_BFQ:!);/6M"O6\MBT:1:A8RV6JV>
MZROH&/MG]DZ9_P!`^Q_\`[;_`.-5\7FF5YADF8XW*,UPE7`YEEV)JX3&X2ND
MJN'Q%&3A4IRY7*,K-7C.$I4ZD7&=.<H2C)_:95FF7YWEN"S?*L72QV6YCAJ6
M+P6+H-NE7P]:"G3J1NE*+:=I0G&-2G-2A4C&<911_:VF?]!"Q_\``RV_^.T?
MVMIG_00L?_`RV_\`CM']DZ9_T#['_P``[;_XU1_9.F?]`^Q_\`[;_P"-5P'>
M']K:9_T$+'_P,MO_`([1_:VF?]!"Q_\``RV_^.T?V3IG_0/L?_`.V_\`C5']
MDZ9_T#['_P``[;_XU0`?VMIG_00L?_`RV_\`CM']K:9_T$+'_P`#+;_X[1_9
M.F?]`^Q_\`[;_P"-4?V3IG_0/L?_``#MO_C5`!_:VF?]!"Q_\#+;_P".T?VM
MIG_00L?_``,MO_CM']DZ9_T#['_P#MO_`(U1_9.F?]`^Q_\``.V_^-4`/34M
M/E=8X[ZS>1V"HB75N[NQZ*JK(69CV`!)J[5)--T^)UDCL;-)$8,CI:VZ.C#H
MRLL896'8@@BKM`!1110`4444`%%%%`!1110`4444`%%%%`'SM^UY_P`FI_M+
M_P#9OWQJ_P#59>*J^4/^"+O_`"B8_P""<G_9F?[/W_JO='KZO_:\_P"34_VE
M_P#LW[XU?^JR\55\H?\`!%W_`)1,?\$Y/^S,_P!G[_U7NCT`?IQ1110`4444
M`%%%%`!1110`4444`%%%%`!69K.LZ1X>TK4=<U_5=.T31=)L[C4-5UC5[ZUT
MS2],L+6)IKJ^U'4+V6"TL;.VB1Y;BZN9HH(8U9Y'5037B?Q=_:'\(_"[4M-\
M%:?IVM?$GXP^);66Y\'_``<\!16VI>-=9A5_)&LZM]HN+;2?!'@RWG.W4O'/
MC._T?PY9I'-'!=7^H+%I\WF6C_L]>,/C!JNG^./VMM3T?Q.EC>6VL>%/V=_"
M\]W<?!'P+>V\BS6%]XI-]#:WGQK\;6&R-O[=\6V-KX/TJ],LOA;P5I\R1ZK-
M]CEO"T*>#P^><48V609'B(NK@5[!8C/,^A&;I_\`"!E,ZM"5?"NI"I3J9UCJ
MV"R2C*ABJ%/'8K,J,,LK_'9CQ5.>-Q&1\+X..?Y[AY*ECG[=X?(\AG*$:B_M
M[-H4L1&CBE3J4JE/)<#1QN=5HU\-6J8+"Y;6GF=#^4/_`(**_$'PA\4?VR?C
M1XZ\$:NNL>%=?O?!TNBZM+:7FE)JEI9?#[PKIIU&RMM6@LKR;2KV>SEN-'U,
M6XL]9TR2TU?3);G3;VTN9NE_X);LG_#>G[/($L))USQA@+-$S'_BVGC7H%<D
MGV`S7]E>J_#/X<Z[?3:IK7@+P7J^I7"P+<:AJGA30-0OIUMH(K6W6:[O-.FN
M)5@MH(;>%7D810110QA8HT132OAG\.="U"VU;1?`/@K2-4LV=K34=+\*:!I]
M_:M)%)!(UO>6>G0W,#/#+)$YBE0M%(\;$H[*?[8K_3:R+_B$=;PMP7ASFM"F
M_#FKP#A,RQ/%6$Q4Z,'PR^'J&.Q$*7#^"CB94TXUZL:<,*JSC)0C04TH_P`/
M8?Z#V>+Q@H>*V,\2,JKU8^)-+Q!Q668;A;%X2G6J+B>'$=?`X>=7/\9+#0J2
MY\/2E4GBG13BY2KN+<NW7H/H/Y4M%%?Y['^B*5DEV5@HHHH&%%%!('4X^M`!
M17GOCCXK?#WX<);#QEXJTS2+R_P-,T4--J'B366+,@CT3PQI<-[XAUF4NI4)
MINF71W<'')'F_P#PG?QJ\>XC^'GPZ@^'VB2XQXS^,XF@U-XB3&\^C_"S0+O^
MWIG^82PKXNU_P>Z[09K%P=E?)9GQMD&6XRIE5*O7SG/*:CSY!P_A:N<YM1=5
M)T'CZ&"52EDN'KMQC2Q^>U\LRURDN?&05VN*MF&&I5'0C.5?$QM?#86$L17C
MS*\?:PIW6'A*Z2JXF5&CWJ)'IGQ4\77'@+X:^/\`QM9VZ7EYX2\'>)/$5I:2
M@F&YN]'TB[OK6"?#QD0RSPQ+*%=7:(NJ'>5K^63Q/\0/''C3Q)=>,/%/BO7M
M8\37MR;R;5I]4O4GAF+;E33Q#-&FF6MO\L=G:6"V]O9P)'%`B*@K^E2W_9YT
M+79X=2^,'B/Q!\:-4B82QV7B^2WLO`>GS@,N[2/AMH:67A6/:I0176N6_B'5
MX]BL=5:3+U\7>*?^"67@K4_$UUJ7A;XGZ[X7\,W5T]PGANX\.V>OW6G12'S&
MLM.UN;5K!FMHV9H[0ZE87MQ!"(TGGO60N_\`"WTOO![Q^\;(\'8W@W)(4,ER
MB>,A6X/J<7Y7ALTIXO$U,-.AG^:TJM7!\.K$T*=*>%5#`9_GE7!TU[7"UI?7
M<7"E^<<=9#Q-Q#]0J8##*.'H.HI8%XZC&LIS<''$UXRE3PG/%1E32I8G$R@M
M82M5J*/:?L9_&;]H/XJ?!J-8=*\(^([KPKKM]X5D\>^.O%NN6=_J$=K::=J-
MHEUHVC>&-3N=:O;"TU2"TN=3EUO36U`11&X)O%NKF7ZQ_P"$/^-^L&*37/C!
MHOAN,C$MI\.OAQI]O.JG@J-7\?:QXW\Q@"P66/1;4YP_E#[M=1\)?A1X0^"_
M@;2/`'@FSEMM&TH32O/=RK<:EJFHW<GG7^K:K=+'$+G4+Z;#S.L4444:0VMM
M#!:6\$,?I-?U;X;>&^?Y1P#PADOB#Q?Q/Q!Q'E609;@LTK8/B;,\KPL,9AZ-
M.,Z-'%Y#+),?FE.@HQPSQN<5\;BL:J3Q%:?-5<5]IE&4XFAEF`P^:8[&8G%T
M,+1IUI4\;7I0C4A%)QC4PSP]6NHV4/:8B52=2SG)WE8\.'P%\.7XD'B[Q=\4
MO'0<DF+Q%\1O$=GIS$GYO,T'P?<>%/#\BL"5:.72Y(]C&,($^6NL\-_"+X7>
M$)([CPS\/?!NBWD9S_:%AX<TJ+4G88^>74VM7U&5^,[Y;IW)R2Q))KT6BOT'
M!\$\(8#$0QF'X;R98^F[QS*M@,/BLU<DT^:IFF*A6S"K.Z3YZN)G/^]8]2GE
M^!IR52&$P_M8[5I4H3K7WNZTU*JWYN;?F)M'/4YZ@DD?D20/P%*`!P!@>@HH
MKZ@[`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HZ]:**`
M/S_^/O@OQ3^SW\1+W]L'X,:)J.N:;>6NG6/[5'PET*$RW/Q'\":/&\-K\4_"
MNGH1'/\`%?X8V#RS^5A9/&7@Z*^T.2=+ZVLY)OMGP7XS\+?$3PIX?\<^"=<T
M_P`2^$O%6DV>N>']=TN83V.J:7?PK/:W4#X5UW(VV6"9([BUG26VN8HKB&6)
M.G(SQ7YMW:R?L&?%*75(@8/V,_C9XPW:M;(N-._9F^,/BN]15U:W"@II/P8^
M)VKS;-2@"QZ7X&\:W:W<7V#1]8,+_J>!_P"-CY1A\EJOGX]R#`QH<.5WK6XO
MR'!4DH<+UI:RK\0Y+AZ;_P!593;K9GED)\,4YU<3@^&,OJ?EN._XUSF^(SJG
M>/`>?XV5?B*@M*/"&>XRK>?$]&-K4<@SFO.W%$8VHY;F<X<33A2PV+XFQ]/]
M)**:CK(JNC!E8!E92&5@1D$,I(((((()!!!!((-.K\LVW/U+?8****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`$)P,_0#W).`/Q)`K\N/@Q_P`%*=1^./[1
MT_PP\&?LK?&+4?@-=^)/%'@?P]^TWI.L>"O$&D-XG\%_$+X\?"G7-=\;?"S1
M]2N/'?P^^$5]\1?V<_B1X*\,_$G6!<SW'B&/PXOBSPIX.T;Q=X9UC4?U';D'
M@'ID'N,\_CC./?%?S0?#_P"#/[2<'_!3A_&'PR_97^(G[*7Q.D^)G@?Q-^U)
MX]^&WCBPB_8?^-_P#/Q*_:R7Q=X^UKP_)XQGLOB3\5OCMX*N?@Y>^&M.A^%G
MAWXO_#/XVQ>.?$GB[5;#PK9W^N?$(`_8SX4?MY?`WXW_`+4WQ?\`V4OAC-XE
M\3^+/@=X*T[Q5X]\;0Z%=67PV36+KXA^)?AIJW@7PQXEU);/_A-/$W@SQ'X5
MU2R\=77A:WU7POX7U53X6O-?;Q=I^O:'I'EWPC_X*0:+\3OAUXK_`&@-=_9J
M_:"^$'[*7ACX8?$;XQQ_M/?$JZ^!(^'^N_#GX=0W^HS^)-+\'>"OC1XP^-,-
MKXG\.Z7?^)_"L>L?#'2YM0T..WN+A+.;4=.@NMB3X/\`Q/'_``4@^)7QFM/"
M)?X<:U_P3[^'GPCT7Q9>:C:V6@7_`,3=)^/OQD\67_A*Y73KJ7Q+8_9]`\2:
M'JE]J=KHQMX[/4MVGW-SJ<4MI'^+]S_P3B\;_%CP1%\(_P!FG]@^Z_X)QWX_
M82_:V_9W_:9O-7\;^%[_`.%GQ<\:?$_X/6_@7X(?#30O%WA?QKXT\9?M"^&?
M!OQ=AC^*>B?'CX@>&/#_`(C\%_#K08_#T<=AXB^(7B+P5I0!^Z/[.?[:UA\<
M_B'??"7QE\#/C/\`LX_$JZ^%FA?'KP)X/^-$'P_;4OB#\$O$6MGPW%XPTN?X
M;^.?'FFZ)KWA77Y=)T?XD?#KQ1>Z1XS\"7WB;PJ=2T^YL]>M+P?;E?E3^S]I
M/QV^.?[:?A7]J+XD?L[>/_V:O"_P@_8R\3?LYW'AWXI:SX`OO$'B_P"+GQ:^
M*GPK^(?CZ/PA#\//%_C.SU7X=_#+3_@OHFEZ=X^U6[TBV\<:GXUD?PQI'V+0
M]2O)/U6H`^=OVO/^34_VE_\`LW[XU?\`JLO%-?*'_!%W_E$Q_P`$Y/\`LS/]
MG[_U7NCUZG^VG\$_!VN?L\_M.^++W6?BS#JD_P`"_C!?O:Z1\>OCCX?\-+/:
M?##Q$L20^#=!^(FF^$+>R<6T?VK3K?0XM/O6:=KRVN&NKDS>,?\`!&+1[2;_
M`().?\$YY7FU0,_[&OP`8B+7-:@C!;X?Z0Q"10:A'%&H+$*B(J(N$15154`'
MZF45C_V'9?\`/?6/_"AU_P#^6=']AV7_`#WUC_PH=?\`_EG0!L45C_V'9?\`
M/?6/_"AU_P#^6=']AV7_`#WUC_PH=?\`_EG0!L45C_V'9?\`/?6/_"AU_P#^
M6=']AV7_`#WUC_PH=?\`_EG0!L45C_V'9?\`/?6/_"AU_P#^6=']AV7_`#WU
MC_PH=?\`_EG0!L45C_V'9?\`/?6/_"AU_P#^6=?/OQ<^-_@+X7ZK8>!],M?&
M?Q,^,?B&TDNO"OP<^'^M:QJOC34X`PBCUC7&GUFWT?P'X.CG;;>^-O&VH:+X
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MBB/B,2C$5O\`%'QO:6_@>`^9=>'-"\<HJ31FA?LT>*/BWJ%GXS_:SUBV\3P6
MUW9ZOX6_9X\-:YKU]\%O`MY:3?:=/OO$]QJDT&H_&;QM8N$9]>\3VEEX0TZY
MW_\`"->"[-HHM2E^PDT#3XU"1R:LB*`JJFOZ\BJJC"JJKJ0554`*JJ`JJ`J@
M*`!]8JW#O".F&6!XNXFAOBZM*.*X1R2LM;83"8BFH<5X^C+EB\3CJ2X9IU*=
M>G1P'$N#KX7,J?R?LN(>+]<2\?PCPS/;"4JLL)Q=G=&5E?%XNA/GX4P%:',X
MX;`U7Q-4A4H5*V/X:Q=#%9=5\Z^$?P-^'OP5TW4[;P?IUY<:YXCNTU/QKXZ\
M3:C<^)?B#X_UM4V-K?C7QAJ;2ZMKE[R_V:"26+2M)AD-EHFFZ9IZ16B>OUC_
M`-AV7_/?6/\`PH=?_P#EG1_8=E_SWUC_`,*'7_\`Y9U\=F.99AF^-KYCFF-Q
M.88[$R4Z^+Q=:=>O5<81IPYJE1RDXTZ<(4J<4U&G2A"G!1A",5]CEV6Y?E&"
MH9=E>#PV7X#"Q<,/A,)1IT*%)2E*I-QITXQBI5*DYU:L[<U2K.=2;E.<I/8H
MK'_L.R_Y[ZQ_X4.O_P#RSH_L.R_Y[ZQ_X4.O_P#RSKB.TV**QSH=B.3/K`'J
M?$6O_P#RSK@_''C/X9_#>WM[CQMXQ/A\WC;-.LKKQ3X@EUC5I=X3R-%T*SU"
MYUO6KDMPMMI6GWD['@)7%F.99=E&#K9CFV/P65Y?AHJ6(QV8XJA@L'0BVHJ5
M;$XFI2HTHN344YSBFVE>[1G5K4J%.56O5IT:4%>=2K.-.G%;7E.;48J^FK1Z
MI44T\-O%+//+'##!&\LTTKK'%#%&A>2265RL<4:(I9GD94502S``FOF+_A)O
MBIX](3X9_#W5O!VB2M^[\=?&CQ!XJTAY8E<HUQHWPOTG6/\`A+;]75DEA'BO
M4?!"L!EH9$;%:%M^S;HNOKYWQC\8>,/C+<M,ER=)\1ZK=Z/X`L[B)PT?]F_#
M[0KJWT>2&,*JQ'Q)<>)KQ06+7C,S$_(?ZXX_-TH\'<-X_.*<K<N=YW*MPMPU
M;XN:EB\;@\1GF9TZM-QJ8/&9)P[F>48I22>:T$^=</U^K7TP&$JUT]L1B'+!
M83O>,ZE.6(K*2M*%3#X6M0FG_&CN:>H?M"^&=0O+K1OA9HOB#XSZ];3-:SIX
M!M[:;PGIMV%#"/7/B/JL]AX&TTIDBXMK?6-3U:+:P72I)`(S4_X0_P".?C\E
M_&_CNP^%F@3@Y\)?"+.H>)I()`'$&J_%+Q+IRRP.#B.8>$/"6ASQG<+;6W&V
M8^SV7A/1--M+>PTZ"\T^PLXDAM+&PU?5[&QM(8^$AM;.TOH;6VB0<)'#$BJ.
M@JW_`&'9?\]]8_\`"AU__P"6='^J6;9O[_%W$^.QU*6KR3AM8CA3(DE\,:]3
M!XW$<29@W%RI8NEB^(7D^/B[SR2BFZ:/J->OKCL94J1?_,-A.?!89+HI.G4E
MBZKM=353%>PJK?#17NG'>!OA%\//AR]S=>%?#5I::OJ`/]J^)KZ6[UOQ=K+-
M@L^L^+=;N-0\1:F6<%PEWJ4D*,Q\J*-?EKTG`'08[_CZUC_V'9?\]]8_\*'7
M_P#Y9T?V'9?\]]8_\*'7_P#Y9U]9E>4Y7DF#I9=DV6X#*<!1<G1P66X2A@L)
M2<Y<TW##X:G3I1E4DW.<E!.<VY2;DVSMHT*.'IJEAZ5*A2C?EIT:<:<%?5M0
M@E%-O5NVKU9L45C_`-AV7_/?6/\`PH=?_P#EG1_8=E_SWUC_`,*'7_\`Y9UZ
M!J;%%8_]AV7_`#WUC_PH=?\`_EG1_8=E_P`]]8_\*'7_`/Y9T`;%%8_]AV7_
M`#WUC_PH=?\`_EG1_8=E_P`]]8_\*'7_`/Y9T`;%%8_]AV7_`#WUC_PH=?\`
M_EG1_8=E_P`]]8_\*'7_`/Y9T`;%%8_]AV7_`#WUC_PH=?\`_EG1_8=E_P`]
M]8_\*'7_`/Y9T`;%%8_]AV7_`#WUC_PH=?\`_EG1_8=E_P`]]8_\*'7_`/Y9
MT`;%%8_]AV7_`#WUC_PH=?\`_EG1_8=E_P`]]8_\*'7_`/Y9T`;%%8_]AV7_
M`#WUC_PH=?\`_EG1_8=E_P`]]8_\*'7_`/Y9T`;%%8_]AV7_`#WUC_PH=?\`
M_EG1_8=E_P`]]8_\*'7_`/Y9T`;%%8_]AV7_`#WUC_PH=?\`_EG1_8=E_P`]
M]8_\*'7_`/Y9T`;%%8_]AV7_`#WUC_PH=?\`_EG1_8=E_P`]]8_\*'7_`/Y9
MT`;%%8_]AV7_`#WUC_PH=?\`_EG1_8=E_P`]]8_\*'7_`/Y9T`;%%8_]AV7_
M`#WUC_PH=?\`_EG1_8=E_P`]]8_\*'7_`/Y9T`;%%8_]AV7_`#WUC_PH=?\`
M_EG1_8=E_P`]]8_\*'7_`/Y9T`;%<]XL\*>'/'7AK7/!WB_1=/\`$7A?Q+I=
M[HNO:'JMNEUIVJZ5J$#V]Y8WD$@*R0SPNRMC#HVV6)XYDCD6S_8=E_SWUC_P
MH=?_`/EG1_8=E_SWUC_PH=?_`/EG6M"O6PU:EB,/5JX?$8>K3K4*]&I*E6HU
MJ4E.E5I58.,Z=2G.,9PG"2E"24HM-)F5:C1Q-&KA\12IU\/7ISHUZ%:$:M&M
M1JQ<*E*K3FI0J4ZD)2A.$XN,HMQDFFT?"'P*\4^(_P!F;XDZ;^R'\6=8O]8\
M$ZY!>S_LE_%37+B2XN/$?AK2HS->?`OQAJ4W#?$7X>:<$;PO>ROCQIX)BMVA
M\O5=(FM)_P!!^O2O"OCA^SYX&^/'P]U7P#XKDUVV\^6UU?PUXET_7M7_`.$A
M\#>,M(D-UX9\<>%+NXOI1I_B3PWJ(CO=/NE`651-8W0EL;RZ@D\8_9E^*7B/
M6M5\3?L]_'F:YT_]HSX2V5G+K=W9:[KUEHGQ>\!W,AM/#GQI\$VYU")&TKQ`
M8_LGBK2;96?PEXNCO-+NH[:*XLHA^E9[1I<<Y5B^-<MI4J7$>6PIU./LIP\(
MTXXE5:M+#TN.,MP\$HPPN88JM2P_$^#I15++<[Q%#,,-R9?GD,#DWYKD-:MP
M-FN$X*S*K5J\.YE.=/@+-L14E4EAY4Z=7$5.!\QKS;E+$Y?A:53$<,XNK)U,
MQR6A6R_$<^/R6>-S?[<HK'_L.R_Y[ZQ_X4.O_P#RSH_L.R_Y[ZQ_X4.O_P#R
MSK\P/T\V**Q_[#LO^>^L?^%#K_\`\LZ/[#LO^>^L?^%#K_\`\LZ`-BBL?^P[
M+_GOK'_A0Z__`/+.C^P[+_GOK'_A0Z__`/+.@#8HK*BT>TADCE2;52T;AU$N
MNZW/&2IR!)#-J$D,J>L<L;HPX92*U:`"BBB@`HHHH`****`"DP,DXY/^&,_7
M'&>I``Z`4M%`!@9SCGIGOCTI``"2``3U(`!/U/?\:6B@!``,X`&3DX`&3ZG'
M4TM%%`'SM^UY_P`FI_M+_P#9OWQJ_P#59>*J^4/^"+O_`"B8_P""<G_9F?[/
MW_JO='KZO_:\_P"34_VE_P#LW[XU?^JR\55\H?\`!%W_`)1,?\$Y/^S,_P!G
M[_U7NCT`?IQ1110`4444`%%%%`!67K>N:+X:TG4=?\1:OIF@Z%H]I-J&K:UK
M5_:Z7I.EV%LC27%]J.HWTL%G8V=O&K237-S-%#$@+.X%>)?%S]HGPI\,M6T[
MP+H^EZS\3_C+XBM)+GPI\'/`:VE]XOU"W#"%-<\0SW4]OH_@'P3#<.JW_C;Q
ME>Z5H<*I-'8OJFHI'ITWG&B?L\^+/BQJ^G>//VM-6T?Q?/87EOJ_A/X`^&9+
MN;X&_#^]MG$EA?ZW!J$5O>?&3QO8!0X\4>,K*#PYIEZ\LOA/P7HTD<>HS?8Y
M=PM"G@J&=\48V609)B(.K@8*BL1GN?P4Y4[Y%E4ZE!U,(ZD*E.IG>/JX/):3
MHXJE1Q>-S&A'+*WQV8\4SJ8VODG"V#AGV=X>:I8Z;K2P^19#.48SMGN:TZ5=
M4\6J<Z=2&2X"EC,YJ*MA:M?"8++:\LSH9C?%/XN?M,$Z=^SPMU\+_@[<YBU'
M]I3Q9H._7?%-J&S*O[/_`,/]=A3^TK>XCV1VWQ4\>6,/A2,2/=^%_#/C.-([
MR/Z`^$GP0^'GP5TK4+#P7I=RVJ^(+M-5\9>-/$.HW?B/Q[X^UT(4EU_QOXPU
M62?6?$6IR%Y#%]KN!8:;%(;+1K'3=/CALX_6E55`50%4``*````,``#@````
M#@``#@4;ASSDCJ!R1^`R?TK+-N*IXG!SR3),%#A[AR4X3J99AJ\L1B\TJ4)*
M5#%<19JZ="OG6+I2C&I2INEA,HP->56KE&499]8KQJ:Y3PK3PV-AG>=XR7$/
M$D83C3S/$T(T,)E<*T>6OA>',J52O0R7"5$W3JU(U<5F^.H*C2S?-\S^KX>5
M-:*XWQ3\1/`7@>+SO&7C/PMX5C*%T/B#7]*TAY1MW!88;ZZAGG=A]V.&*21R
M0$5B0#YI_P`-$^#]3"_\(-X=^)'Q+=G,8D\%>`-?DT@OQM`\5>)(/#7A'8V0
M1(-=:/;EB0%)K\LS/C3A/)\3+`YCQ%E&'S&*365+'4*V<5;VM&AE%"=7,L3-
MW5J>'PM6I+[,79GT%;,,#0G[.KBJ$*O2A[2,J\O*-"+E6F_*,&_(]]H)`&20
M!ZG@5X$?%7[06OB1-"^%7A#P1#N!BOOB/X__`+4U%8V.%9O#/P]TK6+21U3#
MF!_&=L&)\LS*1NI?^%<_&#7V9O%WQTO])MIUS+I?PJ\$^'O",2$[_P!TNM^+
M&^(&OD+N4>?;7&G3$+D>6QR//_USJXO_`)$G"'&.;QM:5:ME-+ABC1F](^UA
MQGB^',=4IIV<ZF!P6-M!\T(U-C+^T'/_`'?`X^NNLI4%@XQW7O+,)X2HUW=*
MG4TU29\4_MH?MP^,?A1XYD^%/PI@TFSUK1K+3K[Q3XHUC3X]7>VN]5M%O[+1
M]&TZ:06`>+3KBTO+^_O4NAYEU%9VUJK0SSGE?V7OV_OB/XSU^3X>>/O!TOQ"
M\4ZS!</X)G\$6FB>']4U/5;6!KJXTK6X=6U73/#MK8+807>HG7(Y[,V<=G-#
M-87K2P,F)^UM^P9\0M7\4#Q_\(9-9^(/]JV5I%XHTOQ1XK&H>,1JMA;K:)J]
MOK'B.ZMX]6LKNRAM+>2P-Y#/IDUNJ:?:OI\JPV>S^Q+^Q5\2?`GQ(T_XM?%C
M38/"X\,VNI+X8\--J&GZEJ][JNJV%QI3ZGJ1TRXO++3[&PL+R]%M;&\DOKJ^
MEBEDBM[:V_TG_.JKF'TS,9]*;ZDX<;Y1P;B>+(T)?4\/+&>'F6^'U;%153%4
M,9B\!4X7Q.;83(I.K3Q.)P\\SJY[!4:F%E6?U,_*W4X]J<9^S?\`:-#`3QRB
M_9Q=3*J65RFDYPJ3I/!3K4\-[RG.#K/%>ZXN;]F?>8\,?'CX@@R>+_&>F_"#
MP_<<GPK\+1'KWC*2VE7<8-4^)GB/3Q8Z?,I54F7PEX1MYXF+_9/$#X29N]\$
M?!SX=?#VYGU/PYX;MU\0WJE=2\7:Q<WOB/QIJI=`LK:GXOU^XU'Q#=K(<N8&
MU!;5"Q6&WC3"#TZBO]'<NX'R+!8NAFN-IXGB'/</+VE+/>),3+-\QPU9IJI4
MRN%:,<OX?C6N_:X;AS`91@IZ-X:Z/U>EEV&ISC6J*>*Q,7>.)Q<W7JPD]W14
MDJ6%YOM0PE*A3?\`(``'3_/O]?>BBBOKSN"BBB@`HHHH`****`"BBB@`HHHH
M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`
MHHHH`*^5_P!ISX!ZK\4]-\.>/_AAJUGX+_:(^$5Y<^(OA!XYN(W-D;F>+R];
M\`>,5@`GU+X=^/K%6T;Q/IQ,@MC);:U:1_:[#9/]445[&0Y[F/#6;83.<JJP
MIXO"2FN6M2AB,+BL/7I3P^,P&.PM52HXW+LPPE6O@LPP.(A/#XW!5Z^&KPG2
MJSB_'S[(\NXDRK%Y/FE*=3"8N,'STJDZ&*PN(H588C!X[`XJFXUL'F&`Q=*C
MC<!C:$H8C!XRA0Q-"<*M*$E\_P#[.7QZTKX]^!I=8DTB[\&_$#PGJMSX-^+7
MPSUB57U_X;_$/2`J:SX<U$@+]LL)25U+PWKL*_8_$/A^ZL=3MRKR7%O;_0%?
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M.(J8'&83.LNI1IK`9O@L6\-2_LK$Y7B,3^L5%>,_`/X\>`/VD?AII/Q8^&=Q
MJUSX1UJ^UG3[&;6])N-$U!KC0=3N-(U`2:?<L\L2+>6LJQ.S$2QA9%P#BO9J
M_(<TRS,<ES''91F^"Q.79IEF+KX',,!C*4Z&*P6,PM25'$8;$T9I3I5J-6$J
M=2G)*4)Q<6DT?KV5YGEV=9=@<WRG&X;,<KS/"4,=E^/P=6%?"XS!XJE&MA\3
MAZU-RA5HUJ4XU*=2#<9PDI)M,****X3O"BBB@`HHHH`****`"BBB@`)`&3T%
M?"_AC_@I%^Q]XP_:/F_98T+XI7%Q\4O[;U;P?I5U<^!_'NG?#7Q5\0_#=QX\
MM_%GPO\`!?Q?U'PU:_#'Q?\`$KPHWPT\;_V]X-\/^*+[5K>?PKXJTZUCO=7\
M'^,-.T#[F;&.02,KTQQ\PPW/&%/S'/8'@]#_`"H_`;XP:'\*?^"C5C\./V4O
M$'CS5M&\??'#3?!_Q@_8&_:%^&&DZM\3/@-'KGQZ_;=\9_&CXT?#'QQH<(U[
MX3_"[X=>(M3;X\^#=0\<:S\0_`7Q"\"_M!:?X6\`>)M#G\0>`]!T@`_I:T[X
MY?"35_C%XF_9_P!*\?>'=2^,W@SP1X>^(WB[X>6%VUWXA\,^"_%FJW^B^&==
MUZ"WCD@TF#7]1TO4(M(M;^X@U"_@M9;^VLY-/V73^/\`PI_;M_9'^-WBSQIX
M*^&/QU\%>)M>\!:%K_BO70LFK:/H]YX-\)ZY)X9\5^.?!_BCQ#I>D>%_B'X"
M\*>(HQH7BGQS\/\`6?$_A+PYK$UKINM:S975Y:1S?G_;?L_Z!X&_X*4?M<:#
M\"/`FB_#;6?C!_P3/M?%&H>(/#^CMHR>*/CE\1_VD?VB);[QEXI\4+%Y^M^+
M[C4KW2Y)]1U74[O4=+T:UTJQM!8Z'8:;:P?E=\0+'5?VJOV0_P!D+]F_]F31
M/$OB#X\?LR_\$AOVU?A%\?OAOIO@_7M(\4?!_P`<:[^Q1X2_9QT[]GCQYI^K
MZ;I</AKXA^//COH@TSPOX)FN5OO$\7@&_P#&VCPW_AC2K37I0#^FO]GK]LG]
MFG]JJ;Q+;?`3XK:-X_O/"5CX=UG6;"#3?$OA_4?^$8\8+J#^#?&^DZ=XNT/P
M]?>(_AYXT72-6/@WXB^'+?5O`WBPZ5J0\/>(=1:PNA%].5^,7[.?Q8^&/[4/
M_!1+X??&7]G"YE\2_"7X6?\`!.GQ'\,/B5XET[P[JVB:/X9\?_%'XV_!CQA\
M+/A!KZZMIVER:;\1O`WACX:_$[4O$_PZFA7Q#\,H=;LX/%&EZ#<>*=.AO_V=
MH`^=OVO/^34_VE_^S?OC5_ZK+Q57RA_P1=_Y1,?\$Y/^S,_V?O\`U7NCUZ!^
MVMX$^,=]\!?VG=:T;XY_V!X5?X'_`!<N8?"'_"JO!VM?9["#X9:]]KT_^W[^
M_BU&;[88;E_M4D0FA^T^6BE(U)\F_P"",MEJTG_!)W_@G.T.M>3&?V-?@`4B
M_LNSD\M3\/M'*IYC2!WV+A-S`%MOF'YG8``_5&BN?_L[6_\`H/?^4FR_^.4?
MV=K?_0>_\I-E_P#'*`.@KYC_`&G/VJ?!/[*^A>#=<\9^&?''BI?''BI_".C:
M?X%T_1=0U"/4(]&U#7);J_76]>\/VMMIL-CIMRT]TMU*T3;2\0C+.OOG]G:W
M_P!![_RDV7_QRORQ_P""J%RFD_#WX/0ZSJ<=Q-JOQ.O[#2I);*ULU2]_X0G7
M[AK=9XW)\V\@@EBAC8J)Y`(5R[1JWRO'?%68<#<#\9\993PC7XZS+A?A/B+/
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MYN/">B>.H(HM07^>^ZECLK>YN[N1;2VLX9;BZN;C,4-K#`I>2:=W`$:QA23G
M#$X1`SE5/]$W[/7P#^&7BCX*_!CQGJ&AV?BF?7?A9X`UJS?QY;WGC:*PM]1\
M*:5=VUOI6E^*=4U'1]'LK:&9(K&RT[2K.&RMU2"&*)5V#^7?H8?2F\5O%K(>
M.:V<^%?!/$&;<,YQE']D^(6/QF>Y+PQE?]M4,SJ2R'&</1ROBG*.),\P:R^E
MF&3TL7+"82GEZQ\<^PF:U,1EV)P_Y5D6;<5\;9Y6RG%<4+"Y7#*EBL;DN`5+
M)\UQD(8FEAW6H9W@L/5S+`X*LZDJ>-6!6#QTJOL'EV;9<H8BG7WOAKKG[*_P
M%M=2\/>`/$D'BKQ7K]V-4\9Z[H<VO_&;XJ^/?$:*Z2:QXZ\0^'+/Q-X@UK6)
M9#*D*ZG/;Z?I:R&QTBRTO3HXK6+TO_A;GC[6\?\`"$_`?Q[=QE]G]I_$#4/#
MOPQTG:6($C6NHWVM^,0F%+$?\(>L@!4%`6&/3M,\-7.BV<6GZ/?6.E6$(Q#9
M:;X=TFPM(AZ1VUH(8(Q[)&*O_P!G:W_T'O\`RD6/_P`<K^HLQH>(O$N-KYCQ
M+Q^J6+Q4XU:V(X?R'#QS.4U"$(TL3F?%F,XMP^,ITH0C2IRI9/@&J48PA"E%
M1C#]HR[)GEF"P^78">"RG+\+!PPV#R;+J&%I4(RDYRBOK$L72ES5)2G.<</2
MG5J3G4FW.;9Y$=*_:0\0[TO_`!5\+?AO:OM81>&/#VO_`!$UM`>6CCUGQ/>^
M%-$B=00OF/X3O4W9(3;@%3\!H-882>/?BA\7?'?F*/M-A<>,Y?!>@S/MP4.A
M?#.T\&6LEOGD07DMZ,\.T@Q7KG]G:W_T'O\`RDV7_P`<H_L[6_\`H/?^4FR_
M^.5Q?\0_R#$:YS4SGB5R:=:EQ%GF:9EEF(DF[2J\.RQ-/AF-DVE&ADM&"6G*
M=G]F8:7^\/$8QOXEB\36K49OO+"\\<'_`.`X>*\CD_"OP:^%7@B6.Y\+?#WP
MAH]_&=W]JVVA6$FM2-\GSSZW=0W&L7#_`"*3)/?2.6&XMNYKTO:.XSSGDEN?
M;.<?A6!_9VM_]![_`,I-E_\`'*/[.UO_`*#W_E)LO_CE?39;E&4Y+AE@\GRS
M+\JPD7>.%RW!8;`X:+LE>-#"TZ5).R6JC?0[*-"AAX*GAZ-*A36T*-.%*"](
MP48_@=!17/\`]G:W_P!![_RDV7_QRC^SM;_Z#W_E)LO_`(Y7HFIT!`/!&1Z&
M@`#@#`]!7/\`]G:W_P!![_RDV7_QRC^SM;_Z#W_E)LO_`(Y0!T%%<_\`V=K?
M_0>_\I-E_P#'*/[.UO\`Z#W_`)2;+_XY0!T%%<__`&=K?_0>_P#*39?_`!RC
M^SM;_P"@]_Y2;+_XY0!T%%<__9VM_P#0>_\`*39?_'*/[.UO_H/?^4FR_P#C
ME`'045S_`/9VM_\`0>_\I-E_\<H_L[6_^@]_Y2;+_P".4`=!17/_`-G:W_T'
MO_*39?\`QRC^SM;_`.@]_P"4FR_^.4`=!17/_P!G:W_T'O\`RDV7_P`<H_L[
M6_\`H/?^4FR_^.4`=!17/_V=K?\`T'O_`"DV7_QRC^SM;_Z#W_E)LO\`XY0!
MT%%<_P#V=K?_`$'O_*39?_'*/[.UO_H/?^4FR_\`CE`'045S_P#9VM_]![_R
MDV7_`,<H_L[6_P#H/?\`E)LO_CE`'045S_\`9VM_]![_`,I-E_\`'*/[.UO_
M`*#W_E)LO_CE`'045S_]G:W_`-![_P`I-E_\<H_L[6_^@]_Y2;+_`..4`=!1
M7/\`]G:W_P!![_RDV7_QRC^SM;_Z#W_E)LO_`(Y0!T%%<_\`V=K?_0>_\I-E
M_P#'*/[.UO\`Z#W_`)2;+_XY0!T%%<__`&=K?_0>_P#*39?_`!RC^SM;_P"@
M]_Y2;+_XY0!T%%<__9VM_P#0>_\`*39?_'*/[.UO_H/?^4FR_P#CE`'045S_
M`/9VM_\`0>_\I-E_\<H_L[6_^@]_Y2;+_P".4`=!17/_`-G:W_T'O_*39?\`
MQRC^SM;_`.@]_P"4FR_^.4`=!17/_P!G:W_T'O\`RDV7_P`<H_L[6_\`H/?^
M4FR_^.4`=!17/_V=K?\`T'O_`"DV7_QRC^SM;_Z#W_E)LO\`XY0!T%%<_P#V
M=K?_`$'O_*39?_'*/[.UO_H/?^4FR_\`CE`'P9_P5?!/[`WQY`!)\GX?<#D_
M\E2\%5_%JR/D_*W4_P`)]?I7^@%\2_A#X>^,?@G6OAS\38++Q?X(\1"P76_#
MVH:>;>TU`:9J=GK%AYL^F:A87T9MM3T^SNT-O=PDR0*KEXF>-_DS_AUO^Q1_
MT0KP?_W_`/&7_P`VM?W=]%_Z4_!'@?P'F_"O$N0\5YICLPXMQV?TL1D6&R>M
MA(83%91D67PI5)9AG.75EB(U<KKSE&%"=)4YTFJLIRG"'\$?2F^BEQSXZ<?Y
M/Q9PSG_">58#+N$<#P_6P^?8G.*.,GB\+G&>9C4K4XY?DN8T7AY4<THPA*5>
M-5U:=52I1@H3GQG_``1Y_P"3%/AU_P!C7\4/_4^UNOU!KQKX5_!7PI\$O!EA
M\/?A596/@OP7I=SJ-Y8:!IUA)=6MM<ZM>S:CJ,R3:MJ6HWS-=7MQ-<.);N15
M9RL2QQJB+Z+_`&=K?_0>_P#*39?_`!ROY(\2N)L%QIXA<;<7Y=0Q6&P'$W%.
M>9[@L/CHT88RAA<TS'$8RA2Q4</6Q%".(ITZT8U51KUJ:FI*%2<;2?\`7_AG
MPOC>"?#S@CA#,:^%Q6/X8X5R+(L;B,#*M/!U\3E66X;!5JN%E7HX>O*A4J49
M3I2K4*-1P:YZ<)7BN@HKG_[.UO\`Z#W_`)2;+_XY1_9VM_\`0>_\I-E_\<KX
M@^X.@HK$@L=7CFB>;6O.B1PTD/\`9EI%YJ#JGF(Y=-W3<H)':MN@`HHHH`**
M**`"BBB@`K'B\/Z'!KM[XHATC3HO$>I:5I>A:AKT=G`NKWVB:'>:QJ.C:1>:
M@$%U<Z9I-_XAUV]TVQEE>VL;K6=4N+:..6^N6DV**`#'.?PZG'Y=/QZT@`'K
MWZDGJ<]R?7KV'`XXI:*`$``]>F.23T^I/XGJ>,YP*6BB@#YV_:\_Y-3_`&E_
M^S?OC5_ZK+Q57RA_P1=_Y1,?\$Y/^S,_V?O_`%7NCU]7_M>?\FI_M+_]F_?&
MK_U67BJOE#_@B[_RB8_X)R?]F9_L_?\`JO='H`_3BBBB@`KS7XF_!OX5?&?2
M].T3XL?#[PE\0])TC4#JVEZ=XNT2RUNTT_4S;369O[2&]CD6"[^RW$UOY\86
M012NH.#7I5%=6"QN-R[$TL;E^+Q6`QE!N5#%X+$5<+B:,I1E"4J5>A.G5IN4
M)2@W"<6XRE%Z-I\N.P.!S/"UL#F6#PN88+$14,1@\;AZ6*PM>$91FHUL/7A4
MHU8J<8R49PDE*,7:Z3/F&\_8M_9/U&UCL=0_9\^%5]91;0EI=^$=.N;<;?N[
MH9D>-]O!4NK%2-PP<8^B=!T+1O"^B:/X:\.Z99:+H'A_2[#1-$T?3;>.TT[2
MM(TNUBL=.TVPM8@L5M9V5G!#;6T$:B.&&)(T`50*U:*QHU:N'R^&4T*E2AE5
M/&8C,:>6T9RI9?#,,6HK%XZ&#@XX:.,Q2C%8C$JFJ]=1BJLY65N3`Y%D>68B
MKB\MR;*LOQ5>C3P];$X++\)A<16P])WI4*M:A1IU*E&F]:=*<G"#;<8IML**
M**S/5"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHJEJ4T%O
MI][<7,[VMO!:7,T]S'N\RWAAADDEGCVQRMYD,:M+'MBD8.BD1N0%(!R7AWXH
M_#7Q=XH\7^"/"GQ"\#^)O&GP^N;*S\?>$/#WBW0-:\4>![O4H3<Z;:^,/#^F
MZA<ZMX8N=0MP;BQ@UNTLI;J#]Y"KK74VVKZ5>7$EI::E875U"':6VM[VVGN(
MEC<1N9((97E0([!'+(`KD*<,0*_D]_8,L?AI^R=\>/`T&I>%?V:_B5H_B_X7
M^(?#O[(O_!1OX5:OJO@'4_&VE6G[&L'[1&L^+OVGOA^UM+J?C+2_BS\,O!!^
M*/Q6^*UOXP^(WA<?''3YM5;P7X+\3>+])N5X.+P7XE_X)X_LNZGX1\"^#OV'
M?&'Q<^.W_!'?]KWXI?#']M#]C/X9>(/!GQT.O_`GX,_#CQGXJ\?^,?BUK7B;
MQ7KWQL\'?&.;QWI/Q!\*_&'3(_A^T'Q-L_#&G2^"[V+7M#N=%`/Z_P#3]6TO
M5A>G2]1L-1&G:A=:3J!L+RVO!8ZI8LJ7NFWAM991:W]HS*MU93F.YMV91-$A
M8`Z%?BS^SE\+/@?^SY_P4:^&'PY_9/\`#/@SP'\(?B!_P3&O_'/Q'\/_``RC
ML;'POXMU7P1\<OA)X<_9T^*'BB#1R;/Q%XP\0^%_&'QQTNQ^).K?:/$OCW2=
M/U%-2U_7X?#=O_9G[34`?.W[7G_)J?[2_P#V;]\:O_59>*J^4/\`@B[_`,HF
M/^"<G_9F?[/W_JO='KW?]I&P_:*^(?@#XS?"?P)\*/AY?Z3X\^'OC?P)X?\`
M&'B+XU7OAUUD\8>#=1T"/5-4\.6GPB\1S6<%A>ZI(TUM;:O?S36UKYT3K),M
MNGY1_LL_L_?\%\_V4/V;_@9^S1X(O?\`@D!KWA'X#_"KP1\*?#NM^*-2_;5E
M\1ZMH_@C0;/0K+4-<DTG1=/TN35+J*T$U[)IUA8V3SN[6UG:PE+>,`_H=HK\
M7=W_``<._P#/O_P1C_\``[]N7_Y`HW?\'#O_`#[_`/!&/_P._;E_^0*`/VBH
MK\7=W_!P[_S[_P#!&/\`\#OVY?\`Y`HW?\'#O_/O_P`$8_\`P._;E_\`D"@#
M]HJ*_`;P3\8?^"_?COXA_&3X;:7HW_!'FUUCX)Z[X,T#Q%>WU[^VT-.U6Y\;
M^`=$^(>G3Z,8+>2Y-O:Z5KMM97?VZ&VE-]!<&)&M_*DD]7W?\'#O_/O_`,$8
M_P#P._;E_P#D"@#]HJ*_%W=_P<._\^__``1C_P#`[]N7_P"0*-W_``<._P#/
MO_P1C_\``[]N7_Y`H`_:*BOQ=W?\'#O_`#[_`/!&/_P._;E_^0*-W_!P[_S[
M_P#!&/\`\#OVY?\`Y`H`_:*BOQ=W?\'#O_/O_P`$8_\`P._;E_\`D"C=_P`'
M#O\`S[_\$8__``._;E_^0*`/VBHK\7=W_!P[_P`^_P#P1C_\#OVY?_D"C=_P
M<._\^_\`P1C_`/`[]N7_`.0*`/VBHK\-/''B_P#X.#?`7@OQ=XXU73_^"-MU
MIG@[PQX@\57]K8WO[<!O;JR\.Z1>:S=V]H)K..'[3/;V,L<'G21Q"5E,CA<U
M!\//&_\`P<%?$GP#X(^(>C:;_P`$;[+2?'?A#PSXRTRRU&]_;?&H6=AXIT2P
MUZRM;X6]I+;_`&NWM=0BBN?(EEA,R.8I&3!H`_=*BOQ=W?\`!P[_`,^__!&/
M_P`#OVY?_D"C=_P<._\`/O\`\$8__`[]N7_Y`H`_:*BOQ=W?\'#O_/O_`,$8
M_P#P._;E_P#D"C=_P<._\^__``1C_P#`[]N7_P"0*`/VBHK\7=W_``<._P#/
MO_P1C_\``[]N7_Y`HW?\'#O_`#[_`/!&/_P._;E_^0*`/VBHK\7=W_!P[_S[
M_P#!&/\`\#OVY?\`Y`HW?\'#O_/O_P`$8_\`P._;E_\`D"@#]HJ*_%W=_P`'
M#O\`S[_\$8__``._;E_^0*\F\8?&3_@OUX+^*'PA^%&I:-_P1ZN==^,K?$!?
M#^H6=[^VT=*TL_#KPU;^*=6_M@S6\=U_IME<I!8?8H+C%P&-QLCP:`/W[HK\
M7=W_``<._P#/O_P1C_\``[]N7_Y`HW?\'#O_`#[_`/!&/_P._;E_^0*`/VBH
MK\7=W_!P[_S[_P#!&/\`\#OVY?\`Y`HW?\'#O_/O_P`$8_\`P._;E_\`D"@#
M]HJ*_%W=_P`'#O\`S[_\$8__``._;E_^0*-W_!P[_P`^_P#P1C_\#OVY?_D"
M@#]HJ*_%W=_P<._\^_\`P1C_`/`[]N7_`.0*-W_!P[_S[_\`!&/_`,#OVY?_
M`)`H`_:*BOQ=W?\`!P[_`,^__!&/_P`#OVY?_D"D+_\`!PXH+&W_`.",>%!)
M_P!._;EZ`9/2P)Z>@/T-`'[1T5^`OPH^,?\`P7[^+P^(Q\/Z-_P1ZT[_`(5I
M\5_&_P`(=8&KWG[;2F^U[P)/8V^IZEIWV2WG!TJ[>_B:S^TF&["JWG0H<8]8
MW?\`!P[_`,^__!&/_P`#OVY?_D"@#]HJ*_%W=_P<._\`/O\`\$8__`[]N7_Y
M`HW?\'#O_/O_`,$8_P#P._;E_P#D"@#]HJ*_%W=_P<._\^__``1C_P#`[]N7
M_P"0*-W_``<._P#/O_P1C_\``[]N7_Y`H`_:*BOQ=W?\'#O_`#[_`/!&/_P.
M_;E_^0*-W_!P[_S[_P#!&/\`\#OVY?\`Y`H`_:*BOQ=W?\'#O_/O_P`$8_\`
MP._;E_\`D"C=_P`'#O\`S[_\$8__``._;E_^0*`/VBHK\!?C?\8O^"_GP&^&
M>O\`Q2\4Z-_P1YU;1?#UUX:M;K3]#O?VVFU.=_%'BS0?!]FT'VVWM[41V]_X
M@M+FZ,DRM]DAG\E9)=B'U</_`,'#;9*V_P#P1C(RPR;[]N4'Y6*G(^P<'(/'
M..Q(Y(!^T=%?B[N_X.'?^??_`((Q_P#@=^W+_P#(%&[_`(.'?^??_@C'_P"!
MW[<O_P`@4`?M%17XN[O^#AW_`)]_^",?_@=^W+_\@4;O^#AW_GW_`.",?_@=
M^W+_`/(%`'[145^+N[_@X=_Y]_\`@C'_`.!W[<O_`,@4;O\`@X=_Y]_^",?_
M`('?MR__`"!0!^T5%?B[N_X.'?\`GW_X(Q_^!W[<O_R!1N_X.'?^??\`X(Q_
M^!W[<O\`\@4`?M%17XN[O^#AW_GW_P"",?\`X'?MR_\`R!7E%Q\8O^"_=O\`
M&_2O@,^C?\$>6\4:O\*M?^+<&K+>_MM?V'%H?A[QEX;\$W6FS$VXOO[4GU'Q
M/9W5N4MFM/LMO<B6=)?)$@!^_-%?B[N_X.'?^??_`((Q_P#@=^W+_P#(%&[_
M`(.'?^??_@C'_P"!W[<O_P`@4`?M%17XN[O^#AW_`)]_^",?_@=^W+_\@4;O
M^#AW_GW_`.",?_@=^W+_`/(%`'[145^3_P`)V_X+C_\`"RO`W_"\H/\`@E(O
MP?\`^$HT?_A93?"B\_;!?XDKX+^UI_;Y\#IXPLD\+-XG^P^9_8ZZ^Z:2;O9]
MM80[J_6`9P,XSCG'3/?'M0`4444`%%%%`!1110`4$`\'G_ZQR#]0>0>QYHHH
M`^/_`(-_L#_LA?L_?%SXB_'/X/\`P%^'?@3XF_$][C_A(O$>A>'=.M'LK;4E
MM)/$.G>$[*.V6Q\&:9XOU.QM_$'C/3O#$&F6GBSQ'&NM:Y%>7B1/'U?P@_8X
M_96^`.M>+?$7P6_9]^$GPQUKQSISZ)XFU#P9X(T31)M0\.O?W6JGPK&+:U$>
MF^#QJE]>:FGA#28[#PPFHW5Q>KI`N96E/TK10!X'\#OV6?V<OV:$\3Q_`'X)
M_#3X0+XRNM/N?$Q\`>$]*\./J\>C1W4.@:;<RV,"2KH7AN&_U"'PQX<@>'P_
MX:BU'48]!TS3DO[M9O?***`"BBB@`HHKEE\<>#&UUO#"^+/#3>)$D:)O#ZZ_
MI#:V)53S&B.D+>'41(J'>8S:[POS;<8-`'4T444`>8>#OA)X6\#^//BQ\1=&
MDU=]?^,NL^$M=\7)?7T=SIT5[X+\$:/X`T@:+:+;0OI\#Z%HEF][')/=&XU`
MSW2O$L@A3T^L_5=6TO0]/N=6UK4;'2=+LD$MYJ.IWEMI]A:1EU027-Y>2PVU
MO&7=$#S2HI=E0'<R@V)KNVM[:2\GN(8;6*%[B6YEECC@C@CC:62:29V6)(4B
M5I7E9Q&L2F1F"`M0!8HIJ.KJKHRNCJ&5E(965@&5E920000002""""0:=0`4
M444`%%%4M1U'3](LKG4M4OK/3=/LXC-=WU_=065G;0J0&EN+JZDBMX(P2`9)
M9$0$@%AD4`7:*P]!\3^'/%-M)>^&M>T;Q!9Q2F&6[T/5=/U>UCF`#&&2XTZY
MN84E"L&\MY`^TYVXYK<H`YKQGX4TSQWX1\4^"M;:[31_%WAS7?"^JO83K;7J
MZ;XATJ\T>_:SN&BF6"Z6TO9C;S-#*L4P20QN%*&#P'X-TCX=>"/!_@#0&O7T
M+P1X6\.^$-&?4;A;O4'TGPQHUEH6FM?7210+<WC65A`;J=8(5FG,DBQ1A@B]
M96:VL:4FJQZ$VI6"ZU+82:I'I#7ML-4DTV*=+6748]/,HO'L([F6.WDO$@:V
MCG=87E61@M`&E15=KNU2XBM'N($NIXYI8+9I8UGFCMO)^T/%"S"25(/M$'G,
MBLL/GP^85\V/=8H`****`"BBB@`HKF-=\:^#_"]Q:VOB3Q3X<T"YOE+V=OK>
MO:3I,]VH?RRUM#J-Y;27"B3Y"84<!_DSNXKI(Y$E19(V5XW4,CJ0RNK`%65@
M2&5@0RLI*LI#*2I!(`^O+?%?PA\*^,?B1\+/BEJTNKKXE^$!\=-X4CL[Z.WT
MJ4_$+P[;^&->_MBR:UE>_P!FFVT;:?Y=S:_9;K=,_GJ?+'J5%`!16;I6L:3K
MEE'J6C:GI^K:=*]Q'%?Z9>VNH64KVEQ+:W21W=G+-;N]M<P36]PBREH)XI(9
M0DB,HMV]U;7:/);3PW"1SSVTC02QRK'<6LKP7,#F-F"3V\\;PSPL1)#*CQRJ
MCJR@`GHHHH`****`"BBN6TGQQX-U[4+G2=$\5^&M8U2S$AN]-TK7](U+4+81
M2>5*UQ96-[<74"Q2$)*TL2"-OE<J>*`.II&4,K*>C`J<=<$8-+10!Y?\,?A'
MX5^$W_"?#PM)J\G_``L?XG>,?BSX@_M:^COMGBCQQ-93ZU'IOEVMM]DTE'L(
M/L-B_P!HDMU,@:YFW`KZA6=J.KZ5HZV;:KJ5AIJZA?VNE6#:A>VUDM[J=\YC
MLM.M&NI85N;^[=2EK9P&2YN&!6&)R"*LW%W;6D8ENKB&VB:2"$27$L<*>;<S
MQVUO'OE9%$D]S-%;PH3OEGECAC#2R(C`%BBBB@`HHHH`***R]9US1O#MA+JF
MO:MIFBZ;"T:3:AJ^H6>F6,32L$B62[OI[>VC:1R%17E!=CM4$\4`:E%96C:[
MHOB*QCU/0-6TS6]-E9UBU#2+^TU.QD:,[76.\L9KBV=D/#JLI93@,!FM6@#R
M_P",GPD\+?'+X>:Y\,O&DNKP^'-?N/#]S?2:%?1Z;J:R>&O%&B>+=.%O>2VM
MXD2-JF@6*W2FW?SK-KB`&-I1*GIZJ%&!ZLW/JS%C^I./:EK-AUG2;C4[W1;?
M4]/GU?3H+6YU#2X;VUEU&QMK[S?L5Q>6*2M=VL%WY,WV6:XACBN?*D\EY-C8
M`-*BJXN[5KEK(7$!NTA6Y:U$T9N%MWD>%9S!N\T0M-')$LI3RS*CQABZ,HL4
M`%%%%`!1110`45RVI>./!NC:K;Z%J_BSPSI>M78A-KI.HZ_I%CJ=P+ABL'D:
M?=7L-Y-YS`K%Y<#>:P(3<0174@YY_F"/T/-`!7E\_P`)/"UQ\9--^.4DFKCQ
MII7PTUOX4VL*WT8T(^&->\6^'_&E])+IOV4R/JRZOX:TY;>]%XJ16375N;9V
MF$L?J%0W%Q!:0375S-%;VUM%)/<3SR)%#!#$ADEFFED98XHHD5GDED94C16=
MV502`":BJ5AJ6GZK8VNIZ9>VFHZ=?0175E?V-S!>65Y;7"J\%Q:7=M)+;W,$
MR,K130221R@@HS9J:UNK:]MXKJSN(+JVG020W%M-'/!*A)`>*:%GCD4D$!D9
ME)!YXH`GHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@".;_5
M2_\`7-__`$$U_.'\$OV5?V%OBQX<_P""P_Q1_:X^$'P-FM?#W_!0;]JA?$7[
M0'C3PKX2T7XB_#7PAX;^$/P3U*WU_P`-_&Z6SL_'/P_NO!DDEWKGAO6_#_BC
M2KWP[JT:ZCI$UO>@.?Z/R`001D$$$'H0>"#]:^&_&'_!/#_@GSJ?Q&\2_M`?
M$#]D[]FW5OB'J^O/X[\6_$7QI\-O!^IW=_XFA%FY\7Z_>>(;2XTN?6K;^SK"
M5->U"`W=M)8V<J7,<EO"R@'X5?#3]O'_`(*0^*?@U\,_"WA]?B)8_$?]G_\`
MX)D?L9?M%?$GQ#>?#C]G?6[?XF_&#XW?#3Q_XLOM>_:G\0?M%?'7X/:Q\.?@
M_!9?"^#3_%VJ?"NSL/%-MXPO_B?JVN^.?#C>%=*\-W?W3:_M5_M2?&/QC^T9
M\0(/VCO@5^QSX&_9"TO]DZYU[X>>/_#W@?XF_#?QC<_&3X&?"S]H#XAZU\7_
M`(OKKMKK-EX`N_\`A9&H?!?X2>)/@YK7ANT?Q7X'UGQI<:K\0[6^B\(67Z5_
M'?\`9=_9`^/<_A_XC?M#_!GX*?$N3PEI:V>D>+OB3X;\-:O;6_AC4=3M-5_L
M"^U?55%GJW@O5-82RU&7PQK<^H>%=2U(6]Y)IEQ=,DC6?BC^R[^R9XV\=^$/
MC1\7/@Q\&]<\>>!7\-Z?X6\>^,O#'APZGIC:)K8U+P/IYU+48X;?4!X9\471
MUCP+8ZJ+]/#7B6Z?5O"T.GZO<-<N`>:_MF_#7X&?&&?X0^`OB3I_P?\`B#\6
MSJ_Q&\6_LS_`SX^^*-8M_@]\5/BCX8^'&LP:C-XR^'.GV&OV7Q.A\!>#=;UK
MQ+;V5]X2\677@QS<>-]!TFWUG2+;5]-_$?Q%\,(OB=_P;Z?M->`/$?CWXM>$
MKS]D[P7_`,%&_"7C_P`(_#'QU)X>^&'C/XB_`WQ/\>]-;X:>&?%.G6T_B[Q/
M^Q_\/?%GV;2OA#X&M?$'AV[U'X=^#/"?PW^+46H1:+XM\)77]&/QU^#GP%^.
M?A72/`OQ_P#`W@'Q[X:F\4Z7J/AG2O'=EITYL_&UK#?1Z1J7A*ZNY+;4M*\7
M1V5QJMG:7WAR[M=<;3+W5K!97L+Z_@FTK7X!_!.Q^"]Q^SG8?"CX?Z?\!KOP
M5JOPYN?@_8>%-'L?AU-X$URQN].UKPG)X2M+6#1VT+5K*_OH-3T\VWE7XO;M
M[OS9;F>1P#L/!,L8\)>$HFDC$TGAC0Y$CW(KNJ:1IXD=(AM)1#(@8HNQ"Z@[
M=R@]97CFJ_`KP!K'QC^&?QQNM/D3QK\(_AY\2/ACX)>V%I;V>G^%OBIJ/P[U
M'Q7:2;+3[?,DDGPO\+1V=FM_%ID(AFN)K&YO4L+JQ]CH`****`"OR?\`^"XE
MK;WW_!+#]KVQO+:"\L[[P5X0LKRSNH8[FUO+2[^+7P[M[JTNK:97BN+:Y@DD
M@N+>5'BFAD>*1&1F4_K!7G_Q3^%7PW^-_P`/_%/PI^+O@CPS\2/AOXWTQM&\
M7>"/&.DVNN^&?$>E-<071T_6-)O4DM;ZU-S:V\_E3(RB:"*089%(`/Q3_:D^
M&W[._P"P_P#M?_L)>.OV1/@]\//A%\6_%?B+]IFV^,_PE_9[\(^'OAN?C7^R
MI\/_`-DGXX_%'Q++\0/`G@'3M*TSQ!:^$_C?X0^!-IX$\<:[H=YJ'AGQUXMT
MOPYHFH?\5OJ&D:M\^?";_@I-^WMX8^$&A_M.?$?P9=?$3P1\4OV"/V@?VO8/
M"7C;1OV9/A3X3TGQI\-O@7IWQ\\`Z'^R[+\,/C[\0OCC\7_A!JD6HGX?>-9_
M'_A#6?&^C)JG@[Q_J.O>#Q>:GX/F_<+X%_LE_L<?LJ^(;V'X`_`GX&_!?QGX
MSTN:VU&[\#>#_"WAOQMXHT+3KJ*^DLKK5885\4ZUH.FWS17GV!KNYTFPO&%S
MY$,Y$E/^%W[)/['GP3^(WB;Q'\)O@3\$/AY\3/&6@ZNVNW?A3PAX8TCQ+<>$
M]=UW^T?$=M8V<$(N-'\(^(?%$B:GXDT_0K/3?#VO>(EM[_6;>\U2&"5`#Q/]
MDG7_`(ZZ?XTT'P_\:_VR_@[^T3+\4_V=?"_QPTGP3H_P[\)_#?Q]X;OKC6-+
MLO$/B_X<0>"M9N(-?_9KU(>*-)T;PS=>,;;Q%XUT?7[6T%W\2O%L.M36^E?G
M9^V[X`^"/A#XG_#[]KWX.:=\*O%MOX&_X*7?`&W_`&N_CAX<\:ZQXN_;5\)?
M%";XC?"KX&>'_P!GGX37^K6EY8Z)\.9X_%_@;PS\6O@&/%&CVD_P5\2>/3X!
M\!ZGXO\`%\&L77[+?`[]FK]E?]G/7?%UA\`?A%\(_A1XB\36FDWGBRR\`>']
M!T'6+C0K.YU+_A'+&YM+$"^T[P?I-W>:T?#&@6L5EX4TBYOM6.AZ=:S7E[YM
M.[_97_9*\5?'>3X^W?P4^#FN?M`>%[_1;Z[^(3>&/#U[XWTKQ#I^AG2_#7B'
M59T226'QCIGA>8:/X=\5:I:_\)5IWADQ:5I.JP:1'%;H`?#>K_"2W\&?\%G_
M`(&?$FX\>_$_QIKGQ4_8I_;;,FE>-?%K:CX*^'GAWPE\5OV%+#0_!OPK\$:=
M8:5X=\(Z0;J_UC6]?UI[35/&WC+5]263Q3XIU/3M%\-Z9HW[`1RQS*6BD210
M[QEHW5U#QN8Y$)4D!T=61U)W*P*L`P(')7OP^\$:EXY\/?$V^\*Z%=_$+PGX
M9\4^#/#/C.?3K>3Q)H/A3QOJ/A;5O%WA[2M69#=66D>)-3\$^$;[6;&%UAO[
MKPYHTTZL]A`5Y/X+_!/P/\!O"VM^$?`-K/::5XA^)/Q6^*^JI/\`9$$OC#XR
M?$3Q'\3_`!K<P6]A:6-E:6MQXG\4:G+;6\%JC+"4DNYKW4)+N_N@#URBBB@`
MHHHH`_$?XR?`?X'_`!^_X+/^'_#GQW^#/PI^-?AS1?\`@E[XAUC2-"^+7PZ\
M(?$C1=(U:;]K?1[&;5=,TSQCH^LV6G:B]A+-:R7]I#!=&U>2%IO*9EKX0\#_
M`+1_Q/\`V?M>\??LD_L3CQC??`KQ_P#\%1/CG\$OV?/$/PNT+X:_%#5OA5\+
M?A5^QA\-_P!H+XW?"+]FS2OCE\0/!7P;NH](_:7N/BSX0\*Z3X@U[6_#'PRT
M#PW\6_#7A/P9K4W@G2-#T+]_/CU^P[^R#^U!XG\/>-OVAOV<OA%\8_%GA/1I
MO#OA[Q%X_P#!FF>(M8TGP_<:G_;-QH5I>W<9F&CW&J_\3"?2W,EG/=_OI('<
MYK5U+]FC]D_XE?!?1_@1-\&?@KXA^!7@S4[-?"WPUT7PCX43P#X(UWPM>W,^
MGS^$-&\.VUOIW@W7_#FH7-Y+9WOAT:3K.D75U>-'/!+=W)F`/R=^&O[5?[;W
MQJ\2?LU_LM>(_B#X;_9U^(OCGQ;^W3%XT^-NG^&?@/\`$#XF>*?"O[(7B#X0
M:%X'\*6OPWT#Q[\8?@E\,OC=XTMOC0NJ?&CPE=:AXQNO"!^$/CJ'0/"WA6#Q
M+93^#_O._P#$GPM^*7[`5_/^UY^T+\(_%_PR\4>#;WX>_&_X^?!?QKKGP>^$
MWB^U_P"$XE^&?B&[T?Q1I/BZ]U;P+IGB?5[<>%/%6GV'C2YM=.U+4/$'AN#7
M'THB>O4)_P!CW]C/Q]\%/!GP;3X#?!'7/@?X+U*YUGX?^$]%\*^'1X4\+Z]]
MHU:VU;Q!X2N=!6)](\1:C<ZGXAMO$>O:3J$&LZW-K/B*#7[V^?5]62Y]E/P]
M^#>F?"2Z^%C>"OAM9_`S3/!NH>`;[X>2>'O#$/PKL?A_ING7'A[5?!M[X6DM
M5\)6_A"RTF"[T74=`N;--(M["*XT^[MDB26(`'XY?LC?!V^\%?M9_P#!2K]E
M1;;0OV6;[XB_"_\`9J^*7@'3/V(7TCP_\+OAI\)]?D^,_P`(]$\;Z#IGB/P1
M%8?#O]JWQA?>`==3XBWTO@#_`(1G5_!_AGX3ZOX.?6M5\+>(-5'TE_P1^\,Z
M-\/_`-C.^\%Z/<:N^A^$?VO?^"@GA72+KQ1XDUCQ7XBNK'1_V[_VA=)T^?Q#
MXN\37NH>(?%/B"]C@BEU7Q#KVH7VM:[J<T^H7]S/>74C-]I?`3]G+]GK]G?P
M_J>G?L^?"OP!\-=$\7WECK^MS>!]'LK-O%5U;Z=#8:1J>L:S$;B_U\6&C1VV
MFZ'+?:A>0:9HT5OI^D"VTY(X:S?&7[*GP1\8_#>S^$K>"])\->`K7XT>&OC^
MV@^%--TO2+:X^)_ASXX6'[13^)74V-PL&J>(OBW8-XJ\2ZM9K;:SJ%_J.K7<
M&HV=_?->(`?1=%(!CCZG\2<G\R:6@`HHHH`CE^Z/^ND/_HU*_CV\*_`#]F+P
M+_P0);]K+2?A=\+OAM^V%X0\-_&GQ]^S_P#M$>"?!7A?PE^T1?\`[5.F_M&_
M$RW^`^C^'OB)H.FZ?X\\7^(?'/Q!C\*^`Y?!=QJ>KVOCW1M:N?!VL:5J6C:I
M=6;_`-AA`/!&>0>?4$$'\"`1[BOA3P?_`,$]_P#@GC\!_&]A\8/"7[*?[,_P
MZ\=Z?XC.LZ'X]3X<^#-,UC1/%VLZA<SG5O#>L:I;,/#_`(EU/4=1O&34-#>P
MU>ZN+ZZ6*9WN)0P!^7OC/]O/]NW4OC3^T/XL^'7A/68?AK^S%^USX#_9DN/A
M_J>@?LP^&/@/XLT.)?@K!\1]5^*_QT^+'Q[\&_&CP1\4?&+?%K4-6^!\'@SP
M;'X,6T?X6Z5)X>^*5WXMU&<_3WP:^/\`^T5\3_B%JGQR\0_M4_!GX8_"BR_;
M^^-?[&UC^S!XP^'WANWL=<\-?"KXI>._@=X>TS2_B7_:]O\`$L_M1?$K5_!]
ME\7/#NFO>3>`CX.UV#PBOPWF54\?M]V>._V4?V0_$GQA\.?M`?$3X'_!75/C
M-;ZUX4AT#XC>*?"GAM_$U]XI\.)/%X!N!>:C$B:[XM\*H9AX$U"]AU'Q#X8V
M9\+W&GF%/+UW_94_9?L/C6?VDY/@C\*+3XXS743_`/"U)/">B6_BU];U#3(O
M!L.MC5'A0'Q?>^'YH?!<?BA8O^$JN?#DL?A1=5DTB4:<P!\1?\%%_P!G_P"%
M/[1__";^$_#>@?LR?%W]L?1/V7_',?PT^&/[5_C+Q'<?#;P'\*_'GB'^QO%_
MQJT?X?:;8Z];Z%XFC\2Z%HWA^W^+NF:/I6O:2-/LO#4WC?PUH][,M]\3_&71
M?#WQ]_X)[?\`!)?]IC3_`(G_`+2>I>'O#_Q1_P""25YX0\%_$/QG::=%XUUC
MQ9^T]^S/H,WQ4^/6F^&+58_BK\2AH:ZD;"YOO$>J?#./5M<O/'V@>'KO7)/#
M_B'3OVY^/'[+O[,O[2;>%;3]H/X-?"_XKS^'9-8A\*#Q[X<TK6;VRMM9M;<^
M)]$L)KI5O)]`\16>G61\5^&#)<:#XAMM,L&U_2[Z+3[4P>E^(_A9\-_%_AGP
M_P"#/$W@;PKK?A+PIKO@3Q-X9\-:AH>GS:%H&O\`PPU_1_%7P[U;1M*$*66F
MWO@GQ'X?T/6O"\MG##_8NH:3I]Q8K"UI#L`.Z66,R/")$,L85WC#J9$21I!&
M[(#N57,;A&8`,48*25;$E>1Z+\%/`^@_&WX@?M`6-K.OQ$^)7P^^&OPQ\27O
M^AQ6LWA3X4ZW\1/$/A.W"6]I#=W-W!JGQ0\522W6HWE]Y=O+:VNGQV$*70N_
M7*`"BBB@`K\DO^"P7A;PSXX^$7[)O@SQIX<T+QAX/\5?\%,/^">6@>*/"GBC
M1]/\0^&_$F@:I^T?X9M-4T77M"U:VO-+UC2-1M))+:_T[4+6XL[NWD>&XADC
M9E/ZVUY%\;O@'\%_VDO`ES\,?CU\,?!GQ;^']WJNCZY<>$/'>AVGB#0GUGP]
M>KJ.A:J+&\5HTU'2+]%O--O(REQ9W*K-!(C@&@#\#OVO?$WPP_X)A?M0>-OB
M5^PQ\*_AGX+U#PY_P3%_;3^/O[3/[/?PRTC3_!GPGU+4?@WXB^!,7[)?Q-^)
M?PW\$3^']`\+ZU)XK\5_%SPY%XUM;'1O$_B[X;6?Q"L9=4N].\#VUWH5GQ-^
MW=^WQ^SKX*^/Z^/XCXA:T^!GPF\;?#OXC?M(^%_V7/AIKG@'XA?$O]HSX=?L
M]ZOXMN/A#^S/^T-\1M1\9?LQ:!I?Q+;XK:?X@\03Z%=Z&OPW\1>"/$/Q9\53
M>)K#5M"_:GX+_LP?LC_L^:;XN^%_P+^"/P/^%UGXSTV&\^('A#P/X+\'Z)=^
M,M),%[HEM=^.+"TM/[4\4::+2]U#1[6?Q*-1LEM+J[TZW807$\+X_P`*OV//
MV+_A)8_$WX??"G]G[X$>%]/\?:!8^&_BSX0T3P3X4FA\2>"KJPU.QT;P7XQT
M2XM[UY_A^FFWNMVGA_P5J%O'X.M++4=8AT;1X8;^^$P!F?LS-\6/"WC;XR?"
M'XO_`+4_@3]I76_!EM\,O%>F1P^!O"/PZ^-O@#2/'UAXHLWT_P"+'AWX?7%K
MX+G\.>)-9\&:GJGPGUFP\*>&=7NM'@\1Z/KS>(YM#M?$-]^3FN^`?@E\)/VT
M/^">O[17P"TKX4:Q\"_C!^U/\?OA[KG[0'PK\8:UXZ_:K^-?[2'QC\'_`+1]
MMXL\#_&SQ;K]HR^/OV:?`_BSP?XHE\4>&(O%7B/Q3\*?&WPR^&-OI/ACP=\/
M/A=JT5I^W'P0_9\^`/[..D:UX-^!'PQ\!?"[3]8OX/$OB/2_!FD66F7>LZ@]
MJNBV&L:].AEU7598--TF'0M)NM3N+E+'2M)@T33#;V.G1VD'(^"?V6/V2=#^
M,WB;]H7P#\%O@U8_&N\UKQ1%XC^)7AOPSX=/BFU\4^(8K>#QW<2ZA8I(NB>+
MO$\*6T?CG4;2+3_$7B5"B^)KK40[;P#X:_9V^$L/PI_X*Y?M>RMX_P#B?\2-
M6^)/[$_[+?Q)UW7OBEXK/B2[TRZUG]I;]LJQT[PAX,TNSL-'\->`_A[X1T33
M-.T7PSX0\*Z)IMJ([>XU[Q%<>(?&.LZ_XEU3]@HI8YHTEAD26*10R21NLB.I
MZ,KH2K`]BI(/8UQR?#OP1#X[UCXGV_A;0K?XC:_X-T'X>ZQXXBTRU'B;4O!/
MA?6/$GB'PYX6O=5,9N+K0=$USQAXIU;3=,F9[6UO]?U:X2,/?3EN8^`_P5\#
M?LY_!WX<_`[X:V=Q8>!/A=X4TOP=X7M+I[=IX=)TJ-D@6065M96,)+/(XM=.
ML;'3K176UT^RM+*&"VB`/6Z***`"BBB@#\+/#/[,O[,7[0__``5&_P""G4G[
M2/P#^!WQHL?#'P*_X)[VVD7WQD^&7@;Q[_PBNE:OX3_:7E\0#1=3\8:-J4WA
MNVOQ86<VIS:9=6`E:RM9YY=]K#)'\/?L[?M6_M-V7@C]GG]E#]FC7?C#XA^%
MVLZU_P`%*?'7P7^+_P`./"_P8^.OQ=\6?LI_LV?MHV_P*_9<\-^$-2_:E^+7
M@GP1XB^'FG^!/&VEW6J^/)9_'7CG6_AMH/PK7P]!8Z=XKU'Q[9_O;\9/^"?O
M[#WQ[^(4_P`7_CG^RS\"?BG\0I=)TG1M1\8_$'X>Z!XEU34-"\/1W:Z/I6LS
M:M;SV^JZ1I,-[?):V.JPW5E;0W5THC6*:4-U7Q+_`&;/V3?V@/AOX+T'XD?"
M;X/?$+X8_#RT-U\.X[S0O#T_AOP+IMCH[>'9CX(U/2?LL'A728_#D$GAZ^A\
M/7VGZ9+X?CDT6_BDTM&M5`/R:^&7[6/[;7[4^K?#7X83?&GX0?L=^,O#/[#-
MW^U#\2_'/AWP[\)?COX=^(7CP_'/XI?!&R:WF?Q[XY\`:!\$?"ME\*+?XB?%
MW1O!/CK7/&&C2_%;PQX%M_BYX7N_#5WJVO?HU\8$^`7Q^_9>^"EE^TOXW^$W
MBOP3\:]8_9WNM'.C>-M:\-_`CX\?%+Q%>^'O%OPP\&:;)_:5U<^//A5\5?'5
MMI*Z+\//$5QKVF_$CP]<Z;X:\0:=XF@U&?3=1[WQM^QO^QS\:/!'PR\+^,OV
M>/@9XW^'OPTT.+2_A/H<O@/PK<>%?"?@V_T_3[5_"_@ZTTNTATRS\`ZWI>G:
M1:ZCX1T\-X/U^PTW2H-2TF_@L+)8?4/B9X$^"?Q$^$VJ^`?BOX8^'7BKX+^(
M-*TG2]4\->,K#P]>^`+W3$O-/?P[$UIJ0&B1K9ZG!I%SX;GMC#-I^JVNEW>B
M36]_:V4T8!^.?["7P8O?%/@?_@HK^QQXTUG7/V>O$?A']K^P\0>/?#O[%WBR
MX\#?!GP/X-^*OP6^#/Q+T7X6_LU^+[OP[9^-/ACHGC'PE%'JGQSTS3M$\!>/
M]%^)WC[XB^)O`5SX1TGQGX.UU?L3_@D`8+;_`();_P#!/R`LD*_\,H_!2UMH
MWD.YO+\$V'EPHTSM-/((8B2SO+<2A'EF>1_,D/V;\'_@=\(/@!X,'P^^"_PX
M\(_#3P<VJ:IKMSH/A'1;72+34=?UN19=:\0:P\*&ZUKQ!K$D<;ZKKNKW%]J^
MHF*'[9>S+#$$XK4/V5?@E<:1^SAX9TGP9I7A+PC^REXWTCQ[\%/"'A'3]-T3
MP[X0U;P_\/?&WPST.RTRRALI'TS1M,\+^/M>M8;#1IM-,R-!974T^DO?:=>`
M'T712`!0`.@``^@X%+0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!7Y^_\%#+7]EFV^'OPR\6_M5^&/$7Q8\/^$/BQI]Y\*_V<O#^DMX[N?VC?
MCAK?A/Q7X;\`_#.T^"TP.C?&;Q!&FJ:SXJ\+>'?%NSP5X+UC0$^+GBV_\/Z)
M\/KKQ3H7Z!5\]?M`_LG?LV_M5Z;X9T?]HWX*?#KXSZ;X-U._UGPI:?$'PY:>
M((O#FK:IIYTG4M1T8W.'T^]OM*9]-N[BV=))["6:SD8V\TL;@'X<_#']DRZ\
M'?&?_@GA^S9^UEX$^'A^%7Q7\1_\%./VGK7]C^XFT_X@_L\?"#XBZYJ/PG\1
M?!#]GC0-$UC3_P#A#?'Z?`KX3?$KXWZEI%E9Z$G@JQ\9GQ]XO^&?AS2/#'AC
MPO-H_G'['?P]^&7Q_P#C!^R]\`/CQX6\(_&3]ESX?_!S_@K8/V;O`?Q0-M\0
MOAWJV@_"O_@I=IGP'^'.LZ9I/BF75=(\477PK_9?FT#P3\/-;N&U:\\)?#?Q
M)=7F@WEI;:Y<ZA+^ZT7[`W[&4/P;M/V?8?V:OA#%\&].\73>/M)^'\?A"R30
MM$\<7$,EK<>+]!52+W0?$L]E-=:=/K>CWECJ$VEWVH:7).VGZA>VUQTOQ$_8
MU_93^+'PY\"?"'XA_L\_"#Q3\,?A?;V]G\-O`NH^!-!7PSX`T^WT9_#:Z7X,
MTNSM+6#PSI,WAN6;PW>Z3HPL]-U+P]-/HFHVMWIDTMJP!_)-X=\!?%W]K+X&
M^%-*T+0O@O\`&KQ#\)O^"/&J_:]6_;'\2W=QIW@'X4_$7X^?M):%^SI\=?V7
MM;>'5]4M?CMK'PF^!C7GQ`^,GBZ\\.^'X!X:_9^OO^%G6%R?$\\G]>O[*WC?
M1?B9^S)^SM\2/#>H^-]8\._$#X%_"+QMH.K?$Q+>/XCZGHOBKX?>'=<TK4?'
M\=HSVD?C:^L;Z"[\5K:N]L->FOS;N\!C=N<^*?[%?[)?QM3P-%\5_P!G/X.>
M/(/AMH,?A+P/:^(?`6@7=IX<\%H;`GP)86D=I#;'P!*=*TO[1X#N8KCP?<_V
M;8?:-$D^R0;/IBVMK>SMX+6T@AMK:VBC@M[>WB2&"""%%CBAAAB5(XHHHU6.
M..-52-%5$554``$U%%%`!1110`4A&01DC((R#@CW![$>M+2$`@@C((((/0@\
M$'ZT`?@7^U)^SK\&?CW^U#XN^#?[-_P^;Q?^UYK'QW_9]^/'[2'[:6OL^K:A
M^PAX%^'.H?#/Q/X;\#_#OXG3VQUWPU\3?B'X%\"QZ-\*OV9?AUJ5IH]II7Q+
M\8?&?XTV]AX+\6"T^)/S[)X5\!S^&/$/[45SIF@/^VK9?\'`&A?"/3_BE-/"
M/B]9^"#^WQX5_9^M?@?#XI41>)8?AE<?L'7DD<OPPCD/A"?P%J%W\0G\//<7
M4OB,_LIXJ_X)I_L$>-_B;K'QF\6?LE_`[7?BIX@\5Q^.M<\>W_@>PD\3:OXQ
MBELID\3:EJ2-')>ZVKZ9IP_M&X#W!CL+*(N8K6!$]AE_91_9KG^.,7[2LWP-
M^%\GQZ@13%\5V\':.?&JWB:&_A9-:_MC[/YC>)(_"<LGA"+Q0R'Q)%X1D?PM
M'JJ:`S:>0#^>CX3>%M$M/`G[!/[3_A_0]#T[]MSXN?\`!7+X_?#+XN_%BSL[
M27XN^+-(UOXJ_ME>!OC'\,?&NLX&N>(/!'PS^$G@+3+O3OAIK33^&/`^F?"3
MP5?:7I&C_P#"+Z5J-MF_L2>%O%/P>_:#_P""0WA;PW\`/!/PY\3^)?!/[2OA
M3]I;]JGX=?&;X9_%33_^"@7AO2?V>=2\9:Q^T#I?B7X>:_K_`(W^+7P\\8_'
M2T^&?Q<NOB)\?++PQXF^'7CGXAZ#\/?#%E>_\)7K5T_]$NA?LF?LS^&?C9K'
M[1_A_P"!7PMT;XZZ^-3;5OBIIW@W1K3QI>7.N6-CIFO:FVL16RS1:UXATO2]
M,TKQ#KMLL.M:_I>FV&FZQJ%]8V<$",^$O[)'[,GP(\9^+OB)\&_@/\+/AIXW
M\=1W=OXH\4>#/!NCZ%K&HV6HZW+XFU/3$N[*WC;3='U3Q+/-XDU31=(73])U
M+Q%(^NWUE<:J1=@`^B?K1110`4444`%%%%`'AG[3?A[X9^*_V>OC3X=^,_C;
M4?AQ\(=6^&?C*U^*/CK2O'-S\,[SPM\/#HEW)XTUD?$"RN+2]\'6UIX<CU$W
M_B*SN[2[TRP:ZN+:[MIPDR?SE_%7X3:99?`/]JK]J7X/?!U/V*OV*/CQ!^P!
M^S/H/PIT#0W^`VL?%CX"2?MF^#="^/G[5OQ6^'6B6?A]/A+I_C_X'_%/Q#\,
M/!UOKEMI/Q;;X(:?J?B_XL7'AXZIX;\*^$/Z9_BI\*?AO\;_`(?>*/A3\7O!
M'AKXC_#;QMIW]D>+O!'C'2K;7/#/B/2_M-O>'3]9TF\5[6_LVNK2VF:WG1HV
M>&,LI"XKY]^%?_!/[]BGX)VGQ`T_X6_LO_!;P;IOQ7\+77@?XF:7IG@;2I-*
M\>^#KYIFOO"_B[3-0CO;#7]!OOM-PM]I>HVT]I>)/-'<1R)(ZD`^(_@[\#?!
MVC_MC?\`!1[]EO\`9]U34OV;/@MJ_P`!OV(?%^IV'[-K^'/AX?A=\;O'VH?M
M&>'OB'J'P[T:#0M3\)?#CQIX[^#GP]^#_P#PDM_H?AFQUB.R7P]XVM$M?$VH
MV'B6;X3_`&=_`W@_5?V3?^"0W[/7CK2K?7_V;O%W_!1O]N'P;\0?"7CS5;[Q
M)X?\?3?#/6O^"BGC3X%^#/B5<>*+K4)?B-#?_%'P/X3\3G3?&ESK+^-_'/A;
M0KW6TUK52%N/Z)?@G^SS\$/V</"][X,^!?PN\%_"WPWJFM3^)-7TWP=HEMI2
MZUX@N+6ST]];URZ0/?ZUJRZ9INEZ1!?ZK=WEU:Z-I6E:/:R0Z9IMC:09.M_L
MM_LZ>(_A%<?`37/@K\-M3^#=SK6H^)F^&]UX4TN3PG#XFU7QEJ'Q$O?$UEI8
MA6/3O$C^/=5U'QG#X@T]K76+3Q1>3:[9WMOJ+?:*`/C;_@ES96/AGP_^VE\,
M_"$,&G?!SX1?\%!?VB?A[\"O#>E!8_"O@WP%::3\-O$GBGP1X,M82UCI/A7P
M;\;?$_Q;\/:9X:THQZ1X0EL;SPEI=EI=EH<.DV'ZB5POPT^&'P[^#7@;P[\,
M_A1X)\,?#KP!X3LY+'P[X/\`!VC6.@>'](@N+NXU"\-IINGQ0VZ7&H:G>7NJ
M:G>.KWFJ:K>WNIZC<75_>7-S+W5`!1110`4444`%?E'_`,%$]!_9IN/&OPDO
MOB1\!!^VC^TGXF\'?$WX:_LK_L?^(4TSQ3X$\6:QXANO".H>//B?XG\*^*].
MU?P!\./#'@>UT_PSIOQ%_:8\7:?++\,O`VN7?A#PD-6\7_$32/!7C']7*^4?
MCY^PS^R#^U)XET/QE^T-^SI\)_C!XK\-:%-X8T#Q%X[\)V6MZSI/AVXU,ZU<
M:'8ZC,4N8-*GU<C4YK!9/L\M_'#=21M-#"Z`'XK>#_V0_AWI7Q%U7]E+]O'5
M_"7Q\TW]E;_@B_\`!9/"NO\`Q)N[K5O#6@:YKWQ$_:.T7]I/XO\`PT'C:YN-
M:\*ZCX4L?AW\#O"VE?%"745^(_@CP?H'@<W?BO2]0UNZGU&?XD>$?'/Q1_8^
M_P""&W[2/QB^)?Q>U3XC6?Q4_P""3$FO^`+SQ=/8?#[5_B1\0/%'PYN?&7Q5
M\?\`ABTL;34_&WQ+O;*^N=/MF\:ZMJN@>$YKN^U?P_X;TWQ7<W&NU^S?BC]@
M[]C7QMX)^&'PX\8?LS?!CQ/X&^#-E<Z5\,/"^N^!='U32/!NAW\UM<:KX;TB
MVNX9=OA77)[&PE\0>%;I[KPYX@?3M.;6M+OS869A]^\7_#7P!X_L_#>G^-?!
MWAWQ38^#O%_A/Q_X5L];TJTO[;P_XU\":G#K7@SQ1I$,T9CL-;\+ZM;P:AH>
MH6ZI/IUW#'-;,C(N`#\GOCW\+1X?_P""OO[`'Q7NO'_Q,\47OCWP3^V7H&F^
M"_$GBG[1\,_AEH/AOX)?##SK#X;^!]/L=.TG2M0\4ZP)O$?B_P`7ZV-?\<:U
M?31Z,/$=KX.TG1/#6G?LQ7%:U\./`?B/QCX*^(.N^$/#VK^-_AQ#XH@\!^*]
M0TNVNM>\(0^-=/LM)\6Q>'M2E1KG2T\1Z9IUA8ZRMLZ"_M;2WAGW)$H':T`%
M%%%`!1110`4AQ@YZ=_I[^QZ'UI:0@'@C/(//J""#^!`(]Q0!^!MA^SG\&OBO
M^VAX+LOV0?A\$US]FW]L/Q;^T!^VE_P4!UEI-1\;:OX_U*/QN_B']B7P-\49
M8H?%/Q<OM6/C32?!OQ8\&Q:E<?!+]G+X,>%M(^&,MO)\4;?PUX=\)_-?[(?A
M7PGHW@;_`((O?M'>&-'T&#]L#]H[]J/X[Z!^U%\1K0P0_%+XOZ3XI^#'[8/C
M3]ISPW\6=8@,6M^--'^'7Q>^'?@=X=%\4'4++X5>(/`O@[PYH,'AJ+3K'3S^
MTOAC_@FI^P3X+^)]A\9_"7[)GP.\.?%/2_&-Q\0=/\=Z-X(L+#Q%:>-[S5KG
M7;SQ5#?0,A77+S6KV\U:[U#89[K4KJYO9VDN)Y)&]?\`!_[)_P"S5\/_`(O>
M*?CWX(^!?PN\*_&7QJ-8_P"$F^)&A>#=&T[Q9JC^);JQO_%4[ZI;VR/;7?C#
M4=,TW4O&5Y8):7?B[4M.L-0\2SZK>6=O-&`?EY\%_@5X4\#_`+<'_!5WP?XV
M^-/QBU'2?BC^QE^R/XG^*/QG\=_%F71_&WA6Q\;>(_V^--UG4?!OC#3K?P]X
M?^"OAKX<>$[6TM_!%MX(TKPWHO@>+1?^$JD-UXGN]=\1:EL?\$[_`((^`M3_
M`&@]:_:K_9?^!FC_`+,?[%@_9PT?X`?!W2=.\+7/@#Q!^V$;;QKH_B_3?VI_
M%O@@1Z;<P>"_#.A:1+X6^`/CGXA::_Q:^*FA?$7XB^/M:-AX'UCP'-K_`.IW
MC#]G_P""?C__`(6I_P`)K\+?`_BC_A>'P]TGX3_%\ZWX>L;\_$GX::$OBU-'
M\"^,S-&3K_A;3D\>>,TM-&OC)9PIXHUQ%CVZE<A_*O@'^PA^QY^RYXIU+QM^
MSS^SE\*/@]XLUCP]-X3U/7_`?A:VT+4KWPW/?Z=J<NB3SP.V[37O](TRZ-L%
M""6QMBN!$HH`^M:***`"BBB@`HHHH`^2?VXM*_9TU3]FKQY+^UEXBN?#_P"S
MWH5[X*\5_$F&'4]:LK3Q9IOA7QSX=UW2?AUK&D^&[>\U_P`>Z)\2?$MEHO@?
M4_A-H]CJ5]\7H-<_X5I%I&M#Q0VD7WX;:W^SWJ?A_3?AAKOCKX-:=^S'^RG^
MWK_P5/\`V5H[W]AR;3]&T#PIX/\`@IX5^!OCZS\&6_QQ\!^'"?AOX;\?_M/_
M`!Y\`?"+7_BS\%_#T5QX5\R3P#\,_&TWBWQO?>.O[6_HB^-WP#^#'[27@6?X
M9?'GX9^#?BSX`N=5T?79_"'CK1;;7M!DUGP]=C4-"U4V%T#$-0T>_5;[3+M<
M365XD=U;O'/'&Z^.>"OV`/V*_AW\-OB)\'O!?[,7P8T#X7_%F32)_B/X#L_!
M&EOX8\877A^0S^'[[6]*NDN(+C4-`N]E_H6HH(K[1M2@MM2TVXM;^UMKF(`_
M.3X2?`GPWXP\'_\`!6']F7X?>+?'7P=_9F^'?[7+VW@;0?V?/%J?#N'2-.U7
M]D+]GSXK_'7X)^#]=T>SNM0^&O@'7/C%XL\67GB_1?AA<^#]:T+5?$_B_1?#
MNJ>$YKR^CBS?@I\(?@M\;_\`@G=_P2O\&^(_#/[/_P`5?VCM*_X)Y_#GQ;^S
M+\!?VG=?UZ7X(^+M0@^!GP+\,?$7QOXG^%.DZ;XDM?'LOPZT'Q1I6G6.NMX.
M\1:WX"MO'%_'HLVA1>+-5U5?V;^&GP1^$?P<^'EO\)OA;\.?"'@+X;VR:RJ>
M#?#&AV>E:%-+XCNKN^\1WE[:6\8_M'4O$>H7]_J/B#5=0>ZU/6]1O;N_U2[N
M[NYFF?S[QW^Q[^R]\3/AC\//@SXZ^!'PR\2?##X26&C:7\+/!M_X6L5TCX<:
M=H'A\>$M)LO`HM5M[OPI:VGA3?X7\C0[JRCN/#DL^AW:W&EW$UJX!\V?\$AM
M:AU;_@G1^S)8IJOBO7+SP'X7\4_![7=4\7:S8>([BZ\5_!#XD>-/A!XP/AKQ
M%IEU?6.O_#6#Q3X)U>U^$FMPWUZ^I_"VW\'W-W=37S7+G])JYSPAX/\`"?P_
M\+^'_!'@3PSX?\&>#/">D6'A_P`+^$_"NCZ?X>\->'-"TJW2TTS1="T/2;>T
MTS2=*TZTBCMK+3[&V@M;6"-(H8D10*Z.@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBO/_B'X_/P^TVQU$>"OB!XW^W7_P!@
M^P?#WPW_`,)+J5G_`*--<_;+ZU^VV/V>P_<^1]I\Q_\`2988MG[S<.',LRP6
M3X'$YEF-;ZO@L)!5,16]G5K>S@YQ@I>SH0JU9^].*M"G)ZWM9-F=:M3H4YU:
MLN2G!7E*TI63:6T4Y/5K9,]`J"ZNK:RMY;N\N(;6U@0R3W%S+'!!#&O5Y9IF
M2*-!W=W51W-?-?\`PTN?^B`?M,_^&H/_`,OZ_*C_`(*!?';Q?\0/%/A?P6=!
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M[8Y^`'[3)/<_\*H(S_Y<%?/^!/TLN$?%WA7&9SG67UN#,XRS,Y99C<K;QV=X
M2LG0H8BAC<%F&$RRES4JT*SA5P^(P]*OAZM.<;UJ4J5:IR\-<:X+/<%4Q&(I
M/+Z]&LZ-2C>IB:<O<C.-2G5A1CI)2LX3C&49)_%%QD_INBO'OA]\7CX_UFZT
M<_"_XP>"OLVG2:C_`&I\0/!/_"-Z/<>7<VUO]AM;[^U+WS=1D^T^?':^4NZV
M@N9?,'E;6VOC"WCI?A-\3C\+M=\+>%_B7_PKWQH/AWXE\<1M-X+\/^.V\-ZF
MO@_6_%\"$//X8TKQ&=,OM>@C(DFTJ"[C3+,`?Z<R7/,KXAP,<RR?%?6\%.I4
MI1K>PQ&'O4I-*I'V>*I4:JY6TKN'*_LMH^PH8BCBJ:JT)\]-MQ4N64=8[JTX
MQEIZ6['HH=&.%92<9P&!.,XS@'IGC/K2AE)P&!(SD`@G@X/'L>#Z&OY\?V2/
M&?CKX2?'W]GSPG^T3\2?^"B'[/OQ>\3Z)XQ\.?%OP9^V3KVB_M!?LM?M5>,]
M,^%OB/QGK2?`CXZ>"_$VN_"/X.>,_"FH^%M8^*WAC3?#=M\(KCQ)\+_#_C;P
MM<?!I8;:WG\%^<?L,_MH>*==_;@O[GXT_M`^.?"?PZ^,D'Q0UK]GZT^,OB7Q
MA9^%OV\OA_\`M!?M!02_L7_$']DGX&:_X?LK;X0>&_@/\(?"^M_#_P"(_P#9
M#6GB;X@KXV\'?%CQWHC>%/%?A?QQ=^L;']*?F(#@N@.<8W#.>F,9SG/;K3BR
MK]Y@/J0/7U^A_(U_)Q9_$OX]_$#P?^UYKOP5\<_\%7/&/[;NE?MG?MN_#S]G
M.?P19_%GQ%^QAINK^`?VI/B3X-^!WA;Q?<^/-(;]E.Q^"GA?0-'\.>'OBNNI
MW\.J:3X9T[Q5;V%U'XW@T]:_876?!7B3]J_XG?M3)XC^,'QO\`?#[X'7_P`+
MOA)X6MOV>_CAX]^#BWGQ.\(?#/5OBE\7M?;4_"%_9WVIV5[=_&WP9X'N;/4C
M<6\5[\,8(IH3=6%PL@!^H(=""0ZD`9)##`'J3G@?6C<IR0RD+U.1QWYYXXYY
MK^>GX#?#3]J'5O\`@DM\#/C%\#_C]^TK\3?VE_VE_@C^QMXX^(O_``LO]IZ[
MU3QGXET/6)?!_C'X_P#AW]F_7/C!<7?PT^"WQ@^(G@#4_'NE>!=>.G:?HFEZ
MN^B":_T%M(T_Q-H_H?[-<;?%/4?VH?V9-&_:7_X*(_LX^+/$OP0\/>(-#^#7
M[7<>JZA^TG\!O$EIXEUO1YOVEO@1^T?KGB[X@:)\6_A;J&L-X6T'Q3X%L?''
MQ.\`:'XB\-0V>KW>@Z-\1[_P[JX!^ZN1D#(R<X'<XZX'MD9^M(65<9(&>!D@
M9/7`SUXYK\/?^"8/[5OQ@_;\^(/BOXH_$KXC:#X:L/V6O#6F?!)OA)\)]9UR
MS\#?M"^-_%MF-0U+]N];36--TO5M<_9L^-^B:!'/^Q-IKRZCHEKX>7XI^)=7
MUCQ1XE_L%O!_N?Q<E\>?M*_M]Z_^R=??%[XK_!OX(?!']E;X5_M!Z]IOP3\:
M:G\)O'GQE^(/QP^+'QB^'V@VVL?%+PVT'CK2/A]\*=#^".J7$WAKP1K'AIO%
MGBKX@VDWBS4KW2O#.FZ/>`'ZG@@C(((/0@Y!_$4M?E)X[^+?Q*_8&^#6G^%M
M7^/'PQ_:!.H?&OQ3X.\+?%?]K?XU>&_@Y-\)?!-[X'E\=^"_AS\3O$OA_2_'
M7Q(_:(^)VGS0#0O"S^#OAO!\0/%GA#6-'\2>/S`WAS7/'/BCB_AA_P`%*_C+
M^T)X<_98TWX%_L\_#[5?B/\`M%6W[:$>OZCXR^,_B;0/A%\,[C]BCXP^%_@W
MXMUN+78?@]+\1O&GA?XF:]XA@N/A\I^'/A/Q59V>HZ3-XN\/Z1Y.MIIP!^Q]
M%?D'X-_X*-?'+XZ:Q\)_`GP"_9=\)'XD>-O@_P#'+XC^/[/XR?'2[\(>$/AA
MXT_9K_:,'[,?Q0^$@\0>"OA;X^U#QE?ZO\3[+7]-\"^-]/T/2]$NM!T:X\6:
MYIEA$UKH-[X/XE_X+C>&=0TG0=:^%GPT\&W$NG_LU?#/]HWQ_P""/BY\4_$'
M@CXBZA?_`!(L_']S#\`O@YI'@?X3?%+1?&_Q;T&3X<ZYI^IZIXGUSP1X!N=>
MU3P1HVDZS?VOB;5-=\)@'[Z$@<DX'J:,@=3CM^/I7X&?MO\`[>W[1/Q!_9M_
M;5US]D+X;W?AWP1^SY\-OAU:>,/C+K7Q(U;X9_'+1/'?Q8^%OPK^.V?A=\,1
MX$URT=OA#\*?BOX)UOXAKXX\9^#=:U'5]6\0^$/"^GMJ_A2276OL'_@I_P#&
MCXB_`KX8?LZ>-?AN?B1J&IW/[<W[)OA?7O!OPHETI?&_Q+\&>)/B6VG^)_AM
MI=KKVL^'="U)/%^G#^SKK3-9\0Z'IMY`#'<ZG;(`Q`/TRR,XR,XSCOCUQZ<B
MBOY^?&W_``4K\9>!?VUO$GQ`^*?PC_:S^`7P#^!O_!*S]KO]H?QA\'?C!IWP
MST=_B9XG^&GQQ_9G32/%/@O1/`GQ5^(^C:GXKTC0M<U[P3IU[K^K^'C9OXVC
MMU2>RO[RZLO;OA5_P55U_P`9V_QLTO5_A5\)M;\7?#G]GO6/VBO#MY\+_P!H
M2XF^"PL-"URP\/>(?AC\7?CQ\:/A5\&?!WPF\7>%KS7?#VL7GB2X@U_POXA\
M%2^)O%'AV*6?PA?Z'=@'[,9`ZG';\?2DR/4=2.O<=1]1WK^?+5?^"E?C_P".
M=EKW@'P[K'PW\/\`B;X4_M@_\$IEO?B=^S'\6?&7Q#^&OQ#^$?[5/[:=K\-M
M>\$Q>(/&OPJ^%NIS7W]C?#SQAX9\=1:1I^O>$/$7AGQ3I4^D>((;ZYUO0=#X
M_P`$?M5_M^>*?B)^S+8O/X$\1>/_`!/_`,%&/^"JGP1B\"1?%C7_``O\)M=^
M''P.TGX\:1X#TWXE^(+#X.0Z[-H/PDU7P?9VOA6WT3P-XA\2^+HM'\.>)=8N
M](US5M?31`#^CZF[ESC<N<XQD9SUQC.<XYQ7PK\,/VP?$/C;]C'XF?M+^(OA
M:GAWX@?!ZT_:CT/QW\)M`\5/XQL'^(W[*GC+XG?#[Q=H?A/Q@-!T&YU_P_XJ
M\1?#*ZO/"6K7/AO2-5ET37--&J:-8:M%=V4?RK^S?\"_B_X[_9^_9E_;%U_]
MO7XYZ+\=_B%X;^!OQZ^)&H^(/&,&L?LJ^(=$^)=CX/\`%GCGX*:=^S9>WFA_
M#7PM\.=2\,>(+_X??#/Q5X=N=)^*_A75#X6\=:CX[\8^((=>L?%8!^RU%?CI
M\1?^"HVK?#7]JSPC\"]8\%_`J^\-^)/VG/!G[,-QH/AK]HY?&O[2&B7?Q'U7
M3O#_`(,^+?BKX8>#/AUKGP]\`^$[W7+^%KCP%X\^+/A_XE1^#[JR\5/IMOK=
MU;>!;GC?$7_!6;QYX;\$Z;\0/$GP/^$_@/PU\6OVFOB]^RK^SMJ'C?X_^(8X
M-=\3_L^^,OV@/#WQ?^*?QA_X1WX*:W+\./AK9Z1\"-0O_`>C^&(_B'X[\8^(
MM;T;PSJ>D^$+/4D\26@!^WM`(/(((YY'/0X/Y'@^]?'7[%?[5J?M<?"GQ!XW
ME\*1^$]<\#_$_P`4?"CQ,-%U'7/$/P^\2:MX771-2MO&/PI\9^(O"7@75?&O
MP[\5>'/$FAZII6LW?A/1+W3]4EUSPEJMFNL^&=1>3\T?V./VU?VH]6^"G[*_
MPK\*>$M%_:"^.?[0OB__`(*C>)!\2?CK\8M6\">&?!GA']E']M_6OA_HNG>)
MK_P_\//B'XMUZV?PM\0?"7@OPE8^'=`FN-)M_#VG)J&S1XKS4+,`_?.CKTK\
M03_P4D^._P"TG\(-17]F+]G/3;/QY8?L6W7[2WQCM_&WQO\`^$5O?AM?>+];
M^.OPL\'_``P^$.N:!\.O%%M\0_B5>>//@)\4M3T;Q/XEL_A]X(M-%\->%[O5
M+FSN_&HB\,^,:!_P5^U3X6?"7X-^"!I7A#XJ?$7X9?L+_LI_'3XXZC\6?BCX
MN\%_$SXM>*?BQ\%9?&:>!O@OH?ACX1_$VU\;?%K7+'PW<Z_J=YX[UOP!X7F\
M3>,O!OA>#4IY-;U[7?"0!_1+17Y<>)_^"BWB/2OVB/A'^S=H7[/FL:QXJ_:?
MT'X;_$_]F#7M6\6MX4T+QA\#Y=(M=<_:5\:?$ZVU7PN=:^%7C#]F;2YM/GU/
MX:RV/B+5?B1??$'X6:-X8U*RO-3^(3_#;]1ADCD8]NN/KCC/KC(ST)ZT`+17
MS1\5/VE#\+?%1\+#X!?M+?$7&F6.I?\`"1_"SX5_\)?X5/VYK@?8%UC^WM.S
MJ5G]GS?6OV;_`$<36Y\Q_,^7S9OVV6(_Y-'_`&W>JG_D@1/1@?\`H;1Z=>W7
MGI7VN!\.^,,RPF&Q^"RCVV$Q=*%?#U?[0RNG[2E42<)^SJXVG4C=23Y9PC)=
M4F?$8_Q&X-RS&8G`8[.'1Q>$JSH8BE_9^:5/9U:;49Q]I2P52E.S=N:$Y1?1
MM'T]<?%OX66D\]K=?$GP!;7-M-+;W%O/XS\-0SP3P2-%-!-#)JBR1312HT<L
M4BJ\;JR.H92!KZ!X\\$>*KJ:Q\,^,/"WB*\M[<W<]IH7B+1M8N8;421PFYEM
M].O;F:.`2RQQ&9T6,22(A;<Z@_P'_&"\CU3XM?%'5!I=WI?]I_$CQ[J)TW6=
M-AL=8T\WWBW6;K[#JUB3,;/4[+S?LNH6AFE^S7D4T'FR>7O;]'/^"07Q33X1
M?'WXB^(5^&7Q3^);ZC\'K[1O[(^#_@F/QEX@L1)XV\(WQU/4=/34-+-MHR_8
MEM)+SSY`+Z>S@,1,H=/[;XX^@M0X6\.LWXRR[CK'YOFN7Y-ALRP^1U,AP."I
M8K$5Y86,L++,)YY.G1C!5IOVSIR4N1)1]Y6_A[@;Z>-7BKQ(RG@K,>!,#E&5
M9CG6)RROGM//<=C:F&P]!8AQQ<<OADL*E64_8+]RIIQ=1W?NG]?]%?$'_#;1
M_P"C1_VW?_#!'_YK:^D/A+\33\6/#%QXF/P^^)_PU^SZQ=Z/_P`(_P#%GPG_
M`,(;XGF^R6]E<?VI;Z3_`&AJ7F:/<_;?(M+[[0OG7%I>Q>4OD;G_`(:SC@CB
M?(,'_:&;99]5PBJTZ+J_7<OK_O*J;A'V>&Q=:K[UGKR<JMJUI?\`NS)N.>%N
M(,8LORC,_K>+=*=94OJ684/W=-1<Y>TQ.$HTO=4EIS\SZ)GIQ(`))``Y))P`
M/4D]*`RG."#C&<$'&>F<=,]O6OSR_;]^(?Q*T^\_9(_9\^&7Q`UOX.WG[8/[
M3:?`_P`6_&/PO;:3)XR\!?#WPY\#?C3\?/&,/P\OM?L-8T/0_B+X]T[X.K\.
M?#/B74=&U9_"D/BC5_%.CV4GB+1=&DB^0?C3\1_&'_!,3XT^`I?#GQ9^-?[0
M'P5^+7[/?[8OC?Q)\'_CW\7=<^*WB?PUX]_90^"4'QVT+QS\.OBEXUM=>\?:
M'X>\7:)H_B#X=?$/PSK&K:_X4@UOQ)\/?$WAC2?#^H6VO6OBCY0^L/W,HK\9
M=3_X*E_$3X2Z%XV\2?M'_LUZ-X4M;C]C:V_;/^#>D?"KXR#XCZUXHT2\\7^`
M_AW#\%O'LFO_``_\`Z+X0^)P\:?%'X=6*^(?#^H^,?AQ/;^(M5G77%M_"LEY
MK?K7BK]K[]KWX97O@;X9?$7]E3X7O\;OCK\4O"_PQ_9]F\#_`+15_KGP0\17
MNI_#WXN?%?XD7WQ!\8ZU\)/#_P`2?!2?`GP%\(-;U3Q-'9?"K7[?XC7.O>"-
M/^'EXU_K/B2S\%`'Z@9'KUZ>]'3K7XF>*OVQ_P!H+QC\<_V9OA_9^"1X`^,W
MPR_:_P#VC_@%\;?@UX?^*;ZE\)_B]XAT/_@FK\5?VF?@Y'8_$.?PCI.JW7PV
M\<6_B7X4>,[.Z\0^!=-U_P`"^*;>^T[5M#U&Z\+)<ZMPG[4__!4GXB^+_P!B
MOXF?$7]D7PC!X>\?VO\`P3D;]L?Q%XU\6^(!;I^S[KOC'Q1_P@O@_P"'%WIG
M_""^*K3Q)\3(-6\&_M!1R6>J:?INCZ=KWP3DT_54CM?$:7NE`'[W?TZT5^0M
MQ^VK\1_"WQ8^)_P9\'?"R+Q?^T7XZ_:^\$?LZ^&O#OC/X_:_-\"]$\36?_!/
M;X6?M5_$GQCI&N2?"Z3Q-X"^$_@KPF-4L[?PEH/@W6_$GQ)^(UR/$9A\*OX]
MUI?"61^T;_P4H^.'[,EI\(])^+_[/'PF^#OBGQGH_P`6M0\1>,?C5^T3J_A#
M]F6Y\0_#?QK#X6\'?#OP=^T;H7P;\5>%M`\2?'7P]<V_Q*\#:A\>=-^#UIX:
M\)^=8>)[";Q)IVOZ=H@!^R!(`R2`!U).`/Q-('1L[64XZX8''UP>/QK\K_\`
M@JK\6?'OAC_@G+XE^)7P]U7XG>"?%FO^/?V,-//_``H[QAIEK\5O[#^*/[5_
MP`\)^-?!_P`.O&NBZQ:Z*WB;Q3X0\5Z_X*TG6],\0VFDWLVKI<VFNVMA<1ZG
M%^>6@?M'_$'X':S^WIHNO3?M^>!_A/X*_P"";/Q2_:(\)?!']M#XJ6D/[1/C
M/QK\+)/$A^(OCO\`9;^/_AS4OC3<^%/#'A3PQJ_@CPYX[O-;\>>)];\%^/?&
M?PV\3^'OAYIFF1:E?^)`#^E^C^G6OR,^(7_!1GXC^"++]HWXG^&_@%HOBC]E
M_P#8M\;Z-\-_VA?'6K_%V]TWXQZE>Z=X.^&?C'XN^*/A'\.!\.=0\.>,-`^"
M>@_$:VEUL^+_`(B>"]<^(VK^'/&6G^#M.A;3=`N?%?SO)_P4Y^,GP.\7_M4^
M'/C3:_"+5]9UC_@HYXH_9@_9E77_`(D^(_"O@'P/X*\)_LG?#WXZ^(K[XG:_
MHWP4U'Q!I_AW0/#V[7-/70?#_CWQ7XP^*'Q%N/`8GT/PMI6F^-&`/W[HR,XS
MSUQWQZU^.W@/_@ISX[^-NF?"+X?_``8^!_A34OVAOBA\1_VA/`DR>,?B-XP\
M._LZZ7X;_9HT;P=K_C?XO^%_BD/A*_CSXC>!/%MC\3_A38_#FTT?X5:5K%]K
MWC+5=*\2OX?_`.$`\37)\V\7_M6?MW:'^U5XTG\/_`30+?5/"7_!.'PG\</B
M%^S?\2_VDX=)^'_A#QEX7_:'^/.B:^W@?QCX$^&OCQ/&7BWXI^%?"EE:^"?%
M>H^'?!^D6/AC3=%G^(-IX=U=W\+1@'[I$@<DX'J:*_(__@H;^TWXJO\`_@CU
M\7OVL?@=XC\7_"KQ'XM_9D\!_&/X>>(-(U&+3/&?A"+Q^O@/Q%IOEZA9FX@M
MM8M-*\0MI]Y+;&:$R-<B%WB=6,GQE_X*)?&#X9^./VE-0T?]G/PAX@^`7[('
MQ^^!GP1^,GCC4OC9>:-\2O$L7QS\+?L^^)O^$H^%/PXM/AEK.C7Y^&-I\?\`
M2+WQ-H_C;QSX4'BFTT6\M/"6IRZC*T<`!^ME%?G9\.OVM_V@/C%\5O%TGPL_
M9P\,^)?V;?`'[2?C3]EWQ7XXN_C-#H/QECU[X9ZRW@_XF?%_2OA=J7@N/P=?
M?"KP7\1+75/"$FC2_%*W^)?B+2=(U3QOH'AJ>!-'\.:]^B2D,H(QR.Q!&>XR
M.#@\<4`+1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1@'J
M,T44`)@>@_(5\Y_M"_LP_#C]HW2=-MO%J:AI6O:$9_[!\5Z"]M#K%A#=%'NM
M/F2[M[FSU'2[F2**:2QO(&\J=/M%G-:3O+))]&T5X'$_"W#O&>1X_AKBK)\#
MGN0YI2C2Q^69A15;#5XPJ0JTI-:3IU:-:G3K8>O1E3KX>O3IUJ%2G5IPG'FQ
MF"PN88:KA,;0IXG#5DE4HU8\T)<LE*+Z.,H2C&<)Q:E"<5*+4DFOB?X`?L,?
M"SX$>)5\;1:CKOC;Q=:13P:/J?B)=.M[305N8G@N+C2]+TVWB@749[:66U?4
M+N:[GBMY)8[,6OG3&3[7VKZ#\A2T5Y_!/`/!OAQDD.'.!^'LNX;R:&(JXN6#
MR^G->WQ=90C5Q>*Q%:=7%8S%3A2HTGB,57K5O8T:-%35*C2A#'+LLP&4X983
M+L+2PF'4W4=.FG[U222<YSFY3J3<8QCSSE*7+&,;\L8I)@#H`/PKC_B)\/O!
M?Q9\`^-?A=\1_#FF>,/A]\1O"?B+P+XX\)ZU";C2/$WA'Q9I%WH7B/0-4@5X
MVFL-7TB_N[&[1)(W,,[&.2.0*Z]C17UYWGYY?#G_`()Q?#GP;XK^'FO^.?CA
M^U'^T1X>^#D>M'X.?#3]H;XM6/Q`^'_PWU#6_!FO_#:77;>SLO!WAOQ+\0?$
MEC\./%GBGP1I'B/XS>*?B7K.EZ-XCUJZM;U=?U&XUIN`\-?\$D_@!X<\0_`7
MQ"?BK^U)KDO[)=[I;?LCZ?KGQOO)+#]FGP]97]G!JO@GX?/IGA[2]4\3^%?%
MGP_LD^"_B>/XRZG\4M;O?@[/=^";/6].BN9+X_J910!XA\"?V?\`P'^SQX:\
M8^%/`3Z[-I7CCXR_&SXYZP/$6I1:M<Q^,_CW\4/$WQ;\;V]A,EE9"VT"W\4>
M*]3A\/::\<\NF:.EI8RWM[+`UU+L?#?X-^$?A=X4\3^$?#KZM<6GC+QS\4OB
M)XDU/5[NWN]:U/Q/\7?&?B#QOXHN9[RWLK.+R+6_\0RZ3H-NMJ%TGP[IFBZ2
MK31Z>LLGJ]%`'Q9J'[!7P&U/]DGX3_L;W:^.1\.O@7X:^$FC?"'QE8>,KW0_
MC#\/O$'P+@TI/A9\2O"WQ&T*WTV_T?XC^%KO1K.^BU^RLHK/46DU+3-7TB_\
M/:QJNC7GE%Y_P3#^%WBC0_BE8?%;XZ_M4_&CQ1\8/`.D_!OQC\2_B#\5M$M?
M'L?P&A\6:=XN\8?`SPK<?#WP'X#\,^!_`'Q9NM.&D?%J\\(^%](\?>-]`FCT
MZ]\;VYT?PW/HGZ544`?-$O[)_P`([;X[?"G]H7PK8:E\//'7PG^%>M_`RRL?
MA_-IGAGPAXQ^#.HM:WOA_P"&/CSPQ;Z3+8ZWX3^&WB&TC\4_"JVL6T>]^'NM
M76NP^'KZWT+Q9XLT76\+X]_L?>"/CEX\\$?%[3O'OQ;^!?QN\`:#KW@S0_C+
M\"/%6D>%O&MY\//%%]IVK^(/AQXKL/%7A?QQX#\=>";[7M'TGQ%9:1XR\&:Y
M+X:\0V/]M^$KS0=1OM4GO_K2B@#\V=/_`."7?P(\.0?#+6?`WCSXZ^!?B_\`
M#7XA?%GXJ/\`M#Z1X\T3Q!\:?B'X]^._A;2/!OQ@\1_%'6OB'X,\;>$_&%]X
MV\.^&?!^C([^"[!?!.B>"_"/ASX;+X,\,Z#9Z*OCM_\`\$NI?"OQ=_97G^#'
MQG^./@#X=_!?3_V__%'B#XAVWQ<MM:^.$?Q+_;'^)7P>^)5]&FH>/?`?CC0O
MB+X6UO7])^*>J:[#\1M-UV[T?5[[PSK%E/>:UIVEZEH_[$44`?C[/_P3".@_
M'[X*WOP=^)?Q2^`_P4^$G['GQD^!D7BOX6_%(V_QKUSQS\6OC?X'^)GBG5/%
M.I>.?!_CNR\6S>.9-/\`%GC3Q5X_U7'C.S^)%^OB3P[>:3J][-J</M^H_P#!
M,WX&:?::+IGP=\<_'O\`9HT6S^!/@/\`9J\3:5^S[\5+GP6/B%\&_AA_:L?@
M#P_XKUG5]&\4>)]/\4^%K/Q'XMT_3/B]X"UWP3\9X[3Q7K(D^(4EPNE7.F?H
MG10!^<OQM_X)C?`KXW3_`!4MKWQW\>_A]X/^//A_P%H7QV^'GPT^)PT3PE\7
M[CX8:+IWAGP-XG\8/KGA_P`3^*H?%>D^%]"\,>%]:U;POXH\-CXA^&?"GAOP
M]\3[;QIH^E0V;?5GQM^`/@7X^V?PUL?',NOQ0?"KXU_"_P"/7AG^P-3BTQY?
M&_PD\0_\)-X6AU9I;*]%]H$NH_+J^F(MM+?6W[F.]M3^\KVZB@#Y.^+'[%?P
M(^.'Q0U+XH_%#1-7\4W6N_LN?&']C_Q'X0N=9DM?!/B+X+_'/Q3X#\6>/]/U
M33+""VU4:]=WWP\T.TTS7]/URQN=)L)]26UB%[/;7UGXWKG_``38^&GCSX;_
M`!(^&?QC^.O[6/QRTCX@^`?"7PXL]0^*/QMEU'4/A]H7@;Q=I/C_`,,:IX+L
M/#?AKPQX4N?'=GXV\.>%_$>J?$WQ_P"&?'?Q$\7R^&M(TCQKXF\1>&DO-$O/
MT5HH`_/.'_@F]\*KWQGXG^(WCGXL_M#_`!1\?>,]?_9-\2>)?%'CWX@>'KJ6
M_O\`]BSXX:U\?/@=!I^@^'O`WAOPCX3TC3_&/B+7++Q+H7@OP[X=T?Q-HVJZ
MC-?62>)]0OO$UQU?@7]@7X/>`/BGH?Q7TKQ-\5-0U/PG^T-^T%^TMX-\-:YX
MNT[4?"/A#Q[^T_X>\3:-\8M,T2Q7PY;:M_PAWB'5O&7B?QM::!J>MZD^B>+=
M8N)]*U"VT*.UT&#[AHH`\>^#OP/\%?!#PEXD\%^$#J]YHGBKXG_&7XLZLGB.
M^AU:=_$WQT^)WBSXL^-[:)UL[2)=$7Q/XRUB#1M-DAE-CHPM-.GN+UH7N)OC
M'P]_P2R^!.@+X+\'2?$G]HKQ#^S?\-O'&@?$#X>_L>>)OBG!J_[-/A/6?!?B
M'3_&'PZTJV\.R>%HOB#KGP_^&7C'2=(\3_#KX3>+_B7XD^%OA+4=$\/6VF>$
M$T;PUX=TK2OTOHH`_-VX_P""8?P6G\3Q:JGQ._:%L_!EA^UE!^VSH'P?T_XB
MZ-8?#'0?VA7^+47QMUWQ2EE:^"HO%WB71/%7Q`EUO5]6\%>//&7BWPEIK>)-
M3?PCI'AF\L?#-[X?]%OOV!_@X_PJ\%_#'0/$7Q3\%7WPP^/7Q0_:3^%?Q3\(
M>,;73/BI\-_BM\8?'_Q5\>>.]3\.ZY=:#J&@7^@ZS#\:OB1X$OO!WBWPMXE\
M+:O\.O$4_AGQ#I6LF.*_7[=HH`\=^"?P:T[X)^#KGPK;>.?BE\2]1U;Q-KOC
M'Q)X[^,/CG4/'?C;Q'XB\0WD=S>W-Q>3Q:?H7A_2+2&WLM+T#P9X'\/>$_`O
MA;1["TTOPUX9TJU219?#_@E^P?\`!+X!ZI\%]6\#WGCR:Z^!%E^UG8>"1K_B
M6UU.&:#]LSXT:!\=_BX=>CBT:R.I26OC;PYI\/@QXFL_[`T%KG3;A=5EF%['
M]I44`?F<?^"5_P`!=.\,:)X8\#_$/]H7X8);?"7Q=\!?&>M?#WXFV6BZ_P#%
M?X+^+_'WC/XER?#[X@W]YX3U6(V_AOQ7\1_']UX&\7^"[3P9\1_!5KXS\3V/
MA[QG8VVN:BL^YJ'_``32^#]O9Z'8?#GXI_M'?`Z&#X!?"_\`9G\=2_!;XJP^
M"=0^+GPE^#>ES:%\.[#QUJ__``C&IZMI'C'PYH6HZ]HMA\5/A5>_#7XHVND^
M(+ZPM/%]M;V/AY-$_16B@#X,\9?\$ZO@'XY\;^(?BGK>I?$[_A;=[XP^!/BO
MP+\58/&S2>._@G9_L[020?#WP/\`!W5M1TO4(?#'@&[_`+;^(LGQ!\.:I9^(
M?^%ICXO_`!1M/B'>^(M.\26]GI?WD!M``Z#I[#L..P'`]ASGK2T4`)@'J`?P
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MGP1X7XGP?&61<"X?`<2Y?CJN983,XYUQ+7G1QU95%5KK#8K.:V#FY^UJ7A4P
M\Z2YW:"M&R8'H/R%+@#H,445^&G[K9=OZ_I(\-_:%_9W^&?[3GP\;X<_$^PU
MAK*R\0^'?&WA'Q/X4\0ZMX-\??#CXB^#=136/!7Q(^'/C;0+BUUSPAXW\):M
M&MWI&LZ=/ME@EOM'U:UU3P_JVKZ3?_,VG?\`!-_X47J?%34OBS\4_P!H']H7
MQ]\5/@5\0/V;9?BC\:?'OA_5_&'P_P#@W\4M,BT_Q[X3^%&E^#_`_@CX=>`)
MO%=Q9Z1J_B;Q+I7@-_%7BG4O#OA=?%&M:SI?AK1=,LOT+HH`^+?'?[`_[//Q
M.AM+'Q_I'B3Q1HMO^RCXC_8WGT*]\27%II]]\(_$VL^`]?O;J:XTFWT_6++Q
MW9:K\./#5[HGC+1M5TN_T.\@EO\`38K?4!:7=IP5S_P3@^&^M1SZYXR^-W[3
MWCOXP6?B3X7>*/`W[0'B?XI:0?BM\*]1^#NF>-=%\$Q?#N#0O!&A_##3+(Z1
M\3OBAI?C6WUGX:Z\WQ5TWXB>)]/^*<OC&QDTNWTO]#Z*`/A3P;^P5\)/AMJW
M@7XA:7JGQ0\=_%;X=_&SXI?M,7/CCQQX\MK[Q3\7?C7\3?@;XA_9\U76OB7?
MQ^'[/0C86?PKU;3?!?A#P_X4T'PEX3\#Z3X7\(V>A:';Z5H9TZ[^?_V</^"=
M6B7?[.'[9W@;]H;PE!X*UK_@H3\1?C)XY^+?@/X>_$"\\0O\(_!GQ+2ZTWPS
M\+_`WQ'_`+)TR,2>$X+O6_B%<3:'H-KX4TKXM?$3X@7/ANPO=#N(;G4/UKHH
M`^`KG_@G;\*[JWU+5I?B=\>%^+%[\8_AY^T#8?'NW\:>&K/XL^'OC#\/_P!G
M?PE^RU)XST>>T\"P>`Y!X]^#7A:X\-_$KPKK7@+6/!'B[_A+/%<D_AJU@O=,
MM='H:A_P3G\"R>$[#PUX=_:"_:S\%WMSH7Q8\/\`Q'\5:'\8K'5]:^-=I\:_
M$USXP\?WOQ/TCQWX,\9>`IM>NM?U#4YO#'B/P3X+\$:[\.M&U*Z\&_#J_P#"
MW@D6WARW_0RB@#Y%^+G[%7P=^*_[)^B_L:V]SXU^&'PB\(Z7\#=(\`W'PO\`
M$4.D^,O`%K^SEXP\`^-_A$?#'B#Q-I7BV'SO#&M?#3PD#)KFF:W_`&C964UO
MJ"W#74LI\9'_``3)^$NOZ9\8D^,/QA_:6_:#\7_&/]G?XG_LL7OQ)^,7Q-T7
M4O%G@/X*_&6"UC^)?AGX7:5X-\#>"/AUX+O?%USI/AJ_UWQ+!X$O?$6KW'A'
MPK!JFI7NF:+;:>?T@HH`_/GXB?\`!-SX'_$KQ)X_O-8\8?&C3/AU\9?$GP]\
M9?'OX#:!X^M-/^#/QV\6_#?1O"WAO1]>^(>B3>&[WQ5!)KOASP)X%\/_`!$T
MCP+XR\%>&_BCHWA'2=-^(>B^([6;5X]4=XF_X)Q_!_7_`![\2OB9IGQ#^.?@
MCQIX\^.WA3]ICP[K7@OQSHNG7'P<^.6A?"M?@AXF\=?"D:EX.UA;.+XK_"=(
M_`_Q6\$>.?\`A//AQXKT>/,7@_2KV:XNIOT$HH`^#[W]@'X?W6A?#=XOC'^T
ME;_%[X6>.?B#\0O"O[25S\4[?Q)\;X]<^*]F=+^)&F7EWXS\+^)?AM<>`O%>
MCPZ1I3?"J+X:6OPO\-6WAGPC/X)\(>&=2\*:!?V.S\-OV"O@E\+K[6-4\/ZG
M\3M1U3Q%^SM)^S;XBU7Q=\0=3\8:OK_A:_\`B%\2_BIXB\8:OK.OV][JU[\1
M_%7CWXM^-M?UWQ#+>?V<9+^UL=+T'2],T^TLX_M>B@#Y#^('[%/P>^)/[&"_
ML)^(;KQM'\%%^#G@OX'"[TSQ#;VGCO\`X0SP'I?AS2=$F_X25])N+;^W'M?"
M^FF_U'^QO*N9FNI%LX1,JQP>.OV(/@U\0O#G[3GA?7KKQPFF_M9?%/X<_%_X
MHG3_`!%;6MU;^*_A?X7^"_A'PW%X3F;2)QHFCR:5\"?!3:I83QZE)>W<VO3I
M=6RZG%%9?8=%`'P[%^P-\*+/XKW_`,1M*\<?&O0O">L?'&T_:7U[X":%\0QI
M/P/UWX]VGV>\'Q)U+0K30X_&@EO?$UCIWCO6O`MEX^L_A7XC^(%@GC3Q!X$U
M/7KS5+N_^I/A?X%G^&G@3P]X(N?'/CWXE3:!;W5O)XV^)^LV'B#QUKQN=1O=
M0$_B#6-,T?0+&^N+9;P:?:R6^D6:QZ=9V4#I))$\\O?44`%%%%`!1110`444
M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110
M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%
M%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110!__9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>oncylogo.jpg
<TEXT>
begin 644 oncylogo.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_[2Q64&AO=&]S:&]P(#,N,``X0DE-!"4`
M`````!``````````````````````.$))30/J`````!VP/#]X;6P@=F5R<VEO
M;CTB,2XP(B!E;F-O9&EN9STB551&+3@B/SX*/"%$3T-465!%('!L:7-T(%!5
M0DQ)0R`B+2\O07!P;&4@0V]M<'5T97(O+T141"!03$E35"`Q+C`O+T5.(B`B
M:'1T<#HO+W=W=RYA<'!L92YC;VTO1%1$<R]0<F]P97)T>4QI<W0M,2XP+F1T
M9"(^"CQP;&ES="!V97)S:6]N/2(Q+C`B/@H\9&EC=#X*"3QK97D^8V]M+F%P
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M970N;6]D1&%T93PO:V5Y/@H)"0D)/&1A=&4^,C`P."TP-2TR,E0R,3HR.#HU
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M<'!L92YP<FEN="YT:6-K970N;6]D1&%T93PO:V5Y/@H)"0D)/&1A=&4^,C`P
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M8VME="YM;V1$871E/"]K97D^"@D)"0D\9&%T93XR,#`X+3`U+3(R5#(Q.C(X
M.C4P6CPO9&%T93X*"0D)"3QK97D^8V]M+F%P<&QE+G!R:6YT+G1I8VME="YS
M=&%T949L86<\+VME>3X*"0D)"3QI;G1E9V5R/C`\+VEN=&5G97(^"@D)"3PO
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M;V1$871E/"]K97D^"@D)"0D\9&%T93XR,#`X+3`U+3(R5#(Q.C(X.C4P6CPO
M9&%T93X*"0D)"3QK97D^8V]M+F%P<&QE+G!R:6YT+G1I8VME="YS=&%T949L
M86<\+VME>3X*"0D)"3QI;G1E9V5R/C`\+VEN=&5G97(^"@D)"3PO9&EC=#X*
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M96%L/@H)"0D)"0D\<F5A;#XP+C`\+W)E86P^"@D)"0D)"3QR96%L/C<S-#PO
M<F5A;#X*"0D)"0D)/')E86P^-3<V/"]R96%L/@H)"0D)"3PO87)R87D^"@D)
M"0D)/&ME>3YC;VTN87!P;&4N<')I;G0N=&EC:V5T+F-L:65N=#PO:V5Y/@H)
M"0D)"3QS=')I;F<^8V]M+F%P<&QE+G!R:6YT:6YG;6%N86=E<CPO<W1R:6YG
M/@H)"0D)"3QK97D^8V]M+F%P<&QE+G!R:6YT+G1I8VME="YM;V1$871E/"]K
M97D^"@D)"0D)/&1A=&4^,C`P."TP-2TR,E0R,3HR.#HU,%H\+V1A=&4^"@D)
M"0D)/&ME>3YC;VTN87!P;&4N<')I;G0N=&EC:V5T+G-T871E1FQA9SPO:V5Y
M/@H)"0D)"3QI;G1E9V5R/C`\+VEN=&5G97(^"@D)"0D\+V1I8W0^"@D)"3PO
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M+C`\+W)E86P^"@D)"0D)"3QR96%L/C<S-#PO<F5A;#X*"0D)"0D)/')E86P^
M-3<V/"]R96%L/@H)"0D)"3PO87)R87D^"@D)"0D)/&ME>3YC;VTN87!P;&4N
M<')I;G0N=&EC:V5T+F-L:65N=#PO:V5Y/@H)"0D)"3QS=')I;F<^8V]M+F%P
M<&QE+G!R:6YT:6YG;6%N86=E<CPO<W1R:6YG/@H)"0D)"3QK97D^8V]M+F%P
M<&QE+G!R:6YT+G1I8VME="YM;V1$871E/"]K97D^"@D)"0D)/&1A=&4^,C`P
M."TP-2TR,E0R,3HR.#HU,%H\+V1A=&4^"@D)"0D)/&ME>3YC;VTN87!P;&4N
M<')I;G0N=&EC:V5T+G-T871E1FQA9SPO:V5Y/@H)"0D)"3QI;G1E9V5R/C`\
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M"0D)/&1A=&4^,C`P,RTP-RTP,50Q-SHT.3HS-EH\+V1A=&4^"@D)"0D)/&ME
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M="Y!4$E697)S:6]N/"]K97D^"@D\<W1R:6YG/C`P+C(P/"]S=')I;F<^"@D\
M:V5Y/F-O;2YA<'!L92YP<FEN="YT:6-K970N<')I=F%T94QO8VL\+VME>3X*
M"3QF86QS92\^"@D\:V5Y/F-O;2YA<'!L92YP<FEN="YT:6-K970N='EP93PO
M:V5Y/@H)/'-T<FEN9SYC;VTN87!P;&4N<')I;G0N4&%G949O<FUA=%1I8VME
M=#PO<W1R:6YG/@H\+V1I8W0^"CPO<&QI<W0^"CA"24T#Z0``````>``#````
M2`!(``````+>`D#_[O_N`P8"4@-G!2@#_``"````2`!(``````+8`B@``0``
M`&0````!``,#`P````%__P`!``$```````````````!H"``9`9```````"``
M`````````````````````````````````#A"24T#[0``````$`$L`````0`!
M`2P````!``$X0DE-!"8```````X`````````````/X```#A"24T$#0``````
M!````!XX0DE-!!D```````0````>.$))30/S```````)```````````!`#A"
M24T$"@```````0``.$))32<0```````*``$``````````3A"24T#]0``````
M2``O9F8``0!L9F8`!@```````0`O9F8``0"AF9H`!@```````0`R`````0!:
M````!@```````0`U`````0`M````!@```````3A"24T#^```````<```____
M_________________________P/H`````/__________________________
M__\#Z`````#_____________________________`^@`````____________
M_________________P/H```X0DE-!`````````(``#A"24T$`@```````@``
M.$))300(```````0`````0```D````)``````#A"24T$'@``````!``````X
M0DE-!!H``````T4````&``````````````#A```#P`````@`3P!.`$,`(`!,
M`&\`9P!O`````0`````````````````````````!``````````````/`````
MX0`````````````````````!`````````````````````````!`````!````
M````;G5L;`````(````&8F]U;F1S3V)J8P````$```````!28W0Q````!```
M``!4;W`@;&]N9P``````````3&5F=&QO;F<``````````$)T;VUL;VYG````
MX0````!29VAT;&]N9P```\`````&<VQI8V5S5FQ,<P````%/8FIC`````0``
M````!7-L:6-E````$@````=S;&EC94E$;&]N9P`````````'9W)O=7!)1&QO
M;F<`````````!F]R:6=I;F5N=6T````,15-L:6-E3W)I9VEN````#6%U=&]'
M96YE<F%T960`````5'EP965N=6T````*15-L:6-E5'EP90````!);6<@````
M!F)O=6YD<T]B:F,````!````````4F-T,0````0`````5&]P(&QO;F<`````
M`````$QE9G1L;VYG``````````!"=&]M;&]N9P```.$`````4F=H=&QO;F<`
M``/``````W5R;%1%6%0````!````````;G5L;%1%6%0````!````````37-G
M951%6%0````!```````&86QT5&%G5$585`````$```````YC96QL5&5X=$ES
M2%1-3&)O;VP!````"&-E;&Q497AT5$585`````$```````EH;W)Z06QI9VYE
M;G5M````#T53;&EC94AO<GI!;&EG;@````=D969A=6QT````"79E<G1!;&EG
M;F5N=6T````/15-L:6-E5F5R=$%L:6=N````!V1E9F%U;'0````+8F=#;VQO
M<E1Y<&5E;G5M````$453;&EC94)'0V]L;W)4>7!E`````$YO;F4````)=&]P
M3W5T<V5T;&]N9P`````````*;&5F=$]U='-E=&QO;F<`````````#&)O='1O
M;4]U='-E=&QO;F<`````````"W)I9VAT3W5T<V5T;&]N9P``````.$))300H
M```````,`````3_P````````.$))3004```````$`````CA"24T$#``````(
M2`````$```"@````)@```>```$=````(+``8``'_V/_@`!!*1DE&``$"`0!(
M`$@``/_M``Q!9&]B95]#30`!_^X`#D%D;V)E`&2``````?_;`(0`#`@("`D(
M#`D)#!$+"@L1%0\,#`\5&!,3%1,3&!$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#`$-"PL-#@T0#@X0%`X.#A04#@X.#A01#`P,#`P1$0P,
M#`P,#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,_\``$0@`)@"@`P$B
M``(1`0,1`?_=``0`"O_$`3\```$%`0$!`0$!``````````,``0($!08'"`D*
M"P$``04!`0$!`0$``````````0`"`P0%!@<("0H+$``!!`$#`@0"!0<&"`4#
M##,!``(1`P0A$C$%05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q
M8W,U%J*R@R9$DU1D1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75
MY?569G:&EJ:VQM;F]C='5V=WAY>GM\?7Y_<1``("`0($!`,$!08'!P8%-0$`
M`A$#(3$2!$%187$B$P4R@9$4H;%"(\%2T?`S)&+A<H*20U,58W,T\24&%J*R
M@P<F-<+21)-4HQ=D154V=&7B\K.$P]-UX_-&E*2%M)7$U.3TI;7%U>7U5F9V
MAI:FML;6YO8G-T=79W>'EZ>WQ__:``P#`0`"$0,1`#\`]56/U+ZQ,Q\S]F]/
MQW]3ZF`'/QZ2&MK:?HNS,E_Z+&W?F?X7_@T7ZQ]2NZ;TFV_&:'Y=A;1B,/>Z
MYPIH_P`U[_44^B='HZ1@MQJR;;GDV962[5]USO==?:[Z3G/<FDDFAIW*FCO^
MO3O>*NEU`Z^DY][G#^2ZUK&L_P#`TJ?K+=C9->'U_#/3+;B&49(>+<6QQXK;
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M,?IQ;B8[?MG5K],7`J,O<?W[?]!CM^G9=;^8B2!NAK],(L^MO6GL^C73AU/\
M[(NM_P"C7;6LJC$ZB>M]<ZATDQGXN4P''L);5DTNIJ<[%?/MJMW^_&RO\%9_
M.?H;%T'U?Z59TS!<W)L%V=E6.R<ZYH@.NL^GL_X*MNVJK_@V)JNLOLS_`+&<
M5[1ZUE'J<QZ;/5;<]FWVTW?099]!,K07IJ3_`(R6A]4;V9.3UK)K994V[,#O
M3N:66-/HT-LKLK=]%]=K7UJETW]EC(S!];!5^U#?9L=G@>CZ$_JXZ:[)_5OL
M^SZ3:?TWJ?TGWKJ<G)-%F,P5NL^TV^D7-X8/3MN]1_\`(_0^G_UQ1S\MV)C^
MLVIUQ+V,AO#0]P9ZMKO=LHJW>I=9M_1UH\.F_P`OAHIS.I![OJKD-^JX:QWI
M.&(,<!GYWZ7[/]';9_.^E_PBSO\`L%/2X+*&7;/H;8Z@+(_=_P"4?MWJ?]>]
M1=%@YSLM][#46"AX:+6G=58"UMFZBV&>ILW>G;[/YU-]KR?VE]C]`>EZ?J^O
MN,1.S9M]/;ZO\CU/H)$`T=/W=E//YC>J._Q<7-ZH'G/.&X6A^MG?T_4V_P"%
M]+9ZG_"+9Z9UGI-[,?$HS*;,@UM`J:\%Q+6[G^WZ7M:U'ZEU!V"V@BDW>O;Z
M1(,!@V67>I8Z'>W]#Z?]>Q6JG^I6Q^GN:':&1J/S7:(@4=#L`-5/,=<QLGHN
M57E]$M&,[K.0S$R:7,]2IMUTBOJE=4M]/(JV_I_\#E_X;](MC`Z%T["P'X/I
MC(KN)?E/R(L??8[6R[*<_P#G7O=_ZC1.G=1=FM#S6*-S=WHO<?69K&S(HV?H
M;/W_`-+8BY64['LQF-I?=]HM-1+(]@%=M_J/W>W9^A]/_KB0`U/0J>=Z=T7H
M]GUFZSCV8&.^BJO$-5;J6%C2]MWJ^DQS?3;OV_I-BM?6D?K?0(''4J^!Q^CO
M\%L8&4[,QA>ZI]!+[&>G9HX>F]],N_K^GO5A`1'#0ZZ_]TIYOZR;_P!JX!ZB
M'N^KX:_[2&!QK]>1Z'[0;5[OL?\`7_5O5_I"O=+/U8^U._8XQ/M!K][L0,^@
M"-'OH&WZ?YBO8^4;LC*I-;F#&>U@>[A^ZNN[>S^KZOI_V%3ZCUJS`NO9]CNO
MKIH;<+:P7`O>;FUX^UK7.]WH?SOO]+U:_6]-GO2T!XOV*>>S*>CLS\Z]N?TW
M)MLM<ZVCJ]8?:QP]CJ,:]UE=C,1NW]#5]FO_`.#70?5F\7]'I>W!_9K`7M9C
MZANT.,6TAS:K/1N_G*_4JJ5W.RCAXK\@5/O+(_1UB7>YP9N_XNO=ZEO_``2E
MBWF^LO/IF#'Z)_J-_P`_96D(U+?\%/\`_]'U59O7OV#]@=^WO0^QS_VHB-W_
M``7Y_J_\5^D7S.DA+8[?793[HRCZI.JWXV3U=F'VKJ'4?1C^3^B=[/[:VOJS
M_P`U/3L_YO\`H[Y_3Q/K_P#H1]H_6_\`MU?.*2CCN/E^G_<I^U^JDE\JI*5#
M]5)+Y5224_522^54DE/U4DOE5))3]5)+Y5224_522^54DE/U4DOE5))3]5)+
MY5224__9.$))300A``````!3`````0$````/`$$`9`!O`&(`90`@`%``:`!O
M`'0`;P!S`&@`;P!P````$@!!`&0`;P!B`&4`(`!0`&@`;P!T`&\`<P!H`&\`
M<``@`$,`4P````$`.$))300&```````'``@````!`0#_X0E@17AI9@``24DJ
M``@````'`!(!`P`!`````0"+>1H!!0`!````8@```!L!!0`!````:@```"@!
M`P`!`````@"]#S$!`@`=````<@```#(!`@`4````D````&F'!``!````I```
M`,X````L`0```0```"P!```!````061O8F4@4&AO=&]S:&]P($-3($UA8VEN
M=&]S:`"`,C`P.#HP-3HR,B`Q-3HR.3HS.``#``&@`P`!`````0#__P*@!``!
M````P`,```.@!``!````X0`````````&``,!`P`!````!@#F_QH!!0`!````
M'`$``!L!!0`!````)`$``"@!`P`!`````@"DI0$"!``!````+`$```("!``!
M````+`@```````!(`````0```$@````!````_]C_X``02D9)1@`!`@$`2`!(
M``#_[0`,061O8F5?0TT``?_N``Y!9&]B90!D@`````'_VP"$``P("`@)"`P)
M"0P1"PH+$14/#`P/%1@3$Q43$Q@1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P!#0L+#0X-$`X.$!0.#@X4%`X.#@X4$0P,#`P,$1$,#`P,
M#`P1#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#/_``!$(`"8`H`,!(@`"
M$0$#$0'_W0`$``K_Q`$_```!!0$!`0$!`0`````````#``$"!`4&!P@)"@L!
M``$%`0$!`0$!``````````$``@,$!08'"`D*"Q```00!`P($`@4'!@@%`PPS
M`0`"$0,$(1(Q!4%181,B<8$R!A21H;%"(R054L%B,S1R@M%#!R624_#A\6-S
M-1:BLH,F1)-49$7"HW0V%])5XF7RLX3#TW7C\T8GE*2%M)7$U.3TI;7%U>7U
M5F9VAI:FML;6YO8W1U=G=X>7I[?'U^?W$0`"`@$"!`0#!`4&!P<&!34!``(1
M`R$Q$@1!46%Q(A,%,H&1%*&Q0B/!4M'P,R1BX7*"DD-3%6-S-/$E!A:BLH,'
M)C7"TD235*,79$55-G1EXO*SA,/3=>/S1I2DA;25Q-3D]*6UQ=7E]59F=H:6
MIK;&UN;V)S='5V=WAY>GM\?_V@`,`P$``A$#$0`_`/55C]2^L3,?,_9O3\=_
M4^I@!S\>DAK:VGZ+LS)?^BQMWYG^%_X-%^L?4KNF])MOQFA^786T8C#WNN<*
M:/\`->_U%/HG1Z.D8+<:LFVYY-F5DNU?=<[W77VN^DYSW)I))H:=RIH[_KT[
MWBKI=0.OI.?>YP_DNM:QK/\`P-*GZRW8V37A]?PSTRVXAE&2'BW%L<>*VY(#
M/1M?^95D,8MY`S<+%S\6W#S*VW8][=ME;N"#_K[7)<)&Q/U4G26']5[\FMF7
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MK?\`HUVUK*HQ.HGK?7.H=),9^+E,!Q["6U9-+J:G.Q7S[:K=_OQLK_!6?SGZ
M&Q=!]7^E6=,P7-R;!=G95CLG.N:(#KK/I[/^"K;MJJ_X-B:KK+[,_P"QG%>T
M>M91ZG,>FSU6W/9M]M-WT&6?03*T%Z:D_P",EH?5&]F3D]:R:V65-NS`[T[F
MEEC3Z-#;*[*W?1?7:U]:I=-_98R,P?6P5?M0WV;'9X'H^A/ZN.FNR?U;[/L^
MDVG]-ZG])]ZZG)R319C,%;K/M-OI%S>&#T[;O4?_`"/T/I_]<4<_+=B8_K-J
M=<2]C(;PT/<&>K:[W;**MWJ76;?T=:/#IO\`+X:*<SJ0>[ZJY#?JN&L=Z3AB
M#'`9^=^E^S_1VV?SOI?\(L[_`+!3TN"RAEVSZ&V.H"R/W?\`E'[=ZG_7O471
M8.<[+?>PU%@H>&BUIW56`M;9NHMAGJ;-WIV^S^=3?:\G]I?8_0'I>GZOK[C$
M3LV;?3V^K_(]3Z"1`-'3]W93S^8WJCO\7%S>J!YSSAN%H?K9W]/U-O\`A?2V
M>I_PBV>F=9Z3>S'Q*,RFS(-;0*FO!<2UNY_M^E[6M1^I=0=@MH(I-WKV^D2#
M`8-EEWJ6.AWM_0^G_7L5JI_J5L?I[FAVAD:C\UVB(%'0[`#53S'7,;)Z+E5Y
M?1+1C.ZSD,Q,FES/4J;==(KZI75+?3R*MOZ?_`Y?^&_2+8P.A=.PL!^#Z8R*
M[B7Y3\B+'WV.ULNRG/\`YU[W?^HT3IW479K0\UBC<W=Z+W'UF:QLR*-GZ&S]
M_P#2V(N5E.Q[,9C:7W?:+342R/8!7;?ZC]WMV?H?3_ZXD`-3T*GG>G=%Z/9]
M9NLX]F!COHJKQ#56ZEA8TO;=ZOI,<WTV[]OZ38K7UI'ZWT"!QU*O@<?H[_!;
M&!E.S,87NJ?02^QGIV:.'IO?3+OZ_I[U80$1PT.NO_=*>;^LF_\`:N`>HA[O
MJ^&O^TA@<:_7D>A^T&U>[['_`%_U;U?Z0KW2S]6/M3OV.,3[0:_>[$#/H`C1
M[Z!M^G^8KV/E&[(RJ36Y@QGM8'NX?NKKNWL_J^KZ?]A4^H]:LP+KV?8[KZZ:
M&W"VL%P+WFYM>/M:USO=Z'\[[_2]6OUO39[TM`>+]BGGLRGH[,_.O;G]-R;;
M+7.MHZO6'VL</8ZC&O=978S$;M_0U?9K_P#@UT'U9O%_1Z7MP?V:P%[68^H;
MM#C%M(<VJST;OYROU*JE=SLHX>*_(%3[RR/T=8EWN<&;O^+KW>I;_P`$I8MY
MOK+SZ9@Q^B?ZC?\`/V5I"-2W_!3_`/_1]56;U[]@_8'?M[T/L<_]J(C=_P`%
M^?ZO_%?I%\SI(2V.WUV4^Z,H^J3JM^-D]79A]JZAU'T8_D_HG>S^VMKZL_\`
M-3T[/^;_`*.^?T\3Z_\`Z$?:/UO_`+=7SBDHX[CY?I_W*?M?JI)?*J2E0_52
M2^54DE/U4DOE5))3]5)+Y5224_522^54DE/U4DOE5))3]5)+Y5224_522^54
MDE/_V?_B#%A)0T-?4%)/1DE,10`!`0``#$A,:6YO`A```&UN=')21T(@6%E:
M(`?.``(`"0`&`#$``&%C<W!-4T94`````$E%0R!S4D="````````````````
M``#VU@`!`````-,M2%`@(```````````````````````````````````````
M````````````````````````$6-P<G0```%0````,V1E<V,```&$````;'=T
M<'0```'P````%&)K<'0```($````%')865H```(8````%&=865H```(L````
M%&)865H```)`````%&1M;F0```)4````<&1M9&0```+$````B'9U960```-,
M````AG9I97<```/4````)&QU;6D```/X````%&UE87,```0,````)'1E8V@`
M``0P````#')44D,```0\```(#&=44D,```0\```(#&)44D,```0\```(#'1E
M>'0`````0V]P>7)I9VAT("AC*2`Q.3DX($AE=VQE='0M4&%C:V%R9"!#;VUP
M86YY``!D97-C`````````!)S4D="($E%0S8Q.38V+3(N,0``````````````
M$G-21T(@245#-C$Y-C8M,BXQ````````````````````````````````````
M``````````````````````````````!865H@````````\U$``0````$6S%A9
M6B``````````````````````6%E:(````````&^B```X]0```Y!865H@````
M````8ID``+>%```8VEA96B`````````DH```#X0``+;/9&5S8P`````````6
M245#(&AT='`Z+R]W=W<N:65C+F-H```````````````6245#(&AT='`Z+R]W
M=W<N:65C+F-H````````````````````````````````````````````````
M`````````````&1E<V,`````````+DE%0R`V,3DV-BTR+C$@1&5F875L="!2
M1T(@8V]L;W5R('-P86-E("T@<U)'0@``````````````+DE%0R`V,3DV-BTR
M+C$@1&5F875L="!21T(@8V]L;W5R('-P86-E("T@<U)'0@``````````````
M``````````````!D97-C`````````"Q2969E<F5N8V4@5FEE=VEN9R!#;VYD
M:71I;VX@:6X@245#-C$Y-C8M,BXQ```````````````L4F5F97)E;F-E(%9I
M97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0``````````````````
M````````````````=FEE=P``````$Z3^`!1?+@`0SQ0``^W,``03"P`#7)X`
M```!6%E:(```````3`E6`%````!7'^=M96%S``````````$`````````````
M```````````"CP````)S:6<@`````$-25"!C=7)V````````!``````%``H`
M#P`4`!D`'@`C`"@`+0`R`#<`.P!``$4`2@!/`%0`60!>`&,`:`!M`'(`=P!\
M`($`A@"+`)``E0":`)\`I`"I`*X`L@"W`+P`P0#&`,L`T`#5`-L`X`#E`.L`
M\`#V`/L!`0$'`0T!$P$9`1\!)0$K`3(!.`$^`44!3`%2`5D!8`%G`6X!=0%\
M`8,!BP&2`9H!H0&I`;$!N0'!`<D!T0'9`>$!Z0'R`?H"`P(,`A0"'0(F`B\"
M.`)!`DL"5`)=`F<"<0)Z`H0"C@*8`J("K`*V`L$"RP+5`N`"ZP+U`P`#"P,6
M`R$#+0,X`T,#3P-:`V8#<@-^`XH#E@.B`ZX#N@/'`],#X`/L`_D$!@03!"`$
M+00[!$@$501C!'$$?@2,!)H$J`2V!,0$TP3A!/`$_@4-!1P%*P4Z!4D%6`5G
M!7<%A@66!:8%M07%!=4%Y07V!@8&%@8G!C<&2`99!FH&>P:,!IT&KP;`!M$&
MXP;U!P<'&0<K!ST'3P=A!W0'A@>9!ZP'OP?2!^4'^`@+"!\(,@A&"%H(;@B"
M")8(J@B^"-((YPC["1`))0DZ"4\)9`EY"8\)I`FZ"<\)Y0G["A$*)PH]"E0*
M:@J!"I@*K@K%"MP*\PL+"R(+.0M1"VD+@`N8"[`+R`OA"_D,$@PJ#$,,7`QU
M#(X,IPS`#-D,\PT-#28-0`U:#70-C@VI#<,-W@WX#A,.+@Y)#F0.?PZ;#K8.
MT@[N#PD/)0]!#UX/>@^6#[,/SP_L$`D0)A!#$&$0?A";$+D0UQ#U$1,1,1%/
M$6T1C!&J$<D1Z!('$B8211)D$H02HQ+#$N,3`Q,C$T,38Q.#$Z03Q1/E%`84
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MN#/Q-"LT932>--@U$S5--8<UPC7]-C<V<C:N-NDW)#=@-YPWUS@4.%`XC#C(
M.04Y0CE_.;PY^3HV.G0ZLCKO.RT[:SNJ.^@\)SQE/*0\XSTB/6$]H3W@/B`^
M8#Z@/N`_(3]A/Z(_XD`C0&1`ID#G02E!:D&L0>Y",$)R0K5"]T,Z0WU#P$0#
M1$=$BD3.11)%546:1=Y&(D9G1JM&\$<U1WM'P$@%2$M(D4C721U)8TFI2?!*
M-TI]2L1+#$M32YI+XDPJ3'),NDT"34I-DTW<3B5.;DZW3P!/24^33]U0)U!Q
M4+M1!E%049M1YE(Q4GQ2QU,34U]3JE/V5$)4CU3;52A5=57"5@]67%:I5O=7
M1%>25^!8+UA]6,M9&EEI6;A:!UI66J9:]5M%6Y5;Y5PU7(9<UETG77A=R5X:
M7FQ>O5\/7V%?LV`%8%=@JF#\84]AHF'U8DEBG&+P8T-CEV/K9$!DE&3I93UE
MDF7G9CUFDF;H9SUGDV?I:#]HEFCL:4-IFFGQ:DAJGVKW:T]KIVO_;%=LKVT(
M;6!MN6X2;FMNQ&\>;WAOT7`K<(9PX'$Z<95Q\')+<J9S`7-=<[AT%'1P=,QU
M*'6%=>%V/G:;=OAW5G>S>!%X;GC,>2IYB7GG>D9ZI7L$>V-[PGPA?(%\X7U!
M?:%^`7YB?L)_(W^$?^6`1X"H@0J!:X'-@C""DH+T@U>#NH0=A("$XX5'A:N&
M#H9RAM>'.X>?B`2(:8C.B3.)F8G^BF2*RHLPBY:+_(QCC,J-,8V8C?^.9H[.
MCS:/GI`&D&Z0UI$_D:B2$9)ZDN.339.VE""4BI3TE5^5R98TEI^7"I=UE^"8
M3)BXF229D)G\FFB:U9M"FZ^<')R)G/>=9)W2GD">KI\=GXN?^J!IH-BA1Z&V
MHB:BEJ,&HW:CYJ16I,>E.*6IIAJFBZ;]IVZGX*A2J,2I-ZFIJARJCZL"JW6K
MZ:Q<K-"M1*VXKBVNH:\6KXNP`+!UL.JQ8+'6LDNRPK,XLZZT);2<M1.UBK8!
MMGFV\+=HM^"X6;C1N4JYPKH[NK6[+KNGO"&\F[T5O8^^"KZ$OO^_>K_UP'#`
M[,%GP>/"7\+;PUC#U,11Q,[%2\7(QD;&P\=!Q[_(/<B\R3K)N<HXRK?+-LNV
MS#7,M<TUS;7.-LZVSS?/N-`YT+K1/-&^TC_2P=-$T\;42=3+U4[5T=95UMC7
M7-?@V&38Z-ELV?':=MK[VX#<!=R*W1#=EMX<WJ+?*=^OX#;@O>%$X<SB4^+;
MXV/CZ^1SY/SEA.8-YI;G'^>IZ#+HO.E&Z=#J6^KEZW#K^^R&[1'MG.XH[K3O
M0._,\%CPY?%R\?_RC/,9\Z?T-/3"]5#UWO9M]OOWBO@9^*CY./G'^E?ZY_MW
M_`?\F/TI_;K^2_[<_VW____;`$,`"`8&!P8%"`<'!PD)"`H,%`T,"PL,&1(3
M#Q0=&A\>'1H<'"`D+B<@(BPC'!PH-RDL,#$T-#0?)SD].#(\+C,T,O_;`$,!
M"0D)#`L,&`T-&#(A'"$R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,O_``!$(`.$#P`,!(@`"$0$#$0'_Q``?```!
M!0$!`0$!`0```````````0(#!`4&!P@)"@O_Q`"U$``"`0,#`@0#!04$!```
M`7T!`@,`!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9
M&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY
M>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*
MTM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q``?`0`#`0$!`0$!`0$!
M`````````0(#!`4&!P@)"@O_Q`"U$0`"`0($!`,$!P4$!``!`G<``0(#$00%
M(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9&B8G*"DJ
M-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"@X2%AH>(
MB8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8
MV=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@`,`P$``A$#$0`_`/?Z***`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBLC7/$NE^'H=]_<!7(RD*<NWT']3Q2
M;25V!KU2U#5].TJ/S+^\AMU[;VP3]!U->2Z[\3=5U`M%IP%A;GHR\R$?7M^'
MYUQ4T\MQ*99Y7DD;JSL23^)KEGBDOA*43V#4/BKHUL2MG!<79'\6-BG\^?TK
MG;KXM:I)D6MA:PCU<LY_I7GRJ68*H))[`5L6?A/7[\`V^DW)4]&=-@/XMBL?
M;59;#LC5E^)7B>0_+>11?[D"?U!J+_A8OBK_`*"8_P#`>+_XFK$/PR\22KEH
M;>+V>8?TS4__``JOQ!_STLO^_I_PHM7\PT*L7Q*\3QD;KR*7_?@3^@%:=K\6
MM5C(^U6-K,/]C<A_F:SYOAEXDB4E8;>7V289_7%9%YX1\06`+3Z3<A1U9$W@
M?BN:7-6CW#0])T_XK:1<$+>6UQ:D_P`0&]?TY_2NNT[6M-U:/?87L,X[A&^8
M?4=17S>RLC%64J1U!&*=%+)!(LD4C1NO(93@C\:N.*DOBU#E1].T5XKH?Q+U
M?32L5]B_MQQ\YQ(![-W_`!S7J.A>*=*\0Q9LK@>:!EH'X=?P[CW%=5.M&>Q+
M5C9HHHK404444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`444
M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110
M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%
M%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4A(`))P!0S*B%F8*H&2
M2<`"O'O&_CV35'DTW2I"EB"5DE'!F]O9?YUG4J*"NQI7-OQ;\24M&DL=#99)
MA\KW755_W?4^_3ZUY7<7,]W<//<2O+*YRSN<DU&!DX')KT/PI\-9;U4O=;W0
MP'E;8<.X_P!K^Z/U^E<#<ZTB]$<9I&A:EKEQY.GVKRD?>;HJ_4]!7H^B_"BV
MB"RZQ=-,_P#SQ@^51]6ZG\,5Z#9V5MI]LEM:01P0I]U$&!4]=4,-&/Q:DN1G
MZ?H>EZ4@6QL8(<?Q*@W?GUK0HHKH22V)"BBBF`4444`4-0T73-54K?6,$^?X
MF0;OSZUP^L_"BUF#2Z/=-`_:&8[E/T/4?K7H]%1*G&6Z'<^<=7T'4]"G\K4+
M5XLGY7ZJWT/0U1@GEMIDF@E>*5#E70X(/UKZ5NK2WOK9[>Z@CFA<89'7(->6
M^*_AI):A[W0PTL(Y>U/++_NGN/;K]:XZF'<=8E*1>\)?$I9C'8ZZRI(<*EWT
M!_W_`$^M>E`A@"""#R"*^82"K%6!!'!![5W7@CQY)I$D>G:G(TFGDX20\F'_
M`!7V[55'$?9F#CV/9:*;'(DL:R1L'1@"K*<@CU%.KM("BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHKC_B!XH.@Z3]FMGQ?70*H1U1>[?T'_P!:IE)15V!R_P`1?&1N99-$
MTZ7]PAQ<R*?OM_<'L._K7G**SNJ(I9F.``,DFD)).3UKU;X<^#A!%'KFH19F
M<9MHV'W!_?(]3VKSDI5IFFR+7@?P%'IB1ZGJL8>^/S1PMR(?<_[7\J[^BBO1
MA!05D9MW"BBBJ`****`"BBB@`HHHH`****`"BBB@#A/&W@*/6%?4=,18[\#+
MQ@8$_P#@WOWKQQT:-V1U*NIPRD8(-?3U>=?$7P<+R"36]/B_TF,9N(U'^L4?
MQ?4?J*Y*]&_O1*BS(^'?C)K*:/1=1ES;2'%O(Q_U;'^$^Q_0UZY7S!TKVOX>
M>*#K>EFRNGS?6H`)/61.S?7L?P]:6&JW]QA)=3M****["0HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@".>>.VMY)Y6"QQJ79CV`&37SQXBUF77]<N+^0G:[8C4_P`*#H/\]Z]0^*.L
MFQT&/3XFQ+>MAL'_`)9KR?S.!^=>-@%B`!DG@"N'%3N^5%Q1U7@/PU_PD&M!
MYTS8VN'EST8]E_'^0KW0````8`Z`5A^$=#70/#UO:E0)V'F3G')<]1^'3\*W
M:Z*-/DCYDMW"BBBMA!1110`4444`%%%%`!1110`4444`%%%%`!2$`C!Z4M%`
M'AOC_P`,C0=9\ZW3%E=Y>,#HC=U_J/8UAZ!K$VA:U;:A"3^[;YU_O(>H_*O<
M_%FB+K_AZXL\#S@/,A/HXZ?GR/QKY\961V1@0RG!![&O.K0]G.Z+3NCZ9MKB
M*[M8KF!P\4J!T8=P1D5+7`_"S63>:++IDK9DLVRF3UC;_`Y_,5WU=T)<\5(A
MJP44458!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110
M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%
M%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`444
M4`%%%%`!1110`445'<3+;VTLS?=C0N<^@&:`/#OB)J9U'Q?<H&S%:@0*/<?>
M_4G\J9X`TD:KXLM@Z[H;;]^_''R]/UQ7.74[75W-<.26E<N<^I.:]3^$FGA+
M"_U!E^:200J?91D_S'Y5YM/]Y5NRWHCTBBBBO2("BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`*\)^(6DC2_%EPT:[8;H"=/3)^\/S!_.O=J\Z^+
M5@)-+LK]5^:&4QL?9AG^8K#$1O"_8<=SC/A_J9TWQ?:9;$=P3`_/][I^N*]X
MKYCAE:">.9#AXV#*1V(.:^EK2X6[LH+E>%EC60?0C-9X26CB.1-111762%%%
M59M3L+:4Q3WUM%(.J22JI'X$T7L!:HJDNL:8S!5U*S+$X`$ZY/ZU=I)I@%%%
M%,`HHJG)JVFPR-'+J%JCJ<,K3*"#[C-%[`7**@M[VUO-QMKF&?;][RG#8^N*
MGH`****`"BBB@`HHJK=:E8V7_'U>00GTDD"G]:+V`M45AOXQ\.QMAM8M<^SY
M_E0GC'P[(<+K%KGW?'\ZGGCW"QN455MM2L+P@6U[;S$]HY0Q_2K55>X!1110
M`4444`%%%5+G5-/LB1=7UO"1VDE`/Y4-V`MT5A-XR\.(V#K%KGV;-*GC'P[(
M<+K%KGW?'\ZGGCW"QN455M=2L;W_`(];RWF/I'(&/Z5:JD[@%%%%`!1110`4
M4A(4%F(`'))[52_MK2O^@G9_]_U_QI72`O45%!<0747F6\T<L9XW1L&'YBI:
M8!1110`4444`%%5+G5-/LI!'=7MO`Y&0LDH4D>N#4/\`PD&C?]!6R_[_`*_X
MTN9`:-%-21)45XW5T895E.013J8!1110`4453?5]-C=DDU&T5U."K3*"#^=)
MNP%RBJD.J:?<2K%#?6TDC=$296)_`&K=.]P"BFO(D4;22.J(HRS,<`#ZU3_M
MK2O^@G9?]_U_QI72`O451_MK2O\`H)V?_?\`7_&C^VM*_P"@G9_]_P!?\:.9
M`7J*H_VUI7_03L_^_P"O^-']M:5_T$[/_O\`K_C1S("]15'^VM*_Z"=G_P!_
MU_QH_MK2O^@G9?\`?]?\:.9`7J*:CI*BO&RNC#(93D$4ZF`445!=7MK91A[J
MYB@0G`:5PH)].:`)Z*SUU[2&8*NJ61).`!.O/ZUH4DT]@"BBBF`4444`%%%1
M3W5O:INN)XH5]9'"C]:`):*Q9?%WAZ%MKZO:9]I,_P`J8OC/PXQP-8M?Q;%3
MSQ[A8W:*H6^MZ5=X%OJ-I(3T"S+G\LU?III[`%%%%,`HHHH`**KW5_9V*[KJ
MZA@';S9`N?SK'E\;^&X<[M6@)'9,M_(5+DENP.@HKF1X_P##)./[37_OVW^%
M6HO&7AV<@)J]MD_WFV_SI>TCW'8W**@M[VUNUW6US#,/6-PW\JGJQ!1110`4
M444`%%%%`!6+XNN/LWA'59`<'[.R@^YX_K6U7,?$(E?`NI$'M&/_`"(M1-VB
MQK<\&KWCX>6WV;P58\<R;I#[Y8_TQ7@]?0WA%0OA'2@.GV9/Y5QX5>\RI&U1
M117>0%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`5S/C^V%SX*U`
M8RT861?;##^F:Z:LGQ0GF>%-67&2;27`]]IJ9J\6@1\ZU]!^#)S<^#]+<MDB
M$*?P./Z5\^5[K\.'W^";/DG#2#G_`'C7%A7[[+EL=71117>0%?/OC3_D<M5_
MZ[FOH*OGSQI_R.6J_P#7<URXOX45'<PJ]-\!^/?+\K1]8E^3A;>X<]/16/IZ
M&N7\(>'HO$LNH63-Y=PMOYD$G8,&`P?8YK"O;*XTZ\EM+N)HIXFVLI[5RP<J
M=IHIZZ'TQ17EG@/Q[Y?E:/K$OR<+;W#GIZ*Q]/0UZG7HTZBFKHAJP5\VZT`N
MNZ@!T%S)_P"A&OI*OG#7T\OQ%J2YSBYD_P#0C7/B]D.)V_PB_P"0CJ?_`%Q3
M^9KUBO)_A#_R$M3_`.N*?S->L5IAOX:%+<****W$%<IXG\=Z;X>+6Z?Z5?`?
MZE#PO^\>WTZU#X_\5/X?TY+:T?%]<@[6_P">:]V^O8?_`%J\2=VD=G=BS,<E
MB<DFN6O7Y?=CN4E<Z/5O'6OZPS*;QK>)N!%;?(/SZG\Z--\#^(M8`E6S:.-N
M?-N6V9_/D_E7?^`_!5MIUC#JE_"LE]*H=%<9$*GI@?WO?M7>5,*#G[U1@W;8
M\CA^$>I,O[[4K5#Z(K-_A3+CX2ZL@S;WUG+[-N0_R->OT5K]6IBYF>!W7@;Q
M+8R`?V;+)SPT!#_RKT[P1H>M:7:>;J^HSN77Y+1GWB/ZD]_8<5UU%$*$8.Z!
MNX4445N(*YCQ5XUL?#*>21]HOF&5@4XVCU8]A^M7_$^MKX?T"YO\`R*-L2G^
M)ST_Q_"OGRYN9KRYDN;B1I)I6+.['))-<U>MR:+<I*YO:OXVU[67827CP0L>
M(;<E%^G')_&GZ9X$\1:LHE6T,,;<B2Y;9G\.OZ5U'PP\,P3QOKEW$)"KE+=6
M&0".K?7L/QKU*LZ=%U%S38-VV/)(OA'J)7][J=JA]%1F_P`*;-\(]34'R=1M
M'/HZLO\`0UZ[16WU:GV%S,\`U3P;K^AJ9I[1C$O/G0-N`]^.1^-2Z1X[U[2&
M4"[:YA'_`"RN#O&/8]1^=>]$9&#7C_Q*\*PZ7/'JMC&([>X?;+&HX1^N1Z`\
M_C]:QJ4737-!E)WW.[\+^--/\2H(E_T>]`RUNYZ^ZGN/UKI:^9+>XFM+B.XM
MY&CFC8,CJ<$&OH'PKK8\0>'[>^8`38V3`=G'7\^OXUI0K<^CW$U8VJ***Z23
M*\3_`/(K:K_UZR?^@FOG2OHOQ/\`\BMJO_7K)_Z":^=*X<7\2+B>R_"G_D5Y
M_P#KY;^0KNZX3X4_\BO/_P!?+?R%=W731_AHE[A1116H@HHHH`Y[Q7X3M?$]
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MY"RZE(OS-U$0_NK_`%-<*4J\KO8K9$?@GP3%X?@6\O%634G7D]1"#V'OZFNR
MHHKOC%15D09/B;3)M8\.WMA;NJS3)A2QXR"#@_E7E'_"K_$?]RU_[_?_`%J]
MMHJ*E&,W=C3L>)?\*O\`$?\`<M?^_P!_]:L[6_!6L:!8B\O8X?)+A"8Y-V">
MG%>_5QGQ0_Y$YO\`KXC_`*UC4P\(Q;0U)GB5=78_#O7]0L8;R&.`13('3?+@
MX/3BN4KZ+\,_\BOI7_7K'_Z"*PH4U-M,J3L>3_\`"K_$?]RU_P"_W_UJ4?"_
MQ&2!MM1[^=_]:O;**ZOJL">9E+2+`:7I%I8A@WD1*A8=R!R:NT45NE96)"O,
M_B__`,>^D_[\O\EKTRO,_B__`,>^D_[\O\EK+$?PV-;GE@ZBOIFT_P"/.#_K
MFO\`*OF4=17TU:?\>4'_`%S7^5883J5(FHHHKM("L7Q!XGTWPW;B2\E)E8?N
MX$Y=_P`.P]S3_$VNQ>'=$FOW`9Q\D2$_?<]!_7\*^?[^_N=3O9;R\E:6>0Y9
MC_(>@KGK5N31;E)7.IUGXDZWJ3,EJXL8#T$7WR/=O\,5DZ?X>\0>)'\Z"VN+
M@,>9YFPI_P"!-UKIOAWX-AU4'5]2CWVR-MAA8<2,.I/J!Z>M>N*BH@5%"J!@
M`#`%90I2J+FFP;ML>0V_PFU>0`W%]9Q9[+N<C]!4DOPCU%5_<ZG:NWHZLO\`
MC7KE%;?5J8N9GA-[\//$EB"PLA.H[P.&_3K^E=9X#\->(K687-]>W5E:*>+4
MMDR?53PH_6O2J*(X>,970^8****W)(YYXK:"2>9Q'%&I9V;H`.]>0>)?B5?W
M\TEOI#M:6@.!*/\`6./7/\/X<UZ%XXM+N^\(WT%D"TI4$JO5E!!('X5X"002
M",$5QXFI*+Y45%&CI^F:KXBOFCM8IKN<\NS-G'NS'I^-=A:?"74Y%!NK^U@)
M[(&<C^56?AKXFTG3;*;3KV1+::27S%F?A7&`,$]L8[^M>I12QS('BD5T/1E.
M12HT82C=Z@VSRX_""?!VZS&3[VY'_LU9EW\*]>@R;>6TN1V"N5;]1C]:]GHK
M9X:FQ<S/GFZ\-^(-)??+I]W$5/$D8)'YK7IWP_M?$GV;[5J]]/\`96&(K><;
MG/\`M$GD#VKN**(4%"5TP;N%%%%;B"BBB@`HHHH`*YCXA`MX%U(`=HS_`.1%
MKIZQ/%]N;GPCJD0&3]G9@/<<_P!*B:O%C6Y\]5]#>$6#>$=*(Z?9D_E7SS7O
M'P\N?M/@JQYYCW1GVPQ_IBN/"OWF5(ZBBBBN\@****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`K)\4/Y?A35FSC%I)@^^TUK5S/Q`N1;>"M0.<-(%
MC7WRPS^F:F;M%L$>"U[K\.$V>";/@C+2'G_>->%5]!^#(#;>#]+0K@F$,?Q.
M?ZUQ85>^RY;&[1117>0%?/GC3_D<M5_Z[FOH.OGSQI_R.6J_]=S7+B_A14=S
M<^%3X\52+G&ZV;CUY%=WXU\'1>)+/S[<*FHPC]VYX$@_NM_0]J\_^%[8\8J/
M6!Q_*O;**$5*E9@]&?,EQ;S6EQ);W$;131MM=&&"IKT3P'X\^S&/2-7E_<\+
M!<.?N?[+'T]#V^G3J?&G@J'Q';FYM@L6I1CY7/`D']UOZ&O$[JUGLKJ2VN8F
MBFC;:Z,,$&L)1E0E=#T9]-`YKYT\3*4\4:HK=1<R?S-=W\/_`!S_`*K1=5E_
MV;:=S^2,?Y'\*XSQG$8O&.JJ1C,Y;\^?ZU=>:G!20)69U?PA_P"0EJ?_`%Q3
M^9KUBO)_A#_R$M3_`.N*?S->L5OAOX:)EN%%%%;B/"?B+=/<^-+P,3MA"1(/
M0``_S)/XU@Z5`MUK%E;O]R6XC1OH6`KJOB?ICV?B@WFT^3>1A@W;<!@C]`?Q
MKD+*X-G?6]RHR89%D`^A!KRZFE1W[FBV/ID#`P.E%06EU#?6<-U;N'AE0.C#
MN#4]>H9A1110`4444`%%%%`'G/Q<F9=*TZ$$[7F9C^`_^O7DM>S_`!2TY[OP
MU'=1@DVDP9@/[IX)_/%>,5YV)7[PTCL>^>`D6/P5INT8W(S'Z[C725Q7PPU!
M+OPH+;=^\M9&1A['D']3^5=K7=2=X(A[A1115B"N7^(<*S>"KXM_RSV./J&%
M=17)?$>[2V\&72,1NG9(U![G.?Y`U%3X&-;GAE>L_"*8G3=1A.<+*K#\1_\`
M6KR:O8/A-:-%H-W<L,":?"GU"C_$FN##?Q$7+8]`HHHKTC,RO$__`"*VJ_\`
M7K)_Z":^=*^B_$__`"*VJ_\`7K)_Z":^=*X<7\2+B>R_"G_D5Y_^OEOY"N[K
MA/A3_P`BO/\`]?+?R%=W731_AHE[A1116H@HHHH`****`,#Q3X6M/$UAY<F(
M[J,'R9P.5/H?4>U>%:GIEWH]_)97L1CFC/([$=B#W%?2E<;\2=*M;SPO/>R1
MC[3:X:.0#D`L`1].:YJ]%27,MRDSS'3_`!CJVFZ#<:1!+B&7[KG.Z('J%/;-
M8MK;3WMU';6T32S2-M1%&234->N?"G2K5=)GU0QAKIY3$'(Y50!P/KFN2G%U
M)*+93T-?P;X+@\.6XN+@++J4B_/)U$8_NK_4]ZZVBBO2C%15D9A1115`%%%%
M`!7&?%#_`)$YO^OB/^M=G7&?%#_D3F_Z^(_ZUG5^!C6YXE7T7X9_Y%?2O^O6
M/_T$5\Z5]%^&?^17TK_KUC_]!%<N$^)E2-6BBBNX@****`"O,_B__P`>^D_[
M\O\`):],KS/XO_\`'OI/^_+_`"6L<1_#8UN>5CJ*^FK3_CR@_P"N:_RKYE'4
M5]-6G_'E!_US7^5883J5(FHHHKM(/*OB[=.;K3;3/[L(\N/4D@?T_6O-*]7^
M+6F22V=EJ<:DK"QBD]@W(/Y@C\17E%>9B$_:.YI'8^B/"D"6_A/2XT&!]F1C
M]2,G]2:V*YSP-J46I>$K%D8%X(Q#(O<,O'ZC!_&NCKT8-.*L9L****H`HHHH
M`****`"N2\2>`-+UYGN(O]#O3R98Q\KG_:7O]:ZVBIE%25F!X+K/@/7='+,;
M4W4`_P"6MO\`,,>XZC\JPX+R^T]_W%Q<6[`_P.5KZ6J">QM+K_CXM89?^ND8
M;^=<TL*KWBRN8\(M?'7B6TQLU69QZ2@/_P"A`UMV?Q7UF%@+NVM;A>^`48_B
M#C]*]$NO!7AR[!\S28%)[Q@H?TQ7-ZI\)]/F1GTR[EMY.R2_.A_J/UJ?95H[
M,+HLZ;\4]&NB%O8I[-C_`!$;U_,<_I796=]:ZA;K<6=Q'/$>CQL"*^=-5TN[
MT;49;&]CV31GG!R".Q![BM#PIXAN?#^LPS1.QMY&"SQ9X=?\1VHAB9)VF-Q[
M'T'12`A@".AYI:[2`HHHH`****`"HKB$7%M+"WW9$*'/N,5+10!\R7,#6UU-
M`X^:)RA^H.*]3^$FH!["_P!/9OFCD$RCV88/\A^=<E\1-,.G>+[E@N([H"=/
MQ^]^H-,\`:L-*\66Q=ML-S^X?GCYNGZXKS:?[NK9EO5'O%%%%>D0%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`5YS\6K_R]+L;!6YFE,K#V48'Z
MFO1J\)^(6K#5?%EP$;,-J/(3G@X^\?SS^588B5H6[CCN<S#$T\\<*#+R,%4#
MN2<5]+6ENMI906R\K%&L8^@&*\-^'^F'4O%]IE<QVY,[\?W>GZXKWBL\)'1R
M'(****ZR0KY\\:?\CEJO_7<U]!UY-XF^'VN:CXCO;VU2!X9Y-ZDR[3R.F#7-
MB8N459%1,CX9MCQI`/6*0?I7N%>8>#/`VMZ+XDAOKQ8$AC1@VV3<3D8Q7I]5
MAXN,+,4MPKE/&7@V#Q):^?`%BU&-?W<G0./[K?T/:NKHK645)68CYENK6>QN
MI+:YB:*>)MKHW!!IU[>W&H7'VBZD,DNU5+GJ0!@9]\"O;_%_@RV\2V_FQ[8=
M008CF/1A_=;V]^U>='X8^),G]U;G_ML*\^="<79:HM-&M\(?^0EJ?_7%/YFO
M6*X/X?>$]3\.W-[-J`B42HJH$?<>"37>5V4$U!)DO<****V$9'B/P_;>(])>
MRG^5Q\T4N,F-O7_$5X3K>@ZAH%Z;:^A*_P!R0<HX]0:^C:KWMA::E;-;7EO'
M/"W5'&1_^NL*M%5->HT['B?A/QS>>&R+>13<V!.3$3RGNI_I7JNE^,]!U9%,
M-_''(?\`EE.=C#\^OX5S>J_"C3[AFDTV[DM6/(CD&]/\1^M<O=?"_P`0P,?)
M%M<+ZI+C_P!"Q6,?;4]+70]&>U*RNH*L"#T(.:"0!DD`>]>$#P9XMM3B*PN%
MS_SSE']#4R^!?%UX`);:3'_3:<?XUI[>7\C"QZY?^)M$TU2;K4K=6'\"ON;\
MAS4NCZYI^NVIN-/N%E0'#+T93[CJ*\PM/A-JTI!NKVU@4]=N78?AP/UKL?#?
M@"T\.WJWJ7]S-.`00"$1A[@=?SJH3JMZQT%9'7T445N(CG@BNK>2"=`\4BE7
M5NA!ZBO#?%_@R[\.73S1(TNG.W[N4#.S_9;T/OWKW:FR1I-&T<J*Z,,,K#((
M]"*RJTE46HT['SYX7\27'AG51=1+YD+C;-%G&]?\1VKVO2?%FBZS&K6M]&)"
M.89"%<'TP>OX5SNM?"[2[YVFT^9[&0\[`-T?Y=1^=<A=_"_Q#;L?)%M<KZQR
MX_\`0L5SQ56EI:Z'HSVNBO"U\)^,K3Y(;6\0?],IP!^AI6\,>-9_DDM[]E/9
MY^/_`$*M/;R_E86/7]4\1:3H\;-?7T,;#_EF&RY^BCFO&?&7BR3Q/?KY:M%9
M09$4;'DGNQ]_Y5<MOAEXDN''F100`_Q23`_RR:ZC2/A/:0,LFJWC7)'/E1#8
MOXGJ?TJ)^UJZ6L@5D>?>'?#5]XDOU@M4*Q`CS9R/EC']3[5[YIFG6^DZ;!8V
MJ[885VCU/J3[D\U)9V5MI]LEM:0)#"GW408`J>MJ5%4UYB;N%%%%;",KQ/\`
M\BMJO_7K)_Z":^=*^DM8LY-0T6]LXBHDGA>-2W0$C'->/?\`"L?$G_/&W_[_
M``KCQ,)2:LBHLZOX7ZC96_AV>*>[@BD%P3MDD"G!`YYKN/[7TW_H(VG_`'^7
M_&O'/^%8^)/^>-O_`-_A1_PK'Q)_SQM_^_PHA4J1BER@TCV/^U]-_P"@C:?]
M_E_QH_M?3?\`H(VG_?Y?\:\<_P"%8^)/^>-O_P!_A1_PK'Q)_P`\;?\`[_"J
M]M4_E"R/:8+NVNMWV>XBFV_>\MPV/KBIJXGX?^$KSPXEY/J'EB>?:JJC;MJC
M/7ZD_I7;5T0;<;M6)844450!7-^/O^1)U+_<7_T(5TE8_BC3)]8\-WMA;%1-
M*@V;S@$@@X_2IFKQ:0(^=Z]I^%?_`"*3_P#7R_\`):X?_A6/B7_GC;_]_A7I
M7@?0[OP_X>^R7NP3-*TA"-D`'`Z_A7'AZ<HSNT7)Z'2T445W$!1110`4444`
M%<9\4/\`D3F_Z^(_ZUV=<YXVT6[U[PX]E9;#-YJN`[8!`]_QJ*J;@TAK<\"K
MZ+\,_P#(KZ5_UZQ_^@BO)?\`A6/B3_GC;_\`?X5[#H]I)8:+96DI4R0P)&VT
M\9``.*YL-"46[H<F7J***["0HHHH`*\S^+__`![Z3_OR_P`EKTRN+^(/AG4/
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M(VM:W.#_`,])P!^IK3V\_P"1A;S/9KW6=,TY2;R_MH<=GD`/Y=:J:1XJT;7+
MF6WL+P22Q\[6!4L/49ZBO,K3X5Z[.0;B6TMQWRY8_H/ZUTND_"RVL;B*YN-4
MN'FC8,OD`1X/UY--3JM_#H%D>@T445T$E#6-9L]"T][V^DV1KP`.68^@'<US
MEE\3O#UU@2R3VK'_`)ZQY'YKFK_B?P=:>*#&]Q=7,3Q*0FQ@5'OM-<+>?"34
MHV)L]0MIE["12A_J*YZDJJ?NK0:L>E6GB/1;X`V^J6CYZ#S0#^1YK25E8`JP
M(/0@UX7/\.?$T.<6*R#UCE4_UJNGA'Q7;G]WIMXA_P!AO\#4^WFMXCLCWVL;
M5?%6BZ-&QN[Z+>/^649WN?P']:\>/A/Q=<?*]A>L/21^/U-6[;X9^)+AAYD$
M$"G^*64?R&30Z\W\,0LC'\4:ZWB+79K_`,KRD("1IW"CIGWJ?PCX<N?$.L1(
MB$6L3!IY<<*/3ZFNYTGX36L++)JMZUP1R8H1M7\2>3^E=]8V%KIMJMM9P)!"
MO1$&!_\`7-1##RE+FF-R[%@```#H*6BBNT@****`"BBB@`HHHH`X/XI:,;W0
MH]1B7,MFWS8_N-P?R./UKQP$J00<$<@U]-W$$=U;RV\RAXI5*.I[@C!%?._B
M'1I=!UNXL)02$;,;'^)#T-<.*A9\R+BSV_PCKBZ_X>M[HL#.H\N<9Y#CJ?QZ
M_C6[7A7@/Q+_`,(_K02=\6-UA)<]%/9OP_D:]T!!`(.0>A%=%&ISQ\R6K"T4
M45L(****`"BBB@`HHHH`****`"BBB@`HHHH`***0D`$DX`H`Q?%FMIH'AZYO
M-P$Q'EPCU<]/RZ_A7SVS%V+,26)R2>YKK/'WB;^W]:\JW?-C:DI'Z.W=O\/8
M5B:!H\VNZU;:?"#^\;YV_NH.I_*O.K3]I.R+6B/3_A9HQL]&FU.5<27;83(Z
M(O\`B<_D*[^HK:WBM+6*V@0)%$@1%'8`8%2UW0CR142&[A1115@%%%%`!111
M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
M0`5QWQ!\+G7=)%U:IF^M02@'61.Z_P!1_P#7KL:*F45)68'S`1@X->K_``Y\
M8BXBCT/4)<3(,6TC'[X_N'W':L[XB^#3:RR:WIT7[ASFYC4?</\`>'L>_I7G
M2,T;AT8JRG((."#7G)RHS--T?3U%<!X'\>QZHD>FZK*$OA\L<K<";V/^U_.N
M_KT834U=&;5@HHHJ@"BBB@`HHHH`****`"BBB@`HHHH`*\Y^(WC$6L+Z)I\O
M^D2#%S(I_P!6O]T>Y[^@^M6?''CR/28Y--TN17OR,22+R(?\6_E7CSNTCL[L
M6=CEF8Y)/K7)7KV]V)20VO;/AYX7.B:5]MNDQ?78!(/6-.R_7N?P]*Y?X=^#
M#>S1ZUJ,7^C1G-O&P_UC#^(^P_4UZY2PU*WOL)/H%%%%=A(4444`%%%>#7,E
MQJ'CJ6SFO[B**:^,;.)"-JE\<=JRJ5.2VFXTKGO-%<6/AWIL>2-:U=?4_:E'
M_LM<CXGM_P#A&ECFTGQ;<3S;]IMS<;F7WX./S%*5245=K\0L>Q45R?@'5=9U
M;16GU:,%0V()R-K2KW)'MZ]ZZRM(RYE=""BBBJ`***S?$,CQ>'-2>-BKK;.0
MRG!!VFDW97`TJ*\C^%5W<S>(+N.6XE=/LQ.UG)&=R_XUZY44Y\\>8;5@HHHK
M004444`%%>>^.?'L^CW;:7I847*J#+,PSY>>0`/7'K3=(\%ZAK5E%?Z_K=^S
MS*'$$4F-H/3)/\@*R]K>7+%7'8]#WK_>'YTM<@?AOHI7"SZ@I[,+@Y'Z5S?B
M'1]>\&0#4=)UNZFLU8!XYFW%,],@\$?@*)3E%7:"QZG17(^"/&/_``DT$L%S
M&L=]``6"?==?[P';GJ*ZZKC)25T(****H`HHKF=7\$V6L:C)>S:AJ43N`"D,
MX"C`QP"#BE)M;(#IJ*\F\;^%8O#>C17MEJ>HN[3B)EFFR,%6/8#TI/!'A:/Q
M)I,UY>ZGJ*,LQC589L#``/.0?6L?:RYN2VOJ.QZU17*:?X"L-.U"&\34=4E:
M%@ZI)<#:3[X`KJZUBV]T(****H`HHKGO',\MOX,U*6"1XY`B@,AP1EU!Y^AI
M2=DV!T-%>+>!M.;Q+>745]K%_$L*!E$5Q@MD^^>/\:[;_A`-/_Z#NL_^!8_^
M)K*%24U=(;1V=%<[H_A"UTB_6]BU+4KEE4@+/<;DYXS@`9KHJUBVUJ(****8
M!1110`4=*\N\3?$BZ>^?3=`50`_E_:2-Q=LX^4=,>]:MGX!O+V-9M?UV^FF8
M9:*&4A5]LG.?P`K'VO,[05QV[G=[E)P&'YTM<<_PWT9E_=W.HQ-V9;CG]16I
MH'AH:$7(U._N]PP%GERJ_0>M6G*^J`W:***L04444`%%%<I\1IY8/!MR\,KQ
ML7C!*-@XW#BIE+EBV!U=%>;_``HOI)K74HI[IG*NC*LCY(R#DC->C>8G]]?S
MI0GSQYAM6'45Y[\5;YX=(L8X+HH[SDE4?!(`]NV:TOAI/+/X01II7D83.`7;
M)`XXI*I>?(%M+G84445H(****`"BBB@`HHHH`****`"BBN,^)T\T'A0&&5XR
M;A`2C$9&#4SERQ;!'9T5P/PIN)I]"O?.FDDVW.!O8G'RCUKOJ(2YHJ0,****
MH`HHHH`**\,\77%[/X\O;6.\E3=.L:?O"`N0`/H.:W-"\::EX8U!M&\2I*\:
M'`E;YGC]\_Q+7.L0N:S17*>KT5%;W$-W;I<6\J2PR#<CH<@BO%A?W@^)P47<
M^/[1V8WG&W?C&/3'%:5*G);S$E<]NHHHK004444`%%9/B'7[7PYI3WMSEN=L
M<:]7;TKSS3-5\4>/=2FA@O\`^SK*(`R>2"-H/09ZD\'N.AK.=51?+NQV/6"P
M'4@4`@]"#7'1?#?3=N;K4-2N9>[M/C^E-?X<622![35M4MN>0L^?Z4<T^WXA
MH=I14%I;BTM([<2RR[!C?*^YF]R:GK004444`%%%%`!1110`4444`(RJZ,CJ
M&5A@@C((KQ[QOX"DTII-2TJ,O8D[I(AR8??W7^5>Q4A`(((R#6=2FIJS&G8^
M802""#@BO0_"GQ*ELE2RUO=-`.%N1RZ#_:_O#]?K6IXM^&J71DOM#58Y3\SV
MO16_W?0^W3Z5Y9<6\UI.\%Q$\4J'#(ZX(/TK@:G1D7HSZ4L[RVU"V2YM)TFA
M<?*Z'(-3U\X:1KNI:'<>=I]T\1/WEZJWU'0UZ/HOQ7MI0L6L6K0O_P`]H/F4
M_5>H_#-=4,3&7Q:$N)Z116?I^N:7JJAK&^@FS_"KC=^76M"NA-/8D****8!1
M110`45GZAK>F:4I-]?008_A9QN_+K7#ZU\5[:(-%H]JTS]/.F^51]%ZG\<5$
MJD8;L:5ST&[O+:PMGN+N>.&%!EG=L`5Y9XK^)<MV)++1"T,)RKW)X=O]W^Z/
M?K]*XO5]=U+7;CSM0NGE(^ZG15^@Z"J,$$US.D,$3RRN<*B#))^E<=3$.6D2
ME$82222<D]2:[KP1X#DU=X]1U.-H]/!RD9X,W^"^_>MKPE\-5@,=]KJJ\@^9
M+3J%_P!\]_I7I0`4````<`"JHX?[4P<NPD<:11K'&H1%`"JHP`/04ZBBNT@*
M***`"BBB@`KP"6SBU#Q])9SL5BFU`HY4X(!>O?ZXV]^&NB7M]-=O)=(\SEV"
MR#`).>.*PKTW.UAIV'-\-?#S##+=D>AG-<_XE\$:%X?TU]0@U&6UG3)A64B0
M2-_=`QG_``K<_P"%9Z3_`,_FH?\`?[_ZU*GPQ\/AMTINYCG^.;_`5+IW6D4.
MYB_#[QCJVI:J-*O1]IB,999@N#'@=\<8[?E7IM4-,T;3M&A,6GVD<"G[Q4<M
M]3U-7ZUIQE&-I.XF%%%%:""LOQ)_R+.I_P#7M)_Z":U*AN[6.]LYK68$Q3(4
M;!P<$8I-75@/(_A-_P`C)=?]>I_]"6O8JYWP_P"#-,\-W<MS9M.TLB;"9'!P
M,Y[#V%=%6=&#A"S&W<****U$%%%%`'B/Q'T6ZL/$L]\T;-:W9#I)C(!P`5/O
MQ^5>I>%=;L]:T.VDMY5,L<:I+%GYD8#!R/3WK7N+>"[@:"XB26)QAD=0P/X&
MN5N?AOH,LQFMEN;.3L;>4C'TSFL%3E"3E'J.]SKZXKXEZQ;V?AJ6Q\R,W-TR
MJ(\@D+G);';I^M2?\(`I&T^(=:,?]S[3Q_*I+/X<^'[:;SI89KN3J3<2%@3]
M!C-.7/)62L&ARGPFTRY_M&[U1HRMMY)A5B.&8L"<?3;^M>L4R**.")8HHUCC
M485$&`!["GU5.')'E!NX4445H(****`.%^*__(J0?]?B?^@/3?A/_P`BQ<?]
M?3?^@K74:]H-GXBT\65[Y@C#B0&-L$,,C^1-)H.@6?AVP:SLC(8V<R,9&R23
M@?TK'D?M>?H.^EC5HHHK804444`%<UX__P"1'U/_`'4_]#6NEJGJNF6^L:9/
M876[R9@`VTX/!!&/Q%3-7BT"/'/A_P"&].\17MY'J!D(AC5D1'VYR>M=[_PK
M'PW_`,\KG_O\:B3X6Z)&<I<7RGU$H']*?_PK/2?^?S4/^_W_`-:N>%)Q5G%,
MILZ71](M-#T];&R#B%26`=RQR:OURFG^`-,TZ_AO(KJ_:2%MRAIN"??`KJZZ
M(7MJK$A1115`%-D3S(V0DC<",CM3J*`/`&LY_"/B^W.I6Y9+><2=.)$!^\/6
MO<]-U6PU:V$]A=1SH1GY6Y'U'4?C3K_3;+5+<P7UK%<1^DBYQ]/3\*YB;X::
M$TADMFN[1_6&8\?GFN>%.5-OEU0V[G8TT.C,RJREE^\`>1]:Y`?#VU/$NL:O
M(G=6N>#^E:NB^$M)T"=Y[&*03.NUG>4L2/Y5JG)O5!H;E%%%6(****`"N0^)
MG_(E7'_76/\`]"%=?6?K6CVNNZ9)87>_RG(.4.""#D5$US1:0T>5_#SPMI?B
M&&^DU&.20Q,BH%<J!G.>E=M_PK3PS_SZ3?\`?]O\:U/#WAFP\-0S1V1E/G,&
M=I&R>.E;59TZ,5%*2U!L\@^(7A/2O#^GV=QIT<D;R2E'#2%@1C/>NL^%_P#R
M)R_]?$G]*W/$'ARR\26D=O>F4+&^]3&V"#C%2Z)HMKH&FK8V>\Q!BV7.22:(
MTN6IS+8+Z&E1116X@HHHH`****`"BBB@`HHHH`*XCXJ?\BDO_7RG\C7;UF:[
MH=IX@TXV5YY@CW!P8VP0145(N46D-;G(?"/_`)`5_P#]?/\`[**]"K(\/^';
M+PW9R6UD9"LC[V,C9).,?TK7HI1<8),'N%%%%6(****`/"/%+;?B-=-Z7:'_
M`-!KUSQ'X7T_Q+:>5=+LF0?NIU'S)_B/:J&H^`-'U+67U.9K@3.X=E23"DC\
M/:NJ`P,5A3I-.7-LQMGC5M=Z]\-]4%O=(9]-D;H#\CCU4_PM[?\`ZZS(KN"_
M^),%Y;,6AGU!)$)&#@L#R*]OO]/M=4LWM+V!9H''*L/U'H:YFR^&^AV&I0WL
M)N2\,@D1&DRH(Z=LUG*A*Z2>@[G7T445UDA1110!Q7Q+T6[U;08I;-&E>UD,
MC1J,EE(P2!WQ7.?#'Q!IVFI=:=>R);S32!TED.`W&-I/;']37K%86J^#M"UB
M1I;JP03-R98SL8_7'7\:PG3?/SQW&GI8W%974,I!4\@@Y!H9U12SL%4=23@"
MN-3X;Z?`<6NIZG;I_=CGP/Y5(/ASI,F/MEUJ%WC_`)[7!(J^:?;\0T.N!!`(
M.0:6J]C90:=916=JA2"(812Q.!]35BM$(****`"BBB@`HHHH`****`"BBB@`
MK'USPSI?B&'9?6X,@&$F3AU^A_H>*V**32:LP/%]=^&6K:<6ETXB_M^N%&)!
M_P`![_A^5<7-#+;RF*:-XY%ZJZD$?A7TY5'4-'T[58]E_90W`]77)'T/45RS
MPJ?PE*1\W*S(P9201T(-;-GXMU^P`$&K7(4=%=]X'X-FO2M0^%6C7!+6<]Q:
M,>BYWJ/SY_6N=NOA+JD9_P!%O[68?[89#_(UC[&K'8=T9T/Q.\21@!IK>3W>
M$?TQ4_\`PM3Q!_SSLO\`OT?\:JR_#7Q/&?ELXI?]R=/ZD5%_PKKQ5_T#!_X$
M1?\`Q5%Z_F&A9E^)WB24$++;Q^Z0C^N:Q[SQ;K]^"MQJUR5/54?8#^"XK4B^
M&OB>0C=9Q1?[\Z?T)K3M?A+JLA'VJ^M81_L;G/\`(4N6M+N&AY^S,[$L22>I
M)IT44D\BQQ1M([<!5&2?PKV#3_A3H]N0UY<7%T1_"#L7].?UKKM.T73=)CV6
M%E#`.Y1?F/U/4U<<+)_%H',>2:%\,]6U(K+?XL+<\G>,R$>R]OQKU'0O"^E>
M'HMME;CS2,/._+M^/8>PK9HKJIT8PV);N%%%%:B"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
=**`"BBB@`HHHH`****`"BBB@`HHHH`****`/_]D_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
